Conditions;ICD-10;ICD-11
Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency;E71.3;5C52.01
3-methylcrotonyl-CoA carboxylase deficiency;E71.1;5C50.E0
3-methylcrotonyl-CoA carboxylase deficiency;E71.1;5C50.E0
3C syndrome;Q87.8;
3C syndrome;Q87.8;
6-pyruvoyl-tetrahydropterin synthase deficiency;E70.1;5C59.01
Abetalipoproteinemia;E78.6;5C81.1
Achondroplasia;Q77.4;LD24.00
Blue cone monochromatism;H53.5;9B70
Blue cone monochromatism;H53.5;9B70
Fatal infantile lactic acidosis with methylmalonic aciduria;E71.1;5C53.20
3-hydroxy-3-methylglutaric aciduria;E71.1;5C50.E0
Succinic semialdehyde dehydrogenase deficiency;E72.8;5C50.E1
Argininosuccinic aciduria;E72.2;5C50.A0
Fumaric aciduria;E88.8;5C53.1
Glutaryl-CoA dehydrogenase deficiency;E72.3;5C50.E1
Mevalonic aciduria;E88.8;5C52.10
Hereditary orotic aciduria;E79.8;3A03.0
Oxoglutaric aciduria;E88.8;5C53.1
Isovaleric acidemia;E71.1;5C50.E0
Propionic acidemia;E71.1;5C50.E0
Propionic acidemia;E71.1;5C50.E0
Acrocallosal syndrome;Q04.0;LD2F.1Y
Acrocallosal syndrome;Q04.0;LD2F.1Y
Acrodermatitis enteropathica;E83.2;5C64.20
Acromesomelic dysplasia, Maroteaux type;Q77.8;LD24.9
Dyschromatosis symmetrica hereditaria;L81.8;EC23.Y
Medium chain acyl-CoA dehydrogenase deficiency;E71.3;5C52.01
Neonatal adrenoleukodystrophy;E71.3;5A74.Y
Neonatal adrenoleukodystrophy;E71.3;5A74.Y
Neonatal adrenoleukodystrophy;E71.3;5A74.Y
Neonatal adrenoleukodystrophy;E71.3;5A74.Y
Neonatal adrenoleukodystrophy;E71.3;5A74.Y
Neonatal adrenoleukodystrophy;E71.3;5A74.Y
Neonatal adrenoleukodystrophy;E71.3;5A74.Y
Neonatal adrenoleukodystrophy;E71.3;5A74.Y
Neonatal adrenoleukodystrophy;E71.3;5A74.Y
Neonatal adrenoleukodystrophy;E71.3;5A74.Y
Neonatal adrenoleukodystrophy;E71.3;5A74.Y
Neonatal adrenoleukodystrophy;E71.3;5A74.Y
Neonatal adrenoleukodystrophy;E71.3;5A74.Y
Adenosine monophosphate deaminase deficiency;G71.3;5C55.0Y
Adenosine monophosphate deaminase deficiency;G71.3;5C55.0Y
Adenylosuccinate lyase deficiency;E79.8;5C55.0Y
X-linked agammaglobulinemia;D80.0;4A01.00
Congenital bilateral absence of vas deferens;Q55.4;LB57
Congenital bilateral absence of vas deferens;Q55.4;LB57
Aicardi-Goutières syndrome;G31.8;5C55.2
Aicardi-Goutières syndrome;G31.8;5C55.2
Aicardi-Goutières syndrome;G31.8;5C55.2
Aicardi-Goutières syndrome;G31.8;5C55.2
Aicardi-Goutières syndrome;G31.8;5C55.2
Aicardi-Goutières syndrome;G31.8;5C55.2
Aicardi-Goutières syndrome;G31.8;5C55.2
Aicardi-Goutières syndrome;G31.8;5C55.2
Albers-Schönberg osteopetrosis;Q78.2;LD24.10
X-linked recessive ocular albinism;E70.3;9E1Y
X-linked recessive ocular albinism;E70.3;9E1Y
Alkaptonuria;E70.2;5C50.10
Glycogen storage disease due to aldolase A deficiency;E74.0;5C51.3
Allan-Herndon-Dudley syndrome;G31.8;5A00.0Y
Alpha-1-antitrypsin deficiency;E88.0;5C5A
Alpha-sarcoglycan-related limb-girdle muscular dystrophy R3;G71.0;8C70.41
Alström syndrome;E34.8;LD2H.Y
Leber congenital amaurosis;H35.5;9B70
Leber congenital amaurosis;H35.5;9B70
Leber congenital amaurosis;H35.5;9B70
Leber congenital amaurosis;H35.5;9B70
Leber congenital amaurosis;H35.5;9B70
Leber congenital amaurosis;H35.5;9B70
Leber congenital amaurosis;H35.5;9B70
Leber congenital amaurosis;H35.5;9B70
Leber congenital amaurosis;H35.5;9B70
Leber congenital amaurosis;H35.5;9B70
Leber congenital amaurosis;H35.5;9B70
Leber congenital amaurosis;H35.5;9B70
Leber congenital amaurosis;H35.5;9B70
Leber congenital amaurosis;H35.5;9B70
Leber congenital amaurosis;H35.5;9B70
Leber congenital amaurosis;H35.5;9B70
Leber congenital amaurosis;H35.5;9B70
Leber congenital amaurosis;H35.5;9B70
Leber congenital amaurosis;H35.5;9B70
Leber congenital amaurosis;H35.5;9B70
Leber congenital amaurosis;H35.5;9B70
Leber congenital amaurosis;H35.5;9B70
Chylomicron retention disease;E78.6;5C81.1
Congenital alpha2-antiplasmin deficiency;D68.8;3B50.0
Hereditary thrombophilia due to congenital antithrombin deficiency;D68.5;3B61.0Y
Fanconi anemia;D61.0;3A70.0
Fanconi anemia;D61.0;3A70.0
Fanconi anemia;D61.0;3A70.0
Fanconi anemia;D61.0;3A70.0
Fanconi anemia;D61.0;3A70.0
Fanconi anemia;D61.0;3A70.0
Fanconi anemia;D61.0;3A70.0
Fanconi anemia;D61.0;3A70.0
Fanconi anemia;D61.0;3A70.0
Fanconi anemia;D61.0;3A70.0
Fanconi anemia;D61.0;3A70.0
Fanconi anemia;D61.0;3A70.0
Fanconi anemia;D61.0;3A70.0
Fanconi anemia;D61.0;3A70.0
Fanconi anemia;D61.0;3A70.0
Fanconi anemia;D61.0;3A70.0
Fanconi anemia;D61.0;3A70.0
Fanconi anemia;D61.0;3A70.0
Fanconi anemia;D61.0;3A70.0
Fanconi anemia;D61.0;3A70.0
Fanconi anemia;D61.0;3A70.0
Fanconi anemia;D61.0;3A70.0
Familial abdominal aortic aneurysm;I71.4;BD50.4Z
Apert syndrome;Q87.0;LD24.G2
Idiopathic aplastic anemia;D61.3;3A70.12
Idiopathic aplastic anemia;D61.3;3A70.12
Idiopathic aplastic anemia;D61.3;3A70.12
Idiopathic aplastic anemia;D61.3;3A70.12
Argininemia;E72.2;5C50.A2
Aromatase deficiency;E25.8;5A9Y
Aspartylglucosaminuria;E77.1;5C56.21
Friedreich ataxia;G11.1;8A03.10
Ataxia with vitamin E deficiency;G11.1;8A03.10
Familial paroxysmal ataxia;G11.8;8A03.14
Autosomal recessive spastic ataxia of Charlevoix-Saguenay;G11.1;8A03.1Y
Ataxia-telangiectasia;G11.3;4A01.31
Dentatorubral pallidoluysian atrophy;G11.8;8A01.12
Leber hereditary optic neuropathy;H47.2;8C73.Y
Leber hereditary optic neuropathy;H47.2;8C73.Y
Leber hereditary optic neuropathy;H47.2;8C73.Y
Leber hereditary optic neuropathy;H47.2;8C73.Y
Leber hereditary optic neuropathy;H47.2;8C73.Y
Leber hereditary optic neuropathy;H47.2;8C73.Y
Leber hereditary optic neuropathy;H47.2;8C73.Y
Leber hereditary optic neuropathy;H47.2;8C73.Y
Leber hereditary optic neuropathy;H47.2;8C73.Y
Leber hereditary optic neuropathy;H47.2;8C73.Y
Leber hereditary optic neuropathy;H47.2;8C73.Y
Leber hereditary optic neuropathy;H47.2;8C73.Y
NON RARE IN EUROPE: Autism;F84.0;
NON RARE IN EUROPE: Autism;F84.0;
NON RARE IN EUROPE: Autism;F84.0;
NON RARE IN EUROPE: Autism;F84.0;
NON RARE IN EUROPE: Autism;F84.0;
NON RARE IN EUROPE: Autism;F84.0;
NON RARE IN EUROPE: Autism;F84.0;
NON RARE IN EUROPE: Autism;F84.0;
NON RARE IN EUROPE: Autism;F84.0;
NON RARE IN EUROPE: Autism;F84.0;
NON RARE IN EUROPE: Autism;F84.0;
NON RARE IN EUROPE: Autism;F84.0;
NON RARE IN EUROPE: Autism;F84.0;
NON RARE IN EUROPE: Autism;F84.0;
NON RARE IN EUROPE: Autism;F84.0;
NON RARE IN EUROPE: Autism;F84.0;
BOR syndrome;Q87.8;LD2F.1Y
BOR syndrome;Q87.8;LD2F.1Y
BOR syndrome;Q87.8;LD2F.1Y
Bannayan-Riley-Ruvalcaba syndrome;Q87.8;LD2D.Y
Bardet-Biedl syndrome;Q87.8;5A61.0
Bardet-Biedl syndrome;Q87.8;5A61.0
Bardet-Biedl syndrome;Q87.8;5A61.0
Bardet-Biedl syndrome;Q87.8;5A61.0
Bardet-Biedl syndrome;Q87.8;5A61.0
Bardet-Biedl syndrome;Q87.8;5A61.0
Bardet-Biedl syndrome;Q87.8;5A61.0
Bardet-Biedl syndrome;Q87.8;5A61.0
Bardet-Biedl syndrome;Q87.8;5A61.0
Bardet-Biedl syndrome;Q87.8;5A61.0
Bardet-Biedl syndrome;Q87.8;5A61.0
Bardet-Biedl syndrome;Q87.8;5A61.0
Bardet-Biedl syndrome;Q87.8;5A61.0
Bardet-Biedl syndrome;Q87.8;5A61.0
Bardet-Biedl syndrome;Q87.8;5A61.0
Bardet-Biedl syndrome;Q87.8;5A61.0
Bardet-Biedl syndrome;Q87.8;5A61.0
Bardet-Biedl syndrome;Q87.8;5A61.0
Bardet-Biedl syndrome;Q87.8;5A61.0
Bardet-Biedl syndrome;Q87.8;5A61.0
Bardet-Biedl syndrome;Q87.8;5A61.0
Bardet-Biedl syndrome;Q87.8;5A61.0
Bardet-Biedl syndrome;Q87.8;5A61.0
Bardet-Biedl syndrome;Q87.8;5A61.0
Bardet-Biedl syndrome;Q87.8;5A61.0
Barth syndrome;E71.1;5C50.E0
Congenital contractural arachnodactyly;Q68.8;LD28.00
Behçet disease;M35.2;4A62
Behçet disease;M35.2;4A62
Behçet disease;M35.2;4A62
Behçet disease;M35.2;4A62
Behçet disease;M35.2;4A62
Behçet disease;M35.2;4A62
Behçet disease;M35.2;4A62
Behçet disease;M35.2;4A62
Behçet disease;M35.2;4A62
Behçet disease;M35.2;4A62
Behçet disease;M35.2;4A62
Behçet disease;M35.2;4A62
Behçet disease;M35.2;4A62
Behçet disease;M35.2;4A62
Beta-mannosidosis;E77.1;5C56.21
Beta-sarcoglycan-related limb-girdle muscular dystrophy R4;G71.0;8C70.41
Birt-Hogg-Dubé syndrome;C44.9;LD27.5
Björnstad syndrome;E88.8;EC21.1
Blackfan-Diamond anemia;;
Blackfan-Diamond anemia;;
Blackfan-Diamond anemia;;
Blackfan-Diamond anemia;;
Blackfan-Diamond anemia;;
Blackfan-Diamond anemia;;
Blackfan-Diamond anemia;;
Blackfan-Diamond anemia;;
Blackfan-Diamond anemia;;
Blackfan-Diamond anemia;;
Blackfan-Diamond anemia;;
Blackfan-Diamond anemia;;
Blackfan-Diamond anemia;;
Blackfan-Diamond anemia;;
Blackfan-Diamond anemia;;
Blackfan-Diamond anemia;;
Blackfan-Diamond anemia;;
Blackfan-Diamond anemia;;
Blackfan-Diamond anemia;;
Blackfan-Diamond anemia;;
Blackfan-Diamond anemia;;
Blackfan-Diamond anemia;;
Blackfan-Diamond anemia;;
Bloom syndrome;Q87.1;4A01.31
Borjeson-Forssman-Lehmann syndrome;Q87.8;LD29
Brugada syndrome;I49.8;BC65.1
Brugada syndrome;I49.8;BC65.1
Brugada syndrome;I49.8;BC65.1
Brugada syndrome;I49.8;BC65.1
Brugada syndrome;I49.8;BC65.1
Brugada syndrome;I49.8;BC65.1
Brugada syndrome;I49.8;BC65.1
Brugada syndrome;I49.8;BC65.1
Brugada syndrome;I49.8;BC65.1
Brugada syndrome;I49.8;BC65.1
Brugada syndrome;I49.8;BC65.1
Brugada syndrome;I49.8;BC65.1
Brugada syndrome;I49.8;BC65.1
Brugada syndrome;I49.8;BC65.1
Brugada syndrome;I49.8;BC65.1
Brugada syndrome;I49.8;BC65.1
Brugada syndrome;I49.8;BC65.1
Brugada syndrome;I49.8;BC65.1
Brugada syndrome;I49.8;BC65.1
Brugada syndrome;I49.8;BC65.1
Brugada syndrome;I49.8;BC65.1
Brugada syndrome;I49.8;BC65.1
Budd-Chiari syndrome;I82.0;DB98.5
Budd-Chiari syndrome;I82.0;DB98.5
Budd-Chiari syndrome;I82.0;DB98.5
Butyrylcholinesterase deficiency;;
Chronic beryllium disease;J63.2;CA60.6
Beta-ketothiolase deficiency;E71.1;5C50.DY
Cerebral autosomal dominant arteriopathy-subcortical infarcts-leukoencephalopathy;I67.8;8B22.C0
CHARGE syndrome;Q87.8;5A61.0
CHARGE syndrome;Q87.8;5A61.0
CHILD syndrome;Q87.8;LD24.04
Campomelic dysplasia;Q87.1;LD2A.Y
Parathyroid carcinoma;C75.0;2D12.Y
Lynch syndrome;D48.9;
Lynch syndrome;D48.9;
Lynch syndrome;D48.9;
Lynch syndrome;D48.9;
Lynch syndrome;D48.9;
Lynch syndrome;D48.9;
Lynch syndrome;D48.9;
Lynch syndrome;D48.9;
Lynch syndrome;D48.9;
Lynch syndrome;D48.9;
Lynch syndrome;D48.9;
Hereditary breast and ovarian cancer syndrome;;
Hereditary breast and ovarian cancer syndrome;;
Hereditary breast and ovarian cancer syndrome;;
Hereditary breast and ovarian cancer syndrome;;
Hereditary breast and ovarian cancer syndrome;;
Hereditary breast and ovarian cancer syndrome;;
Hereditary breast and ovarian cancer syndrome;;
Hereditary breast and ovarian cancer syndrome;;
Hereditary breast and ovarian cancer syndrome;;
Hereditary breast and ovarian cancer syndrome;;
Hereditary breast and ovarian cancer syndrome;;
Hereditary breast and ovarian cancer syndrome;;
Hereditary breast and ovarian cancer syndrome;;
Hereditary breast and ovarian cancer syndrome;;
Differentiated thyroid carcinoma;C73;
Differentiated thyroid carcinoma;C73;
Differentiated thyroid carcinoma;C73;
Differentiated thyroid carcinoma;C73;
Differentiated thyroid carcinoma;C73;
Differentiated thyroid carcinoma;C73;
Differentiated thyroid carcinoma;C73;
Differentiated thyroid carcinoma;C73;
Differentiated thyroid carcinoma;C73;
Differentiated thyroid carcinoma;C73;
Differentiated thyroid carcinoma;C73;
Differentiated thyroid carcinoma;C73;
Differentiated thyroid carcinoma;C73;
Differentiated thyroid carcinoma;C73;
Differentiated thyroid carcinoma;C73;
Differentiated thyroid carcinoma;C73;
Differentiated thyroid carcinoma;C73;
Differentiated thyroid carcinoma;C73;
Differentiated thyroid carcinoma;C73;
Differentiated thyroid carcinoma;C73;
Differentiated thyroid carcinoma;C73;
Differentiated thyroid carcinoma;C73;
Differentiated thyroid carcinoma;C73;
Differentiated thyroid carcinoma;C73;
Differentiated thyroid carcinoma;C73;
Differentiated thyroid carcinoma;C73;
Differentiated thyroid carcinoma;C73;
Differentiated thyroid carcinoma;C73;
Differentiated thyroid carcinoma;C73;
Carbamoyl-phosphate synthetase 1 deficiency;E72.2;5C50.A1
Nasopharyngeal carcinoma;C11.0;2E60.0
Nasopharyngeal carcinoma;C11.1;2E60.0
Nasopharyngeal carcinoma;C11.2;2E60.0
Nasopharyngeal carcinoma;C11.3;2E60.0
Familial isolated dilated cardiomyopathy;I42.0;BC43.00
Familial isolated dilated cardiomyopathy;I42.0;BC43.00
Familial isolated dilated cardiomyopathy;I42.0;BC43.00
Familial isolated dilated cardiomyopathy;I42.0;BC43.00
Familial isolated dilated cardiomyopathy;I42.0;BC43.00
Familial isolated dilated cardiomyopathy;I42.0;BC43.00
Familial isolated dilated cardiomyopathy;I42.0;BC43.00
Familial isolated dilated cardiomyopathy;I42.0;BC43.00
Familial isolated dilated cardiomyopathy;I42.0;BC43.00
Familial isolated dilated cardiomyopathy;I42.0;BC43.00
Familial isolated dilated cardiomyopathy;I42.0;BC43.00
Familial isolated dilated cardiomyopathy;I42.0;BC43.00
Familial isolated dilated cardiomyopathy;I42.0;BC43.00
Familial isolated dilated cardiomyopathy;I42.0;BC43.00
Familial isolated dilated cardiomyopathy;I42.0;BC43.00
Familial isolated dilated cardiomyopathy;I42.0;BC43.00
Familial isolated dilated cardiomyopathy;I42.0;BC43.00
Familial isolated dilated cardiomyopathy;I42.0;BC43.00
Familial isolated dilated cardiomyopathy;I42.0;BC43.00
Familial isolated dilated cardiomyopathy;I42.0;BC43.00
Familial isolated dilated cardiomyopathy;I42.0;BC43.00
Familial isolated dilated cardiomyopathy;I42.0;BC43.00
Familial isolated dilated cardiomyopathy;I42.0;BC43.00
Familial isolated dilated cardiomyopathy;I42.0;BC43.00
Familial isolated dilated cardiomyopathy;I42.0;BC43.00
Familial isolated dilated cardiomyopathy;I42.0;BC43.00
Familial isolated dilated cardiomyopathy;I42.0;BC43.00
Familial isolated dilated cardiomyopathy;I42.0;BC43.00
Familial isolated dilated cardiomyopathy;I42.0;BC43.00
Familial isolated dilated cardiomyopathy;I42.0;BC43.00
Familial isolated dilated cardiomyopathy;I42.0;BC43.00
Familial isolated dilated cardiomyopathy;I42.0;BC43.00
Familial isolated dilated cardiomyopathy;I42.0;BC43.00
Familial isolated dilated cardiomyopathy;I42.0;BC43.00
Familial isolated dilated cardiomyopathy;I42.0;BC43.00
Familial isolated dilated cardiomyopathy;I42.0;BC43.00
Familial isolated dilated cardiomyopathy;I42.0;BC43.00
Familial isolated dilated cardiomyopathy;I42.0;BC43.00
Familial isolated dilated cardiomyopathy;I42.0;BC43.00
Familial isolated dilated cardiomyopathy;I42.0;BC43.00
Familial isolated dilated cardiomyopathy;I42.0;BC43.00
Familial isolated dilated cardiomyopathy;I42.0;BC43.00
Familial isolated dilated cardiomyopathy;I42.0;BC43.00
Familial isolated dilated cardiomyopathy;I42.0;BC43.00
Familial isolated dilated cardiomyopathy;I42.0;BC43.00
Familial isolated dilated cardiomyopathy;I42.0;BC43.00
Familial isolated dilated cardiomyopathy;I42.0;BC43.00
NON RARE IN EUROPE: Familial isolated hypertrophic cardiomyopathy;;
NON RARE IN EUROPE: Familial isolated hypertrophic cardiomyopathy;;
NON RARE IN EUROPE: Familial isolated hypertrophic cardiomyopathy;;
NON RARE IN EUROPE: Familial isolated hypertrophic cardiomyopathy;;
NON RARE IN EUROPE: Familial isolated hypertrophic cardiomyopathy;;
NON RARE IN EUROPE: Familial isolated hypertrophic cardiomyopathy;;
NON RARE IN EUROPE: Familial isolated hypertrophic cardiomyopathy;;
NON RARE IN EUROPE: Familial isolated hypertrophic cardiomyopathy;;
NON RARE IN EUROPE: Familial isolated hypertrophic cardiomyopathy;;
NON RARE IN EUROPE: Familial isolated hypertrophic cardiomyopathy;;
NON RARE IN EUROPE: Familial isolated hypertrophic cardiomyopathy;;
NON RARE IN EUROPE: Familial isolated hypertrophic cardiomyopathy;;
NON RARE IN EUROPE: Familial isolated hypertrophic cardiomyopathy;;
NON RARE IN EUROPE: Familial isolated hypertrophic cardiomyopathy;;
NON RARE IN EUROPE: Familial isolated hypertrophic cardiomyopathy;;
NON RARE IN EUROPE: Familial isolated hypertrophic cardiomyopathy;;
NON RARE IN EUROPE: Familial isolated hypertrophic cardiomyopathy;;
NON RARE IN EUROPE: Familial isolated hypertrophic cardiomyopathy;;
NON RARE IN EUROPE: Familial isolated hypertrophic cardiomyopathy;;
NON RARE IN EUROPE: Familial isolated hypertrophic cardiomyopathy;;
NON RARE IN EUROPE: Familial isolated hypertrophic cardiomyopathy;;
NON RARE IN EUROPE: Familial isolated hypertrophic cardiomyopathy;;
NON RARE IN EUROPE: Familial isolated hypertrophic cardiomyopathy;;
NON RARE IN EUROPE: Familial isolated hypertrophic cardiomyopathy;;
NON RARE IN EUROPE: Familial isolated hypertrophic cardiomyopathy;;
NON RARE IN EUROPE: Familial isolated hypertrophic cardiomyopathy;;
NON RARE IN EUROPE: Familial isolated hypertrophic cardiomyopathy;;
NON RARE IN EUROPE: Familial isolated hypertrophic cardiomyopathy;;
NON RARE IN EUROPE: Familial isolated hypertrophic cardiomyopathy;;
NON RARE IN EUROPE: Familial isolated hypertrophic cardiomyopathy;;
Carnitine palmitoyl transferase 1A deficiency;E71.3;5C52.00
Systemic primary carnitine deficiency;E71.3;5C52.00
Carnitine-acylcarnitine translocase deficiency;E71.3;5C52.00
Cataract-glaucoma syndrome;;
Hereditary hyperferritinemia-cataract syndrome;H26.0;
Chédiak-Higashi syndrome;E70.3;EC23.20
Woolly hair;Q84.1;EC21.0
Woolly hair;Q84.1;EC21.0
Woolly hair;Q84.1;EC21.0
Woolly hair;Q84.1;EC21.0
Woolly hair;Q84.1;EC21.0
Primary sclerosing cholangitis;K83.0;DB96.2
Primary sclerosing cholangitis;K83.0;DB96.2
Primary sclerosing cholangitis;K83.0;DB96.2
Primary sclerosing cholangitis;K83.0;DB96.2
Metaphyseal chondrodysplasia, Schmid type;Q78.5;LD24.7
Chordoma;C76.7;2B5J
Birdshot chorioretinopathy;H30.1;9B65.0
Choroideremia;H31.2;9B61
X-linked hypohidrotic ectodermal dysplasia;Q82.4;LD27.02
X-linked hypohidrotic ectodermal dysplasia;Q82.4;LD27.02
Cherubism;K10.8;LD24.22
Primary biliary cholangitis;K74.3;DB96.1
Primary biliary cholangitis;K74.3;DB96.1
Primary biliary cholangitis;K74.3;DB96.1
Primary biliary cholangitis;K74.3;DB96.1
Primary biliary cholangitis;K74.3;DB96.1
Primary biliary cholangitis;K74.3;DB96.1
Primary biliary cholangitis;K74.3;DB96.1
Primary biliary cholangitis;K74.3;DB96.1
Hidrotic ectodermal dysplasia;Q82.8;LD27.03
Hidrotic ectodermal dysplasia;Q82.8;LD27.0Y
Coats disease;H35.0;LD21.Y
Coffin-Lowry syndrome;Q87.0;LD2F.1Y
Cohen syndrome;Q87.8;LD90.Y
Occipital horn syndrome;E83.0;LD28.2
Cornelia de Lange syndrome;Q87.1;LD2F.1Y
Cornelia de Lange syndrome;Q87.1;LD2F.1Y
Cornelia de Lange syndrome;Q87.1;LD2F.1Y
Cornelia de Lange syndrome;Q87.1;LD2F.1Y
Cornelia de Lange syndrome;Q87.1;LD2F.1Y
Cornelia de Lange syndrome;Q87.1;LD2F.1Y
Cowden syndrome;Q85.8;LD2D.Y
Cowden syndrome;Q85.8;LD2D.Y
Cowden syndrome;Q85.8;LD2D.Y
Cowden syndrome;Q85.8;LD2D.Y
Cowden syndrome;Q85.8;LD2D.Y
Cowden syndrome;Q85.8;LD2D.Y
Cowden syndrome;Q85.8;LD2D.Y
Cowden syndrome;Q85.8;LD2D.Y
Cowden syndrome;Q85.8;LD2D.Y
NON RARE IN EUROPE: Crohn disease;;
NON RARE IN EUROPE: Crohn disease;;
NON RARE IN EUROPE: Crohn disease;;
NON RARE IN EUROPE: Crohn disease;;
NON RARE IN EUROPE: Crohn disease;;
NON RARE IN EUROPE: Crohn disease;;
NON RARE IN EUROPE: Crohn disease;;
NON RARE IN EUROPE: Crohn disease;;
Crouzon syndrome;Q75.1;LD24.G1
Crouzon syndrome;Q75.1;LD24.G1
Familial cylindromatosis;D23.4;2F22
Familial cylindromatosis;D23.5;2F22
Cystathioninuria;E72.1;5C50.B
Congenital stationary night blindness;H53.6;9D45
Congenital stationary night blindness;H53.6;9D45
Congenital stationary night blindness;H53.6;9D45
Congenital stationary night blindness;H53.6;9D45
Congenital stationary night blindness;H53.6;9D45
Congenital stationary night blindness;H53.6;9D45
Congenital stationary night blindness;H53.6;9D45
Congenital stationary night blindness;H53.6;9D45
Congenital stationary night blindness;H53.6;9D45
Congenital stationary night blindness;H53.6;9D45
Congenital stationary night blindness;H53.6;9D45
Congenital stationary night blindness;H53.6;9D45
Congenital stationary night blindness;H53.6;9D45
Congenital stationary night blindness;H53.6;9D45
Congenital stationary night blindness;H53.6;9D45
Darier disease;Q82.8;EC20.2
Delta-sarcoglycan-related limb-girdle muscular dystrophy R6;G71.0;8C70.41
Denys-Drash syndrome;N04.1;LD2A.Y
Nephrogenic diabetes insipidus;N25.1;
Nephrogenic diabetes insipidus;N25.1;
Dihydropteridine reductase deficiency;E70.1;5C59.01
Familial aortic dissection;I71.0;BD50.Z
Dopamine beta-hydroxylase deficiency;G90.8;5C59.00
Sickle cell anemia;D57.0;3A51.1
Sickle cell anemia;D57.0;3A51.2
Sickle cell anemia;D57.1;3A51.1
Sickle cell anemia;D57.1;3A51.2
Sickle cell anemia;D57.2;3A51.1
Sickle cell anemia;D57.2;3A51.2
Duane retraction syndrome;H50.8;9C82.2
Duane retraction syndrome;H50.8;9C82.2
Duane retraction syndrome;H50.8;9C82.2
Dubin-Johnson syndrome;E80.6;5C58.02
Dubowitz syndrome;Q87.1;LD27.0Y
Dubowitz syndrome;Q87.1;LD27.0Y
Dyggve-Melchior-Clausen disease;Q77.7;LD24.3
Léri-Weill dyschondrosteosis;Q77.8;LD24.A
Dyschromatosis universalis hereditaria;L81.8;EC23.Y
46,XY complete gonadal dysgenesis;Q99.1;LD2A.1
46,XY complete gonadal dysgenesis;Q99.1;LD2A.1
46,XY complete gonadal dysgenesis;Q99.1;LD2A.1
46,XY complete gonadal dysgenesis;Q99.1;LD2A.1
46,XY complete gonadal dysgenesis;Q99.1;LD2A.1
46,XY complete gonadal dysgenesis;Q99.1;LD2A.1
46,XY complete gonadal dysgenesis;Q99.1;LD2A.1
46,XY complete gonadal dysgenesis;Q99.1;LD2A.1
46,XY complete gonadal dysgenesis;Q99.1;LD2A.1
46,XY complete gonadal dysgenesis;Q99.1;LD2A.1
46,XX gonadal dysgenesis;Q99.1;LB45.1
46,XX gonadal dysgenesis;Q99.1;LB45.1
46,XX gonadal dysgenesis;Q99.1;LB45.1
46,XX gonadal dysgenesis;Q99.1;LB45.1
46,XX gonadal dysgenesis;Q99.1;LB45.1
46,XX gonadal dysgenesis;Q99.1;LB45.1
46,XX gonadal dysgenesis;Q99.1;LB45.1
46,XX gonadal dysgenesis;Q99.1;LB45.1
46,XX gonadal dysgenesis;Q99.1;LB45.1
46,XX gonadal dysgenesis;Q99.1;LB45.1
Primary ciliary dyskinesia;Q34.8;LA75.Y
Primary ciliary dyskinesia;Q34.8;LA75.Y
Primary ciliary dyskinesia;Q34.8;LA75.Y
Primary ciliary dyskinesia;Q34.8;LA75.Y
Primary ciliary dyskinesia;Q34.8;LA75.Y
Primary ciliary dyskinesia;Q34.8;LA75.Y
Primary ciliary dyskinesia;Q34.8;LA75.Y
Primary ciliary dyskinesia;Q34.8;LA75.Y
Primary ciliary dyskinesia;Q34.8;LA75.Y
Primary ciliary dyskinesia;Q34.8;LA75.Y
Primary ciliary dyskinesia;Q34.8;LA75.Y
Primary ciliary dyskinesia;Q34.8;LA75.Y
Primary ciliary dyskinesia;Q34.8;LA75.Y
Primary ciliary dyskinesia;Q34.8;LA75.Y
Primary ciliary dyskinesia;Q34.8;LA75.Y
Primary ciliary dyskinesia;Q34.8;LA75.Y
Primary ciliary dyskinesia;Q34.8;LA75.Y
Primary ciliary dyskinesia;Q34.8;LA75.Y
Primary ciliary dyskinesia;Q34.8;LA75.Y
Primary ciliary dyskinesia;Q34.8;LA75.Y
Primary ciliary dyskinesia;Q34.8;LA75.Y
Primary ciliary dyskinesia;Q34.8;LA75.Y
Primary ciliary dyskinesia;Q34.8;LA75.Y
Primary ciliary dyskinesia;Q34.8;LA75.Y
Primary ciliary dyskinesia;Q34.8;LA75.Y
Primary ciliary dyskinesia;Q34.8;LA75.Y
Primary ciliary dyskinesia;Q34.8;LA75.Y
Primary ciliary dyskinesia;Q34.8;LA75.Y
Primary ciliary dyskinesia;Q34.8;LA75.Y
Primary ciliary dyskinesia;Q34.8;LA75.Y
Primary ciliary dyskinesia;Q34.8;LA75.Y
Primary ciliary dyskinesia;Q34.8;LA75.Y
Primary ciliary dyskinesia;Q34.8;LA75.Y
Primary ciliary dyskinesia;Q34.8;LA75.Y
Primary ciliary dyskinesia;Q34.8;LA75.Y
Primary ciliary dyskinesia;Q34.8;LA75.Y
Primary ciliary dyskinesia;Q34.8;LA75.Y
Primary ciliary dyskinesia;Q34.8;LA75.Y
Primary ciliary dyskinesia;Q34.8;LA75.Y
Primary ciliary dyskinesia;Q34.8;LA75.Y
Primary ciliary dyskinesia;Q34.8;LA75.Y
Primary ciliary dyskinesia;Q34.8;LA75.Y
Primary ciliary dyskinesia;Q34.8;LA75.Y
Primary ciliary dyskinesia;Q34.8;LA75.Y
Primary ciliary dyskinesia;Q34.8;LA75.Y
Primary ciliary dyskinesia;Q34.8;LA75.Y
Primary ciliary dyskinesia;Q34.8;LA75.Y
Nager syndrome;Q75.4;LD25.2
Postaxial acrofacial dysostosis;Q75.4;LD25.2
Autosomal recessive hypohidrotic ectodermal dysplasia;Q82.4;LD27.02
Autosomal recessive hypohidrotic ectodermal dysplasia;Q82.4;LD27.02
Autosomal recessive hypohidrotic ectodermal dysplasia;Q82.4;LD27.02
Autosomal recessive hypohidrotic ectodermal dysplasia;Q82.4;LD27.02
Early-onset generalized limb-onset dystonia;G24.1;8A02.0Y
Early-onset generalized limb-onset dystonia;G24.1;8A02.0Y
Early-onset generalized limb-onset dystonia;G24.1;8A02.0Y
Epidermolysis bullosa simplex with muscular dystrophy;Q81.0;EC30
Laminin subunit alpha 2-related congenital muscular dystrophy;G71.2;
Autosomal dominant limb-girdle muscular dystrophy type 1A;G71.0;8C70.40
Calpain-3-related limb-girdle muscular dystrophy R1;G71.0;8C70.41
Dysferlin-related limb-girdle muscular dystrophy R2;G71.0;8C70.41
Facioscapulohumeral dystrophy;G71.0;8C70.3
Facioscapulohumeral dystrophy;G71.0;8C70.3
Facioscapulohumeral dystrophy;G71.0;8C70.3
Facioscapulohumeral dystrophy;G71.0;8C70.3
Oculopharyngeal muscular dystrophy;G71.0;9C82.1
Congenital muscular dystrophy, Fukuyama type;G71.0;8C70.6
Bernard-Soulier syndrome;D69.1;3B62.01
Bernard-Soulier syndrome;D69.1;3B62.01
Bernard-Soulier syndrome;D69.1;3B62.01
Severe combined immunodeficiency due to DCLRE1C deficiency;D81.1;4A01.10
T-B+ severe combined immunodeficiency due to gamma chain deficiency;D81.2;4A01.10
Severe combined immunodeficiency due to adenosine deaminase deficiency;D81.3;4A01.10
NON RARE IN EUROPE: Age-related macular degeneration;;
NON RARE IN EUROPE: Age-related macular degeneration;;
NON RARE IN EUROPE: Age-related macular degeneration;;
NON RARE IN EUROPE: Age-related macular degeneration;;
NON RARE IN EUROPE: Age-related macular degeneration;;
NON RARE IN EUROPE: Age-related macular degeneration;;
NON RARE IN EUROPE: Age-related macular degeneration;;
NON RARE IN EUROPE: Age-related macular degeneration;;
NON RARE IN EUROPE: Age-related macular degeneration;;
NON RARE IN EUROPE: Age-related macular degeneration;;
NON RARE IN EUROPE: Age-related macular degeneration;;
NON RARE IN EUROPE: Age-related macular degeneration;;
Wolf-Hirschhorn syndrome;Q93.3;LD44.41
Wolf-Hirschhorn syndrome;Q93.3;LD44.41
Wolf-Hirschhorn syndrome;Q93.3;LD44.41
Wolf-Hirschhorn syndrome;Q93.3;LD44.41
Wolf-Hirschhorn syndrome;Q93.3;LD44.41
Wolf-Hirschhorn syndrome;Q93.3;LD44.41
Monosomy 5p;Q93.4;LD44.51
Monosomy 5p;Q93.4;LD44.51
Vascular Ehlers-Danlos syndrome;Q79.6;LD28.1Y
Classical Ehlers-Danlos syndrome;Q79.6;LD28.10
Classical Ehlers-Danlos syndrome;Q79.6;LD28.10
Classical Ehlers-Danlos syndrome;Q79.6;LD28.10
Hereditary elliptocytosis;D58.1;3A10.2
Hereditary elliptocytosis;D58.1;3A10.2
Hereditary elliptocytosis;D58.1;3A10.2
Hereditary elliptocytosis;D58.1;3A10.2
Ellis Van Creveld syndrome;Q77.6;LD27.0Y
Ellis Van Creveld syndrome;Q77.6;LD27.0Y
Ellis Van Creveld syndrome;Q77.6;LD27.0Y
Ellis Van Creveld syndrome;Q77.6;LD27.0Y
Ellis Van Creveld syndrome;Q77.6;LD27.0Y
Ellis Van Creveld syndrome;Q77.6;LD27.0Y
Ollier disease;Q78.4;2E83.Z
Ollier disease;Q78.4;2E83.Z
Ollier disease;Q78.4;2E83.Z
Mitochondrial neurogastrointestinal encephalomyopathy;G71.3;5C53.20
Mitochondrial neurogastrointestinal encephalomyopathy;G71.3;5C53.20
Mitochondrial neurogastrointestinal encephalomyopathy;G71.3;5C53.20
Mitochondrial neurogastrointestinal encephalomyopathy;G71.3;5C53.20
Bifunctional enzyme deficiency;E71.3;5C57.1
Bifunctional enzyme deficiency;E71.3;5C57.1
Epidermodysplasia verruciformis;;
Epidermodysplasia verruciformis;;
Epidermodysplasia verruciformis;;
Epidermodysplasia verruciformis;;
Benign familial infantile epilepsy;G40.3;8A61.10
Benign familial infantile epilepsy;G40.3;8A61.10
Benign familial infantile epilepsy;G40.3;8A61.10
Benign familial infantile epilepsy;G40.3;8A61.10
Benign familial infantile epilepsy;G40.3;8A61.10
Juvenile myoclonic epilepsy;G40.3;8A61.30
Juvenile myoclonic epilepsy;G40.3;8A61.30
Juvenile myoclonic epilepsy;G40.3;8A61.30
Juvenile myoclonic epilepsy;G40.3;8A61.30
Juvenile myoclonic epilepsy;G40.3;8A61.30
Juvenile myoclonic epilepsy;G40.3;8A61.30
Juvenile myoclonic epilepsy;G40.3;8A61.30
Juvenile myoclonic epilepsy;G40.3;8A61.30
Progressive myoclonic epilepsy type 1;G40.3;8A61.41
Progressive myoclonic epilepsy type 1;G40.3;8A61.41
Progressive myoclonic epilepsy type 1;G40.3;8A61.41
Autosomal dominant epidermolytic ichthyosis;Q80.3;EC20.03
Autosomal dominant epidermolytic ichthyosis;Q80.3;EC20.03
Lamellar ichthyosis;Q80.2;EC20.02
Lamellar ichthyosis;Q80.2;EC20.02
Lamellar ichthyosis;Q80.2;EC20.02
Lamellar ichthyosis;Q80.2;EC20.02
Lamellar ichthyosis;Q80.2;EC20.02
Lamellar ichthyosis;Q80.2;EC20.02
Lamellar ichthyosis;Q80.2;EC20.02
Lamellar ichthyosis;Q80.2;EC20.02
Lamellar ichthyosis;Q80.2;EC20.02
Lamellar ichthyosis;Q80.2;EC20.02
Progressive symmetric erythrokeratodermia;Q82.8;EC20.0Y
Progressive symmetric erythrokeratodermia;Q82.8;EC20.0Y
Progressive symmetric erythrokeratodermia;Q82.8;EC20.0Y
Progressive symmetric erythrokeratodermia;Q82.8;EC20.0Y
Erythrokeratodermia variabilis;Q82.8;EC20.0Y
Erythrokeratodermia variabilis;Q82.8;EC20.0Y
Erythrokeratodermia variabilis;Q82.8;EC20.0Y
Erythrokeratodermia variabilis;Q82.8;EC20.0Y
Skeletal Ewing sarcoma;C41.4;
Skeletal Ewing sarcoma;C40.3;
Skeletal Ewing sarcoma;C41.2;
Skeletal Ewing sarcoma;C41.3;
Skeletal Ewing sarcoma;C40.0;
Skeletal Ewing sarcoma;C40.1;
Skeletal Ewing sarcoma;C40.2;
Skeletal Ewing sarcoma;C41.4;
Skeletal Ewing sarcoma;C40.3;
Skeletal Ewing sarcoma;C41.2;
Skeletal Ewing sarcoma;C41.3;
Skeletal Ewing sarcoma;C40.0;
Skeletal Ewing sarcoma;C40.1;
Skeletal Ewing sarcoma;C40.2;
Skeletal Ewing sarcoma;C41.4;
Skeletal Ewing sarcoma;C40.3;
Skeletal Ewing sarcoma;C41.2;
Skeletal Ewing sarcoma;C41.3;
Skeletal Ewing sarcoma;C40.0;
Skeletal Ewing sarcoma;C40.1;
Skeletal Ewing sarcoma;C40.2;
Skeletal Ewing sarcoma;C41.4;
Skeletal Ewing sarcoma;C40.3;
Skeletal Ewing sarcoma;C41.2;
Skeletal Ewing sarcoma;C41.3;
Skeletal Ewing sarcoma;C40.0;
Skeletal Ewing sarcoma;C40.1;
Skeletal Ewing sarcoma;C40.2;
Skeletal Ewing sarcoma;C41.4;
Skeletal Ewing sarcoma;C40.3;
Skeletal Ewing sarcoma;C41.2;
Skeletal Ewing sarcoma;C41.3;
Skeletal Ewing sarcoma;C40.0;
Skeletal Ewing sarcoma;C40.1;
Skeletal Ewing sarcoma;C40.2;
Apparent mineralocorticoid excess;E26.8;5A76.Y
Multiple osteochondromas;Q78.6;LD24.20
Multiple osteochondromas;Q78.6;LD24.20
NON RARE IN EUROPE: FG syndrome phenotypic spectrum;;
NON RARE IN EUROPE: FG syndrome phenotypic spectrum;;
NON RARE IN EUROPE: FG syndrome phenotypic spectrum;;
NON RARE IN EUROPE: FG syndrome phenotypic spectrum;;
Fabry disease;E75.2;5C56.01
Congenital factor II deficiency;D68.2;3B14.Z
Congenital factor V deficiency;D68.2;3B14.Z
Congenital factor VII deficiency;D68.2;3B14.Z
Congenital factor X deficiency;D68.2;3B14.1
Congenital factor XI deficiency;D68.1;3B13
Congenital factor XII deficiency;D68.2;3B15
Congenital factor XIII deficiency;D68.2;3B14.Z
Congenital factor XIII deficiency;D68.2;3B14.Z
Congenital intrinsic factor deficiency;D51.0;3A01.0
Farber disease;E75.2;5C56.0Y
Familial atrial fibrillation;I48.9;BC65.Y
Familial atrial fibrillation;I48.9;BC65.Y
Familial atrial fibrillation;I48.9;BC65.Y
Familial atrial fibrillation;I48.9;BC65.Y
Familial atrial fibrillation;I48.9;BC65.Y
Familial atrial fibrillation;I48.9;BC65.Y
Familial atrial fibrillation;I48.9;BC65.Y
Familial atrial fibrillation;I48.9;BC65.Y
Familial atrial fibrillation;I48.9;BC65.Y
Familial atrial fibrillation;I48.9;BC65.Y
Familial atrial fibrillation;I48.9;BC65.Y
Familial atrial fibrillation;I48.9;BC65.Y
Familial atrial fibrillation;I48.9;BC65.Y
Familial atrial fibrillation;I48.9;BC65.Y
Familial atrial fibrillation;I48.9;BC65.Y
Familial atrial fibrillation;I48.9;BC65.Y
Familial atrial fibrillation;I48.9;BC65.Y
Familial atrial fibrillation;I48.9;BC65.Y
Familial atrial fibrillation;I48.9;BC65.Y
Familial atrial fibrillation;I48.9;BC65.Y
Familial atrial fibrillation;I48.9;BC65.Y
Familial atrial fibrillation;I48.9;BC65.Y
Fibrodysplasia ossificans progressiva;M61.1;FB31.1
Familial Mediterranean fever;E85.0;4A60.0
Hyperimmunoglobulinemia D with periodic fever;E85.0;4A60.Y
Frasier syndrome;N04.1;LD2A.Y
Fructose-1,6-bisphosphatase deficiency;E74.1;5C51.5Y
Fucosidosis;E77.1;5C56.21
Galactosialidosis;E77.1;5C56.21
Gamma-sarcoglycan-related limb-girdle muscular dystrophy R5;G71.0;8C70.41
Gerstmann-Straussler-Scheinker syndrome;A81.8;8E02.1
NON RARE IN EUROPE: Gilbert syndrome;E80.4;
Gitelman syndrome;N15.8;5C64.41
Gitelman syndrome;N15.8;5C64.41
Familial glucocorticoid deficiency;E27.1;5A74.Y
Familial glucocorticoid deficiency;E27.1;5A74.Y
Familial glucocorticoid deficiency;E27.1;5A74.Y
Familial glucocorticoid deficiency;E27.1;5A74.Y
Familial glucocorticoid deficiency;E27.1;5A74.Y
NON RARE IN EUROPE: Glucose-6-phosphate-dehydrogenase deficiency;D55.0;
Glycogen storage disease due to glycogen debranching enzyme deficiency;E74.0;5C51.3
Glycogen storage disease due to muscle glycogen phosphorylase deficiency;E74.0;5C51.3
Glycogen storage disease due to liver glycogen phosphorylase deficiency;E74.0;5C51.3
Glycogen storage disease due to muscle phosphofructokinase deficiency;E74.0;5C51.3
Simpson-Golabi-Behmel syndrome;Q87.3;LD2C
Simpson-Golabi-Behmel syndrome;Q87.3;LD2C
Gordon syndrome;Q68.8;LD26.4Y
Gorlin syndrome;C44.9;LD2D.4
Gorlin syndrome;C44.9;LD2D.4
Gorlin syndrome;C44.9;LD2D.4
Chronic granulomatous disease;D71;4A00.0Y
Chronic granulomatous disease;D71;4A00.0Y
Chronic granulomatous disease;D71;4A00.0Y
Chronic granulomatous disease;D71;4A00.0Y
Chronic granulomatous disease;D71;4A00.0Y
Chronic granulomatous disease;D71;4A00.0Y
Greig cephalopolysyndactyly syndrome;Q87.0;LD26.2
Guanidinoacetate methyltransferase deficiency;E72.8;5C53.4
Huriez syndrome;Q82.8;EC20.30
NON RARE IN EUROPE: Hidradenitis suppurativa;L73.2;
NON RARE IN EUROPE: Hidradenitis suppurativa;L73.2;
NON RARE IN EUROPE: Hidradenitis suppurativa;L73.2;
Hirschsprung disease;Q43.1;LB16.1
Hirschsprung disease;Q43.1;LB16.1
Hirschsprung disease;Q43.1;LB16.1
Hirschsprung disease;Q43.1;LB16.1
Hirschsprung disease;Q43.1;LB16.1
Hirschsprung disease;Q43.1;LB16.1
Hirschsprung disease;Q43.1;LB16.1
Hirschsprung disease;Q43.1;LB16.1
Hirschsprung disease;Q43.1;LB16.1
Hirschsprung disease;Q43.1;LB16.1
Hirschsprung disease;Q43.1;LB16.1
Hirschsprung disease;Q43.1;LB16.1
Hirschsprung disease;Q43.1;LB16.1
Hirschsprung disease;Q43.1;LB16.1
Langerhans cell histiocytosis;C96.0;2B31.2
Langerhans cell histiocytosis;C96.0;2B31.20
Langerhans cell histiocytosis;C96.0;2B31.2Y
Langerhans cell histiocytosis;C96.5;2B31.2
Langerhans cell histiocytosis;C96.5;2B31.20
Langerhans cell histiocytosis;C96.5;2B31.2Y
Langerhans cell histiocytosis;C96.6;2B31.2
Langerhans cell histiocytosis;C96.6;2B31.20
Langerhans cell histiocytosis;C96.6;2B31.2Y
Langerhans cell histiocytosis;C96.0;2B31.2
Langerhans cell histiocytosis;C96.0;2B31.20
Langerhans cell histiocytosis;C96.0;2B31.2Y
Langerhans cell histiocytosis;C96.5;2B31.2
Langerhans cell histiocytosis;C96.5;2B31.20
Langerhans cell histiocytosis;C96.5;2B31.2Y
Langerhans cell histiocytosis;C96.6;2B31.2
Langerhans cell histiocytosis;C96.6;2B31.20
Langerhans cell histiocytosis;C96.6;2B31.2Y
Langerhans cell histiocytosis;C96.0;2B31.2
Langerhans cell histiocytosis;C96.0;2B31.20
Langerhans cell histiocytosis;C96.0;2B31.2Y
Langerhans cell histiocytosis;C96.5;2B31.2
Langerhans cell histiocytosis;C96.5;2B31.20
Langerhans cell histiocytosis;C96.5;2B31.2Y
Langerhans cell histiocytosis;C96.6;2B31.2
Langerhans cell histiocytosis;C96.6;2B31.20
Langerhans cell histiocytosis;C96.6;2B31.2Y
Holt-Oram syndrome;Q87.2;LD2F.1Y
46,XX testicular disorder of sex development;;
46,XX testicular disorder of sex development;;
46,XX testicular disorder of sex development;;
46,XX testicular disorder of sex development;;
46,XX testicular disorder of sex development;;
Classic homocystinuria;E72.1;
Homocystinuria due to methylene tetrahydrofolate reductase deficiency;E72.1;5C63.1
Giant cell arteritis;M31.6;4A44.2
Giant cell arteritis;M31.6;4A44.2
Giant cell arteritis;M31.6;4A44.2
Giant cell arteritis;M31.6;4A44.2
Huntington disease;G10;8A01.10
Huntington disease;G10;8A01.10
Familial hyperaldosteronism type I;E26.0;5A72.0
Familial hyperaldosteronism type I;E26.0;5A72.0
Familial hyperaldosteronism type II;E26.0;5A72.0
NON RARE IN EUROPE: Heterozygous familial hypercholesterolemia;E78.0;
NON RARE IN EUROPE: Heterozygous familial hypercholesterolemia;E78.0;
NON RARE IN EUROPE: Heterozygous familial hypercholesterolemia;E78.0;
NON RARE IN EUROPE: Heterozygous familial hypercholesterolemia;E78.0;
NON RARE IN EUROPE: Heterozygous familial hypercholesterolemia;E78.0;
NON RARE IN EUROPE: Heterozygous familial hypercholesterolemia;E78.0;
Dysbetalipoproteinemia;E78.2;5C80.2
NON RARE IN EUROPE: Hyperlipoproteinemia type 4;E78.1;
NON RARE IN EUROPE: Hyperlipoproteinemia type 4;E78.1;
Gyrate atrophy of choroid and retina;E72.4;5C50.9
Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome;E72.4;5C50.AY
Neonatal severe primary hyperparathyroidism;E21.0;5A51.0
Neonatal severe primary hyperparathyroidism;E21.0;5A51.0
Hyperprolinemia type 1;E72.5;5C50.8
Malignant hyperthermia of anesthesia;T88.3;8C78
Malignant hyperthermia of anesthesia;T88.3;8C78
Familial hyperthyroidism due to mutations in TSH receptor;E05.8;5A02.Y
Apolipoprotein A-I deficiency;E78.6;5C81.0
Apolipoprotein A-I deficiency;E78.6;5C81.0
NON RARE IN EUROPE: Familial hypobetalipoproteinemia;;
NON RARE IN EUROPE: Familial hypobetalipoproteinemia;;
NON RARE IN EUROPE: Familial hypobetalipoproteinemia;;
NON RARE IN EUROPE: Familial hypobetalipoproteinemia;;
NON RARE IN EUROPE: Familial hypobetalipoproteinemia;;
NON RARE IN EUROPE: Familial hypobetalipoproteinemia;;
NON RARE IN EUROPE: Familial hypobetalipoproteinemia;;
Autosomal dominant hypocalcemia;E20.8;5A50.0Y
Autosomal dominant hypocalcemia;E20.8;5A50.0Y
Hypochondroplasia;Q77.4;LD24.01
Normosmic congenital hypogonadotropic hypogonadism;E23.0;5A61.0
Normosmic congenital hypogonadotropic hypogonadism;E23.0;5A61.0
Normosmic congenital hypogonadotropic hypogonadism;E23.0;5A61.0
Normosmic congenital hypogonadotropic hypogonadism;E23.0;5A61.0
Normosmic congenital hypogonadotropic hypogonadism;E23.0;5A61.0
Normosmic congenital hypogonadotropic hypogonadism;E23.0;5A61.0
Normosmic congenital hypogonadotropic hypogonadism;E23.0;5A61.0
Normosmic congenital hypogonadotropic hypogonadism;E23.0;5A61.0
Normosmic congenital hypogonadotropic hypogonadism;E23.0;5A61.0
Normosmic congenital hypogonadotropic hypogonadism;E23.0;5A61.0
Normosmic congenital hypogonadotropic hypogonadism;E23.0;5A61.0
Normosmic congenital hypogonadotropic hypogonadism;E23.0;5A61.0
Normosmic congenital hypogonadotropic hypogonadism;E23.0;5A61.0
Normosmic congenital hypogonadotropic hypogonadism;E23.0;5A61.0
Normosmic congenital hypogonadotropic hypogonadism;E23.0;5A61.0
Normosmic congenital hypogonadotropic hypogonadism;E23.0;5A61.0
Normosmic congenital hypogonadotropic hypogonadism;E23.0;5A61.0
Marie Unna hereditary hypotrichosis;Q84.0;EC21.2
Marie Unna hereditary hypotrichosis;Q84.0;EC21.2
Paroxysmal nocturnal hemoglobinuria;D59.5;3A21.0
X-linked lissencephaly with abnormal genitalia;Q04.3;LD20.1
Superficial epidermolytic ichthyosis;Q80.8;EC20.03
Harlequin ichthyosis;Q80.4;EC20.02
Recessive X-linked ichthyosis;Q80.1;EC20.01
Recessive X-linked ichthyosis;Q80.1;EC20.01
NON RARE IN EUROPE: Autosomal dominant ichthyosis vulgaris;Q80.0;
Incontinentia pigmenti;Q82.3;LD27.00
Congenital plasminogen activator inhibitor type 1 deficiency;D68.8;3B50.1
Fatal familial insomnia;A81.8;8E02.2
Hereditary fructose intolerance;E74.1;5C51.50
Lysinuric protein intolerance;E72.0;5C60.Y
Jeune syndrome;Q77.2;LD24.B1
Jeune syndrome;Q77.2;LD24.B1
Jeune syndrome;Q77.2;LD24.B1
Jeune syndrome;Q77.2;LD24.B1
Jeune syndrome;Q77.2;LD24.B1
Jeune syndrome;Q77.2;LD24.B1
Jeune syndrome;Q77.2;LD24.B1
Jeune syndrome;Q77.2;LD24.B1
Jeune syndrome;Q77.2;LD24.B1
Jeune syndrome;Q77.2;LD24.B1
Joubert syndrome;Q04.3;LD20.00
Joubert syndrome;Q04.3;LD20.00
Joubert syndrome;Q04.3;LD20.00
Joubert syndrome;Q04.3;LD20.00
Joubert syndrome;Q04.3;LD20.00
Joubert syndrome;Q04.3;LD20.00
Joubert syndrome;Q04.3;LD20.00
Joubert syndrome;Q04.3;LD20.00
Joubert syndrome;Q04.3;LD20.00
Joubert syndrome;Q04.3;LD20.00
Joubert syndrome;Q04.3;LD20.00
Joubert syndrome;Q04.3;LD20.00
Joubert syndrome;Q04.3;LD20.00
Joubert syndrome;Q04.3;LD20.00
Joubert syndrome;Q04.3;LD20.00
Joubert syndrome;Q04.3;LD20.00
Joubert syndrome;Q04.3;LD20.00
Joubert syndrome;Q04.3;LD20.00
Joubert syndrome;Q04.3;LD20.00
Joubert syndrome;Q04.3;LD20.00
Joubert syndrome;Q04.3;LD20.00
Joubert syndrome;Q04.3;LD20.00
Joubert syndrome;Q04.3;LD20.00
Joubert syndrome;Q04.3;LD20.00
Joubert syndrome;Q04.3;LD20.00
KID syndrome;Q80.8;LD27.2
KID syndrome;Q80.8;LD27.2
Kallmann syndrome;E23.0;5A61.2
Kallmann syndrome;E23.0;5A61.2
Kallmann syndrome;E23.0;5A61.2
Kallmann syndrome;E23.0;5A61.2
Kallmann syndrome;E23.0;5A61.2
Kallmann syndrome;E23.0;5A61.2
Kallmann syndrome;E23.0;5A61.2
Kallmann syndrome;E23.0;5A61.2
Kallmann syndrome;E23.0;5A61.2
Kallmann syndrome;E23.0;5A61.2
Kallmann syndrome;E23.0;5A61.2
Kallmann syndrome;E23.0;5A61.2
Kallmann syndrome;E23.0;5A61.2
Kallmann syndrome;E23.0;5A61.2
Kallmann syndrome;E23.0;5A61.2
Kallmann syndrome;E23.0;5A61.2
Kallmann syndrome;E23.0;5A61.2
Kallmann syndrome;E23.0;5A61.2
Kallmann syndrome;E23.0;5A61.2
Kallmann syndrome;E23.0;5A61.2
Kallmann syndrome;E23.0;5A61.2
Kearns-Sayre syndrome;H49.8;9C82.0
Kearns-Sayre syndrome;H49.8;9C82.0
Kennedy disease;G12.2;8B61.4
Congenital high-molecular-weight kininogen deficiency;D68.8;3B15
Kniest dysplasia;Q77.7;LD24.3
Autosomal dominant severe congenital neutropenia;D70;4B00.00
Autosomal dominant severe congenital neutropenia;D70;4B00.00
Autosomal dominant severe congenital neutropenia;D70;4B00.00
Autosomal dominant severe congenital neutropenia;D70;4B00.00
Autosomal dominant severe congenital neutropenia;D70;4B00.00
Keratoderma hereditarium mutilans;Q82.8;
Noonan syndrome with multiple lentigines;Q87.1;LD2F.1Y
Noonan syndrome with multiple lentigines;Q87.1;LD2F.1Y
Noonan syndrome with multiple lentigines;Q87.1;LD2F.1Y
Lafora disease;G40.3;8A61.41
Lafora disease;G40.3;8A61.41
Trichorhinophalangeal syndrome type 2;Q87.8;LD24.80
Trichorhinophalangeal syndrome type 2;Q87.8;LD24.80
Larsen syndrome;Q74.8;LD24.E
Graham Little-Piccardi-Lassueur syndrome;L66.1;EA91.2
Leprechaunism;E34.8;5A44
Lesch-Nyhan syndrome;E79.1;5C55.01
Acute promyelocytic leukemia;C92.4;XH1A50
Acute promyelocytic leukemia;C92.4;2A60.0
Acute promyelocytic leukemia;C92.4;XH1A50
Acute promyelocytic leukemia;C92.4;2A60.0
Acute promyelocytic leukemia;C92.4;XH1A50
Acute promyelocytic leukemia;C92.4;2A60.0
Acute promyelocytic leukemia;C92.4;XH1A50
Acute promyelocytic leukemia;C92.4;2A60.0
Acute promyelocytic leukemia;C92.4;XH1A50
Acute promyelocytic leukemia;C92.4;2A60.0
Acute promyelocytic leukemia;C92.4;XH1A50
Acute promyelocytic leukemia;C92.4;2A60.0
Acute promyelocytic leukemia;C92.4;XH1A50
Acute promyelocytic leukemia;C92.4;2A60.0
Acute promyelocytic leukemia;C92.4;XH1A50
Acute promyelocytic leukemia;C92.4;2A60.0
Acute promyelocytic leukemia;C92.4;XH1A50
Acute promyelocytic leukemia;C92.4;2A60.0
Acute promyelocytic leukemia;C92.4;XH1A50
Acute promyelocytic leukemia;C92.4;2A60.0
Acute promyelocytic leukemia;C92.4;XH1A50
Acute promyelocytic leukemia;C92.4;2A60.0
Acute promyelocytic leukemia;C92.4;XH1A50
Acute promyelocytic leukemia;C92.4;2A60.0
Acute promyelocytic leukemia;C92.4;XH1A50
Acute promyelocytic leukemia;C92.4;2A60.0
Chronic myeloid leukemia;C92.1;XH4XG8
Chronic myeloid leukemia;C92.1;2B33.2
Chronic myeloid leukemia;C92.1;XH4XG8
Chronic myeloid leukemia;C92.1;2B33.2
Chronic myeloid leukemia;C92.1;XH4XG8
Chronic myeloid leukemia;C92.1;2B33.2
Hereditary leiomyomatosis and renal cell cancer;C64;2C90.Y
Li-Fraumeni syndrome;C97;2B51.Y
Li-Fraumeni syndrome;C97;2B51.Y
Li-Fraumeni syndrome;C97;2B51.Y
Li-Fraumeni syndrome;C97;2B51.Y
Liddle syndrome;I15.1;BA04.Y
Liddle syndrome;I15.1;BA04.Y
Liddle syndrome;I15.1;BA04.Y
Congenital generalized lipodystrophy;E88.1;LD27.60
Congenital generalized lipodystrophy;E88.1;LD27.60
Congenital generalized lipodystrophy;E88.1;LD27.60
Congenital generalized lipodystrophy;E88.1;LD27.60
Congenital generalized lipodystrophy;E88.1;LD27.60
Congenital generalized lipodystrophy;E88.1;LD27.60
Lipoid proteinosis;E78.8;LD27.Y
Miller-Dieker syndrome;Q04.3;LD20.1
Miller-Dieker syndrome;Q04.3;LD20.1
Miller-Dieker syndrome;Q04.3;LD20.1
Oculocerebrorenal syndrome of Lowe;E72.0;5C60.0
Systemic lupus erythematosus;M32.0;4A40.0
Systemic lupus erythematosus;M32.1;4A40.0
Systemic lupus erythematosus;M32.8;4A40.0
Systemic lupus erythematosus;M32.9;4A40.0
Systemic lupus erythematosus;M32.0;4A40.0
Systemic lupus erythematosus;M32.1;4A40.0
Systemic lupus erythematosus;M32.8;4A40.0
Systemic lupus erythematosus;M32.9;4A40.0
Systemic lupus erythematosus;M32.0;4A40.0
Systemic lupus erythematosus;M32.1;4A40.0
Systemic lupus erythematosus;M32.8;4A40.0
Systemic lupus erythematosus;M32.9;4A40.0
Systemic lupus erythematosus;M32.0;4A40.0
Systemic lupus erythematosus;M32.1;4A40.0
Systemic lupus erythematosus;M32.8;4A40.0
Systemic lupus erythematosus;M32.9;4A40.0
Systemic lupus erythematosus;M32.0;4A40.0
Systemic lupus erythematosus;M32.1;4A40.0
Systemic lupus erythematosus;M32.8;4A40.0
Systemic lupus erythematosus;M32.9;4A40.0
Systemic lupus erythematosus;M32.0;4A40.0
Systemic lupus erythematosus;M32.1;4A40.0
Systemic lupus erythematosus;M32.8;4A40.0
Systemic lupus erythematosus;M32.9;4A40.0
Systemic lupus erythematosus;M32.0;4A40.0
Systemic lupus erythematosus;M32.1;4A40.0
Systemic lupus erythematosus;M32.8;4A40.0
Systemic lupus erythematosus;M32.9;4A40.0
Systemic lupus erythematosus;M32.0;4A40.0
Systemic lupus erythematosus;M32.1;4A40.0
Systemic lupus erythematosus;M32.8;4A40.0
Systemic lupus erythematosus;M32.9;4A40.0
Systemic lupus erythematosus;M32.0;4A40.0
Systemic lupus erythematosus;M32.1;4A40.0
Systemic lupus erythematosus;M32.8;4A40.0
Systemic lupus erythematosus;M32.9;4A40.0
Systemic lupus erythematosus;M32.0;4A40.0
Systemic lupus erythematosus;M32.1;4A40.0
Systemic lupus erythematosus;M32.8;4A40.0
Systemic lupus erythematosus;M32.9;4A40.0
Systemic lupus erythematosus;M32.0;4A40.0
Systemic lupus erythematosus;M32.1;4A40.0
Systemic lupus erythematosus;M32.8;4A40.0
Systemic lupus erythematosus;M32.9;4A40.0
Systemic lupus erythematosus;M32.0;4A40.0
Systemic lupus erythematosus;M32.1;4A40.0
Systemic lupus erythematosus;M32.8;4A40.0
Systemic lupus erythematosus;M32.9;4A40.0
Systemic lupus erythematosus;M32.0;4A40.0
Systemic lupus erythematosus;M32.1;4A40.0
Systemic lupus erythematosus;M32.8;4A40.0
Systemic lupus erythematosus;M32.9;4A40.0
Systemic lupus erythematosus;M32.0;4A40.0
Systemic lupus erythematosus;M32.1;4A40.0
Systemic lupus erythematosus;M32.8;4A40.0
Systemic lupus erythematosus;M32.9;4A40.0
Systemic lupus erythematosus;M32.0;4A40.0
Systemic lupus erythematosus;M32.1;4A40.0
Systemic lupus erythematosus;M32.8;4A40.0
Systemic lupus erythematosus;M32.9;4A40.0
Systemic lupus erythematosus;M32.0;4A40.0
Systemic lupus erythematosus;M32.1;4A40.0
Systemic lupus erythematosus;M32.8;4A40.0
Systemic lupus erythematosus;M32.9;4A40.0
Systemic lupus erythematosus;M32.0;4A40.0
Systemic lupus erythematosus;M32.1;4A40.0
Systemic lupus erythematosus;M32.8;4A40.0
Systemic lupus erythematosus;M32.9;4A40.0
Systemic lupus erythematosus;M32.0;4A40.0
Systemic lupus erythematosus;M32.1;4A40.0
Systemic lupus erythematosus;M32.8;4A40.0
Systemic lupus erythematosus;M32.9;4A40.0
Systemic lupus erythematosus;M32.0;4A40.0
Systemic lupus erythematosus;M32.1;4A40.0
Systemic lupus erythematosus;M32.8;4A40.0
Systemic lupus erythematosus;M32.9;4A40.0
Systemic lupus erythematosus;M32.0;4A40.0
Systemic lupus erythematosus;M32.1;4A40.0
Systemic lupus erythematosus;M32.8;4A40.0
Systemic lupus erythematosus;M32.9;4A40.0
Systemic lupus erythematosus;M32.0;4A40.0
Systemic lupus erythematosus;M32.1;4A40.0
Systemic lupus erythematosus;M32.8;4A40.0
Systemic lupus erythematosus;M32.9;4A40.0
Systemic lupus erythematosus;M32.0;4A40.0
Systemic lupus erythematosus;M32.1;4A40.0
Systemic lupus erythematosus;M32.8;4A40.0
Systemic lupus erythematosus;M32.9;4A40.0
Systemic lupus erythematosus;M32.0;4A40.0
Systemic lupus erythematosus;M32.1;4A40.0
Systemic lupus erythematosus;M32.8;4A40.0
Systemic lupus erythematosus;M32.9;4A40.0
Systemic lupus erythematosus;M32.0;4A40.0
Systemic lupus erythematosus;M32.1;4A40.0
Systemic lupus erythematosus;M32.8;4A40.0
Systemic lupus erythematosus;M32.9;4A40.0
Systemic lupus erythematosus;M32.0;4A40.0
Systemic lupus erythematosus;M32.1;4A40.0
Systemic lupus erythematosus;M32.8;4A40.0
Systemic lupus erythematosus;M32.9;4A40.0
Systemic lupus erythematosus;M32.0;4A40.0
Systemic lupus erythematosus;M32.1;4A40.0
Systemic lupus erythematosus;M32.8;4A40.0
Systemic lupus erythematosus;M32.9;4A40.0
Systemic lupus erythematosus;M32.0;4A40.0
Systemic lupus erythematosus;M32.1;4A40.0
Systemic lupus erythematosus;M32.8;4A40.0
Systemic lupus erythematosus;M32.9;4A40.0
Systemic lupus erythematosus;M32.0;4A40.0
Systemic lupus erythematosus;M32.1;4A40.0
Systemic lupus erythematosus;M32.8;4A40.0
Systemic lupus erythematosus;M32.9;4A40.0
Systemic lupus erythematosus;M32.0;4A40.0
Systemic lupus erythematosus;M32.1;4A40.0
Systemic lupus erythematosus;M32.8;4A40.0
Systemic lupus erythematosus;M32.9;4A40.0
Lymphangioleiomyomatosis;D48.7;CB07
Lymphangioleiomyomatosis;D48.7;CB07
Familial hemophagocytic lymphohistiocytosis;D76.1;4A01.23
Familial hemophagocytic lymphohistiocytosis;D76.1;4A01.23
Familial hemophagocytic lymphohistiocytosis;D76.1;4A01.23
Familial hemophagocytic lymphohistiocytosis;D76.1;4A01.23
Burkitt lymphoma;C91.8;XH4KA9
Burkitt lymphoma;C91.8;2A85.6
Burkitt lymphoma;C83.7;XH4KA9
Burkitt lymphoma;C83.7;2A85.6
Follicular lymphoma;C82.1;2A80.Y
Follicular lymphoma;C82.1;2A80.0
Follicular lymphoma;C82.1;2A80.1
Follicular lymphoma;C82.1;2A80.2
Follicular lymphoma;C82.1;2A80.4
Follicular lymphoma;C82.1;2A80.5
Follicular lymphoma;C82.1;2A80.6
Follicular lymphoma;C82.1;2A80
Follicular lymphoma;C82.2;2A80.Y
Follicular lymphoma;C82.2;2A80.0
Follicular lymphoma;C82.2;2A80.1
Follicular lymphoma;C82.2;2A80.2
Follicular lymphoma;C82.2;2A80.4
Follicular lymphoma;C82.2;2A80.5
Follicular lymphoma;C82.2;2A80.6
Follicular lymphoma;C82.2;2A80
Follicular lymphoma;C82.3;2A80.Y
Follicular lymphoma;C82.3;2A80.0
Follicular lymphoma;C82.3;2A80.1
Follicular lymphoma;C82.3;2A80.2
Follicular lymphoma;C82.3;2A80.4
Follicular lymphoma;C82.3;2A80.5
Follicular lymphoma;C82.3;2A80.6
Follicular lymphoma;C82.3;2A80
Follicular lymphoma;C82.4;2A80.Y
Follicular lymphoma;C82.4;2A80.0
Follicular lymphoma;C82.4;2A80.1
Follicular lymphoma;C82.4;2A80.2
Follicular lymphoma;C82.4;2A80.4
Follicular lymphoma;C82.4;2A80.5
Follicular lymphoma;C82.4;2A80.6
Follicular lymphoma;C82.4;2A80
Follicular lymphoma;C82.5;2A80.Y
Follicular lymphoma;C82.5;2A80.0
Follicular lymphoma;C82.5;2A80.1
Follicular lymphoma;C82.5;2A80.2
Follicular lymphoma;C82.5;2A80.4
Follicular lymphoma;C82.5;2A80.5
Follicular lymphoma;C82.5;2A80.6
Follicular lymphoma;C82.5;2A80
Follicular lymphoma;C82.6;2A80.Y
Follicular lymphoma;C82.6;2A80.0
Follicular lymphoma;C82.6;2A80.1
Follicular lymphoma;C82.6;2A80.2
Follicular lymphoma;C82.6;2A80.4
Follicular lymphoma;C82.6;2A80.5
Follicular lymphoma;C82.6;2A80.6
Follicular lymphoma;C82.6;2A80
Follicular lymphoma;C82.7;2A80.Y
Follicular lymphoma;C82.7;2A80.0
Follicular lymphoma;C82.7;2A80.1
Follicular lymphoma;C82.7;2A80.2
Follicular lymphoma;C82.7;2A80.4
Follicular lymphoma;C82.7;2A80.5
Follicular lymphoma;C82.7;2A80.6
Follicular lymphoma;C82.7;2A80
Follicular lymphoma;C82.9;2A80.Y
Follicular lymphoma;C82.9;2A80.0
Follicular lymphoma;C82.9;2A80.1
Follicular lymphoma;C82.9;2A80.2
Follicular lymphoma;C82.9;2A80.4
Follicular lymphoma;C82.9;2A80.5
Follicular lymphoma;C82.9;2A80.6
Follicular lymphoma;C82.9;2A80
Follicular lymphoma;C82.0;2A80.Y
Follicular lymphoma;C82.0;2A80.0
Follicular lymphoma;C82.0;2A80.1
Follicular lymphoma;C82.0;2A80.2
Follicular lymphoma;C82.0;2A80.4
Follicular lymphoma;C82.0;2A80.5
Follicular lymphoma;C82.0;2A80.6
Follicular lymphoma;C82.0;2A80
Follicular lymphoma;C82.1;2A80.Y
Follicular lymphoma;C82.1;2A80.0
Follicular lymphoma;C82.1;2A80.1
Follicular lymphoma;C82.1;2A80.2
Follicular lymphoma;C82.1;2A80.4
Follicular lymphoma;C82.1;2A80.5
Follicular lymphoma;C82.1;2A80.6
Follicular lymphoma;C82.1;2A80
Follicular lymphoma;C82.2;2A80.Y
Follicular lymphoma;C82.2;2A80.0
Follicular lymphoma;C82.2;2A80.1
Follicular lymphoma;C82.2;2A80.2
Follicular lymphoma;C82.2;2A80.4
Follicular lymphoma;C82.2;2A80.5
Follicular lymphoma;C82.2;2A80.6
Follicular lymphoma;C82.2;2A80
Follicular lymphoma;C82.3;2A80.Y
Follicular lymphoma;C82.3;2A80.0
Follicular lymphoma;C82.3;2A80.1
Follicular lymphoma;C82.3;2A80.2
Follicular lymphoma;C82.3;2A80.4
Follicular lymphoma;C82.3;2A80.5
Follicular lymphoma;C82.3;2A80.6
Follicular lymphoma;C82.3;2A80
Follicular lymphoma;C82.4;2A80.Y
Follicular lymphoma;C82.4;2A80.0
Follicular lymphoma;C82.4;2A80.1
Follicular lymphoma;C82.4;2A80.2
Follicular lymphoma;C82.4;2A80.4
Follicular lymphoma;C82.4;2A80.5
Follicular lymphoma;C82.4;2A80.6
Follicular lymphoma;C82.4;2A80
Follicular lymphoma;C82.5;2A80.Y
Follicular lymphoma;C82.5;2A80.0
Follicular lymphoma;C82.5;2A80.1
Follicular lymphoma;C82.5;2A80.2
Follicular lymphoma;C82.5;2A80.4
Follicular lymphoma;C82.5;2A80.5
Follicular lymphoma;C82.5;2A80.6
Follicular lymphoma;C82.5;2A80
Follicular lymphoma;C82.6;2A80.Y
Follicular lymphoma;C82.6;2A80.0
Follicular lymphoma;C82.6;2A80.1
Follicular lymphoma;C82.6;2A80.2
Follicular lymphoma;C82.6;2A80.4
Follicular lymphoma;C82.6;2A80.5
Follicular lymphoma;C82.6;2A80.6
Follicular lymphoma;C82.6;2A80
Follicular lymphoma;C82.7;2A80.Y
Follicular lymphoma;C82.7;2A80.0
Follicular lymphoma;C82.7;2A80.1
Follicular lymphoma;C82.7;2A80.2
Follicular lymphoma;C82.7;2A80.4
Follicular lymphoma;C82.7;2A80.5
Follicular lymphoma;C82.7;2A80.6
Follicular lymphoma;C82.7;2A80
Follicular lymphoma;C82.9;2A80.Y
Follicular lymphoma;C82.9;2A80.0
Follicular lymphoma;C82.9;2A80.1
Follicular lymphoma;C82.9;2A80.2
Follicular lymphoma;C82.9;2A80.4
Follicular lymphoma;C82.9;2A80.5
Follicular lymphoma;C82.9;2A80.6
Follicular lymphoma;C82.9;2A80
Follicular lymphoma;C82.0;2A80.Y
Follicular lymphoma;C82.0;2A80.0
Follicular lymphoma;C82.0;2A80.1
Follicular lymphoma;C82.0;2A80.2
Follicular lymphoma;C82.0;2A80.4
Follicular lymphoma;C82.0;2A80.5
Follicular lymphoma;C82.0;2A80.6
Follicular lymphoma;C82.0;2A80
Follicular lymphoma;C82.1;2A80.Y
Follicular lymphoma;C82.1;2A80.0
Follicular lymphoma;C82.1;2A80.1
Follicular lymphoma;C82.1;2A80.2
Follicular lymphoma;C82.1;2A80.4
Follicular lymphoma;C82.1;2A80.5
Follicular lymphoma;C82.1;2A80.6
Follicular lymphoma;C82.1;2A80
Follicular lymphoma;C82.2;2A80.Y
Follicular lymphoma;C82.2;2A80.0
Follicular lymphoma;C82.2;2A80.1
Follicular lymphoma;C82.2;2A80.2
Follicular lymphoma;C82.2;2A80.4
Follicular lymphoma;C82.2;2A80.5
Follicular lymphoma;C82.2;2A80.6
Follicular lymphoma;C82.2;2A80
Follicular lymphoma;C82.3;2A80.Y
Follicular lymphoma;C82.3;2A80.0
Follicular lymphoma;C82.3;2A80.1
Follicular lymphoma;C82.3;2A80.2
Follicular lymphoma;C82.3;2A80.4
Follicular lymphoma;C82.3;2A80.5
Follicular lymphoma;C82.3;2A80.6
Follicular lymphoma;C82.3;2A80
Follicular lymphoma;C82.4;2A80.Y
Follicular lymphoma;C82.4;2A80.0
Follicular lymphoma;C82.4;2A80.1
Follicular lymphoma;C82.4;2A80.2
Follicular lymphoma;C82.4;2A80.4
Follicular lymphoma;C82.4;2A80.5
Follicular lymphoma;C82.4;2A80.6
Follicular lymphoma;C82.4;2A80
Follicular lymphoma;C82.5;2A80.Y
Follicular lymphoma;C82.5;2A80.0
Follicular lymphoma;C82.5;2A80.1
Follicular lymphoma;C82.5;2A80.2
Follicular lymphoma;C82.5;2A80.4
Follicular lymphoma;C82.5;2A80.5
Follicular lymphoma;C82.5;2A80.6
Follicular lymphoma;C82.5;2A80
Follicular lymphoma;C82.6;2A80.Y
Follicular lymphoma;C82.6;2A80.0
Follicular lymphoma;C82.6;2A80.1
Follicular lymphoma;C82.6;2A80.2
Follicular lymphoma;C82.6;2A80.4
Follicular lymphoma;C82.6;2A80.5
Follicular lymphoma;C82.6;2A80.6
Follicular lymphoma;C82.6;2A80
Follicular lymphoma;C82.7;2A80.Y
Follicular lymphoma;C82.7;2A80.0
Follicular lymphoma;C82.7;2A80.1
Follicular lymphoma;C82.7;2A80.2
Follicular lymphoma;C82.7;2A80.4
Follicular lymphoma;C82.7;2A80.5
Follicular lymphoma;C82.7;2A80.6
Follicular lymphoma;C82.7;2A80
Follicular lymphoma;C82.9;2A80.Y
Follicular lymphoma;C82.9;2A80.0
Follicular lymphoma;C82.9;2A80.1
Follicular lymphoma;C82.9;2A80.2
Follicular lymphoma;C82.9;2A80.4
Follicular lymphoma;C82.9;2A80.5
Follicular lymphoma;C82.9;2A80.6
Follicular lymphoma;C82.9;2A80
Follicular lymphoma;C82.0;2A80.Y
Follicular lymphoma;C82.0;2A80.0
Follicular lymphoma;C82.0;2A80.1
Follicular lymphoma;C82.0;2A80.2
Follicular lymphoma;C82.0;2A80.4
Follicular lymphoma;C82.0;2A80.5
Follicular lymphoma;C82.0;2A80.6
Follicular lymphoma;C82.0;2A80
Follicular lymphoma;C82.1;2A80.Y
Follicular lymphoma;C82.1;2A80.0
Follicular lymphoma;C82.1;2A80.1
Follicular lymphoma;C82.1;2A80.2
Follicular lymphoma;C82.1;2A80.4
Follicular lymphoma;C82.1;2A80.5
Follicular lymphoma;C82.1;2A80.6
Follicular lymphoma;C82.1;2A80
Follicular lymphoma;C82.2;2A80.Y
Follicular lymphoma;C82.2;2A80.0
Follicular lymphoma;C82.2;2A80.1
Follicular lymphoma;C82.2;2A80.2
Follicular lymphoma;C82.2;2A80.4
Follicular lymphoma;C82.2;2A80.5
Follicular lymphoma;C82.2;2A80.6
Follicular lymphoma;C82.2;2A80
Follicular lymphoma;C82.3;2A80.Y
Follicular lymphoma;C82.3;2A80.0
Follicular lymphoma;C82.3;2A80.1
Follicular lymphoma;C82.3;2A80.2
Follicular lymphoma;C82.3;2A80.4
Follicular lymphoma;C82.3;2A80.5
Follicular lymphoma;C82.3;2A80.6
Follicular lymphoma;C82.3;2A80
Follicular lymphoma;C82.4;2A80.Y
Follicular lymphoma;C82.4;2A80.0
Follicular lymphoma;C82.4;2A80.1
Follicular lymphoma;C82.4;2A80.2
Follicular lymphoma;C82.4;2A80.4
Follicular lymphoma;C82.4;2A80.5
Follicular lymphoma;C82.4;2A80.6
Follicular lymphoma;C82.4;2A80
Follicular lymphoma;C82.5;2A80.Y
Follicular lymphoma;C82.5;2A80.0
Follicular lymphoma;C82.5;2A80.1
Follicular lymphoma;C82.5;2A80.2
Follicular lymphoma;C82.5;2A80.4
Follicular lymphoma;C82.5;2A80.5
Follicular lymphoma;C82.5;2A80.6
Follicular lymphoma;C82.5;2A80
Follicular lymphoma;C82.6;2A80.Y
Follicular lymphoma;C82.6;2A80.0
Follicular lymphoma;C82.6;2A80.1
Follicular lymphoma;C82.6;2A80.2
Follicular lymphoma;C82.6;2A80.4
Follicular lymphoma;C82.6;2A80.5
Follicular lymphoma;C82.6;2A80.6
Follicular lymphoma;C82.6;2A80
Follicular lymphoma;C82.7;2A80.Y
Follicular lymphoma;C82.7;2A80.0
Follicular lymphoma;C82.7;2A80.1
Follicular lymphoma;C82.7;2A80.2
Follicular lymphoma;C82.7;2A80.4
Follicular lymphoma;C82.7;2A80.5
Follicular lymphoma;C82.7;2A80.6
Follicular lymphoma;C82.7;2A80
Follicular lymphoma;C82.9;2A80.Y
Follicular lymphoma;C82.9;2A80.0
Follicular lymphoma;C82.9;2A80.1
Follicular lymphoma;C82.9;2A80.2
Follicular lymphoma;C82.9;2A80.4
Follicular lymphoma;C82.9;2A80.5
Follicular lymphoma;C82.9;2A80.6
Follicular lymphoma;C82.9;2A80
Follicular lymphoma;C82.0;2A80.Y
Follicular lymphoma;C82.0;2A80.0
Follicular lymphoma;C82.0;2A80.1
Follicular lymphoma;C82.0;2A80.2
Follicular lymphoma;C82.0;2A80.4
Follicular lymphoma;C82.0;2A80.5
Follicular lymphoma;C82.0;2A80.6
Follicular lymphoma;C82.0;2A80
MELAS;G71.3;8C73.Y
MELAS;G71.3;8C73.Y
MELAS;G71.3;8C73.Y
MELAS;G71.3;8C73.Y
MELAS;G71.3;8C73.Y
MELAS;G71.3;8C73.Y
MELAS;G71.3;8C73.Y
MERRF;G71.3;8C73.Y
MERRF;G71.3;8C73.Y
MODY;E34.8;5A13.6
MODY;E34.8;5A13.6
MODY;E34.8;5A13.6
MODY;E34.8;5A13.6
MODY;E34.8;5A13.6
MODY;E34.8;5A13.6
MODY;E34.8;5A13.6
MODY;E34.8;5A13.6
MODY;E34.8;5A13.6
MODY;E34.8;5A13.6
MODY;E34.8;5A13.6
MODY;E34.8;5A13.6
MODY;E34.8;5A13.6
NON RARE IN EUROPE: Celiac disease;K90.0;
NON RARE IN EUROPE: Celiac disease;K90.0;
NON RARE IN EUROPE: Celiac disease;K90.0;
Marinesco-Sjögren syndrome;G11.1;8C70.6
Marinesco-Sjögren syndrome;G11.1;8C70.6
Marshall syndrome;Q87.0;LD27.0Y
Marshall-Smith syndrome;Q87.3;LD2C
McCune-Albright syndrome;Q78.1;FB80.0
Meckel syndrome;Q61.9;LD2F.13
Meckel syndrome;Q61.9;LD2F.13
Meckel syndrome;Q61.9;LD2F.13
Meckel syndrome;Q61.9;LD2F.13
Meckel syndrome;Q61.9;LD2F.13
Meckel syndrome;Q61.9;LD2F.13
Meckel syndrome;Q61.9;LD2F.13
Meckel syndrome;Q61.9;LD2F.13
Meckel syndrome;Q61.9;LD2F.13
Meckel syndrome;Q61.9;LD2F.13
Meckel syndrome;Q61.9;LD2F.13
Meckel syndrome;Q61.9;LD2F.13
Meckel syndrome;Q61.9;LD2F.13
Meckel syndrome;Q61.9;LD2F.13
Meckel syndrome;Q61.9;LD2F.13
Meckel syndrome;Q61.9;LD2F.13
Meckel syndrome;Q61.9;LD2F.13
Menkes disease;E83.0;5C64.0Y
22q11.2 deletion syndrome;D82.1;LD44.N0
22q11.2 deletion syndrome;D82.1;LD44.N0
22q11.2 deletion syndrome;D82.1;LD44.N0
22q11.2 deletion syndrome;D82.1;LD44.N0
22q11.2 deletion syndrome;D82.1;LD44.N0
22q11.2 deletion syndrome;D82.1;LD44.N0
22q11.2 deletion syndrome;D82.1;LD44.N0
22q11.2 deletion syndrome;D82.1;LD44.N0
22q11.2 deletion syndrome;D82.1;LD44.N0
Microphthalmia, Lenz type;Q11.2;LD21.0
Microphthalmia, Lenz type;Q11.2;LD21.0
Familial or sporadic hemiplegic migraine;G43.1;8A80.10
Familial or sporadic hemiplegic migraine;G43.1;8A80.10
Familial or sporadic hemiplegic migraine;G43.1;8A80.10
Familial or sporadic hemiplegic migraine;G43.1;8A80.10
Moebius syndrome;Q87.0;LD2F.1Y
Moebius syndrome;Q87.0;LD2F.1Y
Immunodeficiency by defective expression of MHC class II;D81.7;4A01.12
Immunodeficiency by defective expression of MHC class II;D81.7;4A01.12
Immunodeficiency by defective expression of MHC class II;D81.7;4A01.12
Immunodeficiency by defective expression of MHC class II;D81.7;4A01.12
Monilethrix;Q84.1;EC21.0
Monilethrix;Q84.1;EC21.0
Monilethrix;Q84.1;EC21.0
Monilethrix;Q84.1;EC21.0
Muckle-Wells syndrome;E85.0;4A60.1
Mucolipidosis type II;E77.0;5C56.20
Mucolipidosis type IV;E75.1;5C56.0Y
Mucopolysaccharidosis type 7;E76.2;5C56.3Y
Multiple sulfatase deficiency;E75.2;5C56.0Y
Cystic fibrosis;E84.0;CA25
Cystic fibrosis;E84.1;CA25
Cystic fibrosis;E84.8;CA25
Cystic fibrosis;E84.0;CA25
Cystic fibrosis;E84.1;CA25
Cystic fibrosis;E84.8;CA25
Cystic fibrosis;E84.0;CA25
Cystic fibrosis;E84.1;CA25
Cystic fibrosis;E84.8;CA25
Cystic fibrosis;E84.0;CA25
Cystic fibrosis;E84.1;CA25
Cystic fibrosis;E84.8;CA25
Cystic fibrosis;E84.0;CA25
Cystic fibrosis;E84.1;CA25
Cystic fibrosis;E84.8;CA25
Cystic fibrosis;E84.0;CA25
Cystic fibrosis;E84.1;CA25
Cystic fibrosis;E84.8;CA25
Cystic fibrosis;E84.0;CA25
Cystic fibrosis;E84.1;CA25
Cystic fibrosis;E84.8;CA25
Cystic fibrosis;E84.0;CA25
Cystic fibrosis;E84.1;CA25
Cystic fibrosis;E84.8;CA25
Cystic fibrosis;E84.0;CA25
Cystic fibrosis;E84.1;CA25
Cystic fibrosis;E84.8;CA25
Cystic fibrosis;E84.0;CA25
Cystic fibrosis;E84.1;CA25
Cystic fibrosis;E84.8;CA25
Cystic fibrosis;E84.0;CA25
Cystic fibrosis;E84.1;CA25
Cystic fibrosis;E84.8;CA25
Cystic fibrosis;E84.0;CA25
Cystic fibrosis;E84.1;CA25
Cystic fibrosis;E84.8;CA25
Cystic fibrosis;E84.0;CA25
Cystic fibrosis;E84.1;CA25
Cystic fibrosis;E84.8;CA25
Cystic fibrosis;E84.0;CA25
Cystic fibrosis;E84.1;CA25
Cystic fibrosis;E84.8;CA25
Cystic fibrosis;E84.0;CA25
Cystic fibrosis;E84.1;CA25
Cystic fibrosis;E84.8;CA25
Cystic fibrosis;E84.0;CA25
Cystic fibrosis;E84.1;CA25
Cystic fibrosis;E84.8;CA25
Cystic fibrosis;E84.0;CA25
Cystic fibrosis;E84.1;CA25
Cystic fibrosis;E84.8;CA25
Cystic fibrosis;E84.0;CA25
Cystic fibrosis;E84.1;CA25
Cystic fibrosis;E84.8;CA25
Cystic fibrosis;E84.0;CA25
Cystic fibrosis;E84.1;CA25
Cystic fibrosis;E84.8;CA25
Muir-Torre syndrome;;
Muir-Torre syndrome;;
Muir-Torre syndrome;;
Muscle-eye-brain disease;G71.0;8C70.6
Muscle-eye-brain disease;G71.0;8C70.6
Muscle-eye-brain disease;G71.0;8C70.6
Muscle-eye-brain disease;G71.0;8C70.6
Muscle-eye-brain disease;G71.0;8C70.6
Muscle-eye-brain disease;G71.0;8C70.6
Muscle-eye-brain disease;G71.0;8C70.6
Muscle-eye-brain disease;G71.0;8C70.6
X-linked centronuclear myopathy;G71.2;8C72.01
Central core disease;G71.2;8C72.02
Vocal cord and pharyngeal distal myopathy;G71.0;8C75
GNE myopathy;G71.8;8C75
Distal myopathy, Welander type;G71.0;8C75
Distal myopathy, Welander type;G71.0;8C75
Proximal myotonic myopathy;G71.1;8C71.0
Tibial muscular dystrophy;G71.0;8C75
Bethlem myopathy;G71.0;
Bethlem myopathy;G71.0;
Bethlem myopathy;G71.0;
Bethlem myopathy;G71.0;
Thomsen and Becker disease;G71.1;8C71.2
Familial atrial myxoma;D15.1;2F01
Familial melanoma;C43.5;QC61.Y
Familial melanoma;C43.6;QC61.Y
Familial melanoma;C43.7;QC61.Y
Familial melanoma;C43.8;QC61.Y
Familial melanoma;C43.0;QC61.Y
Familial melanoma;C43.2;QC61.Y
Familial melanoma;C43.1;QC61.Y
Familial melanoma;C43.4;QC61.Y
Familial melanoma;C43.3;QC61.Y
Familial melanoma;C43.5;QC61.Y
Familial melanoma;C43.6;QC61.Y
Familial melanoma;C43.7;QC61.Y
Familial melanoma;C43.8;QC61.Y
Familial melanoma;C43.0;QC61.Y
Familial melanoma;C43.2;QC61.Y
Familial melanoma;C43.1;QC61.Y
Familial melanoma;C43.4;QC61.Y
Familial melanoma;C43.3;QC61.Y
Familial melanoma;C43.5;QC61.Y
Familial melanoma;C43.6;QC61.Y
Familial melanoma;C43.7;QC61.Y
Familial melanoma;C43.8;QC61.Y
Familial melanoma;C43.0;QC61.Y
Familial melanoma;C43.2;QC61.Y
Familial melanoma;C43.1;QC61.Y
Familial melanoma;C43.4;QC61.Y
Familial melanoma;C43.3;QC61.Y
Familial melanoma;C43.5;QC61.Y
Familial melanoma;C43.6;QC61.Y
Familial melanoma;C43.7;QC61.Y
Familial melanoma;C43.8;QC61.Y
Familial melanoma;C43.0;QC61.Y
Familial melanoma;C43.2;QC61.Y
Familial melanoma;C43.1;QC61.Y
Familial melanoma;C43.4;QC61.Y
Familial melanoma;C43.3;QC61.Y
Familial melanoma;C43.5;QC61.Y
Familial melanoma;C43.6;QC61.Y
Familial melanoma;C43.7;QC61.Y
Familial melanoma;C43.8;QC61.Y
Familial melanoma;C43.0;QC61.Y
Familial melanoma;C43.2;QC61.Y
Familial melanoma;C43.1;QC61.Y
Familial melanoma;C43.4;QC61.Y
Familial melanoma;C43.3;QC61.Y
Familial melanoma;C43.5;QC61.Y
Familial melanoma;C43.6;QC61.Y
Familial melanoma;C43.7;QC61.Y
Familial melanoma;C43.8;QC61.Y
Familial melanoma;C43.0;QC61.Y
Familial melanoma;C43.2;QC61.Y
Familial melanoma;C43.1;QC61.Y
Familial melanoma;C43.4;QC61.Y
Familial melanoma;C43.3;QC61.Y
Familial melanoma;C43.5;QC61.Y
Familial melanoma;C43.6;QC61.Y
Familial melanoma;C43.7;QC61.Y
Familial melanoma;C43.8;QC61.Y
Familial melanoma;C43.0;QC61.Y
Familial melanoma;C43.2;QC61.Y
Familial melanoma;C43.1;QC61.Y
Familial melanoma;C43.4;QC61.Y
Familial melanoma;C43.3;QC61.Y
Familial melanoma;C43.5;QC61.Y
Familial melanoma;C43.6;QC61.Y
Familial melanoma;C43.7;QC61.Y
Familial melanoma;C43.8;QC61.Y
Familial melanoma;C43.0;QC61.Y
Familial melanoma;C43.2;QC61.Y
Familial melanoma;C43.1;QC61.Y
Familial melanoma;C43.4;QC61.Y
Familial melanoma;C43.3;QC61.Y
Familial melanoma;C43.5;QC61.Y
Familial melanoma;C43.6;QC61.Y
Familial melanoma;C43.7;QC61.Y
Familial melanoma;C43.8;QC61.Y
Familial melanoma;C43.0;QC61.Y
Familial melanoma;C43.2;QC61.Y
Familial melanoma;C43.1;QC61.Y
Familial melanoma;C43.4;QC61.Y
Familial melanoma;C43.3;QC61.Y
Familial melanoma;C43.5;QC61.Y
Familial melanoma;C43.6;QC61.Y
Familial melanoma;C43.7;QC61.Y
Familial melanoma;C43.8;QC61.Y
Familial melanoma;C43.0;QC61.Y
Familial melanoma;C43.2;QC61.Y
Familial melanoma;C43.1;QC61.Y
Familial melanoma;C43.4;QC61.Y
Familial melanoma;C43.3;QC61.Y
Familial melanoma;C43.5;QC61.Y
Familial melanoma;C43.6;QC61.Y
Familial melanoma;C43.7;QC61.Y
Familial melanoma;C43.8;QC61.Y
Familial melanoma;C43.0;QC61.Y
Familial melanoma;C43.2;QC61.Y
Familial melanoma;C43.1;QC61.Y
Familial melanoma;C43.4;QC61.Y
Familial melanoma;C43.3;QC61.Y
NON RARE IN EUROPE: Primary ovarian failure;E28.3;
NON RARE IN EUROPE: Primary ovarian failure;E28.3;
NON RARE IN EUROPE: Primary ovarian failure;E28.3;
NON RARE IN EUROPE: Primary ovarian failure;E28.3;
NON RARE IN EUROPE: Primary ovarian failure;E28.3;
NON RARE IN EUROPE: Primary ovarian failure;E28.3;
NON RARE IN EUROPE: Primary ovarian failure;E28.3;
NON RARE IN EUROPE: Primary ovarian failure;E28.3;
NON RARE IN EUROPE: Primary ovarian failure;E28.3;
NON RARE IN EUROPE: Primary ovarian failure;E28.3;
NON RARE IN EUROPE: Primary ovarian failure;E28.3;
NON RARE IN EUROPE: Primary ovarian failure;E28.3;
NON RARE IN EUROPE: Primary ovarian failure;E28.3;
NON RARE IN EUROPE: Primary ovarian failure;E28.3;
NON RARE IN EUROPE: Primary ovarian failure;E28.3;
NON RARE IN EUROPE: Primary ovarian failure;E28.3;
NON RARE IN EUROPE: Primary ovarian failure;E28.3;
NON RARE IN EUROPE: Primary ovarian failure;E28.3;
NON RARE IN EUROPE: Primary ovarian failure;E28.3;
NON RARE IN EUROPE: Primary ovarian failure;E28.3;
NON RARE IN EUROPE: Primary ovarian failure;E28.3;
NON RARE IN EUROPE: Primary ovarian failure;E28.3;
Hereditary methemoglobinemia;D74.0;3A92
Hereditary methemoglobinemia;D74.0;3A92
Familial multiple nevi flammei;Q82.5;LC50
Large congenital melanocytic nevus;D22.9;2F20.20
Large congenital melanocytic nevus;D22.9;2F20.20
Nance-Horan syndrome;Q87.0;LD2F.1Y
Diastrophic dysplasia;Q77.5;LD24.03
Short stature due to growth hormone qualitative anomaly;E23.0;5A61.0
Short stature due to isolated growth hormone deficiency with X-linked hypogammaglobulinemia;E23.0;4A01.00
Short stature due to isolated growth hormone deficiency with X-linked hypogammaglobulinemia;E23.0;4A01.00
Laron syndrome;E34.3;5A61.0
Netherton syndrome;Q80.8;LD27.2
Neuroblastoma;C74.9;XH85Z0
Neuroblastoma;C74.9;2A00.11
Neuroblastoma;C74.9;XH85Z0
Neuroblastoma;C74.9;2A00.11
Neuroblastoma;C74.9;XH85Z0
Neuroblastoma;C74.9;2A00.11
Neuroblastoma;C74.9;XH85Z0
Neuroblastoma;C74.9;2A00.11
Neuroblastoma;C74.9;XH85Z0
Neuroblastoma;C74.9;2A00.11
Neuroblastoma;C74.9;XH85Z0
Neuroblastoma;C74.9;2A00.11
Neuroblastoma;C74.9;XH85Z0
Neuroblastoma;C74.9;2A00.11
Full NF2-related schwannomatosis;Q85.0;LD2D.11
Neurofibromatosis-Noonan syndrome;Q87.1;LD2F.1Y
Neurofibromatosis-Noonan syndrome;Q87.1;LD2F.1Y
Hereditary neuropathy with liability to pressure palsies;G60.0;8C20.Y
Hereditary sensory and autonomic neuropathy type 4;G60.8;8C21.2
Giant axonal neuropathy;G60.8;8C2Y
NARP syndrome;E88.8;8C73.1
Nijmegen breakage syndrome;Q87.8;4A01.31
Noonan syndrome;Q87.1;LD2F.15
Noonan syndrome;Q87.1;LD2F.15
Noonan syndrome;Q87.1;LD2F.15
Noonan syndrome;Q87.1;LD2F.15
Noonan syndrome;Q87.1;LD2F.15
Noonan syndrome;Q87.1;LD2F.15
Noonan syndrome;Q87.1;LD2F.15
Noonan syndrome;Q87.1;LD2F.15
Noonan syndrome;Q87.1;LD2F.15
Noonan syndrome;Q87.1;LD2F.15
Noonan syndrome;Q87.1;LD2F.15
Noonan syndrome;Q87.1;LD2F.15
Noonan syndrome;Q87.1;LD2F.15
Noonan syndrome;Q87.1;LD2F.15
Norrie disease;H35.5;LD21.Y
NON RARE IN EUROPE: Idiopathic infantile nystagmus;;
NON RARE IN EUROPE: Idiopathic infantile nystagmus;;
Multiple endocrine neoplasia type 1;D44.8;2F7A.0
Multiple endocrine neoplasia type 1;D44.8;2F7A.0
Multiple endocrine neoplasia type 1;D44.8;2F7A.0
Multiple endocrine neoplasia type 1;D44.8;2F7A.0
Multiple endocrine neoplasia type 1;D44.8;2F7A.0
Nephroblastoma;C64;2C90.Y
Nephroblastoma;C64;2C90.Y
Nephroblastoma;C64;2C90.Y
Nephroblastoma;C64;2C90.Y
Nephroblastoma;C64;2C90.Y
Nephroblastoma;C64;2C90.Y
Nephroblastoma;C64;2C90.Y
Nephroblastoma;C64;2C90.Y
Genetic steroid-resistant nephrotic syndrome;N04.1;GB41
Genetic steroid-resistant nephrotic syndrome;N04.3;GB41
Genetic steroid-resistant nephrotic syndrome;N04.8;GB41
Genetic steroid-resistant nephrotic syndrome;N04.1;GB41
Genetic steroid-resistant nephrotic syndrome;N04.3;GB41
Genetic steroid-resistant nephrotic syndrome;N04.8;GB41
Genetic steroid-resistant nephrotic syndrome;N04.1;GB41
Genetic steroid-resistant nephrotic syndrome;N04.3;GB41
Genetic steroid-resistant nephrotic syndrome;N04.8;GB41
Genetic steroid-resistant nephrotic syndrome;N04.1;GB41
Genetic steroid-resistant nephrotic syndrome;N04.3;GB41
Genetic steroid-resistant nephrotic syndrome;N04.8;GB41
Genetic steroid-resistant nephrotic syndrome;N04.1;GB41
Genetic steroid-resistant nephrotic syndrome;N04.3;GB41
Genetic steroid-resistant nephrotic syndrome;N04.8;GB41
Genetic steroid-resistant nephrotic syndrome;N04.1;GB41
Genetic steroid-resistant nephrotic syndrome;N04.3;GB41
Genetic steroid-resistant nephrotic syndrome;N04.8;GB41
Genetic steroid-resistant nephrotic syndrome;N04.1;GB41
Genetic steroid-resistant nephrotic syndrome;N04.3;GB41
Genetic steroid-resistant nephrotic syndrome;N04.8;GB41
Genetic steroid-resistant nephrotic syndrome;N04.1;GB41
Genetic steroid-resistant nephrotic syndrome;N04.3;GB41
Genetic steroid-resistant nephrotic syndrome;N04.8;GB41
Genetic steroid-resistant nephrotic syndrome;N04.1;GB41
Genetic steroid-resistant nephrotic syndrome;N04.3;GB41
Genetic steroid-resistant nephrotic syndrome;N04.8;GB41
Genetic steroid-resistant nephrotic syndrome;N04.1;GB41
Genetic steroid-resistant nephrotic syndrome;N04.3;GB41
Genetic steroid-resistant nephrotic syndrome;N04.8;GB41
Genetic steroid-resistant nephrotic syndrome;N04.1;GB41
Genetic steroid-resistant nephrotic syndrome;N04.3;GB41
Genetic steroid-resistant nephrotic syndrome;N04.8;GB41
Genetic steroid-resistant nephrotic syndrome;N04.1;GB41
Genetic steroid-resistant nephrotic syndrome;N04.3;GB41
Genetic steroid-resistant nephrotic syndrome;N04.8;GB41
Genetic steroid-resistant nephrotic syndrome;N04.1;GB41
Genetic steroid-resistant nephrotic syndrome;N04.3;GB41
Genetic steroid-resistant nephrotic syndrome;N04.8;GB41
Genetic steroid-resistant nephrotic syndrome;N04.1;GB41
Genetic steroid-resistant nephrotic syndrome;N04.3;GB41
Genetic steroid-resistant nephrotic syndrome;N04.8;GB41
Genetic steroid-resistant nephrotic syndrome;N04.1;GB41
Genetic steroid-resistant nephrotic syndrome;N04.3;GB41
Genetic steroid-resistant nephrotic syndrome;N04.8;GB41
Genetic steroid-resistant nephrotic syndrome;N04.1;GB41
Genetic steroid-resistant nephrotic syndrome;N04.3;GB41
Genetic steroid-resistant nephrotic syndrome;N04.8;GB41
Genetic steroid-resistant nephrotic syndrome;N04.1;GB41
Genetic steroid-resistant nephrotic syndrome;N04.3;GB41
Genetic steroid-resistant nephrotic syndrome;N04.8;GB41
Genetic steroid-resistant nephrotic syndrome;N04.1;GB41
Genetic steroid-resistant nephrotic syndrome;N04.3;GB41
Genetic steroid-resistant nephrotic syndrome;N04.8;GB41
Genetic steroid-resistant nephrotic syndrome;N04.1;GB41
Genetic steroid-resistant nephrotic syndrome;N04.3;GB41
Genetic steroid-resistant nephrotic syndrome;N04.8;GB41
Genetic steroid-resistant nephrotic syndrome;N04.1;GB41
Genetic steroid-resistant nephrotic syndrome;N04.3;GB41
Genetic steroid-resistant nephrotic syndrome;N04.8;GB41
Genetic steroid-resistant nephrotic syndrome;N04.1;GB41
Genetic steroid-resistant nephrotic syndrome;N04.3;GB41
Genetic steroid-resistant nephrotic syndrome;N04.8;GB41
Genetic steroid-resistant nephrotic syndrome;N04.1;GB41
Genetic steroid-resistant nephrotic syndrome;N04.3;GB41
Genetic steroid-resistant nephrotic syndrome;N04.8;GB41
Genetic steroid-resistant nephrotic syndrome;N04.1;GB41
Genetic steroid-resistant nephrotic syndrome;N04.3;GB41
Genetic steroid-resistant nephrotic syndrome;N04.8;GB41
Genetic steroid-resistant nephrotic syndrome;N04.1;GB41
Genetic steroid-resistant nephrotic syndrome;N04.3;GB41
Genetic steroid-resistant nephrotic syndrome;N04.8;GB41
Genetic steroid-resistant nephrotic syndrome;N04.1;GB41
Genetic steroid-resistant nephrotic syndrome;N04.3;GB41
Genetic steroid-resistant nephrotic syndrome;N04.8;GB41
Genetic steroid-resistant nephrotic syndrome;N04.1;GB41
Genetic steroid-resistant nephrotic syndrome;N04.3;GB41
Genetic steroid-resistant nephrotic syndrome;N04.8;GB41
Genetic steroid-resistant nephrotic syndrome;N04.1;GB41
Genetic steroid-resistant nephrotic syndrome;N04.3;GB41
Genetic steroid-resistant nephrotic syndrome;N04.8;GB41
Genetic steroid-resistant nephrotic syndrome;N04.1;GB41
Genetic steroid-resistant nephrotic syndrome;N04.3;GB41
Genetic steroid-resistant nephrotic syndrome;N04.8;GB41
Genetic steroid-resistant nephrotic syndrome;N04.1;GB41
Genetic steroid-resistant nephrotic syndrome;N04.3;GB41
Genetic steroid-resistant nephrotic syndrome;N04.8;GB41
Genetic steroid-resistant nephrotic syndrome;N04.1;GB41
Genetic steroid-resistant nephrotic syndrome;N04.3;GB41
Genetic steroid-resistant nephrotic syndrome;N04.8;GB41
Genetic steroid-resistant nephrotic syndrome;N04.1;GB41
Genetic steroid-resistant nephrotic syndrome;N04.3;GB41
Genetic steroid-resistant nephrotic syndrome;N04.8;GB41
Mutilating palmoplantar keratoderma with periorificial keratotic plaques;Q82.8;EC20.30
Mutilating palmoplantar keratoderma with periorificial keratotic plaques;Q82.8;EC20.30
Mutilating palmoplantar keratoderma with periorificial keratotic plaques;Q82.8;EC20.30
Congenital central hypoventilation syndrome;G47.3;7A42.1
Congenital central hypoventilation syndrome;G47.3;7A42.1
Congenital central hypoventilation syndrome;G47.3;7A42.1
Congenital central hypoventilation syndrome;G47.3;7A42.1
Congenital central hypoventilation syndrome;G47.3;7A42.1
Ornithine transcarbamylase deficiency;E72.4;5C50.AY
Autosomal recessive malignant osteopetrosis;Q78.2;LD24.10
Autosomal recessive malignant osteopetrosis;Q78.2;LD24.10
Autosomal recessive malignant osteopetrosis;Q78.2;LD24.10
Autosomal recessive malignant osteopetrosis;Q78.2;LD24.10
Osteosarcoma;C41.9;2B51.Y
Osteosarcoma;C41.9;2B51
Osteosarcoma;C41.9;2B51.0
Osteosarcoma;C41.9;2B51.1
Osteosarcoma;C41.9;2B51.2
Osteosarcoma;C41.9;2B51.Y
Osteosarcoma;C41.9;2B51
Osteosarcoma;C41.9;2B51.0
Osteosarcoma;C41.9;2B51.1
Osteosarcoma;C41.9;2B51.2
Osteosarcoma;C41.9;2B51.Y
Osteosarcoma;C41.9;2B51
Osteosarcoma;C41.9;2B51.0
Osteosarcoma;C41.9;2B51.1
Osteosarcoma;C41.9;2B51.2
Pallister-Hall syndrome;Q87.8;LD2F.1Y
Hereditary chronic pancreatitis;K86.1;DC32.2
Hereditary chronic pancreatitis;K86.1;DC32.2
Hereditary chronic pancreatitis;K86.1;DC32.2
Hereditary chronic pancreatitis;K86.1;DC32.2
Hereditary chronic pancreatitis;K86.1;DC32.2
Hereditary chronic pancreatitis;K86.1;DC32.2
Hereditary chronic pancreatitis;K86.1;DC32.2
Papillon-Lefèvre syndrome;Q82.8;EC20.30
Hypokalemic periodic paralysis;G72.3;8C74.10
Hypokalemic periodic paralysis;G72.3;8C74.10
Hypokalemic periodic paralysis;G72.3;8C74.10
Hyperkalemic periodic paralysis;G72.3;8C74.11
Paramyotonia congenita of Von Eulenburg;G71.1;8C74.0
Alopecia universalis;L63.1;ED70.2Y
Bullous pemphigoid;L12.0;EB41.0
Bullous pemphigoid;L12.0;EB41.0
Pendred syndrome;E07.1;5A00.02
Pendred syndrome;E07.1;5A00.02
Pendred syndrome;E07.1;5A00.02
Peters anomaly;Q13.4;9C61.42
Peters anomaly;Q13.4;9C61.42
Peters anomaly;Q13.4;9C61.42
Peters anomaly;Q13.4;9C61.42
Peters anomaly;Q13.4;9C61.42
Peters plus syndrome;Q13.8;LD21.Y
Hemolytic anemia due to glucophosphate isomerase deficiency;D55.2;3A10.Y
Glycogen storage disease due to phosphoglycerate kinase 1 deficiency;E74.0;5C51.3
Hemolytic anemia due to diphosphoglycerate mutase deficiency;D55.2;3A10.Y
Glycogen storage disease due to muscle phosphorylase kinase deficiency;E74.0;5C51.3
Glycogen storage disease due to muscle phosphorylase kinase deficiency;E74.0;5C51.3
Isolated Pierre Robin syndrome;Q87.0;LA56
Gray platelet syndrome;D69.1;3B62.00
Hypoplasminogenemia;L90.5;DA0D.3
Continuous spikes and waves during sleep;G40.4;8A62.Y
Continuous spikes and waves during sleep;G40.4;8A62.Y
Alpers-Huttenlocher syndrome;G31.8;5C53.20
Polycythemia vera;D45;2A20.4
Polycythemia vera;D45;2A20.4
Polycythemia vera;D45;2A20.4
Autosomal dominant polycystic kidney disease;Q61.2;GB81
Autosomal dominant polycystic kidney disease;Q61.2;GB81
Autosomal dominant polycystic kidney disease;Q61.2;GB81
Autosomal dominant polycystic kidney disease;Q61.2;GB81
Autosomal dominant polycystic kidney disease;Q61.2;GB81
Autosomal dominant polycystic kidney disease;Q61.2;GB81
Autosomal dominant polycystic kidney disease;Q61.2;GB81
Autosomal dominant polycystic kidney disease;Q61.2;GB81
Autosomal recessive polycystic kidney disease;Q61.1;GB8Y
Autosomal recessive polycystic kidney disease;Q61.1;GB8Y
Alpha delta granule deficiency;D69.1;3B62.4
Porokeratosis of Mibelli;Q82.8;ED52
Porokeratosis of Mibelli;Q82.8;ED52
Hutchinson-Gilford progeria syndrome;E34.8;LD2B
Hutchinson-Gilford progeria syndrome;E34.8;LD2B
Familial mitral valve prolapse;I34.1;
Prolidase deficiency;E72.8;5C50.F0
Severe hereditary thrombophilia due to congenital protein S deficiency;D68.5;3B61.0Y
Proteus syndrome;Q87.3;LD2C
Proteus syndrome;Q87.3;LD2C
Severe hereditary thrombophilia due to congenital protein C deficiency;D68.2;3B61.0Y
Mitochondrial trifunctional protein deficiency;G71.3;5C52.01
Mitochondrial trifunctional protein deficiency;G71.3;5C52.01
Autoimmune pulmonary alveolar proteinosis;J84.0;CB04.31
Congenital prekallikrein deficiency;D68.8;3B15
Pseudoachondroplasia;Q77.8;LD24.60
NON RARE IN EUROPE: Pseudoarylsulfatase A deficiency;;
46,XY disorder of sex development due to 17-beta-hydroxysteroid dehydrogenase 3 deficiency;;
46,XY disorder of sex development due to 5-alpha-reductase 2 deficiency;;
Pseudoxanthoma elasticum;Q82.8;EC40
Pseudoxanthoma elasticum;Q82.8;EC40
Purine nucleoside phosphorylase deficiency;D81.5;4A01.1Y
Pycnodysostosis;Q78.8;5C56.Y
Hemolytic anemia due to red cell pyruvate kinase deficiency;D55.2;3A10.Y
Rabson-Mendenhall syndrome;E34.8;5A44
NON RARE IN EUROPE: Ulcerative colitis;;
NON RARE IN EUROPE: Ulcerative colitis;;
NON RARE IN EUROPE: Ulcerative colitis;;
NON RARE IN EUROPE: Ulcerative colitis;;
NON RARE IN EUROPE: Ulcerative colitis;;
Infantile Refsum disease;G60.1;5C57.1
Infantile Refsum disease;G60.1;5C57.1
Infantile Refsum disease;G60.1;5C57.1
Infantile Refsum disease;G60.1;5C57.1
Infantile Refsum disease;G60.1;5C57.1
Infantile Refsum disease;G60.1;5C57.1
Infantile Refsum disease;G60.1;5C57.1
Infantile Refsum disease;G60.1;5C57.1
Infantile Refsum disease;G60.1;5C57.1
Infantile Refsum disease;G60.1;5C57.1
Infantile Refsum disease;G60.1;5C57.1
Infantile Refsum disease;G60.1;5C57.1
Infantile Refsum disease;G60.1;5C57.1
Refsum disease;G60.1;5C57.1
Refsum disease;G60.1;5C57.1
Hereditary hemorrhagic telangiectasia;I78.0;LA90.00
Hereditary hemorrhagic telangiectasia;I78.0;LA90.00
Hereditary hemorrhagic telangiectasia;I78.0;LA90.00
Hereditary hemorrhagic telangiectasia;I78.0;LA90.00
Lujan-Fryns syndrome;Q87.8;
Lujan-Fryns syndrome;Q87.8;
Lujan-Fryns syndrome;Q87.8;
X-linked non-syndromic intellectual disability;F73;LD90.Y
X-linked non-syndromic intellectual disability;F70;LD90.Y
X-linked non-syndromic intellectual disability;F71;LD90.Y
X-linked non-syndromic intellectual disability;F72;LD90.Y
X-linked non-syndromic intellectual disability;F73;LD90.Y
X-linked non-syndromic intellectual disability;F70;LD90.Y
X-linked non-syndromic intellectual disability;F71;LD90.Y
X-linked non-syndromic intellectual disability;F72;LD90.Y
X-linked non-syndromic intellectual disability;F73;LD90.Y
X-linked non-syndromic intellectual disability;F70;LD90.Y
X-linked non-syndromic intellectual disability;F71;LD90.Y
X-linked non-syndromic intellectual disability;F72;LD90.Y
X-linked non-syndromic intellectual disability;F73;LD90.Y
X-linked non-syndromic intellectual disability;F70;LD90.Y
X-linked non-syndromic intellectual disability;F71;LD90.Y
X-linked non-syndromic intellectual disability;F72;LD90.Y
X-linked non-syndromic intellectual disability;F73;LD90.Y
X-linked non-syndromic intellectual disability;F70;LD90.Y
X-linked non-syndromic intellectual disability;F71;LD90.Y
X-linked non-syndromic intellectual disability;F72;LD90.Y
X-linked non-syndromic intellectual disability;F73;LD90.Y
X-linked non-syndromic intellectual disability;F70;LD90.Y
X-linked non-syndromic intellectual disability;F71;LD90.Y
X-linked non-syndromic intellectual disability;F72;LD90.Y
X-linked non-syndromic intellectual disability;F73;LD90.Y
X-linked non-syndromic intellectual disability;F70;LD90.Y
X-linked non-syndromic intellectual disability;F71;LD90.Y
X-linked non-syndromic intellectual disability;F72;LD90.Y
X-linked non-syndromic intellectual disability;F73;LD90.Y
X-linked non-syndromic intellectual disability;F70;LD90.Y
X-linked non-syndromic intellectual disability;F71;LD90.Y
X-linked non-syndromic intellectual disability;F72;LD90.Y
X-linked non-syndromic intellectual disability;F73;LD90.Y
X-linked non-syndromic intellectual disability;F70;LD90.Y
X-linked non-syndromic intellectual disability;F71;LD90.Y
X-linked non-syndromic intellectual disability;F72;LD90.Y
X-linked non-syndromic intellectual disability;F73;LD90.Y
X-linked non-syndromic intellectual disability;F70;LD90.Y
X-linked non-syndromic intellectual disability;F71;LD90.Y
X-linked non-syndromic intellectual disability;F72;LD90.Y
X-linked non-syndromic intellectual disability;F73;LD90.Y
X-linked non-syndromic intellectual disability;F70;LD90.Y
X-linked non-syndromic intellectual disability;F71;LD90.Y
X-linked non-syndromic intellectual disability;F72;LD90.Y
X-linked non-syndromic intellectual disability;F73;LD90.Y
X-linked non-syndromic intellectual disability;F70;LD90.Y
X-linked non-syndromic intellectual disability;F71;LD90.Y
X-linked non-syndromic intellectual disability;F72;LD90.Y
X-linked non-syndromic intellectual disability;F73;LD90.Y
X-linked non-syndromic intellectual disability;F70;LD90.Y
X-linked non-syndromic intellectual disability;F71;LD90.Y
X-linked non-syndromic intellectual disability;F72;LD90.Y
X-linked non-syndromic intellectual disability;F73;LD90.Y
X-linked non-syndromic intellectual disability;F70;LD90.Y
X-linked non-syndromic intellectual disability;F71;LD90.Y
X-linked non-syndromic intellectual disability;F72;LD90.Y
X-linked non-syndromic intellectual disability;F73;LD90.Y
X-linked non-syndromic intellectual disability;F70;LD90.Y
X-linked non-syndromic intellectual disability;F71;LD90.Y
X-linked non-syndromic intellectual disability;F72;LD90.Y
X-linked non-syndromic intellectual disability;F73;LD90.Y
X-linked non-syndromic intellectual disability;F70;LD90.Y
X-linked non-syndromic intellectual disability;F71;LD90.Y
X-linked non-syndromic intellectual disability;F72;LD90.Y
X-linked non-syndromic intellectual disability;F73;LD90.Y
X-linked non-syndromic intellectual disability;F70;LD90.Y
X-linked non-syndromic intellectual disability;F71;LD90.Y
X-linked non-syndromic intellectual disability;F72;LD90.Y
X-linked non-syndromic intellectual disability;F73;LD90.Y
X-linked non-syndromic intellectual disability;F70;LD90.Y
X-linked non-syndromic intellectual disability;F71;LD90.Y
X-linked non-syndromic intellectual disability;F72;LD90.Y
X-linked non-syndromic intellectual disability;F73;LD90.Y
X-linked non-syndromic intellectual disability;F70;LD90.Y
X-linked non-syndromic intellectual disability;F71;LD90.Y
X-linked non-syndromic intellectual disability;F72;LD90.Y
X-linked non-syndromic intellectual disability;F73;LD90.Y
X-linked non-syndromic intellectual disability;F70;LD90.Y
X-linked non-syndromic intellectual disability;F71;LD90.Y
X-linked non-syndromic intellectual disability;F72;LD90.Y
X-linked non-syndromic intellectual disability;F73;LD90.Y
X-linked non-syndromic intellectual disability;F70;LD90.Y
X-linked non-syndromic intellectual disability;F71;LD90.Y
X-linked non-syndromic intellectual disability;F72;LD90.Y
X-linked non-syndromic intellectual disability;F73;LD90.Y
X-linked non-syndromic intellectual disability;F70;LD90.Y
X-linked non-syndromic intellectual disability;F71;LD90.Y
X-linked non-syndromic intellectual disability;F72;LD90.Y
X-linked non-syndromic intellectual disability;F73;LD90.Y
X-linked non-syndromic intellectual disability;F70;LD90.Y
X-linked non-syndromic intellectual disability;F71;LD90.Y
X-linked non-syndromic intellectual disability;F72;LD90.Y
X-linked non-syndromic intellectual disability;F73;LD90.Y
X-linked non-syndromic intellectual disability;F70;LD90.Y
X-linked non-syndromic intellectual disability;F71;LD90.Y
X-linked non-syndromic intellectual disability;F72;LD90.Y
X-linked non-syndromic intellectual disability;F73;LD90.Y
X-linked non-syndromic intellectual disability;F70;LD90.Y
X-linked non-syndromic intellectual disability;F71;LD90.Y
X-linked non-syndromic intellectual disability;F72;LD90.Y
X-linked non-syndromic intellectual disability;F73;LD90.Y
X-linked non-syndromic intellectual disability;F70;LD90.Y
X-linked non-syndromic intellectual disability;F71;LD90.Y
X-linked non-syndromic intellectual disability;F72;LD90.Y
X-linked non-syndromic intellectual disability;F73;LD90.Y
X-linked non-syndromic intellectual disability;F70;LD90.Y
X-linked non-syndromic intellectual disability;F71;LD90.Y
X-linked non-syndromic intellectual disability;F72;LD90.Y
X-linked non-syndromic intellectual disability;F73;LD90.Y
X-linked non-syndromic intellectual disability;F70;LD90.Y
X-linked non-syndromic intellectual disability;F71;LD90.Y
X-linked non-syndromic intellectual disability;F72;LD90.Y
X-linked non-syndromic intellectual disability;F73;LD90.Y
X-linked non-syndromic intellectual disability;F70;LD90.Y
X-linked non-syndromic intellectual disability;F71;LD90.Y
X-linked non-syndromic intellectual disability;F72;LD90.Y
X-linked non-syndromic intellectual disability;F73;LD90.Y
X-linked non-syndromic intellectual disability;F70;LD90.Y
X-linked non-syndromic intellectual disability;F71;LD90.Y
X-linked non-syndromic intellectual disability;F72;LD90.Y
X-linked non-syndromic intellectual disability;F73;LD90.Y
X-linked non-syndromic intellectual disability;F70;LD90.Y
X-linked non-syndromic intellectual disability;F71;LD90.Y
X-linked non-syndromic intellectual disability;F72;LD90.Y
X-linked non-syndromic intellectual disability;F73;LD90.Y
X-linked non-syndromic intellectual disability;F70;LD90.Y
X-linked non-syndromic intellectual disability;F71;LD90.Y
X-linked non-syndromic intellectual disability;F72;LD90.Y
Rett syndrome;F84.2;LD90.4
Reynolds syndrome;K74.3;4A43.Y
Reynolds syndrome;M34.8;4A43.Y
Axenfeld-Rieger syndrome;Q13.8;LD2F.1Y
Axenfeld-Rieger syndrome;Q13.8;LD2F.1Y
Estrogen resistance syndrome;E30.8;5A90
Generalized glucocorticoid resistance syndrome;E25.8;5A71.00
Retinitis pigmentosa;H35.5;9B70
Retinitis pigmentosa;H35.5;9B70
Retinitis pigmentosa;H35.5;9B70
Retinitis pigmentosa;H35.5;9B70
Retinitis pigmentosa;H35.5;9B70
Retinitis pigmentosa;H35.5;9B70
Retinitis pigmentosa;H35.5;9B70
Retinitis pigmentosa;H35.5;9B70
Retinitis pigmentosa;H35.5;9B70
Retinitis pigmentosa;H35.5;9B70
Retinitis pigmentosa;H35.5;9B70
Retinitis pigmentosa;H35.5;9B70
Retinitis pigmentosa;H35.5;9B70
Retinitis pigmentosa;H35.5;9B70
Retinitis pigmentosa;H35.5;9B70
Retinitis pigmentosa;H35.5;9B70
Retinitis pigmentosa;H35.5;9B70
Retinitis pigmentosa;H35.5;9B70
Retinitis pigmentosa;H35.5;9B70
Retinitis pigmentosa;H35.5;9B70
Retinitis pigmentosa;H35.5;9B70
Retinitis pigmentosa;H35.5;9B70
Retinitis pigmentosa;H35.5;9B70
Retinitis pigmentosa;H35.5;9B70
Retinitis pigmentosa;H35.5;9B70
Retinitis pigmentosa;H35.5;9B70
Retinitis pigmentosa;H35.5;9B70
Retinitis pigmentosa;H35.5;9B70
Retinitis pigmentosa;H35.5;9B70
Retinitis pigmentosa;H35.5;9B70
Retinitis pigmentosa;H35.5;9B70
Retinitis pigmentosa;H35.5;9B70
Retinitis pigmentosa;H35.5;9B70
Retinitis pigmentosa;H35.5;9B70
Retinitis pigmentosa;H35.5;9B70
Retinitis pigmentosa;H35.5;9B70
Retinitis pigmentosa;H35.5;9B70
Retinitis pigmentosa;H35.5;9B70
Retinitis pigmentosa;H35.5;9B70
Retinitis pigmentosa;H35.5;9B70
Retinitis pigmentosa;H35.5;9B70
Retinitis pigmentosa;H35.5;9B70
Retinitis pigmentosa;H35.5;9B70
Retinitis pigmentosa;H35.5;9B70
Retinitis pigmentosa;H35.5;9B70
Retinitis pigmentosa;H35.5;9B70
Retinitis pigmentosa;H35.5;9B70
Retinitis pigmentosa;H35.5;9B70
Retinitis pigmentosa;H35.5;9B70
Retinitis pigmentosa;H35.5;9B70
Retinitis pigmentosa;H35.5;9B70
Retinitis pigmentosa;H35.5;9B70
Retinitis pigmentosa;H35.5;9B70
Retinitis pigmentosa;H35.5;9B70
Retinitis pigmentosa;H35.5;9B70
Retinitis pigmentosa;H35.5;9B70
Retinitis pigmentosa;H35.5;9B70
Retinitis pigmentosa;H35.5;9B70
Retinitis pigmentosa;H35.5;9B70
Retinitis pigmentosa;H35.5;9B70
Retinitis pigmentosa;H35.5;9B70
Retinitis pigmentosa;H35.5;9B70
Retinitis pigmentosa;H35.5;9B70
Retinitis pigmentosa;H35.5;9B70
Retinitis pigmentosa;H35.5;9B70
Retinitis pigmentosa;H35.5;9B70
Retinitis pigmentosa;H35.5;9B70
Retinitis pigmentosa;H35.5;9B70
Retinitis pigmentosa;H35.5;9B70
Retinitis pigmentosa;H35.5;9B70
Retinitis pigmentosa;H35.5;9B70
Retinitis pigmentosa;H35.5;9B70
Retinitis pigmentosa;H35.5;9B70
Retinitis pigmentosa;H35.5;9B70
Retinitis pigmentosa;H35.5;9B70
Retinitis pigmentosa;H35.5;9B70
Retinitis pigmentosa;H35.5;9B70
Retinitis pigmentosa;H35.5;9B70
Retinitis pigmentosa;H35.5;9B70
Retinitis pigmentosa;H35.5;9B70
Retinitis pigmentosa;H35.5;9B70
Retinitis pigmentosa;H35.5;9B70
Retinitis pigmentosa;H35.5;9B70
Retinitis pigmentosa;H35.5;9B70
X-linked retinoschisis;Q14.1;9B73.11
Saethre-Chotzen syndrome;Q87.0;LD24.GY
Saethre-Chotzen syndrome;Q87.0;LD24.GY
Saethre-Chotzen syndrome;Q87.0;LD24.GY
Sarcoidosis;D86.0;4B20.1
Sarcoidosis;D86.0;4B20.5
Sarcoidosis;D86.0;4B20.2
Sarcoidosis;D86.0;4B20.3
Sarcoidosis;D86.0;4B20.4
Sarcoidosis;D86.0;4B20
Sarcoidosis;D86.1;4B20.1
Sarcoidosis;D86.1;4B20.5
Sarcoidosis;D86.1;4B20.2
Sarcoidosis;D86.1;4B20.3
Sarcoidosis;D86.1;4B20.4
Sarcoidosis;D86.1;4B20
Sarcoidosis;D86.9;4B20.1
Sarcoidosis;D86.9;4B20.5
Sarcoidosis;D86.9;4B20.2
Sarcoidosis;D86.9;4B20.3
Sarcoidosis;D86.9;4B20.4
Sarcoidosis;D86.9;4B20
Sarcoidosis;D86.2;4B20.1
Sarcoidosis;D86.2;4B20.5
Sarcoidosis;D86.2;4B20.2
Sarcoidosis;D86.2;4B20.3
Sarcoidosis;D86.2;4B20.4
Sarcoidosis;D86.2;4B20
Sarcoidosis;D86.3;4B20.1
Sarcoidosis;D86.3;4B20.5
Sarcoidosis;D86.3;4B20.2
Sarcoidosis;D86.3;4B20.3
Sarcoidosis;D86.3;4B20.4
Sarcoidosis;D86.3;4B20
Sarcoidosis;D86.8;4B20.1
Sarcoidosis;D86.8;4B20.5
Sarcoidosis;D86.8;4B20.2
Sarcoidosis;D86.8;4B20.3
Sarcoidosis;D86.8;4B20.4
Sarcoidosis;D86.8;4B20
Sarcoidosis;D86.0;4B20.1
Sarcoidosis;D86.0;4B20.5
Sarcoidosis;D86.0;4B20.2
Sarcoidosis;D86.0;4B20.3
Sarcoidosis;D86.0;4B20.4
Sarcoidosis;D86.0;4B20
Sarcoidosis;D86.1;4B20.1
Sarcoidosis;D86.1;4B20.5
Sarcoidosis;D86.1;4B20.2
Sarcoidosis;D86.1;4B20.3
Sarcoidosis;D86.1;4B20.4
Sarcoidosis;D86.1;4B20
Sarcoidosis;D86.9;4B20.1
Sarcoidosis;D86.9;4B20.5
Sarcoidosis;D86.9;4B20.2
Sarcoidosis;D86.9;4B20.3
Sarcoidosis;D86.9;4B20.4
Sarcoidosis;D86.9;4B20
Sarcoidosis;D86.2;4B20.1
Sarcoidosis;D86.2;4B20.5
Sarcoidosis;D86.2;4B20.2
Sarcoidosis;D86.2;4B20.3
Sarcoidosis;D86.2;4B20.4
Sarcoidosis;D86.2;4B20
Sarcoidosis;D86.3;4B20.1
Sarcoidosis;D86.3;4B20.5
Sarcoidosis;D86.3;4B20.2
Sarcoidosis;D86.3;4B20.3
Sarcoidosis;D86.3;4B20.4
Sarcoidosis;D86.3;4B20
Sarcoidosis;D86.8;4B20.1
Sarcoidosis;D86.8;4B20.5
Sarcoidosis;D86.8;4B20.2
Sarcoidosis;D86.8;4B20.3
Sarcoidosis;D86.8;4B20.4
Sarcoidosis;D86.8;4B20
Schinzel-Giedion syndrome;Q87.0;LD27.0Y
Schwartz-Jampel syndrome;Q78.8;8C71.1
Schwartz-Jampel syndrome;G71.1;8C71.1
NON RARE IN EUROPE: Multiple sclerosis;G35;
NON RARE IN EUROPE: Multiple sclerosis;G35;
NON RARE IN EUROPE: Multiple sclerosis;G35;
NON RARE IN EUROPE: Multiple sclerosis;G35;
NON RARE IN EUROPE: Multiple sclerosis;G35;
NON RARE IN EUROPE: Multiple sclerosis;G35;
Amyotrophic lateral sclerosis;G12.2;8B60.0
Amyotrophic lateral sclerosis;G12.2;8B60.0
Amyotrophic lateral sclerosis;G12.2;8B60.0
Amyotrophic lateral sclerosis;G12.2;8B60.0
Amyotrophic lateral sclerosis;G12.2;8B60.0
Amyotrophic lateral sclerosis;G12.2;8B60.0
Amyotrophic lateral sclerosis;G12.2;8B60.0
Amyotrophic lateral sclerosis;G12.2;8B60.0
Amyotrophic lateral sclerosis;G12.2;8B60.0
Amyotrophic lateral sclerosis;G12.2;8B60.0
Amyotrophic lateral sclerosis;G12.2;8B60.0
Amyotrophic lateral sclerosis;G12.2;8B60.0
Amyotrophic lateral sclerosis;G12.2;8B60.0
Amyotrophic lateral sclerosis;G12.2;8B60.0
Amyotrophic lateral sclerosis;G12.2;8B60.0
Amyotrophic lateral sclerosis;G12.2;8B60.0
Amyotrophic lateral sclerosis;G12.2;8B60.0
Amyotrophic lateral sclerosis;G12.2;8B60.0
Amyotrophic lateral sclerosis;G12.2;8B60.0
Amyotrophic lateral sclerosis;G12.2;8B60.0
Amyotrophic lateral sclerosis;G12.2;8B60.0
Amyotrophic lateral sclerosis;G12.2;8B60.0
Amyotrophic lateral sclerosis;G12.2;8B60.0
Amyotrophic lateral sclerosis;G12.2;8B60.0
Amyotrophic lateral sclerosis;G12.2;8B60.0
Amyotrophic lateral sclerosis;G12.2;8B60.0
Amyotrophic lateral sclerosis;G12.2;8B60.0
Amyotrophic lateral sclerosis;G12.2;8B60.0
Amyotrophic lateral sclerosis;G12.2;8B60.0
Amyotrophic lateral sclerosis;G12.2;8B60.0
Amyotrophic lateral sclerosis;G12.2;8B60.0
Amyotrophic lateral sclerosis;G12.2;8B60.0
Amyotrophic lateral sclerosis;G12.2;8B60.0
Amyotrophic lateral sclerosis;G12.2;8B60.0
Amyotrophic lateral sclerosis;G12.2;8B60.0
Amyotrophic lateral sclerosis;G12.2;8B60.0
Amyotrophic lateral sclerosis;G12.2;8B60.0
Tuberous sclerosis complex;Q85.1;LD2D.2
Tuberous sclerosis complex;Q85.1;LD2D.2
Tuberous sclerosis complex;Q85.1;LD2D.2
Scott syndrome;D69.8;3B62.Y
Seckel syndrome;Q87.1;LD24.D
Seckel syndrome;Q87.1;LD24.D
Seckel syndrome;Q87.1;LD24.D
Seckel syndrome;Q87.1;LD24.D
Seckel syndrome;Q87.1;LD24.D
Seckel syndrome;Q87.1;LD24.D
Seckel syndrome;Q87.1;LD24.D
Seckel syndrome;Q87.1;LD24.D
Seckel syndrome;Q87.1;LD24.D
Seckel syndrome;Q87.1;LD24.D
Shwachman-Diamond syndrome;D61.0;3A70.0
Shwachman-Diamond syndrome;D61.0;3A70.0
Shwachman-Diamond syndrome;D61.0;3A70.0
Shwachman-Diamond syndrome;D61.0;3A70.0
Sialidosis type 1;E77.1;5C56.21
Sjögren-Larsson syndrome;Q87.1;5C52.03
Smith-Lemli-Opitz syndrome;Q87.1;5C52.10
Smith-Magenis syndrome;Q93.5;LD44.H1
Smith-Magenis syndrome;Q93.5;LD44.H1
Smith-Magenis syndrome;Q93.5;LD44.H1
Smith-Magenis syndrome;Q93.5;LD44.H1
Sneddon syndrome;I77.8;4A44.6
Sotos syndrome;Q87.3;LD2C
Sotos syndrome;Q87.3;LD2C
Sotos syndrome;Q87.3;LD2C
Hereditary spherocytosis;D58.0;3A10.Y
Hereditary spherocytosis;D58.0;3A10.Y
Hereditary spherocytosis;D58.0;3A10.Y
Hereditary spherocytosis;D58.0;3A10.Y
Hereditary spherocytosis;D58.0;3A10.Y
Primary myelofibrosis;D47.4;2A20.2
Primary myelofibrosis;D47.4;2A20.2
Primary myelofibrosis;D47.4;2A20.2
Primary myelofibrosis;D47.4;2A20.2
NON RARE IN EUROPE: Ankylosing spondylitis;M45;
Stargardt disease;H35.5;9B70
Stargardt disease;H35.5;9B70
Stargardt disease;H35.5;9B70
Stargardt disease;H35.5;9B70
Stargardt disease;H35.5;9B70
Succinyl-CoA:3-oxoacid CoA transferase deficiency;E71.3;5C52.02
Congenital nephrotic syndrome, Finnish type;N04.8;GB4Z
Syringocystadenoma papilliferum;D23.9;LC0Y
Sebocystomatosis;L72.2;2F22
Testicular seminomatous germ cell tumor;C62.9;2C80.2
Alpha-thalassemia-X-linked intellectual disability syndrome;;
Glanzmann thrombasthenia;D69.1;3B62.0Y
Glanzmann thrombasthenia;D69.1;3B62.0Y
Paris-Trousseau thrombocytopenia;D69.4;3B64.01
X-linked thrombocytopenia with normal platelets;D69.4;3B62.0Y
Fetal and neonatal alloimmune thrombocytopenia;P61.0;3B64.00
Fetal and neonatal alloimmune thrombocytopenia;P61.0;3B64.00
Fetal and neonatal alloimmune thrombocytopenia;P61.0;3B64.00
Fetal and neonatal alloimmune thrombocytopenia;P61.0;3B64.00
Fetal and neonatal alloimmune thrombocytopenia;P61.0;3B64.00
Fetal and neonatal alloimmune thrombocytopenia;P61.0;3B64.00
NON RARE IN EUROPE: Tourette syndrome;F95.2;
NON RARE IN EUROPE: Tourette syndrome;F95.2;
NON RARE IN EUROPE: Tourette syndrome;F95.2;
Townes-Brocks syndrome;Q87.8;LD2F.1Y
Townes-Brocks syndrome;Q87.8;LD2F.1Y
Transcobalamin deficiency;D51.2;3A01.0
Treacher-Collins syndrome;Q75.4;LD2F.16
Treacher-Collins syndrome;Q75.4;LD2F.16
Treacher-Collins syndrome;Q75.4;LD2F.16
Treacher-Collins syndrome;Q75.4;LD2F.16
NON RARE IN EUROPE: Hereditary essential tremor;G25.0;
NON RARE IN EUROPE: Hereditary essential tremor;G25.0;
NON RARE IN EUROPE: Hereditary essential tremor;G25.0;
NON RARE IN EUROPE: Hereditary essential tremor;G25.0;
Familial multiple trichoepithelioma;D23.3;2F22
Familial multiple trichoepithelioma;D23.4;2F22
Familial multiple trichoepithelioma;D23.5;2F22
Triose phosphate-isomerase deficiency;D55.2;3A10.Y
Triple A syndrome;E27.4;5A74.Y
Triple A syndrome;E27.4;5A74.Y
Triple A syndrome;E27.4;5A74.Y
Familial progressive cardiac conduction defect;I45.8;BC63.Y
Familial progressive cardiac conduction defect;I45.8;BC63.Y
Familial progressive cardiac conduction defect;I45.8;BC63.Y
Familial progressive cardiac conduction defect;I45.8;BC63.Y
Desmoid tumor;D48.1;
Desmoid tumor;D48.1;
Tyrosinemia type 1;E70.2;5C50.11
VACTERL/VATER association;Q87.2;LD2F.11
Van der Woude syndrome;Q38.0;LD2F.1Y
Van der Woude syndrome;Q38.0;LD2F.1Y
Familial exudative vitreoretinopathy;H35.0;LA13.3
Familial exudative vitreoretinopathy;H35.0;LA13.3
Familial exudative vitreoretinopathy;H35.0;LA13.3
Familial exudative vitreoretinopathy;H35.0;LA13.3
Familial exudative vitreoretinopathy;H35.0;LA13.3
Familial exudative vitreoretinopathy;H35.0;LA13.3
Von Hippel-Lindau disease;Q85.8;5A75
Von Hippel-Lindau disease;Q85.8;5A75
WAGR syndrome;C64;LD2A.Y
WAGR syndrome;C64;LD2A.Y
WAGR syndrome;C64;LD2A.Y
Waardenburg syndrome type 1;E70.3;EC23.2Y
Waardenburg syndrome type 2;E70.3;EC23.2Y
Waardenburg syndrome type 2;E70.3;EC23.2Y
Waardenburg syndrome type 2;E70.3;EC23.2Y
Waardenburg syndrome type 2;E70.3;EC23.2Y
Waardenburg syndrome type 2;E70.3;EC23.2Y
Waardenburg syndrome type 2;E70.3;EC23.2Y
Waardenburg syndrome type 3;E70.3;EC23.2Y
Waardenburg-Shah syndrome;Q87.8;LD2H.3
Waardenburg-Shah syndrome;Q87.8;LD2H.3
Waardenburg-Shah syndrome;Q87.8;LD2H.3
Waardenburg-Shah syndrome;Q87.8;LD2H.3
Wagner disease;H35.5;9B80
Walker-Warburg syndrome;G71.0;8C70.6
Walker-Warburg syndrome;G71.0;8C70.6
Walker-Warburg syndrome;G71.0;8C70.6
Walker-Warburg syndrome;G71.0;8C70.6
Walker-Warburg syndrome;G71.0;8C70.6
Walker-Warburg syndrome;G71.0;8C70.6
Walker-Warburg syndrome;G71.0;8C70.6
Walker-Warburg syndrome;G71.0;8C70.6
Walker-Warburg syndrome;G71.0;8C70.6
Walker-Warburg syndrome;G71.0;8C70.6
Walker-Warburg syndrome;G71.0;8C70.6
Walker-Warburg syndrome;G71.0;8C70.6
Walker-Warburg syndrome;G71.0;8C70.6
Walker-Warburg syndrome;G71.0;8C70.6
Granulomatosis with polyangiitis;M31.3;4A44.A1
Granulomatosis with polyangiitis;M31.3;4A44.A1
Granulomatosis with polyangiitis;M31.3;4A44.A1
Granulomatosis with polyangiitis;M31.3;4A44.A1
Granulomatosis with polyangiitis;M31.3;4A44.A1
Werner syndrome;E34.8;LD2B
Williams syndrome;Q93.8;LD44.70
Williams syndrome;Q93.8;LD44.70
Williams syndrome;Q93.8;LD44.70
Williams syndrome;Q93.8;LD44.70
Williams syndrome;Q93.8;LD44.70
Williams syndrome;Q93.8;LD44.70
Williams syndrome;Q93.8;LD44.70
Williams syndrome;Q93.8;LD44.70
Williams syndrome;Q93.8;LD44.70
Williams syndrome;Q93.8;LD44.70
Williams syndrome;Q93.8;LD44.70
Williams syndrome;Q93.8;LD44.70
Williams syndrome;Q93.8;LD44.70
Williams syndrome;Q93.8;LD44.70
Williams syndrome;Q93.8;LD44.70
Williams syndrome;Q93.8;LD44.70
Williams syndrome;Q93.8;LD44.70
Williams syndrome;Q93.8;LD44.70
Williams syndrome;Q93.8;LD44.70
Williams syndrome;Q93.8;LD44.70
Wilson disease;E83.0;5C64.00
Wiskott-Aldrich syndrome;D82.0;3B62.0Y
Wiskott-Aldrich syndrome;D82.0;3B62.0Y
NON RARE IN EUROPE: Wolff-Parkinson-White syndrome;;
Fragile X syndrome;Q99.2;LD55
Cerebrotendinous xanthomatosis;E75.5;5C52.11
Xeroderma pigmentosum;Q82.1;LD27.1
Xeroderma pigmentosum;Q82.1;LD27.1
Xeroderma pigmentosum;Q82.1;LD27.1
Xeroderma pigmentosum;Q82.1;LD27.1
Xeroderma pigmentosum;Q82.1;LD27.1
Xeroderma pigmentosum;Q82.1;LD27.1
Xeroderma pigmentosum;Q82.1;LD27.1
Combined immunodeficiency due to ZAP70 deficiency;D81.8;4A01.1Y
Zellweger syndrome;Q87.8;5C57.0
Zellweger syndrome;Q87.8;5C57.0
Zellweger syndrome;Q87.8;5C57.0
Zellweger syndrome;Q87.8;5C57.0
Zellweger syndrome;Q87.8;5C57.0
Zellweger syndrome;Q87.8;5C57.0
Zellweger syndrome;Q87.8;5C57.0
Zellweger syndrome;Q87.8;5C57.0
Zellweger syndrome;Q87.8;5C57.0
Zellweger syndrome;Q87.8;5C57.0
Zellweger syndrome;Q87.8;5C57.0
Zellweger syndrome;Q87.8;5C57.0
Zellweger syndrome;Q87.8;5C57.0
Aarskog-Scott syndrome;Q87.1;LD2F.1Y
Ablepharon macrostomia syndrome;Q87.0;LD2F.1Y
Abruzzo-Erickson syndrome;Q87.8;
Acatalasemia;E80.3;5C57.1
Hyperammonemia due to N-acetylglutamate synthase deficiency;E72.2;5C50.AY
Idiopathic achalasia;K22.0;DA21.0
Idiopathic achalasia;K22.0;DA21.0
Idiopathic achalasia;K22.0;DA21.0
Idiopathic achalasia;K22.0;DA21.0
Acheiropodia;;
D-glyceric aciduria;E74.8;5C50.7Y
Malonic aciduria;E72.8;5C50.E1
Acrodysostosis;Q75.4;LD2F.16
Acrodysostosis;Q75.4;LD2F.16
Acrofacial dysostosis, Weyers type;Q75.4;LD25.2
Acrofacial dysostosis, Weyers type;Q75.4;LD25.2
Hajdu-Cheney syndrome;M89.5;FB86.2
Acro-renal-ocular syndrome;Q87.8;
Acromegaly;E22.0;5A60.0
Acromegaly;E22.0;5A60.0
Acromesomelic dysplasia, Hunter-Thompson type;Q78.8;LD24.9
Acromicric dysplasia;Q77.8;LD24.8Y
Acromicric dysplasia;Q77.8;LD24.8Y
Hereditary sensory and autonomic neuropathy type 2;G60.8;8C21.Y
Hereditary sensory and autonomic neuropathy type 2;G60.8;8C21.Y
Hereditary sensory and autonomic neuropathy type 2;G60.8;8C21.Y
Hereditary sensory and autonomic neuropathy type 2;G60.8;8C21.Y
Hereditary continuous muscle fiber activity;G71.1;8C7Y
Adams-Oliver syndrome;Q87.2;LD2F.1Y
Adams-Oliver syndrome;Q87.2;LD2F.1Y
Adams-Oliver syndrome;Q87.2;LD2F.1Y
Adams-Oliver syndrome;Q87.2;LD2F.1Y
Adams-Oliver syndrome;Q87.2;LD2F.1Y
Adams-Oliver syndrome;Q87.2;LD2F.1Y
Adenine phosphoribosyltransferase deficiency;E79.8;5C55.0Y
ADULT syndrome;Q87.2;LD27.0Y
Testicular regression syndrome;Q55.0;LD2A.Y
Tibial hemimelia-polysyndactyly-triphalangeal thumb syndrome;Q87.2;
Tibial hemimelia-polysyndactyly-triphalangeal thumb syndrome;Q87.2;
Agnathia-holoprosencephaly-situs inversus syndrome;Q87.8;
Agnathia-holoprosencephaly-situs inversus syndrome;Q87.8;
Fetal akinesia deformation sequence;Q87.8;LD2F.1Y
Fetal akinesia deformation sequence;Q87.8;LD2F.1Y
Fetal akinesia deformation sequence;Q87.8;LD2F.1Y
Fetal akinesia deformation sequence;Q87.8;LD2F.1Y
Fetal akinesia deformation sequence;Q87.8;LD2F.1Y
Fetal akinesia deformation sequence;Q87.8;LD2F.1Y
Fetal akinesia deformation sequence;Q87.8;LD2F.1Y
Ocular albinism with late-onset sensorineural deafness;E70.3;LD2H.Y
2q37 microdeletion syndrome;Q93.5;LD44.20
Autosomal dominant palmoplantar keratoderma and congenital alopecia;Q82.8;LD27.0Y
X-linked Alport syndrome-diffuse leiomyomatosis;Q87.8;LD2H.Y
X-linked Alport syndrome-diffuse leiomyomatosis;Q87.8;LD2H.Y
Early-onset autosomal dominant Alzheimer disease;G30.0;6D80.0
Early-onset autosomal dominant Alzheimer disease;G30.0;6D80.0
Early-onset autosomal dominant Alzheimer disease;G30.0;6D80.0
Early-onset autosomal dominant Alzheimer disease;G30.0;6D80.0
Early-onset autosomal dominant Alzheimer disease;G30.0;6D80.0
Early-onset autosomal dominant Alzheimer disease;G30.0;6D80.0
Early-onset autosomal dominant Alzheimer disease;G30.0;6D80.0
Enamel-renal syndrome;K00.5;LA30.6
Metaphyseal anadysplasia;Q78.5;LD24.7
Metaphyseal anadysplasia;Q78.5;LD24.7
Mosaic variegated aneuploidy syndrome;Q99.8;LD7Y
Mosaic variegated aneuploidy syndrome;Q99.8;LD7Y
Mosaic variegated aneuploidy syndrome;Q99.8;LD7Y
Mosaic variegated aneuploidy syndrome;Q99.8;LD7Y
Mosaic variegated aneuploidy syndrome;Q99.8;LD7Y
Vein of Galen aneurysmal malformation;Q28.2;LA90.20
Blue rubber bleb nevus;Q27.8;LC51
Tufted angioma;D18.0;2F2Y
Aniridia-cerebellar ataxia-intellectual disability syndrome;G11.0;
Aniridia-cerebellar ataxia-intellectual disability syndrome;G11.0;
Ankyloblepharon filiforme adnatum-cleft palate syndrome;Q87.0;LD2F.1Y
Microphthalmia with limb anomalies;Q87.2;LD21.0
Aplasia cutis congenita;Q84.8;LC60
Aplasia cutis congenita;Q84.8;LC60
Aplasia cutis congenita;Q84.8;LC60
Aplasia cutis congenita;Q84.8;LC60
Aplasia cutis congenita;Q84.8;LC60
Arnold-Chiari malformation type II;;
Neurogenic arthrogryposis multiplex congenita;Q74.3;LD26.41
Neurogenic arthrogryposis multiplex congenita;Q74.3;LD26.41
Neurogenic arthrogryposis multiplex congenita;Q74.3;LD26.41
Infantile-onset X-linked spinal muscular atrophy;G12.1;8B61.Y
Distal arthrogryposis type 1;Q68.8;LD26.4Y
Distal arthrogryposis type 1;Q68.8;LD26.4Y
Distal arthrogryposis type 1;Q68.8;LD26.4Y
Distal arthrogryposis type 1;Q68.8;LD26.4Y
Distal arthrogryposis type 1;Q68.8;LD26.4Y
Distal arthrogryposis type 1;Q68.8;LD26.4Y
Sheldon-Hall syndrome;Q68.8;LD26.4Y
Sheldon-Hall syndrome;Q68.8;LD26.4Y
Sheldon-Hall syndrome;Q68.8;LD26.4Y
Sheldon-Hall syndrome;Q68.8;LD26.4Y
Sheldon-Hall syndrome;Q68.8;LD26.4Y
Kuskokwim syndrome;Q87.2;
Arthrogryposis-oculomotor limitation-electroretinal anomalies syndrome;Q68.8;LD26.4Y
Progressive pseudorheumatoid arthropathy of childhood;Q77.7;LD24.3
NON RARE IN EUROPE: Asperger syndrome;F84.5;
NON RARE IN EUROPE: Asperger syndrome;F84.5;
Ataxia-oculomotor apraxia type 1;G11.3;5C53.22
Autosomal recessive cerebelloparenchymal disorder type 3;G11.0;
Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome;G11.1;
Cerebellar ataxia-hypogonadism syndrome;G11.8;
Cerebellar ataxia-hypogonadism syndrome;G11.8;
X-linked progressive cerebellar ataxia;G11.1;8A03.1Y
Ataxia-hypogonadism-choroidal dystrophy syndrome;G11.8;
Infantile-onset spinocerebellar ataxia;G11.1;LD90.Y
Lethal ataxia with deafness and optic atrophy;E79.8;LD2H.Y
Atelosteogenesis type I;Q78.8;LD24.E
TMEM70-related mitochondrial encephalo-cardio-myopathy;G71.3;5C53.2Y
Congenital atransferrinemia;E88.0;5D0Y
Burn-McKeown syndrome;Q87.8;
Burn-McKeown syndrome;Q87.8;
Autosomal dominant optic atrophy plus syndrome;H47.2;9C40.8
Autosomal dominant congenital benign spinal muscular atrophy;G12.1;8B61.4
Baller-Gerold syndrome;Q75.0;LD24.GY
Bamforth-Lazarus syndrome;E03.1;5A00.0Y
Congenital intrauterine infection-like syndrome;Q87.8;LD20.2
Barber-Say syndrome;Q87.0;LD27.3
Bartsocas-Papas syndrome;Q87.2;LD26.4Y
Best vitelliform macular dystrophy;H35.5;9B70
Boomerang dysplasia;Q87.1;LD24.E
Bowen-Conradi syndrome;Q87.8;LD20.2
Aymé-Gripp syndrome;Q87.8;
Brachydactyly-elbow wrist dysplasia syndrome;Q73.8;LD26.1
Brachydactyly-elbow wrist dysplasia syndrome;Q73.8;LD26.1
Brachydactyly-arterial hypertension syndrome;Q73.8;LD24.8Y
Branchio-oculo-facial syndrome;Q18.8;LD2F.1Y
Branchioskeletogenital syndrome;Q87.8;LD2F.1Y
Autosomal dominant popliteal pterygium syndrome;Q87.2;LD26.4Y
Buschke-Ollendorff syndrome;;
C syndrome;Q87.8;LD24.GY
Medullary sponge kidney;Q61.5;LB30.8
Caffey disease;M89.8;LD24.1Y
Camurati-Engelmann disease;Q78.3;LD24.1Y
Familial prostate cancer;C61;2C82.Y
Familial prostate cancer;C61;2C82.Y
Familial prostate cancer;C61;2C82.Y
Familial prostate cancer;C61;2C82.Y
Familial prostate cancer;C61;2C82.Y
Familial prostate cancer;C61;2C82.Y
Familial prostate cancer;C61;2C82.Y
Familial prostate cancer;C61;2C82.Y
Familial prostate cancer;C61;2C82.Y
Familial prostate cancer;C61;2C82.Y
Familial prostate cancer;C61;2C82.Y
Familial prostate cancer;C61;2C82.Y
Familial prostate cancer;C61;2C82.Y
Familial prostate cancer;C61;2C82.Y
Familial prostate cancer;C61;2C82.Y
Familial pancreatic carcinoma;C25;2C10.Z
Familial pancreatic carcinoma;C25;2C10.Z
Familial pancreatic carcinoma;C25;2C10.Z
Familial pancreatic carcinoma;C25;2C10.Z
Familial pancreatic carcinoma;C25;2C10.Z
Familial pancreatic carcinoma;C25;2C10.Z
Familial pancreatic carcinoma;C25;2C10.Z
Familial pancreatic carcinoma;C25;2C10.Z
Familial pancreatic carcinoma;C25;2C10.Z
Chronic mucocutaneous candidiasis;B37.2;1F23.14
Chronic mucocutaneous candidiasis;B37.2;1F23.14
Chronic mucocutaneous candidiasis;B37.2;1F23.14
Chronic mucocutaneous candidiasis;B37.2;1F23.14
Chronic mucocutaneous candidiasis;B37.2;1F23.14
Heart defect-tongue hamartoma-polysyndactyly syndrome;Q87.8;
Cardiofaciocutaneous syndrome;Q87.8;LD27.0Y
Cardiofaciocutaneous syndrome;Q87.8;LD27.0Y
Cardiofaciocutaneous syndrome;Q87.8;LD27.0Y
Cardiofaciocutaneous syndrome;Q87.8;LD27.0Y
Atrial standstill;I45.5;BC80.Y
Atrial standstill;I45.5;BC80.Y
Carey-Fineman-Ziter syndrome;Q87.0;LD2F.1Y
Carey-Fineman-Ziter syndrome;Q87.0;LD2F.1Y
Carney complex;D44.8;5A70.Y
Carney complex;D44.8;5A70.Y
Congenital cataract-hypertrophic cardiomyopathy-mitochondrial myopathy syndrome;Q87.8;5C53.Y
Congenital cataract-hypertrophic cardiomyopathy-mitochondrial myopathy syndrome;Q87.8;5C53.Y
Congenital cataract-hypertrophic cardiomyopathy-mitochondrial myopathy syndrome;Q87.8;5C53.Y
Cataract-microcornea syndrome;Q13.8;
Cataract-microcornea syndrome;Q13.8;
Cataract-microcornea syndrome;Q13.8;
Cataract-microcornea syndrome;Q13.8;
Cataract-microcornea syndrome;Q13.8;
Cataract-microcornea syndrome;Q13.8;
Cataract-microcornea syndrome;Q13.8;
Cataract-microcornea syndrome;Q13.8;
Cataract-intellectual disability-hypogonadism syndrome;Q87.8;5A61.0
Cataract-intellectual disability-hypogonadism syndrome;Q87.8;5A61.0
Catel-Manzke syndrome;Q87.8;LD2F.1Y
Cerebrocostomandibular syndrome;Q87.8;LD24.H
Cerebrofaciothoracic dysplasia;Q87.5;LD24.H
CHAND syndrome;Q82.4;LD27.0Y
Uncombable hair syndrome;Q84.1;EC21.0
Uncombable hair syndrome;Q84.1;EC21.0
Tarsal-carpal coalition syndrome;Q74.8;LD26.3
Familial calcium pyrophosphate deposition;M11.1;FA26.0
Familial calcium pyrophosphate deposition;M11.1;FA26.0
Chondrodysplasia-disorder of sex development syndrome;;
Desbuquois syndrome;Q78.8;LD24.E
Desbuquois syndrome;Q78.8;LD24.E
Desbuquois syndrome;Q78.8;LD24.E
Greenberg dysplasia;Q77.3;LD24.04
Otospondylomegaepiphyseal dysplasia;Q77.7;LD24.3
Benign hereditary chorea;G25.5;8A01.0
Benign hereditary chorea;G25.5;8A01.0
Xq21 microdeletion syndrome;Q93.5;
CINCA syndrome;E85.0;4A60.1
Cleidocranial dysplasia;Q74.0;LD24.2Y
Joubert syndrome with hepatic defect;Q04.3;LD20.0Y
Joubert syndrome with hepatic defect;Q04.3;LD20.0Y
Joubert syndrome with hepatic defect;Q04.3;LD20.0Y
Joubert syndrome with hepatic defect;Q04.3;LD20.0Y
CODAS syndrome;Q87.8;
Isolated complex III deficiency;G71.3;5C53.2Y
Isolated complex III deficiency;G71.3;5C53.2Y
Isolated complex III deficiency;G71.3;5C53.2Y
Isolated complex III deficiency;G71.3;5C53.2Y
Isolated complex III deficiency;G71.3;5C53.2Y
Isolated complex III deficiency;G71.3;5C53.2Y
Isolated complex III deficiency;G71.3;5C53.2Y
Isolated complex III deficiency;G71.3;5C53.2Y
Isolated complex III deficiency;G71.3;5C53.2Y
Isolated complex III deficiency;G71.3;5C53.2Y
Isolated complex III deficiency;G71.3;5C53.2Y
Coffin-Siris syndrome;Q87.1;LD27.0Y
Coffin-Siris syndrome;Q87.1;LD27.0Y
Coffin-Siris syndrome;Q87.1;LD27.0Y
Coffin-Siris syndrome;Q87.1;LD27.0Y
Coffin-Siris syndrome;Q87.1;LD27.0Y
Coffin-Siris syndrome;Q87.1;LD27.0Y
Coffin-Siris syndrome;Q87.1;LD27.0Y
Coffin-Siris syndrome;Q87.1;LD27.0Y
Coffin-Siris syndrome;Q87.1;LD27.0Y
Coffin-Siris syndrome;Q87.1;LD27.0Y
Coffin-Siris syndrome;Q87.1;LD27.0Y
COFS syndrome;Q87.1;LD2B
COFS syndrome;Q87.1;LD2B
COFS syndrome;Q87.1;LD2B
COFS syndrome;Q87.1;LD2B
Uveal coloboma-cleft lip and palate-intellectual disability;Q13.8;LD2F.1Y
Renal coloboma syndrome;Q60.4;LA13.7Y
Atrial septal defect-atrioventricular conduction defects syndrome;Q21.1;
NON RARE IN EUROPE: Ventricular septal defect;Q21.0;
NON RARE IN EUROPE: Ventricular septal defect;Q21.0;
NON RARE IN EUROPE: Ventricular septal defect;Q21.0;
NON RARE IN EUROPE: Ventricular septal defect;Q21.0;
NON RARE IN EUROPE: Ventricular septal defect;Q21.0;
Lethal congenital contracture syndrome type 1;Q68.8;LD26.4Y
Corneal dystrophy-perceptive deafness syndrome;H18.5;LD2H.Y
Vici syndrome;Q87.8;4A01.1Y
Corpus callosum agenesis-neuronopathy syndrome;G60.0;LD20.Y
X-linked complicated corpus callosum dysgenesis;Q04.8;LD20.Y
Adrenocortical carcinoma;C74.0;2D11.Z
Adrenocortical carcinoma;C74.0;2D11.Z
Adrenocortical carcinoma;C74.0;2D11.Z
Adrenocortical carcinoma;C74.0;2D11.Z
Adrenocortical carcinoma;C74.0;2D11.Z
Adrenocortical carcinoma;C74.0;2D11.Z
Autosomal recessive Robinow syndrome;Q87.1;LD24.A
Autosomal recessive Robinow syndrome;Q87.1;LD24.A
Coxopodopatellar syndrome;Q74.1;LD24.JY
Craniodiaphyseal dysplasia;M85.2;LD24.1Y
Cranioectodermal dysplasia;Q87.5;LD27.0Y
Cranioectodermal dysplasia;Q87.5;LD27.0Y
Cranioectodermal dysplasia;Q87.5;LD27.0Y
Cranioectodermal dysplasia;Q87.5;LD27.0Y
Cranioectodermal dysplasia;Q87.5;LD27.0Y
Cantú syndrome;Q78.8;LD2F.1Y
Cantú syndrome;Q78.8;LD2F.1Y
SPECC1L-related hypertelorism syndrome;Q87.0;
Craniofrontonasal dysplasia;Q87.1;LD25.3
Craniometaphyseal dysplasia;Q78.8;LD24.1Y
Craniometaphyseal dysplasia;Q78.8;LD24.1Y
Cranio-osteoarthropathy;M89.4;FB86.10
Craniofacial-deafness-hand syndrome;Q87.0;LD2H.Y
Jackson-Weiss syndrome;Q87.8;
Craniosynostosis, Boston type;Q75.8;LD24.GY
Crisponi syndrome;G90.8;LD26.41
Crisponi syndrome;G90.8;LD26.41
Currarino syndrome;Q87.8;LD2F.1Y
Curry-Jones syndrome;Q87.0;
Cutis gyrata-acanthosis nigricans-craniosynostosis syndrome;Q87.8;LD27.0Y
Cutis marmorata telangiectatica congenita;Q82.8;LC52
Cutis marmorata telangiectatica congenita;Q82.8;LC52
Fatal infantile cytochrome C oxidase deficiency;G71.3;8C73.Y
Fatal infantile cytochrome C oxidase deficiency;G71.3;8C73.Y
Fatal infantile cytochrome C oxidase deficiency;G71.3;8C73.Y
Fatal infantile cytochrome C oxidase deficiency;G71.3;8C73.Y
Fatal infantile cytochrome C oxidase deficiency;G71.3;8C73.Y
X-linked intellectual disability-Dandy-Walker malformation-basal ganglia disease-seizures syndrome;Q04.8;LD90
Knobloch syndrome;Q15.8;LD2F.1Y
Knobloch syndrome;Q15.8;LD2F.1Y
Common variable immunodeficiency;D83.0;4A01.0Y
Common variable immunodeficiency;D83.9;4A01.0Y
Common variable immunodeficiency;D83.1;4A01.0Y
Common variable immunodeficiency;D83.2;4A01.0Y
Common variable immunodeficiency;D83.8;4A01.0Y
Common variable immunodeficiency;D83.0;4A01.0Y
Common variable immunodeficiency;D83.9;4A01.0Y
Common variable immunodeficiency;D83.1;4A01.0Y
Common variable immunodeficiency;D83.2;4A01.0Y
Common variable immunodeficiency;D83.8;4A01.0Y
Common variable immunodeficiency;D83.0;4A01.0Y
Common variable immunodeficiency;D83.9;4A01.0Y
Common variable immunodeficiency;D83.1;4A01.0Y
Common variable immunodeficiency;D83.2;4A01.0Y
Common variable immunodeficiency;D83.8;4A01.0Y
Common variable immunodeficiency;D83.0;4A01.0Y
Common variable immunodeficiency;D83.9;4A01.0Y
Common variable immunodeficiency;D83.1;4A01.0Y
Common variable immunodeficiency;D83.2;4A01.0Y
Common variable immunodeficiency;D83.8;4A01.0Y
Common variable immunodeficiency;D83.0;4A01.0Y
Common variable immunodeficiency;D83.9;4A01.0Y
Common variable immunodeficiency;D83.1;4A01.0Y
Common variable immunodeficiency;D83.2;4A01.0Y
Common variable immunodeficiency;D83.8;4A01.0Y
Common variable immunodeficiency;D83.0;4A01.0Y
Common variable immunodeficiency;D83.9;4A01.0Y
Common variable immunodeficiency;D83.1;4A01.0Y
Common variable immunodeficiency;D83.2;4A01.0Y
Common variable immunodeficiency;D83.8;4A01.0Y
Common variable immunodeficiency;D83.0;4A01.0Y
Common variable immunodeficiency;D83.9;4A01.0Y
Common variable immunodeficiency;D83.1;4A01.0Y
Common variable immunodeficiency;D83.2;4A01.0Y
Common variable immunodeficiency;D83.8;4A01.0Y
Common variable immunodeficiency;D83.0;4A01.0Y
Common variable immunodeficiency;D83.9;4A01.0Y
Common variable immunodeficiency;D83.1;4A01.0Y
Common variable immunodeficiency;D83.2;4A01.0Y
Common variable immunodeficiency;D83.8;4A01.0Y
Common variable immunodeficiency;D83.0;4A01.0Y
Common variable immunodeficiency;D83.9;4A01.0Y
Common variable immunodeficiency;D83.1;4A01.0Y
Common variable immunodeficiency;D83.2;4A01.0Y
Common variable immunodeficiency;D83.8;4A01.0Y
Common variable immunodeficiency;D83.0;4A01.0Y
Common variable immunodeficiency;D83.9;4A01.0Y
Common variable immunodeficiency;D83.1;4A01.0Y
Common variable immunodeficiency;D83.2;4A01.0Y
Common variable immunodeficiency;D83.8;4A01.0Y
Common variable immunodeficiency;D83.0;4A01.0Y
Common variable immunodeficiency;D83.9;4A01.0Y
Common variable immunodeficiency;D83.1;4A01.0Y
Common variable immunodeficiency;D83.2;4A01.0Y
Common variable immunodeficiency;D83.8;4A01.0Y
Common variable immunodeficiency;D83.0;4A01.0Y
Common variable immunodeficiency;D83.9;4A01.0Y
Common variable immunodeficiency;D83.1;4A01.0Y
Common variable immunodeficiency;D83.2;4A01.0Y
Common variable immunodeficiency;D83.8;4A01.0Y
Hypotrichosis with juvenile macular degeneration;Q84.0;LD27.0Y
Pterin-4 alpha-carbinolamine dehydratase deficiency;E70.1;5C59.01
Monosomy 13q14;Q93.5;LD44.D
Distal monosomy 15q;;
1p36 deletion syndrome;Q93.5;LD44.11
1p36 deletion syndrome;Q93.5;LD44.11
1p36 deletion syndrome;Q93.5;LD44.11
1p36 deletion syndrome;Q93.5;LD44.11
1p36 deletion syndrome;Q93.5;LD44.11
1p36 deletion syndrome;Q93.5;LD44.11
1p36 deletion syndrome;Q93.5;LD44.11
1p36 deletion syndrome;Q93.5;LD44.11
1p36 deletion syndrome;Q93.5;LD44.11
1p36 deletion syndrome;Q93.5;LD44.11
1p36 deletion syndrome;Q93.5;LD44.11
1p36 deletion syndrome;Q93.5;LD44.11
1p36 deletion syndrome;Q93.5;LD44.11
2q24 microdeletion syndrome;;
Deletion 5q35;Q93.5;LD44.50
Deletion 5q35;Q93.5;LD44.50
Partial chromosome Y deletion;;
Partial chromosome Y deletion;;
Partial chromosome Y deletion;;
Partial chromosome Y deletion;;
Partial chromosome Y deletion;;
Partial chromosome Y deletion;;
Partial chromosome Y deletion;;
Partial chromosome Y deletion;;
NON RARE IN EUROPE: Dementia with Lewy body;;
NON RARE IN EUROPE: Dementia with Lewy body;;
NON RARE IN EUROPE: Dementia with Lewy body;;
NON RARE IN EUROPE: Dementia with Lewy body;;
Absence of fingerprints-congenital milia syndrome;Q82.8;LD27.0Y
Restrictive dermopathy;Q82.8;EE6Y
Restrictive dermopathy;Q82.8;EE6Y
Wolcott-Rallison syndrome;Q87.1;5A13.6
Dihydropyrimidine dehydrogenase deficiency;E79.8;5C55.1
17p11.2 microduplication syndrome;Q92.3;LD41.G1
22q11.2 duplication syndrome;Q92.3;LD41.M
Proximal Xq28 duplication syndrome;Q99.8;LD51
Familial dysautonomia;G90.1;8C21.1
Dysequilibrium syndrome;G11.8;
Dysequilibrium syndrome;G11.8;
Dysequilibrium syndrome;G11.8;
Dysequilibrium syndrome;G11.8;
Dysequilibrium syndrome;G11.8;
45,X/46,XY mixed gonadal dysgenesis;Q98.7;LD2A.Y
Dyskeratosis congenita;Q82.8;3A70.0
Dyskeratosis congenita;Q82.8;3A70.0
Dyskeratosis congenita;Q82.8;3A70.0
Dyskeratosis congenita;Q82.8;3A70.0
Dyskeratosis congenita;Q82.8;3A70.0
Dyskeratosis congenita;Q82.8;3A70.0
Dyskeratosis congenita;Q82.8;3A70.0
Dyskeratosis congenita;Q82.8;3A70.0
Dyskeratosis congenita;Q82.8;3A70.0
Dyskeratosis congenita;Q82.8;3A70.0
Dyskeratosis congenita;Q82.8;3A70.0
Dyskeratosis congenita;Q82.8;3A70.0
Temtamy syndrome;Q87.8;
Dysosteosclerosis;Q78.8;LD24.1Y
Dysosteosclerosis;Q78.8;LD24.1Y
Dysosteosclerosis;Q78.8;LD24.1Y
Acrofacial dysostosis, Rodríguez type;Q75.4;LD25.2
Autosomal dominant spondylocostal dysostosis;Q76.4;LD24.H
Ghosal hematodiaphyseal dysplasia;Q78.8;LD24.1Y
Focal facial dermal dysplasia type III;Q82.8;LD27.0Y
Autosomal dominant hypohidrotic ectodermal dysplasia;Q82.4;LD27.02
Autosomal dominant hypohidrotic ectodermal dysplasia;Q82.4;LD27.02
Autosomal dominant hypohidrotic ectodermal dysplasia;Q82.4;LD27.02
Autosomal dominant hypohidrotic ectodermal dysplasia;Q82.4;LD27.02
Frontometaphyseal dysplasia;Q78.5;LD25.1
Frontometaphyseal dysplasia;Q78.5;LD25.1
Acromelic frontonasal dysplasia;Q75.8;LD25.3
Schimke immuno-osseous dysplasia;Q77.7;4A01.32
Lethal osteosclerotic bone dysplasia;Q78.8;
Renal agenesis, bilateral;Q60.1;LB30.00
Renal agenesis, bilateral;Q60.1;LB30.00
Renal agenesis, bilateral;Q60.1;LB30.00
Renal agenesis, bilateral;Q60.1;LB30.00
Renal agenesis, bilateral;Q60.1;LB30.00
Renal agenesis, bilateral;Q60.1;LB30.00
Spondyloenchondrodysplasia;Q77.7;LD24.3
Spondyloperipheral dysplasia-short ulna syndrome;Q77.7;LD24.3
Thanatophoric dysplasia type 1;Q77.1;LD24.02
Dyssegmental dysplasia, Silverman-Handmaker type;Q77.7;LD24.3
Progressive cone dystrophy;H35.5;9B70
Progressive cone dystrophy;H35.5;9B70
Progressive cone dystrophy;H35.5;9B70
Progressive cone dystrophy;H35.5;9B70
Cone rod dystrophy;H35.5;9B70
Cone rod dystrophy;H35.5;9B70
Cone rod dystrophy;H35.5;9B70
Cone rod dystrophy;H35.5;9B70
Cone rod dystrophy;H35.5;9B70
Cone rod dystrophy;H35.5;9B70
Cone rod dystrophy;H35.5;9B70
Cone rod dystrophy;H35.5;9B70
Cone rod dystrophy;H35.5;9B70
Cone rod dystrophy;H35.5;9B70
Cone rod dystrophy;H35.5;9B70
Cone rod dystrophy;H35.5;9B70
Cone rod dystrophy;H35.5;9B70
Cone rod dystrophy;H35.5;9B70
Cone rod dystrophy;H35.5;9B70
Cone rod dystrophy;H35.5;9B70
Cone rod dystrophy;H35.5;9B70
Cone rod dystrophy;H35.5;9B70
Cone rod dystrophy;H35.5;9B70
Cone rod dystrophy;H35.5;9B70
Cone rod dystrophy;H35.5;9B70
Cone rod dystrophy;H35.5;9B70
Cone rod dystrophy;H35.5;9B70
Cone rod dystrophy;H35.5;9B70
Cone rod dystrophy;H35.5;9B70
Cone rod dystrophy;H35.5;9B70
Cone rod dystrophy;H35.5;9B70
Cone rod dystrophy;H35.5;9B70
Cone rod dystrophy;H35.5;9B70
Cone rod dystrophy;H35.5;9B70
Jalili syndrome;H35.5;LA30.6
TRIM32-related limb-girdle muscular dystrophy R8;G71.0;8C70.41
Melorheostosis with osteopoikilosis;M85.8;LD24.1Y
Ebstein malformation of the tricuspid valve;Q22.5;LA87.03
Isolated ectopia lentis;Q12.1;LA12.Y
Isolated ectopia lentis;Q12.1;LA12.Y
EEC syndrome;Q82.4;LD27.0Y
EEM syndrome;Q87.8;LD27.0Y
Arthrochalasia Ehlers-Danlos syndrome;Q79.6;LD28.1Y
Arthrochalasia Ehlers-Danlos syndrome;Q79.6;LD28.1Y
Kyphoscoliotic Ehlers-Danlos syndrome due to lysyl hydroxylase 1 deficiency;Q79.6;LD28.1Y
Dermatosparaxis Ehlers-Danlos syndrome;Q79.6;LD28.1Y
Dermatosparaxis Ehlers-Danlos syndrome;Q79.6;LD28.1Y
Herpes simplex virus encephalitis;B00.4+;1F00.21
Herpes simplex virus encephalitis;G05.1*;1F00.21
Herpes simplex virus encephalitis;B00.4+;1F00.21
Herpes simplex virus encephalitis;G05.1*;1F00.21
Herpes simplex virus encephalitis;B00.4+;1F00.21
Herpes simplex virus encephalitis;G05.1*;1F00.21
Herpes simplex virus encephalitis;B00.4+;1F00.21
Herpes simplex virus encephalitis;G05.1*;1F00.21
Herpes simplex virus encephalitis;B00.4+;1F00.21
Herpes simplex virus encephalitis;G05.1*;1F00.21
Mitochondrial DNA depletion syndrome, encephalomyopathic form with methylmalonic aciduria;G71.3;5C53.20
Early infantile epileptic encephalopathy;G40.3;8A62.Y
Early infantile epileptic encephalopathy;G40.3;8A62.Y
Early infantile epileptic encephalopathy;G40.3;8A62.Y
Early infantile epileptic encephalopathy;G40.3;8A62.Y
Early infantile epileptic encephalopathy;G40.3;8A62.Y
Early infantile epileptic encephalopathy;G40.3;8A62.Y
Early infantile epileptic encephalopathy;G40.3;8A62.Y
Early infantile epileptic encephalopathy;G40.3;8A62.Y
Early infantile epileptic encephalopathy;G40.3;8A62.Y
Early infantile epileptic encephalopathy;G40.3;8A62.Y
Early infantile epileptic encephalopathy;G40.3;8A62.Y
Early infantile epileptic encephalopathy;G40.3;8A62.Y
Early infantile epileptic encephalopathy;G40.3;8A62.Y
Early infantile epileptic encephalopathy;G40.3;8A62.Y
Early infantile epileptic encephalopathy;G40.3;8A62.Y
Early infantile epileptic encephalopathy;G40.3;8A62.Y
Early infantile epileptic encephalopathy;G40.3;8A62.Y
Early myoclonic encephalopathy;G40.4;8A61.0Y
Early myoclonic encephalopathy;G40.4;8A61.0Y
Juvenile absence epilepsy;G40.3;8A61.31
Myoclonic-astatic epilepsy;G40.4;8A61.22
Myoclonic-astatic epilepsy;G40.4;8A61.22
Myoclonic-astatic epilepsy;G40.4;8A61.22
Myoclonic-astatic epilepsy;G40.4;8A61.22
Myoclonic-astatic epilepsy;G40.4;8A61.22
Myoclonic-astatic epilepsy;G40.4;8A61.22
Myoclonic-astatic epilepsy;G40.4;8A61.22
Rolandic epilepsy;G40.0;8A61.20
Rolandic epilepsy;G40.0;8A61.20
Rolandic epilepsy;G40.0;8A61.20
Amelocerebrohypohidrotic syndrome;G40.8;LD27.0Y
Amelocerebrohypohidrotic syndrome;G40.8;LD27.0Y
Progressive epilepsy-intellectual disability syndrome, Finnish type;E75.4;5C56.1
Benign familial neonatal epilepsy;G40.3;8A61.0Y
Benign familial neonatal epilepsy;G40.3;8A61.0Y
Spinocerebellar ataxia type 34;G11.1;8A03.16
Bilateral striopallidodentate calcinosis;G23.8;LD20.4
Bilateral striopallidodentate calcinosis;G23.8;LD20.4
Bilateral striopallidodentate calcinosis;G23.8;LD20.4
Bilateral striopallidodentate calcinosis;G23.8;LD20.4
Bilateral striopallidodentate calcinosis;G23.8;LD20.4
Bilateral striopallidodentate calcinosis;G23.8;LD20.4
Gollop-Wolfgang complex;Q74.8;LD26.0
Blepharo-cheilo-odontic syndrome;Q87.8;LD27.0Y
Blepharo-cheilo-odontic syndrome;Q87.8;LD27.0Y
Congenital fiber-type disproportion myopathy;G71.2;8C72.1
Congenital fiber-type disproportion myopathy;G71.2;8C72.1
Congenital fiber-type disproportion myopathy;G71.2;8C72.1
Congenital fiber-type disproportion myopathy;G71.2;8C72.1
Congenital fiber-type disproportion myopathy;G71.2;8C72.1
Congenital fiber-type disproportion myopathy;G71.2;8C72.1
Congenital fiber-type disproportion myopathy;G71.2;8C72.1
Congenital fiber-type disproportion myopathy;G71.2;8C72.1
Fibrochondrogenesis;Q77.7;LD24.3
Fibrochondrogenesis;Q77.7;LD24.3
Hereditary gingival fibromatosis;K06.1;DA0B.Y
Hereditary gingival fibromatosis;K06.1;DA0B.Y
Gingival fibromatosis-hypertrichosis syndrome;L68.8;LD27.0Y
Juvenile hyaline fibromatosis;M72.8;EE6Y
Fibrosarcoma;C49.9;
Fibrosarcoma;C49.9;
Idiopathic pulmonary fibrosis;J84.1;CB03.4
Idiopathic pulmonary fibrosis;J84.1;CB03.4
Idiopathic pulmonary fibrosis;J84.1;CB03.4
Idiopathic pulmonary fibrosis;J84.1;CB03.4
Idiopathic pulmonary fibrosis;J84.1;CB03.4
Idiopathic pulmonary fibrosis;J84.1;CB03.4
Idiopathic pulmonary fibrosis;J84.1;CB03.4
Idiopathic pulmonary fibrosis;J84.1;CB03.4
Idiopathic pulmonary fibrosis;J84.1;CB03.4
Idiopathic pulmonary fibrosis;J84.1;CB03.4
Idiopathic pulmonary fibrosis;J84.1;CB03.4
Idiopathic pulmonary fibrosis;J84.1;CB03.4
Idiopathic pulmonary fibrosis;J84.1;CB03.4
Scalp-ear-nipple syndrome;Q87.8;LD27.0Y
Floating-Harbor syndrome;Q87.8;LD2F.1Y
Cole-Carpenter syndrome;Q78.0;LD24.KY
Cole-Carpenter syndrome;Q78.0;LD24.KY
Fraser syndrome;Q87.0;LD2H.0
Fraser syndrome;Q87.0;LD2H.0
Fraser syndrome;Q87.0;LD2H.0
Freeman-Sheldon syndrome;Q87.0;LD26.4Y
Freeman-Sheldon syndrome;Q87.0;LD26.4Y
Essential fructosuria;E74.1;5C51.5Y
Fryns syndrome;Q87.8;LD2F.1Y
Galloway-Mowat syndrome;Q04.3;GB41
Galloway-Mowat syndrome;Q04.3;GB41
Galloway-Mowat syndrome;Q04.3;GB41
Galloway-Mowat syndrome;Q04.3;GB41
Galloway-Mowat syndrome;Q04.3;GB41
Galloway-Mowat syndrome;Q04.3;GB41
Galloway-Mowat syndrome;Q04.3;GB41
Galloway-Mowat syndrome;Q04.3;GB41
Gamma-aminobutyric acid transaminase deficiency;E72.8;5C59.1
GAPO syndrome;Q87.8;LD27.0Y
Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome;E75.2;5C56.0Y
Narcolepsy type 1;G47.4;7A20.0
Narcolepsy type 1;G47.4;7A20.0
Narcolepsy type 1;G47.4;7A20.0
Narcolepsy type 1;G47.4;7A20.0
Narcolepsy type 1;G47.4;7A20.0
Narcolepsy type 1;G47.4;7A20.0
Narcolepsy type 1;G47.4;7A20.0
Narcolepsy type 1;G47.4;7A20.0
Geroderma osteodysplastica;Q82.8;LD2B
Geroderma osteodysplastica;Q82.8;LD2B
Glaucoma-ectopia lentis-microspherophakia-stiff joints-short stature syndrome;Q87.1;
Fanconi-Bickel syndrome;E74.0;5C51.3
Glycogen storage disease due to hepatic glycogen synthase deficiency;E74.0;5C51.3
Focal dermal hypoplasia;Q82.8;LD27.0Y
Gorlin-Chaudhry-Moss syndrome;Q87.0;LD27.0Y
Acromesomelic dysplasia, Grebe type;Q78.8;LD24.9
Acromesomelic dysplasia, Grebe type;Q78.8;LD24.9
GTP cyclohydrolase I deficiency;E70.1;5C59.01
Hip dysplasia, Beukes type;Q65.8;LD24.6Y
Hartnup disease;E72.0;5C60.Y
Hartnup disease;E72.0;5C60.Y
Hartsfield syndrome;Q87.8;
Hawkinsinuria;E70.2;5C50.1Y
Kaposiform hemangioendothelioma;C49.9;XH6PA4
Kaposiform hemangioendothelioma;C49.9;2F72.Y
Solitary fibrous tumor/hemangiopericytoma;;
Solitary fibrous tumor/hemangiopericytoma;;
Isolated hemihyperplasia;Q87.3;LD2C
Alternating hemiplegia of childhood;G98;MB53.0
Alternating hemiplegia of childhood;G98;MB53.0
Alternating hemiplegia of childhood;G98;MB53.0
Alternating hemiplegia of childhood;G98;MB53.0
Hemoglobin C disease;D58.2;3A51.5
Hemoglobin E disease;D58.2;3A51.A
Hennekam syndrome;Q87.8;BD93.0
Hennekam syndrome;Q87.8;BD93.0
Hennekam syndrome;Q87.8;BD93.0
46,XX ovotesticular disorder of sex development;;
46,XX ovotesticular disorder of sex development;;
46,XX ovotesticular disorder of sex development;;
Congenital diaphragmatic hernia;Q79.0;LB00.0
Congenital diaphragmatic hernia;Q79.0;LB00.0
Congenital diaphragmatic hernia;Q79.0;LB00.0
Donnai-Barrow syndrome;Q87.8;LD2F.1Y
Lissencephaly type 1 due to doublecortin gene mutation;Q04.3;LD20.1
Hirschsprung disease-ganglioneuroblastoma syndrome;Q43.1;
Histidinemia;E70.8;5C50.20
Methylcobalamin deficiency type cblE;E72.1;5C50.B
Methylcobalamin deficiency type cblG;E72.1;5C50.B
Infantile systemic hyalinosis;E78.8;EE6Y
Hydranencephaly;Q04.3;LA05.62
Hydrocephalus with stenosis of the aqueduct of Sylvius;Q03.0;LA04.0
Hydrolethalus;Q87.8;LD2F.1Y
Hydrolethalus;Q87.8;LD2F.1Y
Dicarboxylic aminoaciduria;E72.0;5C60.Y
Primary hypomagnesemia with hypercalciuria and nephrocalcinosis with severe ocular involvement;E83.4;5C64.41
Idiopathic hypercalciuria;E83.5;MF98.0
Palmoplantar keratoderma-esophageal carcinoma syndrome;Q82.8;EC20.31
Epidermolytic palmoplantar keratoderma;Q82.8;EC20.30
Epidermolytic palmoplantar keratoderma;Q82.8;EC20.30
Epidermolytic palmoplantar keratoderma;Q82.8;EC20.30
Palmoplantar keratoderma-deafness syndrome;Q82.8;EC20.30
Hyperlysinemia;E72.3;5C50.4
Maternal phenylketonuria;E70.1;5C50.02
Hypertryptophanemia;E70.8;5C50.3
NON RARE IN EUROPE: Hypodontia;;
NON RARE IN EUROPE: Hypodontia;;
NON RARE IN EUROPE: Hypodontia;;
NON RARE IN EUROPE: Hypodontia;;
NON RARE IN EUROPE: Hypodontia;;
NON RARE IN EUROPE: Hypodontia;;
NON RARE IN EUROPE: Hypodontia;;
NON RARE IN EUROPE: Hypodontia;;
NON RARE IN EUROPE: Hypodontia;;
NON RARE IN EUROPE: Hypodontia;;
Hypodontia-dysplasia of nails syndrome;Q82.4;LD27.0Y
Dilated cardiomyopathy-hypergonadotropic hypogonadism syndrome;I42.0;
Hypoparathyroidism-sensorineural deafness-renal disease syndrome;Q87.8;LD27.0Y
Familial isolated hypoparathyroidism due to agenesis of parathyroid gland;E20.8;5A50.0Y
Megacystis-microcolon-intestinal hypoperistalsis syndrome;Q43.8;LD2F.1Y
Megacystis-microcolon-intestinal hypoperistalsis syndrome;Q43.8;LD2F.1Y
Megacystis-microcolon-intestinal hypoperistalsis syndrome;Q43.8;LD2F.1Y
Megacystis-microcolon-intestinal hypoperistalsis syndrome;Q43.8;LD2F.1Y
Hypoplastic left heart syndrome;Q23.4;LA89.3
Hypoplastic left heart syndrome;Q23.4;LA89.3
Hyposmia-nasal and ocular hypoplasia-hypogonadotropic hypogonadism syndrome;Q87.0;
Foveal hypoplasia-presenile cataract syndrome;H26.0;9C2Y
Pontocerebellar hypoplasia type 1;Q04.3;LD20.01
Pontocerebellar hypoplasia type 1;Q04.3;LD20.01
Pontocerebellar hypoplasia type 1;Q04.3;LD20.01
Pontocerebellar hypoplasia type 1;Q04.3;LD20.01
Pontocerebellar hypoplasia type 1;Q04.3;LD20.01
Pontocerebellar hypoplasia type 1;Q04.3;LD20.01
Pancreatic hypoplasia-diabetes-congenital heart disease syndrome;Q87.8;
ICF syndrome;D84.8;4A01.00
ICF syndrome;D84.8;4A01.00
ICF syndrome;D84.8;4A01.00
ICF syndrome;D84.8;4A01.00
Ichthyosis follicularis-alopecia-photophobia syndrome;Q80.8;LD27.2
Neuronal intranuclear inclusion disease;G31.0;8A0Y
Microvillus inclusion disease;P78.3;DA90.Y
Microvillus inclusion disease;P78.3;DA90.Y
Insulin-resistance syndrome type A;E34.8;5A44
Multiple intestinal atresia;Q43.8;LB15.1
Congenital short bowel syndrome;Q43.8;LB15.2
Congenital short bowel syndrome;Q43.8;LB15.2
IVIC syndrome;Q71.8;
Jacobsen syndrome;Q93.5;LD44.B0
Pachyonychia congenita;Q84.5;LD27.Y
Pachyonychia congenita;Q84.5;LD27.Y
Pachyonychia congenita;Q84.5;LD27.Y
Pachyonychia congenita;Q84.5;LD27.Y
Autosomal recessive spondylocostal dysostosis;Q76.8;LD24.H
Autosomal recessive spondylocostal dysostosis;Q76.8;LD24.H
Autosomal recessive spondylocostal dysostosis;Q76.8;LD24.H
Autosomal recessive spondylocostal dysostosis;Q76.8;LD24.H
Autosomal recessive spondylocostal dysostosis;Q76.8;LD24.H
Transient familial neonatal hyperbilirubinemia;P59.8;
Autosomal dominant hyper-IgE syndrome;;
Johanson-Blizzard syndrome;Q87.8;LD27.0Y
Joubert syndrome with oculorenal defect;Q04.3;LD20.0Y
Joubert syndrome with oculorenal defect;Q04.3;LD20.0Y
Joubert syndrome with oculorenal defect;Q04.3;LD20.0Y
Joubert syndrome with oculorenal defect;Q04.3;LD20.0Y
Joubert syndrome with oculorenal defect;Q04.3;LD20.0Y
Joubert syndrome with oculorenal defect;Q04.3;LD20.0Y
Joubert syndrome with oculorenal defect;Q04.3;LD20.0Y
Juberg-Hayward syndrome;Q87.0;LD2F.1Y
Kabuki syndrome;Q87.0;LD2F.1Y
Kabuki syndrome;Q87.0;LD2F.1Y
Sanjad-Sakati syndrome;Q87.1;LD24.D
KBG syndrome;Q87.8;LD2F.1Y
Autosomal dominant keratitis;H16.8;9A7Y
NON RARE IN EUROPE: Isolated keratoconus;;
Non-epidermolytic palmoplantar keratoderma;;
Keratosis follicularis spinulosa decalvans;Q82.8;ED56
Keratosis follicularis spinulosa decalvans;Q82.8;ED56
Keratosis follicularis spinulosa decalvans;Q82.8;ED56
Haim-Munk syndrome;Q82.8;
Isolated Klippel-Feil syndrome;Q76.1;LB73.20
Isolated Klippel-Feil syndrome;Q76.1;LB73.20
Isolated Klippel-Feil syndrome;Q76.1;LB73.20
Familial partial lipodystrophy, Dunnigan type;E88.1;5A44
Schilbach-Rott syndrome;Q87.8;LD2F.1Y
Lacrimoauriculodentodigital syndrome;Q87.8;LD27.0Y
Lacrimoauriculodentodigital syndrome;Q87.8;LD27.0Y
Lacrimoauriculodentodigital syndrome;Q87.8;LD27.0Y
Laurence-Moon syndrome;Q87.8;LD90.Y
Laurin-Sandrow syndrome;Q87.2;LD26.2
Early-onset parkinsonism-intellectual disability syndrome;G20;LD90.1
Legg-Calvé-Perthes disease;M91.1;FB82.1
Lennox-Gastaut syndrome;G40.4;8A62.1
Lennox-Gastaut syndrome;G40.4;8A62.1
Lennox-Gastaut syndrome;G40.4;8A62.1
Lennox-Gastaut syndrome;G40.4;8A62.1
Lennox-Gastaut syndrome;G40.4;8A62.1
Lennox-Gastaut syndrome;G40.4;8A62.1
Lennox-Gastaut syndrome;G40.4;8A62.1
Leukonychia totalis;Q84.4;EC22.0
Choreoacanthocytosis;E78.6;3A10.Y
Pyruvate dehydrogenase E3 deficiency;E74.4;5C53.02
Encephalocraniocutaneous lipomatosis;E88.2;EF02.1
Encephalocraniocutaneous lipomatosis;E88.2;EF02.1
Multiple symmetric lipomatosis;E88.8;EF02.1
Laryngo-onycho-cutaneous syndrome;Q81.8;EC31
Hand-foot-genital syndrome;Q51.2;LD2F.1Y
Isolated split hand-split foot malformation;Q74.8;
Isolated split hand-split foot malformation;Q74.8;
Isolated split hand-split foot malformation;Q74.8;
Isolated split hand-split foot malformation;Q74.8;
Isolated split hand-split foot malformation;Q74.8;
Isolated split hand-split foot malformation;Q74.8;
Isolated split hand-split foot malformation;Q74.8;
Isolated split hand-split foot malformation;Q74.8;
Mucocutaneous venous malformations;Q27.8;LC51
Van den Ende-Gupta syndrome;Q87.0;LD26.41
Marden-Walker syndrome;Q87.0;LD26.41
Shprintzen-Goldberg syndrome;Q87.8;LD28.0Y
Shprintzen-Goldberg syndrome;Q87.8;LD28.0Y
MASA syndrome;G11.4;8B44.02
Matthew-Wood syndrome;Q11.2;LD21.0
Matthew-Wood syndrome;Q11.2;LD21.0
McKusick-Kaufman syndrome;Q87.8;9B70
Megalencephalic leukoencephalopathy with subcortical cysts;E75.2;8A44.3
Megalencephalic leukoencephalopathy with subcortical cysts;E75.2;8A44.3
Melnick-Needles syndrome;Q77.8;LD25.1
Meningioma;D32.9;2A01.0
Meningioma;D32.9;2A01.0
Meningioma;D32.9;2A01.0
Meningioma;D32.9;2A01.0
Meningioma;D32.9;2A01.0
Meningioma;D32.9;2A01.0
Meningioma;D32.9;2A01.0
Meningioma;D32.9;2A01.0
Meningioma;D32.9;2A01.0
Meningioma;D32.9;2A01.0
Meningioma;D32.9;2A01.0
Syndactyly type 8;Q70.0;LB79.Y
Metachondromatosis;Q78.4;LD24.2Y
Acrogeria;L90.8;LD2B
Metaphyseal chondrodysplasia, Spahr type;Q78.5;LD24.7
Metaphyseal dysplasia-maxillary hypoplasia-brachydacty syndrome;Q77.8;LD24.7
Multiple benign circumferential skin creases on limbs;Q82.8;
Multiple benign circumferential skin creases on limbs;Q82.8;
Corpus callosum agenesis-abnormal genitalia syndrome;Q87.8;
Micro syndrome;Q87.0;LD20.1
Micro syndrome;Q87.0;LD20.1
Micro syndrome;Q87.0;LD20.1
Micro syndrome;Q87.0;LD20.1
Autosomal recessive primary microcephaly;Q02;LA05.0
Autosomal recessive primary microcephaly;Q02;LA05.0
Autosomal recessive primary microcephaly;Q02;LA05.0
Autosomal recessive primary microcephaly;Q02;LA05.0
Autosomal recessive primary microcephaly;Q02;LA05.0
Autosomal recessive primary microcephaly;Q02;LA05.0
Autosomal recessive primary microcephaly;Q02;LA05.0
Autosomal recessive primary microcephaly;Q02;LA05.0
Autosomal recessive primary microcephaly;Q02;LA05.0
Autosomal recessive primary microcephaly;Q02;LA05.0
Autosomal recessive primary microcephaly;Q02;LA05.0
Autosomal recessive primary microcephaly;Q02;LA05.0
Autosomal recessive primary microcephaly;Q02;LA05.0
Autosomal recessive primary microcephaly;Q02;LA05.0
Autosomal recessive primary microcephaly;Q02;LA05.0
Autosomal recessive primary microcephaly;Q02;LA05.0
Autosomal recessive primary microcephaly;Q02;LA05.0
Autosomal recessive primary microcephaly;Q02;LA05.0
Autosomal recessive primary microcephaly;Q02;LA05.0
Autosomal recessive primary microcephaly;Q02;LA05.0
Autosomal recessive primary microcephaly;Q02;LA05.0
Autosomal recessive primary microcephaly;Q02;LA05.0
Autosomal recessive primary microcephaly;Q02;LA05.0
Autosomal recessive primary microcephaly;Q02;LA05.0
Autosomal recessive primary microcephaly;Q02;LA05.0
Autosomal dominant primary microcephaly;Q02;LA05.0
Autosomal dominant primary microcephaly;Q02;LA05.0
Autosomal recessive chorioretinopathy-microcephaly syndrome;Q87.8;9B61
Autosomal recessive chorioretinopathy-microcephaly syndrome;Q87.8;9B61
Autosomal recessive chorioretinopathy-microcephaly syndrome;Q87.8;9B61
Pontocerebellar hypoplasia type 2;Q04.3;LD20.01
Pontocerebellar hypoplasia type 2;Q04.3;LD20.01
Pontocerebellar hypoplasia type 2;Q04.3;LD20.01
Pontocerebellar hypoplasia type 2;Q04.3;LD20.01
Pontocerebellar hypoplasia type 2;Q04.3;LD20.01
Microcephaly-lymphedema-chorioretinopathy syndrome;Q87.8;BD93.0
Ear-patella-short stature syndrome;Q87.1;LD24.JY
Ear-patella-short stature syndrome;Q87.1;LD24.JY
Ear-patella-short stature syndrome;Q87.1;LD24.JY
Ear-patella-short stature syndrome;Q87.1;LD24.JY
Ear-patella-short stature syndrome;Q87.1;LD24.JY
Ear-patella-short stature syndrome;Q87.1;LD24.JY
Ear-patella-short stature syndrome;Q87.1;LD24.JY
Microphthalmia with linear skin defects syndrome;Q11.2;LD21.0
Microphthalmia with linear skin defects syndrome;Q11.2;LD21.0
Microphthalmia with linear skin defects syndrome;Q11.2;LD21.0
Lethal intrauterine growth restriction-cortical malformation-congenital contractures syndrome;Q04.2;
Moyamoya disease;I67.5;8B22.B
Moyamoya disease;I67.5;8B22.B
Moyamoya disease;I67.5;8B22.B
Mulibrey nanism;Q87.1;LD2F.1Y
Classic mycosis fungoides;C84.0;
Classic mycosis fungoides;C84.0;
Classic mycosis fungoides;C84.0;
Ataxia-pancytopenia syndrome;D61.0;
Myeloperoxidase deficiency;E80.3;4A00.0Y
Myhre syndrome;Q87.8;
Spinal muscular atrophy-progressive myoclonic epilepsy syndrome;G25.3;
Infantile myofibromatosis;D48.1;2F7C
Infantile myofibromatosis;D48.1;2F7C
Tubular aggregate myopathy;G71.2;8C72.Y
Tubular aggregate myopathy;G71.2;8C72.Y
Tubular aggregate myopathy;G71.2;8C72.Y
Mitochondrial myopathy and sideroblastic anemia;G71.3;3A72.0Y
Mitochondrial myopathy and sideroblastic anemia;G71.3;3A72.0Y
Familial visceral myopathy;K56.0;DA90.2
Isolated complex I deficiency;G71.3;5C53.2Y
Isolated complex I deficiency;G71.3;5C53.2Y
Isolated complex I deficiency;G71.3;5C53.2Y
Isolated complex I deficiency;G71.3;5C53.2Y
Isolated complex I deficiency;G71.3;5C53.2Y
Isolated complex I deficiency;G71.3;5C53.2Y
Isolated complex I deficiency;G71.3;5C53.2Y
Isolated complex I deficiency;G71.3;5C53.2Y
Isolated complex I deficiency;G71.3;5C53.2Y
Isolated complex I deficiency;G71.3;5C53.2Y
Isolated complex I deficiency;G71.3;5C53.2Y
Isolated complex I deficiency;G71.3;5C53.2Y
Isolated complex I deficiency;G71.3;5C53.2Y
Isolated complex I deficiency;G71.3;5C53.2Y
Isolated complex I deficiency;G71.3;5C53.2Y
Isolated complex I deficiency;G71.3;5C53.2Y
Isolated complex I deficiency;G71.3;5C53.2Y
Isolated complex I deficiency;G71.3;5C53.2Y
Isolated complex I deficiency;G71.3;5C53.2Y
Isolated complex I deficiency;G71.3;5C53.2Y
Isolated complex I deficiency;G71.3;5C53.2Y
Isolated complex I deficiency;G71.3;5C53.2Y
Isolated complex I deficiency;G71.3;5C53.2Y
Isolated complex I deficiency;G71.3;5C53.2Y
Isolated complex I deficiency;G71.3;5C53.2Y
Isolated complex I deficiency;G71.3;5C53.2Y
Isolated complex I deficiency;G71.3;5C53.2Y
Isolated complex I deficiency;G71.3;5C53.2Y
Isolated complex I deficiency;G71.3;5C53.2Y
Linear nevus sebaceus syndrome;Q85.8;LD2D.Y
Linear nevus sebaceus syndrome;Q85.8;LD2D.Y
Linear nevus sebaceus syndrome;Q85.8;LD2D.Y
Nail-patella-like renal disease;N07.8;
Nail-patella syndrome;Q87.2;LD24.J0
3M syndrome;Q87.1;LD24.D
3M syndrome;Q87.1;LD24.D
3M syndrome;Q87.1;LD24.D
Geleophysic dysplasia;Q87.1;LD24.8Y
Geleophysic dysplasia;Q87.1;LD24.8Y
Geleophysic dysplasia;Q87.1;LD24.8Y
Langer mesomelic dysplasia;Q87.1;LD24.A
Metatropic dysplasia;Q77.8;LD24.3
Microcephalic osteodysplastic primordial dwarfism type II;Q87.1;LD20.2
Fibular aplasia-complex brachydactyly syndrome;Q73.8;LD26.0
Fibular aplasia-complex brachydactyly syndrome;Q73.8;LD26.0
Osteoglosphonic dysplasia;Q87.1;LD24.2Y
Parastremmatic dwarfism;;
Lenz-Majewski hyperostotic dwarfism;Q87.1;LD24.1Y
Keipert syndrome;Q87.0;
Congenital mesoblastic nephroma;D41.0;2C90.Y
Congenital mesoblastic nephroma;D41.0;2C90.Y
Pierson syndrome;Q13.8;GB41
Hypomyelination neuropathy-arthrogryposis syndrome;Q68.8;
Hypomyelination neuropathy-arthrogryposis syndrome;Q68.8;
Hypomyelination neuropathy-arthrogryposis syndrome;Q68.8;
Cyclic neutropenia;D70;4B00.00
Arthrogryposis-renal dysfunction-cholestasis syndrome;Q89.7;5C58.0Y
Arthrogryposis-renal dysfunction-cholestasis syndrome;Q89.7;5C58.0Y
Knuckle pads-leukonychia-sensorineural deafness-palmoplantar hyperkeratosis syndrome;Q82.8;LD2H.Y
Noonan syndrome-like disorder with loose anagen hair;Q87.1;LD2F.1Y
Noonan syndrome-like disorder with loose anagen hair;Q87.1;LD2F.1Y
Ochoa syndrome;;
Ochoa syndrome;;
Oculocerebrofacial syndrome, Kaufman type;Q87.0;
Oculodentodigital dysplasia;Q87.8;LD27.0Y
Oculofaciocardiodental syndrome;Q87.8;LD21.0
Oculotrichoanal syndrome;Q87.8;
Odonto-onycho-dermal dysplasia;Q82.4;LD27.0Y
Eye defects-arachnodactyly-cardiopathy syndrome;;
Blepharophimosis-intellectual disability syndrome, Ohdo type;Q87.8;LD2F.1Y
Horizontal gaze palsy with progressive scoliosis;H49.4;9C83.00
Horizontal gaze palsy with progressive scoliosis;H49.4;9C83.00
Opitz GBBB syndrome;Q87.8;
Opsismodysplasia;Q78.8;LD24.5Y
Orofaciodigital syndrome type 1;Q87.0;LD25.00
Orofaciodigital syndrome type 2;Q87.0;LD25.00
Orofaciodigital syndrome type 3;;
Orofaciodigital syndrome type 4;Q87.0;LD25.00
Orofaciodigital syndrome type 6;Q04.3;LD25.00
Orofaciodigital syndrome type 6;Q04.3;LD25.00
Orofaciodigital syndrome type 6;Q04.3;LD25.00
Orofaciodigital syndrome type 6;Q04.3;LD25.00
Orofaciodigital syndrome type 6;Q04.3;LD25.00
Orofaciodigital syndrome type 6;Q04.3;LD25.00
Orofaciodigital syndrome type 6;Q04.3;LD25.00
Orofaciodigital syndrome type 6;Q04.3;LD25.00
Orofaciodigital syndrome type 6;Q04.3;LD25.00
Progressive osseous heteroplasia;M61.5;FB31.0
Osteocraniostenosis;Q78.0;LD24.D
Nasu-Hakola disease;G31.8;8A44.3
Nasu-Hakola disease;G31.8;8A44.3
Bruck syndrome;M21.8;LD24.KY
Bruck syndrome;M21.8;LD24.KY
Multicentric carpo-tarsal osteolysis with or without nephropathy;M89.5;FB86.2
Osteopathia striata-cranial sclerosis syndrome;Q78.8;LD24.1Y
Autosomal dominant osteopetrosis type 1;Q78.2;LD24.10
Osteopetrosis with renal tubular acidosis;Q78.2;LD24.10
Osteoporosis-pseudoglioma syndrome;Q87.5;LD24.KY
Lateral meningocele syndrome;Q87.5;LA07.Y
Endosteal hyperostosis, Worth type;Q78.2;LD24.1Y
Otodental syndrome;K00.2;LA30.4
Otofaciocervical syndrome;Q87.0;
Otofaciocervical syndrome;Q87.0;
Pachydermoperiostosis;M89.4;FB86.10
Pachydermoperiostosis;M89.4;FB86.10
Juvenile Paget disease;M88.0;FB85.0
Juvenile Paget disease;M88.8;FB85.0
Juvenile Paget disease;M88.9;FB85.0
Juvenile Paget disease;M88.0;FB85.0
Juvenile Paget disease;M88.8;FB85.0
Juvenile Paget disease;M88.9;FB85.0
X-linked sideroblastic anemia and spinocerebellar ataxia;D64.0;3A72.01
Partial pancreatic agenesis;Q45.0;LB21.4
Partial pancreatic agenesis;Q45.0;LB21.4
Papilloma of choroid plexus;D33.0;2A00.22
Autosomal recessive spastic paraplegia type 11;G11.4;8B44.01
Young-onset Parkinson disease;G20;8A00.00
Young-onset Parkinson disease;G20;8A00.00
Young-onset Parkinson disease;G20;8A00.00
Young-onset Parkinson disease;G20;8A00.00
Young-onset Parkinson disease;G20;8A00.00
Young-onset Parkinson disease;G20;8A00.00
Young-onset Parkinson disease;G20;8A00.00
Young-onset Parkinson disease;G20;8A00.00
Young-onset Parkinson disease;G20;8A00.00
Young-onset Parkinson disease;G20;8A00.00
Young-onset Parkinson disease;G20;8A00.00
Stiff skin syndrome;L98.8;EE6Y
Wrinkly skin syndrome;Q82.8;LD2B
PEHO syndrome;G31.8;LD90.Y
PEHO syndrome;G31.8;LD90.Y
Familial benign chronic pemphigus;;
Pentosuria;E74.8;5C51.0
Camptodactyly-arthropathy-coxa-vara-pericarditis syndrome;M12.8;
Perlman syndrome;Q87.3;2C90.Y
Alopecia-intellectual disability syndrome;Q87.8;
Alopecia-intellectual disability syndrome;Q87.8;
Alopecia-intellectual disability syndrome;Q87.8;
Fuhrmann syndrome;Q74.8;LD2F.1Y
Perrault syndrome;Q87.8;LD2H.Y
Perrault syndrome;Q87.8;LD2H.Y
Perrault syndrome;Q87.8;LD2H.Y
Perrault syndrome;Q87.8;LD2H.Y
Perrault syndrome;Q87.8;LD2H.Y
Perrault syndrome;Q87.8;LD2H.Y
Persistent Müllerian duct syndrome;Q55.8;LD2A.Y
Persistent Müllerian duct syndrome;Q55.8;LD2A.Y
Peutz-Jeghers syndrome;Q85.8;LD2D.0
Phakomatosis pigmentokeratotica;Q85.8;LD2D.Y
Phocomelia, Schinzel type;Q87.2;LD2F.1Y
Phosphoenolpyruvate carboxykinase deficiency;E74.4;5C53.0Y
Phosphoenolpyruvate carboxykinase deficiency;E74.4;5C53.0Y
Sitosterolemia;E78.0;5C52.1Y
Sitosterolemia;E78.0;5C52.1Y
Piebaldism;E70.3;EC23.2Y
Piebaldism;E70.3;EC23.2Y
TARP syndrome;Q87.8;LD2F.1Y
Pitt-Hopkins syndrome;Q87.0;LD2F.1Y
Pityriasis rubra pilaris;L44.0;EA94
Brachyolmia-amelogenesis imperfecta syndrome;Q76.3;LD24.5Y
Neuralgic amyotrophy;G54.5;8B91.0
Familial spontaneous pneumothorax;J93.1;CB21.1
Kindler epidermolysis bullosa;Q81.8;LD2B
Orofaciodigital syndrome type 5;Q87.0;LD25.00
Isolated polycystic liver disease;Q44.6;DB99.10
Isolated polycystic liver disease;Q44.6;DB99.10
Isolated polycystic liver disease;Q44.6;DB99.10
Musculocontractural Ehlers-Danlos syndrome;Q79.6;LD28.1Y
Musculocontractural Ehlers-Danlos syndrome;Q79.6;LD28.1Y
Guttmacher syndrome;Q87.2;LD26.2
Progeroid syndrome, Petty type;E34.8;
Prolactinoma;D35.2;2F37.Y
Prolactinoma;D35.2;XH1QS0
Prolactinoma;D35.2;2F37.Y
Prolactinoma;D35.2;XH1QS0
Prolactinoma;D35.2;2F37.Y
Prolactinoma;D35.2;XH1QS0
Properdin deficiency;D84.1;4A00.1Y
Proteus-like syndrome;Q87.3;LD2C
Prune belly syndrome;Q79.4;LD2F.10
Peroxisomal acyl-CoA oxidase deficiency;E71.3;5C57.1
Autosomal recessive multiple pterygium syndrome;Q79.8;LD26.40
Autosomal recessive multiple pterygium syndrome;Q79.8;LD26.40
Baraitser-Winter cerebrofrontofacial syndrome;Q87.0;
Baraitser-Winter cerebrofrontofacial syndrome;Q87.0;
Familial male-limited precocious puberty;;
Immune thrombocytopenia;D69.3;3B64.10
Pyle disease;Q78.5;LD24.1Y
Pyridoxine-dependent epilepsy;G40.8;8A61.0Y
Pyridoxine-dependent epilepsy;G40.8;8A61.0Y
Ramon syndrome;Q87.8;LD2F.1Y
RAPADILINO syndrome;Q87.1;LD2F.1Y
Caudal regression syndrome;Q76.0;LD2F.1Y
Caudal regression syndrome;Q76.0;LD2F.1Y
NPHP3-related Meckel-like syndrome;Q61.9;
Intellectual disability-cataracts-calcified pinnae-myopathy syndrome;Q87.8;
Blepharophimosis-intellectual disability syndrome, SBBYS type;Q87.8;5A00.0Y
Nicolaides-Baraitser syndrome;Q87.1;
Monoamine oxidase A deficiency;E70.8;5C59.0Y
X-linked intellectual disability, Snyder type;Q87.8;LD90
Costello syndrome;Q87.8;LD2F.1Y
X-linked intellectual disability-psychosis-macroorchidism syndrome;F71.1;LD90
Autosomal dominant vitreoretinochoroidopathy;H35.5;9B70
Revesz syndrome;Q82.8;
Atypical Rett syndrome;F84.2;LD90.Y
Atypical Rett syndrome;F84.2;LD90.Y
Atypical Rett syndrome;F84.2;LD90.Y
Atypical Rett syndrome;F84.2;LD90.Y
Atypical Rett syndrome;F84.2;LD90.Y
Meacham syndrome;Q87.8;LD2F.1Y
Richieri Costa-Pereira syndrome;Q87.8;LD2F.1Y
Roberts syndrome;Q73.8;LD2F.1Y
Autosomal dominant Robinow syndrome;Q87.1;LD24.A
Autosomal dominant Robinow syndrome;Q87.1;LD24.A
Autosomal dominant Robinow syndrome;Q87.1;LD24.A
Autosomal dominant Robinow syndrome;Q87.1;LD24.A
Mayer-Rokitansky-Küster-Hauser syndrome;Q51.8;LB44.Y
Rotor syndrome;E80.6;5C58.0Y
Rotor syndrome;E80.6;5C58.0Y
Roussy-Lévy syndrome;G60.0;8C20.Y
Roussy-Lévy syndrome;G60.0;8C20.Y
Saccharopinuria;E72.3;5C50.4
Sarcosinemia;E72.5;5C50.71
Ulnar-mammary syndrome;Q71.8;LD2F.1Y
Schneckenbecken dysplasia;Q77.7;LD24.3
Schneckenbecken dysplasia;Q77.7;LD24.3
Sclerosteosis;M85.2;LD24.1Y
Sclerosteosis;M85.2;LD24.1Y
Senior-Loken syndrome;Q61.5;9B70
Senior-Loken syndrome;Q61.5;9B70
Senior-Loken syndrome;Q61.5;9B70
Senior-Loken syndrome;Q61.5;9B70
Senior-Loken syndrome;Q61.5;9B70
Senior-Loken syndrome;Q61.5;9B70
Senior-Loken syndrome;Q61.5;9B70
Senior-Loken syndrome;Q61.5;9B70
Senior-Loken syndrome;Q61.5;9B70
Senior-Loken syndrome;Q61.5;9B70
Septo-optic dysplasia spectrum;Q04.4;5A61.0
Septo-optic dysplasia spectrum;Q04.4;5A61.0
Septo-optic dysplasia spectrum;Q04.4;5A61.0
Septo-optic dysplasia spectrum;Q04.4;5A61.0
Septo-optic dysplasia spectrum;Q04.4;5A61.0
Septo-optic dysplasia spectrum;Q04.4;5A61.0
Septo-optic dysplasia spectrum;Q04.4;5A61.0
Sézary syndrome;C84.1;2B02
Sézary syndrome;C84.1;2B02
Sézary syndrome;C84.1;2B02
SHORT syndrome;Q87.1;LD27.6Z
Sialuria;E77.8;5C56.4
X-linked spasticity-intellectual disability-epilepsy syndrome;G25.3;
Supravalvular aortic stenosis;Q25.3;LA8A.3
Hereditary hyperekplexia;G25.8;LD90.Y
Hereditary hyperekplexia;G25.8;LD90.Y
Hereditary hyperekplexia;G25.8;LD90.Y
Hereditary hyperekplexia;G25.8;LD90.Y
Hereditary hyperekplexia;G25.8;LD90.Y
Dehydrated hereditary stomatocytosis;D58.8;3A10.Y
Dehydrated hereditary stomatocytosis;D58.8;3A10.Y
Dehydrated hereditary stomatocytosis;D58.8;3A10.Y
Overhydrated hereditary stomatocytosis;D58.8;3A10.Y
Stormorken-Sjaastad-Langslet syndrome;D69.8;3B62.Y
Stormorken-Sjaastad-Langslet syndrome;D69.8;3B62.Y
Sturge-Weber syndrome;Q85.8;LD23
Stüve-Wiedemann syndrome;Q78.8;LD24.C
Isolated succinate-CoQ reductase deficiency;G71.3;5C53.2Y
Isolated succinate-CoQ reductase deficiency;G71.3;5C53.2Y
Isolated succinate-CoQ reductase deficiency;G71.3;5C53.2Y
Isolated succinate-CoQ reductase deficiency;G71.3;5C53.2Y
Deafness-enamel hypoplasia-nail defects syndrome;Q82.4;LD27.0Y
Deafness-enamel hypoplasia-nail defects syndrome;Q82.4;LD27.0Y
Deafness-lymphedema-leukemia syndrome;D46.7;BD93.0
Multiple synostoses syndrome;Q78.8;LD26.3
Multiple synostoses syndrome;Q78.8;LD26.3
Multiple synostoses syndrome;Q78.8;LD26.3
Cardiospondylocarpofacial syndrome;Q87.8;LD2H.Y
Sweet syndrome;L98.2;EB20
Proximal symphalangism;Q70.9;LB90.Y
Proximal symphalangism;Q70.9;LB90.Y
Cleft lip/palate-ectodermal dysplasia syndrome;Q82.4;LD27.0Y
Filippi syndrome;Q87.8;LD2F.1Y
Cenani-Lenz syndrome;Q78.4;LB79.Y
Cenani-Lenz syndrome;Q78.4;LB79.Y
Autoimmune lymphoproliferative syndrome;D47.9;4A01.22
Autoimmune lymphoproliferative syndrome;D47.9;4A01.22
Autoimmune lymphoproliferative syndrome;D47.9;4A01.22
Autoimmune lymphoproliferative syndrome;D47.9;4A01.22
Autoimmune lymphoproliferative syndrome;D47.9;4A01.22
Synovial sarcoma;C49.9;
Synovial sarcoma;C49.9;
Synovial sarcoma;C49.9;
Spondylocarpotarsal synostosis;Q76.4;LD24.5Y
Spondylocarpotarsal synostosis;Q76.4;LD24.5Y
Catecholaminergic polymorphic ventricular tachycardia;I47.2;BC65.5
Catecholaminergic polymorphic ventricular tachycardia;I47.2;BC65.5
Catecholaminergic polymorphic ventricular tachycardia;I47.2;BC65.5
Catecholaminergic polymorphic ventricular tachycardia;I47.2;BC65.5
Catecholaminergic polymorphic ventricular tachycardia;I47.2;BC65.5
Catecholaminergic polymorphic ventricular tachycardia;I47.2;BC65.5
Catecholaminergic polymorphic ventricular tachycardia;I47.2;BC65.5
Takayasu arteritis;M31.4;4A44.1
Takayasu arteritis;M31.4;4A44.1
Takayasu arteritis;M31.4;4A44.1
Tetraamelia-multiple malformations syndrome;Q87.8;LD2F.1Y
Tetraamelia-multiple malformations syndrome;Q87.8;LD2F.1Y
Tetralogy of Fallot;Q21.3;LA88.2
Tetralogy of Fallot;Q21.3;LA88.2
Tetralogy of Fallot;Q21.3;LA88.2
Tetralogy of Fallot;Q21.3;LA88.2
Tetralogy of Fallot;Q21.3;LA88.2
Tetralogy of Fallot;Q21.3;LA88.2
Tetralogy of Fallot;Q21.3;LA88.2
Tetralogy of Fallot;Q21.3;LA88.2
Tetralogy of Fallot;Q21.3;LA88.2
Tetralogy of Fallot;Q21.3;LA88.2
Tetralogy of Fallot;Q21.3;LA88.2
Tetralogy of Fallot;Q21.3;LA88.2
Tetralogy of Fallot;Q21.3;LA88.2
Essential thrombocythemia;D47.3;3B63.1Z
Essential thrombocythemia;D47.3;3B63.1Z
Essential thrombocythemia;D47.3;3B63.1Z
Essential thrombocythemia;D47.3;3B63.1Z
Essential thrombocythemia;D47.3;3B63.1Z
Essential thrombocythemia;D47.3;3B63.1Z
Congenital amegakaryocytic thrombocytopenia;D61.0;3B64.01
Congenital amegakaryocytic thrombocytopenia;D61.0;3B64.01
Thrombocytopenia-absent radius syndrome;Q87.2;LD2F.1Y
Hoyeraal-Hreidarsson syndrome;D61.0;3A70.0
Hoyeraal-Hreidarsson syndrome;D61.0;3A70.0
Hoyeraal-Hreidarsson syndrome;D61.0;3A70.0
Hoyeraal-Hreidarsson syndrome;D61.0;3A70.0
Hoyeraal-Hreidarsson syndrome;D61.0;3A70.0
Hoyeraal-Hreidarsson syndrome;D61.0;3A70.0
Tibial aplasia-ectrodactyly syndrome;Q73.8;LD26.0
Primary Fanconi renotubular syndrome;E72.0;GB90.42
Primary Fanconi renotubular syndrome;E72.0;GB90.42
Primary Fanconi renotubular syndrome;E72.0;GB90.42
Primary Fanconi renotubular syndrome;E72.0;GB90.42
Toriello-Carey syndrome;Q87.8;LD2F.1Y
Toriello-Lacassie-Droste syndrome;;
Arterial tortuosity syndrome;I77.1;LD28.Y
Tricho-dento-osseous syndrome;Q82.4;LD27.0Y
Trichomegaly-retina pigmentary degeneration-dwarfism syndrome;Q87.1;LD27.0Y
Non-syndromic metopic craniosynostosis;Q75.0;LB70.0Y
Non-syndromic metopic craniosynostosis;Q75.0;LB70.0Y
Trismus-pseudocamptodactyly syndrome;Q68.8;LD26.4Y
Truncus arteriosus;;
Truncus arteriosus;;
Tuberculosis;A16;
Tuberculosis;A15;
VACTERL with hydrocephalus;Q87.8;LD2F.1Y
Hyperostosis corticalis generalisata;M85.2;LD24.1Y
Hyperostosis corticalis generalisata;M85.2;LD24.1Y
NON RARE IN EUROPE: Vitiligo;L80;
NON RARE IN EUROPE: Vitiligo;L80;
Vogt-Koyanagi-Harada disease;H20.8;9A96.1
Vogt-Koyanagi-Harada disease;H30.8;9A96.1
Vogt-Koyanagi-Harada disease;H20.8;9A96.1
Vogt-Koyanagi-Harada disease;H30.8;9A96.1
Weaver syndrome;Q87.3;LD2C
Weaver syndrome;Q87.3;LD2C
Weaver syndrome;Q87.3;LD2C
Weaver syndrome;Q87.3;LD2C
Weill-Marchesani syndrome;Q87.0;9C61.42
Weill-Marchesani syndrome;Q87.0;9C61.42
Weill-Marchesani syndrome;Q87.0;9C61.42
Infantile spasms syndrome;G40.4;8A62.0
Infantile spasms syndrome;G40.4;8A62.0
Infantile spasms syndrome;G40.4;8A62.0
Infantile spasms syndrome;G40.4;8A62.0
Infantile spasms syndrome;G40.4;8A62.0
Infantile spasms syndrome;G40.4;8A62.0
Infantile spasms syndrome;G40.4;8A62.0
Infantile spasms syndrome;G40.4;8A62.0
Infantile spasms syndrome;G40.4;8A62.0
Infantile spasms syndrome;G40.4;8A62.0
Infantile spasms syndrome;G40.4;8A62.0
Infantile spasms syndrome;G40.4;8A62.0
Infantile spasms syndrome;G40.4;8A62.0
Infantile spasms syndrome;G40.4;8A62.0
Whipple disease;M14.8*;DA96.0Y
Whipple disease;K90.8+;DA96.0Y
Autoimmune polyendocrinopathy type 1;E31.0;5B00
Intellectual disability-developmental delay-contractures syndrome;G71.8;
Wiedemann-Rautenstrauch syndrome;E34.8;LD2B
Wilson-Turner syndrome;Q87.8;LD29
Wilson-Turner syndrome;Q87.8;LD29
Wolfram syndrome;E34.8;5A61.5
Wolfram syndrome;E34.8;5A61.5
Woodhouse-Sakati syndrome;Q87.5;5A61.0
Yunis-Varon syndrome;Q87.8;LD24.23
Yunis-Varon syndrome;Q87.8;LD24.23
Zimmermann-Laband syndrome;Q87.8;LD2F.1Y
Zimmermann-Laband syndrome;Q87.8;LD2F.1Y
Zimmermann-Laband syndrome;Q87.8;LD2F.1Y
CHIME syndrome;Q87.8;LD27.0Y
X-linked myopathy with excessive autophagy;G71.8;4A41.21
Hereditary diffuse gastric cancer;C16.9;
Hereditary diffuse gastric cancer;C16.9;
Hereditary diffuse gastric cancer;C16.9;
Short chain acyl-CoA dehydrogenase deficiency;E71.3;5C52.01
Very long chain acyl-CoA dehydrogenase deficiency;E71.3;5C52.01
Tyrosinemia type 2;E70.2;5C50.12
Hereditary pheochromocytoma-paraganglioma;C74.1;
Hereditary pheochromocytoma-paraganglioma;C75.5;
Hereditary pheochromocytoma-paraganglioma;D35.0;
Hereditary pheochromocytoma-paraganglioma;D35.6;
Hereditary pheochromocytoma-paraganglioma;C74.1;
Hereditary pheochromocytoma-paraganglioma;C75.5;
Hereditary pheochromocytoma-paraganglioma;D35.0;
Hereditary pheochromocytoma-paraganglioma;D35.6;
Hereditary pheochromocytoma-paraganglioma;C74.1;
Hereditary pheochromocytoma-paraganglioma;C75.5;
Hereditary pheochromocytoma-paraganglioma;D35.0;
Hereditary pheochromocytoma-paraganglioma;D35.6;
Hereditary pheochromocytoma-paraganglioma;C74.1;
Hereditary pheochromocytoma-paraganglioma;C75.5;
Hereditary pheochromocytoma-paraganglioma;D35.0;
Hereditary pheochromocytoma-paraganglioma;D35.6;
Hereditary pheochromocytoma-paraganglioma;C74.1;
Hereditary pheochromocytoma-paraganglioma;C75.5;
Hereditary pheochromocytoma-paraganglioma;D35.0;
Hereditary pheochromocytoma-paraganglioma;D35.6;
Hereditary pheochromocytoma-paraganglioma;C74.1;
Hereditary pheochromocytoma-paraganglioma;C75.5;
Hereditary pheochromocytoma-paraganglioma;D35.0;
Hereditary pheochromocytoma-paraganglioma;D35.6;
Hereditary pheochromocytoma-paraganglioma;C74.1;
Hereditary pheochromocytoma-paraganglioma;C75.5;
Hereditary pheochromocytoma-paraganglioma;D35.0;
Hereditary pheochromocytoma-paraganglioma;D35.6;
Hereditary pheochromocytoma-paraganglioma;C74.1;
Hereditary pheochromocytoma-paraganglioma;C75.5;
Hereditary pheochromocytoma-paraganglioma;D35.0;
Hereditary pheochromocytoma-paraganglioma;D35.6;
Hereditary pheochromocytoma-paraganglioma;C74.1;
Hereditary pheochromocytoma-paraganglioma;C75.5;
Hereditary pheochromocytoma-paraganglioma;D35.0;
Hereditary pheochromocytoma-paraganglioma;D35.6;
Hereditary pheochromocytoma-paraganglioma;C74.1;
Hereditary pheochromocytoma-paraganglioma;C75.5;
Hereditary pheochromocytoma-paraganglioma;D35.0;
Hereditary pheochromocytoma-paraganglioma;D35.6;
Hereditary pheochromocytoma-paraganglioma;C74.1;
Hereditary pheochromocytoma-paraganglioma;C75.5;
Hereditary pheochromocytoma-paraganglioma;D35.0;
Hereditary pheochromocytoma-paraganglioma;D35.6;
Hereditary pheochromocytoma-paraganglioma;C74.1;
Hereditary pheochromocytoma-paraganglioma;C75.5;
Hereditary pheochromocytoma-paraganglioma;D35.0;
Hereditary pheochromocytoma-paraganglioma;D35.6;
Hereditary pheochromocytoma-paraganglioma;C74.1;
Hereditary pheochromocytoma-paraganglioma;C75.5;
Hereditary pheochromocytoma-paraganglioma;D35.0;
Hereditary pheochromocytoma-paraganglioma;D35.6;
Hereditary pheochromocytoma-paraganglioma;C74.1;
Hereditary pheochromocytoma-paraganglioma;C75.5;
Hereditary pheochromocytoma-paraganglioma;D35.0;
Hereditary pheochromocytoma-paraganglioma;D35.6;
Hereditary pheochromocytoma-paraganglioma;C74.1;
Hereditary pheochromocytoma-paraganglioma;C75.5;
Hereditary pheochromocytoma-paraganglioma;D35.0;
Hereditary pheochromocytoma-paraganglioma;D35.6;
Multiple myeloma;C90.0;2A83.1
Reactive arthritis;M02.3;FA11.2
Primary hypomagnesemia with secondary hypocalcemia;E83.4;5C64.41
Hereditary central diabetes insipidus;;
Primary hypomagnesemia with hypercalciuria and nephrocalcinosis without severe ocular involvement;E83.4;5C64.41
Dermatofibrosarcoma protuberans;C49.9;2B53.Y
Dermatofibrosarcoma protuberans;C49.9;2B53.Y
Tangier disease;E78.6;5C81.0
Infantile convulsions and choreoathetosis;G40.4;8A61.10
Infantile convulsions and choreoathetosis;G40.4;8A61.10
Infantile convulsions and choreoathetosis;G40.4;8A61.10
Hypersensitivity pneumonitis;;CA70
Pulmonary venoocclusive disease;J98.4;BB01.0
Pulmonary venoocclusive disease;J98.4;BB01.0
Tumor necrosis factor receptor 1 associated periodic syndrome;E85.0;4A60.2
Lymphedema-distichiasis syndrome;Q82.0;BD93.0
Metaphyseal chondrodysplasia, Jansen type;Q78.5;LD24.7
Dravet syndrome;G40.4;8A61.11
Dravet syndrome;G40.4;8A61.11
Dravet syndrome;G40.4;8A61.11
Dravet syndrome;G40.4;8A61.11
Dravet syndrome;G40.4;8A61.11
Dravet syndrome;G40.4;8A61.11
Dravet syndrome;G40.4;8A61.11
Lethal multiple pterygium syndrome;Q79.8;LD26.40
Lethal multiple pterygium syndrome;Q79.8;LD26.40
Lethal multiple pterygium syndrome;Q79.8;LD26.40
Lethal multiple pterygium syndrome;Q79.8;LD26.40
Lethal multiple pterygium syndrome;Q79.8;LD26.40
Lethal multiple pterygium syndrome;Q79.8;LD26.40
Autosomal agammaglobulinemia;D80.0;4A01.00
Autosomal agammaglobulinemia;D80.0;4A01.00
Autosomal agammaglobulinemia;D80.0;4A01.00
Autosomal agammaglobulinemia;D80.0;4A01.00
Autosomal agammaglobulinemia;D80.0;4A01.00
Autosomal agammaglobulinemia;D80.0;4A01.00
Autosomal agammaglobulinemia;D80.0;4A01.00
Autosomal agammaglobulinemia;D80.0;4A01.00
Waldenström macroglobulinemia;C88.0;2A85.4
NON RARE IN EUROPE: Non-alcoholic fatty liver disease;;
NON RARE IN EUROPE: Non-alcoholic fatty liver disease;;
Reticular dysgenesis;D81.0;4A01.10
Trichothiodystrophy;L67.8;EC21.1
Trichothiodystrophy;L67.8;EC21.1
Trichothiodystrophy;L67.8;EC21.1
Trichothiodystrophy;L67.8;EC21.1
Trichothiodystrophy;L67.8;EC21.1
Trichothiodystrophy;L67.8;EC21.1
Trichothiodystrophy;L67.8;EC21.1
Trichothiodystrophy;L67.8;EC21.1
Pediatric hepatocellular carcinoma;C22.0;
Pediatric hepatocellular carcinoma;C22.0;
Neuroectodermal melanolysosomal disease;L81.4;LD27.Y
Kleine-Levin syndrome;G47.8;7A22
5-oxoprolinase deficiency;E72.8;5C50.5
Gamma-glutamyl transpeptidase deficiency;E72.8;5C50.5
Glutamate-cysteine ligase deficiency;D55.1;3A10.0Y
NON RARE IN EUROPE: Berger disease;;
Naxos disease;Q87.8;BC43.6
Telethonin-related limb-girdle muscular dystrophy R7;G71.0;8C70.41
FKRP-related limb-girdle muscular dystrophy R9;G71.0;8C70.41
DNAJB6-related limb-girdle muscular dystrophy D1;G71.0;
Congenital muscular dystrophy with integrin alpha-7 deficiency;G71.2;8C70.6
Autosomal dominant primary hypomagnesemia with hypocalciuria;E83.4;5C64.41
Glycogen storage disease due to LAMP-2 deficiency;;
Immunodeficiency by defective expression of MHC class I;D81.6;4A01.11
Immunodeficiency by defective expression of MHC class I;D81.6;4A01.11
Immunodeficiency by defective expression of MHC class I;D81.6;4A01.11
Immunodeficiency by defective expression of MHC class I;D81.6;4A01.11
NON RARE IN EUROPE: Trimethylaminuria;;
Infantile neuroaxonal dystrophy;G23.0;5C64.10
T-B+ severe combined immunodeficiency due to JAK3 deficiency;D81.2;4A01.10
Non-syndromic sagittal craniosynostosis;Q75.0;LB70.0Y
Non-syndromic sagittal craniosynostosis;Q75.0;LB70.0Y
Non-syndromic sagittal craniosynostosis;Q75.0;LB70.0Y
Non-syndromic bicoronal craniosynostosis;Q75.0;LB70.0Y
Non-syndromic bicoronal craniosynostosis;Q75.0;LB70.0Y
Non-syndromic bicoronal craniosynostosis;Q75.0;LB70.0Y
Non-syndromic bicoronal craniosynostosis;Q75.0;LB70.0Y
Desmosterolosis;Q87.8;5C52.10
Hemolytic anemia due to pyrimidine 5' nucleotidase deficiency;D55.3;3A10.Y
Congenital sucrase-isomaltase deficiency;E74.3;5C61.2
X-linked dominant chondrodysplasia punctata;Q77.3;LD24.04
Nanophthalmos;Q11.2;LA10.0
Nanophthalmos;Q11.2;LA10.0
Nanophthalmos;Q11.2;LA10.0
Nanophthalmos;Q11.2;LA10.0
Nanophthalmos;Q11.2;LA10.0
Nanophthalmos;Q11.2;LA10.0
Nanophthalmos;Q11.2;LA10.0
Nanophthalmos;Q11.2;LA10.0
Nanophthalmos;Q11.2;LA10.0
Nanophthalmos;Q11.2;LA10.0
ALDH18A1-related De Barsy syndrome;Q87.8;5C50.8
Primary lateral sclerosis;G12.2;8B60.4
3-hydroxy-3-methylglutaryl-CoA synthase deficiency;E71.3;5C52.02
L-Arginine:glycine amidinotransferase deficiency;E72.8;5C53.4
Glutaric acidemia type 3;E72.3;5C50.E0
Aromatic L-amino acid decarboxylase deficiency;G24.8;5C59.00
Glucose-galactose malabsorption;E74.3;5C61.0
Morning glory disc anomaly;Q14.2;LA13.7Y
Imerslund-Gräsbeck syndrome;D51.1;3A01.Y
Imerslund-Gräsbeck syndrome;D51.1;3A01.Y
Hyperinsulinism-hyperammonemia syndrome;E72.8;5C50.AY
Combined deficiency of factor V and factor VIII;D68.8;3B14.Z
Combined deficiency of factor V and factor VIII;D68.8;3B14.Z
Bleeding disorder due to P2Y12 defect;D69.8;
Distal monosomy 1q;;
COL4A1-related familial vascular leukoencephalopathy;;
Hereditary sensory and autonomic neuropathy type 1;G60.8;8C21.0
Hereditary sensory and autonomic neuropathy type 1;G60.8;8C21.0
Hereditary sensory and autonomic neuropathy type 1;G60.8;8C21.0
Hereditary sensory and autonomic neuropathy type 1;G60.8;8C21.0
Generalized epilepsy with febrile seizures-plus;G40.3;8A61.2Y
Generalized epilepsy with febrile seizures-plus;G40.3;8A61.2Y
Generalized epilepsy with febrile seizures-plus;G40.3;8A61.2Y
Generalized epilepsy with febrile seizures-plus;G40.3;8A61.2Y
Generalized epilepsy with febrile seizures-plus;G40.3;8A61.2Y
Generalized epilepsy with febrile seizures-plus;G40.3;8A61.2Y
Generalized epilepsy with febrile seizures-plus;G40.3;8A61.2Y
Generalized epilepsy with febrile seizures-plus;G40.3;8A61.2Y
Generalized epilepsy with febrile seizures-plus;G40.3;8A61.2Y
Hypocomplementemic urticarial vasculitis;M31.8;4A44.91
Stevens-Johnson syndrome;L51.1;EB13.0
Stevens-Johnson syndrome;L51.1;EB13.0
Myoclonus-dystonia syndrome;G24.1;8A02.11
Myoclonus-dystonia syndrome;G24.1;8A02.11
Myoclonus-dystonia syndrome;G24.1;8A02.11
Myoclonus-dystonia syndrome;G24.1;8A02.11
Immune dysregulation-polyendocrinopathy-enteropathy-X-linked syndrome;E31.0;4A01.21
Andersen-Tawil syndrome;G72.3;BC65.0
Andersen-Tawil syndrome;G72.3;BC65.0
Episodic ataxia type 1;G11.8;8A03.14
Dihydropyrimidinuria;E79.8;5C55.1
Omenn syndrome;D81.8;4A01.10
Omenn syndrome;D81.8;4A01.10
Omenn syndrome;D81.8;4A01.10
Omenn syndrome;D81.8;4A01.10
Omenn syndrome;D81.8;4A01.10
Omenn syndrome;D81.8;4A01.10
Omenn syndrome;D81.8;4A01.10
Omenn syndrome;D81.8;4A01.10
Uveal melanoma;C69.3;2D0Y
Uveal melanoma;C69.3;2D0Y
Uveal melanoma;C69.3;2D0Y
Uveal melanoma;C69.3;2D0Y
Uveal melanoma;C69.3;2D0Y
NON RARE IN EUROPE: Psoriatic arthritis;;
Bietti crystalline dystrophy;H35.5;9B61
Iminoglycinuria;E72.0;5C60.Y
Iminoglycinuria;E72.0;5C60.Y
Iminoglycinuria;E72.0;5C60.Y
Iminoglycinuria;E72.0;5C60.Y
Tietz syndrome;E70.3;EC23.2Y
Hereditary myopathy with lactic acidosis due to ISCU deficiency;G71.3;5C53.1
Gastrointestinal stromal tumor;C26.9;2B5B
Gastrointestinal stromal tumor;C26.9;XH9HQ1
Gastrointestinal stromal tumor;C26.9;2B5B
Gastrointestinal stromal tumor;C26.9;XH9HQ1
Gastrointestinal stromal tumor;C26.9;2B5B
Gastrointestinal stromal tumor;C26.9;XH9HQ1
Gastrointestinal stromal tumor;C26.9;2B5B
Gastrointestinal stromal tumor;C26.9;XH9HQ1
Gastrointestinal stromal tumor;C26.9;2B5B
Gastrointestinal stromal tumor;C26.9;XH9HQ1
Congenital fibrosis of extraocular muscles;H49.8;9C82.2
Congenital fibrosis of extraocular muscles;H49.8;9C82.2
Congenital fibrosis of extraocular muscles;H49.8;9C82.2
Congenital fibrosis of extraocular muscles;H49.8;9C82.2
Miyoshi myopathy;G71.0;8C75
Lathosterolosis;Q87.8;5C52.10
Paroxysmal extreme pain disorder;G90.8;8E43.Y
Paroxysmal extreme pain disorder;G90.8;8E43.Y
Paroxysmal extreme pain disorder;G90.8;8E43.Y
Hereditary persistence of fetal hemoglobin-beta-thalassemia syndrome;D56.4;3A50.4
Hereditary persistence of fetal hemoglobin-beta-thalassemia syndrome;D56.4;3A50.4
Hereditary persistence of fetal hemoglobin-beta-thalassemia syndrome;D56.4;3A50.4
Hereditary persistence of fetal hemoglobin-beta-thalassemia syndrome;D56.4;3A50.4
Char syndrome;Q87.8;
Hereditary papillary renal cell carcinoma;C64;2C90.Y
Familial cold urticaria;L50.2;4A60.1
Congenital cataracts-facial dysmorphism-neuropathy syndrome;Q87.8;LD2F.1Y
Monosomy 22q13.3;;
Aceruloplasminemia;E83.1;3A00.Y
Achromatopsia;H53.5;9B70
Achromatopsia;H53.5;9B70
Achromatopsia;H53.5;9B70
Achromatopsia;H53.5;9B70
Achromatopsia;H53.5;9B70
Achromatopsia;H53.5;9B70
Achromatopsia;H53.5;9B70
Thiamine-responsive megaloblastic anemia syndrome;D53.1;5C63.Y
Pleural mesothelioma;C45.0;2C26.0
Craniolenticulosutural dysplasia;Q75.8;LB70.Y
Striate palmoplantar keratoderma;Q82.8;EC20.31
Striate palmoplantar keratoderma;Q82.8;EC20.31
Striate palmoplantar keratoderma;Q82.8;EC20.31
Keratolytic winter erythema;L30.8;EC20.30
Schöpf-Schulz-Passarge syndrome;Q82.8;LD27.0Y
Blomstrand lethal chondrodysplasia;Q78.8;LD24.1Y
Familial short QT syndrome;I49.8;BC65.2
Familial short QT syndrome;I49.8;BC65.2
Familial short QT syndrome;I49.8;BC65.2
Familial short QT syndrome;I49.8;BC65.2
Familial short QT syndrome;I49.8;BC65.2
Ethylmalonic encephalopathy;E88.8;5C50.E1
Formiminoglutamic aciduria;E70.8;3A02.Y
Generalized arterial calcification of infancy;Q28.8;BD52
Generalized arterial calcification of infancy;Q28.8;BD52
WHIM syndrome;D81.8;4A00.Y
Potocki-Shaffer syndrome;Q93.5;LD44.B1
Potocki-Shaffer syndrome;Q93.5;LD44.B1
Potocki-Shaffer syndrome;Q93.5;LD44.B1
Corpus callosum agenesis-intellectual disability-coloboma-micrognathia syndrome;Q87.8;
Mohr-Tranebjaerg syndrome;E88.8;8A02.12
Mantle cell lymphoma;C83.1;2A85.5
Mantle cell lymphoma;C83.1;2A85.5
Mantle cell lymphoma;C83.1;2A85.5
MALT lymphoma;C88.4;
MALT lymphoma;C88.4;
MALT lymphoma;C88.4;
MALT lymphoma;C88.4;
MALT lymphoma;C88.4;
Retinitis punctata albescens;H35.5;9B70
Retinitis punctata albescens;H35.5;9B70
Retinitis punctata albescens;H35.5;9B70
Retinitis punctata albescens;H35.5;9B70
Branchiootic syndrome;Q87.0;LD2F.1Y
Branchiootic syndrome;Q87.0;LD2F.1Y
Inclusion body myopathy with Paget disease of bone and frontotemporal dementia;G71.8;4A41.21
Inclusion body myopathy with Paget disease of bone and frontotemporal dementia;G71.8;4A41.21
Inclusion body myopathy with Paget disease of bone and frontotemporal dementia;G71.8;4A41.21
X-linked creatine transporter deficiency;E72.8;5C53.4
Pseudo-von Willebrand disease;D69.8;3B62.Y
Isolated follicle stimulating hormone deficiency;E23.6;5A61.0
Caroli disease;Q44.6;LB20.00
Muenke syndrome;Q87.0;LD24.GY
Brody myopathy;G71.8;8C7Y
X-linked dystonia-parkinsonism;G24.1;8A00.20
Goldmann-Favre syndrome;H35.5;9B70
Paroxysmal dystonic choreathetosis with episodic ataxia and spasticity;G24.8;8A02.2
Congenital chloride diarrhea;K90.8;DA90.1
Congenital lactase deficiency;E73.0;5C61.61
Congenital cornea plana;Q13.4;LA11.1
GRACILE syndrome;E88.8;5C53.2Y
Arthrogryposis-anterior horn cell disease syndrome;Q68.8;LD2F.1Y
Gnathodiaphyseal dysplasia;M85.8;LD24.2Y
Myosin storage myopathy;G71.2;8C72.0Y
Left ventricular noncompaction;I42.8;BC44
Left ventricular noncompaction;I42.8;BC44
Left ventricular noncompaction;I42.8;BC44
Left ventricular noncompaction;I42.8;BC44
Left ventricular noncompaction;I42.8;BC44
Left ventricular noncompaction;I42.8;BC44
Left ventricular noncompaction;I42.8;BC44
Left ventricular noncompaction;I42.8;BC44
Left ventricular noncompaction;I42.8;BC44
Left ventricular noncompaction;I42.8;BC44
Left ventricular noncompaction;I42.8;BC44
Left ventricular noncompaction;I42.8;BC44
Left ventricular noncompaction;I42.8;BC44
Left ventricular noncompaction;I42.8;BC44
Craniopharyngioma;D44.4;
Craniopharyngioma;D44.4;
TNP03-related limb-girdle muscular dystrophy D2;G71.0;8C70.40
HNRNPDL-related limb-girdle muscular dystrophy D3;G71.0;
Hypotrichosis simplex;L65.8;EC21.2
Hypotrichosis simplex;L65.8;EC21.2
Hypotrichosis simplex;L65.8;EC21.2
Hypotrichosis simplex;L65.8;EC21.2
Hypotrichosis simplex;L65.8;EC21.2
Hypotrichosis simplex;L65.8;EC21.2
Hypotrichosis simplex;L65.8;EC21.2
Chondrosarcoma;C49.9;2B50
Atelosteogenesis type II;Q77.5;LD24.03
Atelosteogenesis type III;Q78.8;LD24.E
Mazabraud syndrome;M85.0;FB80.0
Classic hairy cell leukemia;C91.4;2A82.2
Laing early-onset distal myopathy;G71.0;
Sorsby pseudoinflammatory fundus dystrophy;H35.5;9B61
Neonatal ichthyosis-sclerosing cholangitis syndrome;Q80.8;DB96.2Y
McLeod neuroacanthocytosis syndrome;G10;3A10.Y
Enlarged parietal foramina;Q75.8;
Enlarged parietal foramina;Q75.8;
Pulmonary alveolar microlithiasis;J84.0;CB06
Loeys-Dietz syndrome;Q87.4;BD50.Z
Loeys-Dietz syndrome;Q87.4;BD50.Z
Loeys-Dietz syndrome;Q87.4;BD50.Z
Idiopathic bronchiectasis;J47;CA24
Idiopathic bronchiectasis;J47;CA24
Idiopathic bronchiectasis;J47;CA24
Idiopathic bronchiectasis;J47;CA24
Megalencephaly-capillary malformation-polymicrogyria syndrome;Q87.3;LD2F.1Y
Craniorachischisis;Q00.1;LA00.00
Antley-Bixler syndrome with genital anomaly and disorder of steroidogenesis;Q87.8;LD24.GY
Distal myopathy with posterior leg and anterior hand involvement;G71.0;8C75
Angel-shaped phalango-epiphyseal dysplasia;Q78.8;LD24.8Y
Acrocapitofemoral dysplasia;Q78.8;LD24.8Y
Childhood absence epilepsy;G40.3;8A61.21
Childhood absence epilepsy;G40.3;8A61.21
Childhood absence epilepsy;G40.3;8A61.21
Childhood absence epilepsy;G40.3;8A61.21
Childhood absence epilepsy;G40.3;8A61.21
Childhood absence epilepsy;G40.3;8A61.21
NON RARE IN EUROPE: Non rare thrombophilia;D68.5;
NON RARE IN EUROPE: Non rare thrombophilia;D68.5;
NON RARE IN EUROPE: Non rare thrombophilia;D68.5;
NON RARE IN EUROPE: Non rare thrombophilia;D68.5;
NON RARE IN EUROPE: Non rare thrombophilia;D68.5;
NON RARE IN EUROPE: Non rare thrombophilia;D68.5;
NON RARE IN EUROPE: Non rare thrombophilia;D68.5;
NON RARE IN EUROPE: Non rare thrombophilia;D68.5;
NON RARE IN EUROPE: Non rare thrombophilia;D68.5;
NON RARE IN EUROPE: Non rare thrombophilia;D68.5;
Ovarian hyperstimulation syndrome;N98.1;GA32.0
NON RARE IN EUROPE: Recurrent acute pancreatitis;;
NON RARE IN EUROPE: Recurrent acute pancreatitis;;
NON RARE IN EUROPE: Recurrent acute pancreatitis;;
Dejerine-Sottas syndrome;G60.0;8C20.Y
Dejerine-Sottas syndrome;G60.0;8C20.Y
Dejerine-Sottas syndrome;G60.0;8C20.Y
Dejerine-Sottas syndrome;G60.0;8C20.Y
Hereditary motor and sensory neuropathy type 5;G60.0;8C20.Y
Hereditary sensory and autonomic neuropathy type 5;G60.8;8C21.3
Hereditary sensory and autonomic neuropathy type 5;G60.8;8C21.3
Spinocerebellar ataxia with axonal neuropathy type 2;G60.2;9C82.4
Spinocerebellar ataxia with axonal neuropathy type 2;G60.2;9C82.4
Nevus comedonicus syndrome;Q82.5;LD2D.Y
Becker nevus syndrome;D22.5;LC02
Carvajal syndrome;I42.0;BC43.6
Biotin-thiamine-responsive basal ganglia disease;G93.8;5C63.Y
Lhermitte-Duclos disease;Q04.8;2A00.21
Beta-ureidopropionase deficiency;E79.8;5C55.1
Permanent neonatal diabetes mellitus-pancreatic and cerebellar agenesis syndrome;P70.2;KB60.2Y
Monomelic amyotrophy;G12.8;8B60.6
Monomelic amyotrophy;G12.8;8B60.6
Autosomal dominant multiple pterygium syndrome;Q79.8;LD26.40
Multiple self-healing squamous epithelioma;D48.5;2C31.1
Carpenter syndrome;Q87.0;LD24.GY
Carpenter syndrome;Q87.0;LD24.GY
Obesity due to congenital leptin deficiency;E66.8;5B81.Y
Goldberg-Shprintzen megacolon syndrome;Q87.8;LD2F.1Y
CEDNIK syndrome;Q82.8;LD27.2
Dilated cardiomyopathy with ataxia;E71.1;5C50.E0
Diaphanospondylodysostosis;Q78.8;LD24.5Y
Autosomal dominant optic atrophy and cataract;H47.2;9C40.8
B-cell chronic lymphocytic leukemia;C91.1;2A82.0
B-cell chronic lymphocytic leukemia;C91.1;2A82.0
B-cell chronic lymphocytic leukemia;C91.1;2A82.0
B-cell chronic lymphocytic leukemia;C91.1;2A82.0
B-cell chronic lymphocytic leukemia;C91.1;2A82.0
B-cell chronic lymphocytic leukemia;C91.1;2A82.0
B-cell chronic lymphocytic leukemia;C91.1;2A82.0
B-cell chronic lymphocytic leukemia;C91.1;2A82.0
B-cell chronic lymphocytic leukemia;C91.1;2A82.0
B-cell chronic lymphocytic leukemia;C91.1;2A82.0
Hyaluronidase deficiency;E76.2;5C56.3Y
Late-onset retinal degeneration;H35.5;9B70
Thrombocytopenia with congenital dyserythropoietic anemia;D69.4;
X-linked intellectual disability with isolated growth hormone deficiency;E23.0;LD90.Y
3-methylglutaconic aciduria type 1;E71.1;5C50.E0
3-methylglutaconic aciduria type 3;E71.1;5C50.E0
3-methylglutaconic aciduria type 3;E71.1;5C50.E0
Congenital membranous nephropathy due to fetomaternal anti-neutral endopeptidase alloimmunization;P96.0;GB41
Familial renal glucosuria;E74.8;5C61.5
Pure hair and nail ectodermal dysplasia;Q82.8;LD27.0Y
Pure hair and nail ectodermal dysplasia;Q82.8;LD27.0Y
Pure hair and nail ectodermal dysplasia;Q82.8;LD27.0Y
Limb-mammary syndrome;Q82.4;LD27.0Y
Naegeli-Franceschetti-Jadassohn syndrome;Q82.4;LD27.0Y
Anhidrotic ectodermal dysplasia-immunodeficiency-osteopetrosis-lymphedema syndrome;Q78.2;LD27.0Y
Pyogenic arthritis-pyoderma gangrenosum-acne syndrome;L88;
NON RARE IN EUROPE: Immunoglobulin A deficiency;D80.2;
Low phospholipid-associated cholelithiasis;K80.8;DC11.Y
Intrahepatic cholestasis of pregnancy;O26.6;JA65.0
Intrahepatic cholestasis of pregnancy;O26.6;JA65.0
Intrahepatic cholestasis of pregnancy;O26.6;JA65.0
Intrahepatic cholestasis of pregnancy;O26.6;JA65.0
Tyrosinemia type 3;E70.2;5C50.1Y
Hypotrichosis-lymphedema-telangiectasia-renal defect syndrome;Q82.0;
Bosley-Salih-Alorainy syndrome;Q87.8;LD2H.Y
Athabaskan brainstem dysgenesis syndrome;G96.8;LD2H.Y
Congenital lactic acidosis, Saguenay-Lac-Saint-Jean type;G31.8;5C53.24
Leigh syndrome with cardiomyopathy;;
Leigh syndrome with cardiomyopathy;;
Leigh syndrome with cardiomyopathy;;
Leigh syndrome with cardiomyopathy;;
Leigh syndrome with cardiomyopathy;;
Cholangiocarcinoma;C24.8;2C12.10
Cholangiocarcinoma;C24.9;2C12.10
Cholangiocarcinoma;C22.1;2C12.10
Cholangiocarcinoma;C24.0;2C12.10
Cholangiocarcinoma;C24.8;2C12.10
Cholangiocarcinoma;C24.9;2C12.10
Cholangiocarcinoma;C22.1;2C12.10
Cholangiocarcinoma;C24.0;2C12.10
Cholangiocarcinoma;C24.8;2C12.10
Cholangiocarcinoma;C24.9;2C12.10
Cholangiocarcinoma;C22.1;2C12.10
Cholangiocarcinoma;C24.0;2C12.10
Small cell lung cancer;C34.9;2C25.1
Small cell lung cancer;C34.9;2C25.1
Small cell lung cancer;C34.9;2C25.1
Infant acute respiratory distress syndrome;P22.0;KB23.0
Infant acute respiratory distress syndrome;P22.0;KB23.0
Infant acute respiratory distress syndrome;P22.0;KB23.0
Immunodeficiency due to interleukin-1 receptor-associated kinase-4 deficiency;D84.8;4A00.2
Dopa-responsive dystonia due to sepiapterin reductase deficiency;G24.1;5C59.01
Sensory ataxic neuropathy-dysarthria-ophthalmoparesis syndrome;G71.3;5C53.21
Sensory ataxic neuropathy-dysarthria-ophthalmoparesis syndrome;G71.3;5C53.21
Hyperinsulinism due to short chain 3-hydroxylacyl-CoA dehydrogenase deficiency;E71.3;5C52.01
Split hand-split foot-deafness syndrome;Q87.2;LD2H.Y
Rh deficiency syndrome;D58.8;3A10.Y
Rh deficiency syndrome;D58.8;3A10.Y
Rh deficiency syndrome;D58.8;3A10.Y
Classic glucose transporter type 1 deficiency syndrome;G40.4;5C61.5
Congenital brain dysgenesis due to glutamine synthetase deficiency;E72.8;5C50.Y
Radio-ulnar synostosis-amegakaryocytic thrombocytopenia syndrome;Q87.2;3B64.01
Radio-ulnar synostosis-amegakaryocytic thrombocytopenia syndrome;Q87.2;3B64.01
Familial platelet disorder with associated myeloid malignancy;D69.4;
Familial platelet disorder with associated myeloid malignancy;D69.4;
Familial platelet disorder with associated myeloid malignancy;D69.4;
Familial thrombocytosis;D68.8;3B63.0
Familial thrombocytosis;D68.8;3B63.0
Familial thrombocytosis;D68.8;3B63.0
Rapid-onset dystonia-parkinsonism;G24.1;8A02.12
Benign paroxysmal torticollis of infancy;G24.3;8A02.2
Obesity due to pro-opiomelanocortin deficiency;E66.8;5B81.Y
Obesity due to prohormone convertase I deficiency;E66.8;5B81.Y
Obesity due to melanocortin 4 receptor deficiency;E66.8;5B81.Y
HANAC syndrome;I99;GB4Y
Growth delay due to insulin-like growth factor type 1 deficiency;E34.3;5A61.0
Growth delay due to insulin-like growth factor I resistance;E34.3;5A61.0
Wolman disease;E75.5;5C56.0Y
Cholesteryl ester storage disease;E75.5;5C56.0Y
Familial isolated restrictive cardiomyopathy;I42.5;BC43.2Y
Familial isolated restrictive cardiomyopathy;I42.5;BC43.2Y
Familial isolated restrictive cardiomyopathy;I42.5;BC43.2Y
Familial isolated restrictive cardiomyopathy;I42.5;BC43.2Y
Familial isolated restrictive cardiomyopathy;I42.5;BC43.2Y
Retinal arterial tortuosity;;
Bradyopsia;H53.8;9D7Y
Bradyopsia;H53.8;9D7Y
Familial drusen;H35.5;9B70
Familial drusen;H35.5;9B70
Familial drusen;H35.5;9B70
Central areolar choroidal dystrophy;H31.2;9B61
Central areolar choroidal dystrophy;H31.2;9B61
Central areolar choroidal dystrophy;H31.2;9B61
Oguchi disease;H53.6;9B70
Oguchi disease;H53.6;9B70
Primary immunodeficiency with natural-killer cell deficiency and adrenal insufficiency;D84.8;
Periodontal Ehlers-Danlos syndrome;Q79.6;LD28.1Y
Periodontal Ehlers-Danlos syndrome;Q79.6;LD28.1Y
B4GALT7-related spondylodysplastic Ehlers-Danlos syndrome;Q79.6;LD28.1Y
X-linked Ehlers-Danlos syndrome;Q79.6;LD28.1Y
X-linked sideroblastic anemia;D64.0;3A72.00
Acquired idiopathic sideroblastic anemia;D64.3;2A33
Acquired idiopathic sideroblastic anemia;D64.3;2A33
Congenital muscular dystrophy, Ullrich type;;
Congenital muscular dystrophy, Ullrich type;;
Congenital muscular dystrophy, Ullrich type;;
Congenital muscular dystrophy, Ullrich type;;
6q terminal deletion syndrome;Q93.5;LD44.60
MORM syndrome;Q87.8;9B70
Trichorhinophalangeal syndrome type 1 and 3;;
Gaucher disease type 1;E75.2;5C56.0Y
Gaucher disease type 1;E75.2;5C56.0Y
Gaucher disease type 2;E75.2;5C56.0Y
Gaucher disease type 3;E75.2;5C56.0Y
Infantile neurovisceral acid sphingomyelinase deficiency;E75.2;5C56.0Y
Chronic visceral acid sphingomyelinase deficiency;E75.2;5C56.0Y
Odontoleukodystrophy;E75.2;8A44
Majeed syndrome;D84.8;4A00.Y
Anophthalmia/microphthalmia-esophageal atresia syndrome;Q87.8;LD21.0
Monosomy 9q22.3;Q93.5;LD44.90
Juvenile polyposis of infancy;D12.6;2B90.Y
Juvenile polyposis of infancy;D12.6;2B90.Y
PPARG-related familial partial lipodystrophy;E88.1;5A44
Familial partial lipodystrophy, Köbberling type;E88.1;5A44
AKT2-related familial partial lipodystrophy;E88.1;5A44
Acquired partial lipodystrophy;E88.1;EF01.0
Hereditary inclusion body myopathy-joint contractures-ophthalmoplegia syndrome;G71.8;4A41.21
Grange syndrome;Q87.8;LD28.Y
Congenital bile acid synthesis defect type 4;K76.8;5C52.11
Pyridoxal phosphate-responsive seizures;G40.8;5C63.Y
Atrophoderma vermiculata;L66.4;ED56
Hyperprolinemia type 2;E72.5;5C50.8
Thyrotoxic periodic paralysis;G72.3;5A02.Y
Thyrotoxic periodic paralysis;G72.3;5A02.Y
Thyrotoxic periodic paralysis;G72.3;5A02.Y
Myxofibrosarcoma;C49.9;2B53.0
Myxofibrosarcoma;C49.9;2B53.0
Myxofibrosarcoma;C49.9;2B53.0
Eiken syndrome;M85.8;FB83.0Y
Developmental malformations-deafness-dystonia syndrome;Q87.8;LD2H.Y
Mandibulofacial dysostosis-microcephaly syndrome;Q87.0;
Neonatal diabetes-congenital hypothyroidism-congenital glaucoma-hepatic fibrosis-polycystic kidneys syndrome;P70.2;GB8Y
Hepatic veno-occlusive disease-immunodeficiency syndrome;K76.5;4A01.33
DEND syndrome;P70.2;KB60.2Y
DEND syndrome;P70.2;KB60.2Y
DEND syndrome;P70.2;KB60.2Y
Generalized epilepsy-paroxysmal dyskinesia syndrome;G40.3;8A61.2Y
Dowling-Degos disease;L81.8;EC23.0
Dowling-Degos disease;L81.8;EC23.0
Dowling-Degos disease;L81.8;EC23.0
Dowling-Degos disease;L81.8;EC23.0
Familial progressive hyperpigmentation;L81.4;EC23.0
Acrokeratosis verruciformis of Hopf;Q82.8;EC20.Y
Disseminated superficial actinic porokeratosis;Q82.8;ED52
Disseminated superficial actinic porokeratosis;Q82.8;ED52
Disseminated superficial actinic porokeratosis;Q82.8;ED52
Disseminated superficial actinic porokeratosis;Q82.8;ED52
2-aminoadipic 2-oxoadipic aciduria;E72.3;
Hydroxykynureninuria;E70.8;5C50.3
2-methylbutyryl-CoA dehydrogenase deficiency;E71.1;5C50.E0
Isobutyryl-CoA dehydrogenase deficiency;E71.1;5C50.E0
Hemochromatosis type 2;E83.110;
Hemochromatosis type 2;E83.110;
Hypoxanthine guanine phosphoribosyltransferase partial deficiency;E79.8;5C55.0Y
Crigler-Najjar syndrome type 1;E80.5;5C58.00
Crigler-Najjar syndrome type 2;E80.5;5C58.00
Galactokinase deficiency;E74.2;5C51.41
Classic galactosemia;E74.2;5C51.40
Glycogen storage disease due to liver and muscle phosphorylase kinase deficiency;E74.0;5C51.3
Biotinidase deficiency;E53.8;5C50.E0
Holocarboxylase synthetase deficiency;E53.8;5C50.E0
Pyruvate dehydrogenase E1-alpha deficiency;E74.4;5C53.02
Pyruvate dehydrogenase E1-alpha deficiency;E74.4;5C53.02
Pyruvate dehydrogenase E2 deficiency;E74.4;5C53.02
Pyruvate dehydrogenase phosphatase deficiency;E74.4;5C53.02
Mild phenylketonuria;E70.1;5C50.0Y
Classic phenylketonuria;E70.0;5C50.00
GM1 gangliosidosis type 1;E75.1;5C56.00
GM1 gangliosidosis type 2;E75.1;5C56.00
GM1 gangliosidosis type 3;E75.1;5C56.00
Glycogen storage disease due to glucose-6-phosphatase deficiency type Ia;E74.0;5C51.3
Glycogen storage disease due to glucose-6-phosphatase deficiency type Ib;E74.0;5C51.3
Sanfilippo syndrome type A;E76.2;5C56.3Y
Sanfilippo syndrome type B;E76.2;5C56.3Y
Sanfilippo syndrome type C;E76.2;5C56.3Y
Sanfilippo syndrome type D;E76.2;5C56.3Y
Hereditary coproporphyria;E80.2;5C58.1Y
Acute intermittent porphyria;E80.2;5C58.1Y
Congenital erythropoietic porphyria;E80.0;5C58.12
Congenital erythropoietic porphyria;E80.0;5C58.12
Autosomal erythropoietic protoporphyria;E80.0;5C58.12
Alpha-N-acetylgalactosaminidase deficiency type 1;E77.1;5C56.21
Alpha-N-acetylgalactosaminidase deficiency type 2;E77.1;5C56.21
Alpha-N-acetylgalactosaminidase deficiency type 3;E77.1;5C56.21
Methylmalonic acidemia with homocystinuria, type cblC;D58.8;5C50.E0
Methylmalonic acidemia with homocystinuria, type cblD;E72.1;5C50.E0
Methylmalonic acidemia with homocystinuria type cblF;E72.1;5C50.E0
Fish-eye disease;E78.6;5C81.0
Familial LCAT deficiency;E78.6;5C81.0
Hyperinsulinism due to glucokinase deficiency;E16.2;
Congenital bile acid synthesis defect type 1;K76.8;5C52.11
Congenital bile acid synthesis defect type 3;K76.8;5C52.11
Congenital bile acid synthesis defect type 2;K76.8;5C52.11
Progressive familial intrahepatic cholestasis type 2;K76.8;5C58.03
Progressive familial intrahepatic cholestasis type 3;K76.8;5C58.03
Progressive familial intrahepatic cholestasis type 1;K76.8;5C58.03
Progressive familial intrahepatic cholestasis type 1;K76.8;5C58.03
Vitamin B12-responsive methylmalonic acidemia type cblA;E71.1;5C50.E0
Vitamin B12-responsive methylmalonic acidemia type cblB;E71.1;5C50.E0
Vitamin B12-unresponsive methylmalonic acidemia type mut-;E71.1;5C50.E0
L-2-hydroxyglutaric aciduria;E72.8;5C50.E1
D-2-hydroxyglutaric aciduria;E72.8;5C50.E1
D-2-hydroxyglutaric aciduria;E72.8;5C50.E1
PMM2-CDG;E77.8;5C54.0
MPI-CDG;E77.8;5C54.0
ALG6-CDG;E77.8;5C54.0
ALG3-CDG;E77.8;5C54.0
DPM1-CDG;E77.8;5C54.2
MPDU1-CDG;E77.8;5C54.2
ALG12-CDG;E77.8;5C54.0
ALG8-CDG;E77.8;5C54.0
ALG2-CDG;E77.8;5C54.0
ALG1-CDG;E77.8;5C54.0
ALG9-CDG;E77.8;5C54.0
MGAT2-CDG;E77.8;5C54.0
MOGS-CDG;E77.8;5C54.0
B4GALT1-CDG;E77.8;5C54.2
COG7-CDG;E77.8;5C54.2
Brachytelephalangic chondrodysplasia punctata;Q77.3;LD24.04
3-phosphoserine phosphatase deficiency, infantile/juvenile form;E72.8;5C50.6
3-phosphoglycerate dehydrogenase deficiency, infantile/juvenile form;E72.8;5C50.6
Congenital non-bullous ichthyosiform erythroderma;;
Congenital non-bullous ichthyosiform erythroderma;;
Congenital non-bullous ichthyosiform erythroderma;;
Congenital non-bullous ichthyosiform erythroderma;;
Congenital non-bullous ichthyosiform erythroderma;;
Congenital non-bullous ichthyosiform erythroderma;;
Congenital non-bullous ichthyosiform erythroderma;;
Keratoderma hereditarium mutilans with ichthyosis;Q82.8;EC20.30
Autosomal dominant generalized epidermolysis bullosa simplex, severe form;Q81.0;EC30
Autosomal dominant generalized epidermolysis bullosa simplex, severe form;Q81.0;EC30
Epidermolysis bullosa simplex with mottled pigmentation;Q81.0;EC30
Epidermolysis bullosa simplex with mottled pigmentation;Q81.0;EC30
Autosomal dominant generalized epidermolysis bullosa simplex, intermediate form;Q81.0;EC30
Autosomal dominant generalized epidermolysis bullosa simplex, intermediate form;Q81.0;EC30
Localized epidermolysis bullosa simplex;Q81.0;EC30
Localized epidermolysis bullosa simplex;Q81.0;EC30
PLEC-related intermediate epidermolysis bullosa simplex without extracutaneous involvement;Q81.0;EC30
Intermediate generalized junctional epidermolysis bullosa;Q81.8;
Intermediate generalized junctional epidermolysis bullosa;Q81.8;
Intermediate generalized junctional epidermolysis bullosa;Q81.8;
Intermediate generalized junctional epidermolysis bullosa;Q81.8;
Intermediate generalized junctional epidermolysis bullosa;Q81.8;
Junctional epidermolysis bullosa with pyloric atresia;Q81.8;EC31
Junctional epidermolysis bullosa with pyloric atresia;Q81.8;EC31
Severe generalized junctional epidermolysis bullosa;Q81.1;EC31
Severe generalized junctional epidermolysis bullosa;Q81.1;EC31
Severe generalized junctional epidermolysis bullosa;Q81.1;EC31
Late-onset junctional epidermolysis bullosa;Q81.8;EC31
Autosomal recessive generalized dystrophic epidermolysis bullosa, severe form;Q81.2;EC32
Autosomal recessive generalized dystrophic epidermolysis bullosa, severe form;Q81.2;EC32
Recessive dystrophic epidermolysis bullosa inversa;Q81.2;EC32
Localized dystrophic epidermolysis bullosa, pretibial form;Q81.2;EC32
Self-improving dystrophic epidermolysis bullosa;Q81.2;EC32
Woolly hair nevus;D23.4;LC01
Oculocutaneous albinism type 1A;E70.3;EC23.20
Oculocutaneous albinism type 2;E70.3;EC23.20
Oculocutaneous albinism type 2;E70.3;EC23.20
Oculocutaneous albinism type 3;E70.3;EC23.20
Oculocutaneous albinism type 1B;E70.3;EC23.20
Oculocutaneous albinism type 4;E70.3;EC23.20
Pseudohypoparathyroidism type 1A;E20.1;5A50.1
Pseudohypoparathyroidism type 1C;E20.1;5A50.1
Pseudopseudohypoparathyroidism;E20.1;5A50.1
Milroy disease;Q82.0;BD93.0
Milroy disease;Q82.0;BD93.0
Cutaneous mastocytoma;Q82.2;2A21.1Y
Porphyria variegata;;
Atypical Werner syndrome;E34.8;LD2B
Griscelli syndrome type 1;E70.3;EC23.2Y
Griscelli syndrome type 2;E70.3;4A01.23
Griscelli syndrome type 3;E70.3;EC23.2Y
Griscelli syndrome type 3;E70.3;EC23.2Y
Phakomatosis cesioflammea;Q85.8;LD2D.Y
Phakomatosis cesioflammea;Q85.8;LD2D.Y
Phakomatosis cesiomarmorata;Q85.8;LD2D.Y
X-linked congenital generalized hypertrichosis;Q84.2;LD27.0Y
Autosomal dominant deafness-onychodystrophy syndrome;Q87.8;LD27.0Y
DOORS syndrome;Q87.8;LD27.0Y
DOORS syndrome;Q87.8;LD27.0Y
Punctate palmoplantar keratoderma type 1;Q82.8;EC20.32
Punctate palmoplantar keratoderma type 1;Q82.8;EC20.32
Ichthyosis hystrix of Curth-Macklin;Q80.8;EC20.03
Cholesterol-ester transfer protein deficiency;E78.4;5C80.3
Cholesterol-ester transfer protein deficiency;E78.4;5C80.3
Autosomal recessive hyperinsulinism due to SUR1 deficiency;E16.1;
Autosomal recessive hyperinsulinism due to Kir6.2 deficiency;E16.1;
Mild hyperphenylalaninemia;E70.1;5C50.0Y
Gardner syndrome;D12.6;LD2D.3
Proximal spinal muscular atrophy type 1;G12.0;8B61.0
Proximal spinal muscular atrophy type 1;G12.0;8B61.0
Proximal spinal muscular atrophy type 1;G12.0;8B61.0
Proximal spinal muscular atrophy type 2;G12.1;8B61.1
Proximal spinal muscular atrophy type 2;G12.1;8B61.1
Proximal spinal muscular atrophy type 2;G12.1;8B61.1
Proximal spinal muscular atrophy type 3;G12.1;8B61.2
Proximal spinal muscular atrophy type 3;G12.1;8B61.2
Proximal spinal muscular atrophy type 3;G12.1;8B61.2
Proximal spinal muscular atrophy type 4;G12.1;8B61.3
Proximal spinal muscular atrophy type 4;G12.1;8B61.3
Glomuvenous malformation;Q27.8;LC51
Congenital primary aphakia;Q12.3;LA12.2
Microtia;Q17.2;LA22.0
Narcolepsy type 2;G47.4;7A20.1
Narcolepsy type 2;G47.4;7A20.1
Narcolepsy type 2;G47.4;7A20.1
Narcolepsy type 2;G47.4;7A20.1
Desmoplastic small round cell tumor;C48.2;
Desmoplastic small round cell tumor;C48.2;
CAMOS syndrome;G11.1;
CAMOS syndrome;G11.1;
Megalencephaly-polymicrogyria-postaxial polydactyly-hydrocephalus syndrome;Q04.8;
Megalencephaly-polymicrogyria-postaxial polydactyly-hydrocephalus syndrome;Q04.8;
Megalencephaly-polymicrogyria-postaxial polydactyly-hydrocephalus syndrome;Q04.8;
Enteric anendocrinosis;P78.3;DA90.Y
Leukoencephalopathy-spondyloepimetaphyseal dysplasia syndrome;G37.8;
Hypercoagulability syndrome due to glycosylphosphatidylinositol deficiency;E88.8;3B61.0Y
Hypercoagulability syndrome due to glycosylphosphatidylinositol deficiency;E88.8;3B61.0Y
Microcytic anemia with liver iron overload;D50.8;3A00.Y
Syndromic diarrhea;K52.8;DA90.0
Syndromic diarrhea;K52.8;DA90.0
Senior-Boichis syndrome;Q61.8;GB8Y
Senior-Boichis syndrome;Q61.8;GB8Y
Fibronectin glomerulopathy;N07.6;MF81
Desmin-related myopathy with Mallory body-like inclusions;G71.8;4A41.21
Palmoplantar keratoderma-XX sex reversal-predisposition to squamous cell carcinoma syndrome;Q56.0;
Bothnia retinal dystrophy;H35.5;9B70
Cystic leukoencephalopathy without megalencephaly;E75.2;5C55.2
Cystic leukoencephalopathy without megalencephaly;E75.2;5C55.2
NON RARE IN EUROPE: Aldosterone-producing adenoma;D35.0;
NON RARE IN EUROPE: Aldosterone-producing adenoma;D35.0;
NON RARE IN EUROPE: Aldosterone-producing adenoma;D35.0;
NON RARE IN EUROPE: Aldosterone-producing adenoma;D35.0;
NON RARE IN EUROPE: Aldosterone-producing adenoma;D35.0;
Neurogenic scapuloperoneal syndrome, Kaeser type;G12.1;
Hypomyelination-congenital cataract syndrome;G37.8;
Camptodactyly-tall stature-scoliosis-hearing loss syndrome;Q87.2;LD2F.1Y
Severe achondroplasia-developmental delay-acanthosis nigricans syndrome;Q77.4;
Platyspondylic dysplasia, Torrance type;Q77.8;LD24.5Y
Spondylometaphyseal dysplasia-cone-rod dystrophy syndrome;Q77.8;LD24.4
Familial digital arthropathy-brachydactyly;M06.8;LD24.8Y
Microcephalic osteodysplastic dysplasia, Saul-Wilson type;Q78.8;LD24.D
IMAGe syndrome;Q87.1;5A74.Y
IMAGe syndrome;Q87.1;5A74.Y
Infantile osteopetrosis with neuroaxonal dysplasia;Q78.2;LD24.10
Diaphyseal medullary stenosis-bone malignancy syndrome;M89.8;LD24.1Y
Endosteal sclerosis-cerebellar hypoplasia syndrome;Q87.8;LD2F.1Y
Singleton-Merten dysplasia;Q78.8;LD24.KY
Singleton-Merten dysplasia;Q78.8;LD24.KY
Idiopathic juvenile osteoporosis;M81.5;FB83.1Y
Idiopathic juvenile osteoporosis;M81.5;FB83.1Y
Idiopathic juvenile osteoporosis;M81.5;FB83.1Y
Spondylo-ocular syndrome;Q87.5;LD24.KY
Familial expansile osteolysis;M89.5;FB86.2
Dysspondyloenchondromatosis;Q78.4;LD24.2Y
Ischiovertebral syndrome;;
Genitopatellar syndrome;Q87.8;LD2F.1Y
Keutel syndrome;Q87.8;LD2F.1Y
Fetal Gaucher disease;E75.2;5C56.0Y
X-linked intellectual disability, Cantagrel type;Q87.8;LD90
Christianson syndrome;Q87.8;8A03.1Y
KDM5C-related syndromic X-linked intellectual disability;Q87.8;LD90
MEHMO syndrome;Q87.8;LD29
BRESEK syndrome;Q87.8;LD90
X-linked intellectual disability, Siderius type;Q87.8;LD90
X-linked intellectual disability, Stocco Dos Santos type;Q87.8;LD90
X-linked intellectual disability, Cabezas type;Q87.8;LD90
X-linked epilepsy-learning disabilities-behavior disorders syndrome;Q87.8;
HSD10 disease, atypical type;G25.5;5C52.01
X-linked intellectual disability-hypotonia-facial dysmorphism-aggressive behavior syndrome;Q87.8;LD90
Fried syndrome;Q87.8;
Rheumatoid factor-negative polyarticular juvenile idiopathic arthritis;M08.3;FA24.1
Rheumatoid factor-negative polyarticular juvenile idiopathic arthritis;M08.3;FA24.1
Rheumatoid factor-negative polyarticular juvenile idiopathic arthritis;M08.3;FA24.1
Rheumatoid factor-negative polyarticular juvenile idiopathic arthritis;M08.3;FA24.1
Rheumatoid factor-negative polyarticular juvenile idiopathic arthritis;M08.3;FA24.1
Rheumatoid factor-negative polyarticular juvenile idiopathic arthritis;M08.3;FA24.1
Rheumatoid factor-negative polyarticular juvenile idiopathic arthritis;M08.3;FA24.1
Oligoarticular juvenile idiopathic arthritis;M08.4;FA24.0
Oligoarticular juvenile idiopathic arthritis;M08.4;FA24.0
Oligoarticular juvenile idiopathic arthritis;M08.4;FA24.0
Oligoarticular juvenile idiopathic arthritis;M08.4;FA24.0
Oligoarticular juvenile idiopathic arthritis;M08.4;FA24.0
Oligoarticular juvenile idiopathic arthritis;M08.4;FA24.0
Oligoarticular juvenile idiopathic arthritis;M08.4;FA24.0
Systemic-onset juvenile idiopathic arthritis;M08.2;FA24.4
Systemic-onset juvenile idiopathic arthritis;M08.2;FA24.4
Systemic-onset juvenile idiopathic arthritis;M08.2;FA24.4
Systemic-onset juvenile idiopathic arthritis;M08.2;FA24.4
Short stature-pituitary and cerebellar defects-small sella turcica syndrome;E23.0;
AA amyloidosis;E85.3;5D00.1
ATTRV30M amyloidosis;E85.1;5D00.20
AGel amyloidosis;E85.1;5D00.2Y
ATTRV122I amyloidosis;E85.4;5D00.20
X-linked reticulate pigmentary disorder;E85.0+;5D00.Y
X-linked reticulate pigmentary disorder;L99.0*;5D00.Y
DPAGT1-CDG;E77.8;5C54.0
X-linked severe congenital neutropenia;D70;4B00.00
POMT1-related limb-girdle muscular dystrophy R11;G71.0;8C70.41
Helicoid peripapillary chorioretinal degeneration;H31.2;9B70
Benign adult familial myoclonic epilepsy;G40.3;8A61.32
Benign adult familial myoclonic epilepsy;G40.3;8A61.32
Benign adult familial myoclonic epilepsy;G40.3;8A61.32
Benign adult familial myoclonic epilepsy;G40.3;8A61.32
Benign adult familial myoclonic epilepsy;G40.3;8A61.32
Benign adult familial myoclonic epilepsy;G40.3;8A61.32
Aplasia of lacrimal and salivary glands;Q10.4;LA14.10
Aplasia of lacrimal and salivary glands;Q38.4;LA14.10
Congenital analbuminemia;R77.0;5D0Y
Hemolytic anemia due to adenylate kinase deficiency;D55.3;3A10.Y
Alport syndrome-intellectual disability-midface hypoplasia-elliptocytosis syndrome;Q87.8;
Alport syndrome-intellectual disability-midface hypoplasia-elliptocytosis syndrome;Q87.8;
Alport syndrome-intellectual disability-midface hypoplasia-elliptocytosis syndrome;Q87.8;
Atrichia with papular lesions;L65.8;EC21.2
Familial avascular necrosis of femoral head;M87.8;FB82.1
Familial avascular necrosis of femoral head;M87.8;FB82.1
Chronic neutrophilic leukemia;D47.1;2A20.1
Chronic myeloproliferative disease, unclassifiable;D47.1;2A22
Juvenile myelomonocytic leukemia;C93.3;2A42
Juvenile myelomonocytic leukemia;C93.3;2A42
Juvenile myelomonocytic leukemia;C93.3;2A42
Juvenile myelomonocytic leukemia;C93.3;2A42
Juvenile myelomonocytic leukemia;C93.3;2A42
Juvenile myelomonocytic leukemia;C93.3;2A42
Myelodysplastic syndrome associated with isolated del(5q) chromosome abnormality;D46.7;2A36
Acute myeloid leukaemia with myelodysplasia-related features;C92.8;2A60.1
Acute basophilic leukemia;C94.7;2A60.37
Acute basophilic leukemia;C94.7;2A60.37
T-cell large granular lymphocyte leukemia;C91.7;2A90.1
Subcutaneous panniculitis-like T-cell lymphoma;C86.3;2B00
Epilepsy with myoclonic absences;G40.4;8A61.23
Dermatopathia pigmentosa reticularis;Q82.4;
Hereditary palmoplantar keratoderma, Gamborg-Nielsen type;Q82.8;EC20.3
Hereditary palmoplantar keratoderma, Gamborg-Nielsen type;Q82.8;EC20.3
Mal de Meleda;Q82.8;EC20.30
Autosomal recessive non-syndromic intellectual disability;F70;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F73;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F72;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F71;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F70;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F73;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F72;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F71;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F70;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F73;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F72;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F71;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F70;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F73;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F72;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F71;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F70;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F73;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F72;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F71;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F70;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F73;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F72;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F71;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F70;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F73;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F72;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F71;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F70;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F73;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F72;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F71;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F70;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F73;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F72;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F71;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F70;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F73;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F72;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F71;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F70;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F73;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F72;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F71;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F70;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F73;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F72;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F71;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F70;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F73;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F72;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F71;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F70;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F73;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F72;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F71;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F70;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F73;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F72;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F71;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F70;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F73;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F72;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F71;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F70;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F73;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F72;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F71;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F70;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F73;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F72;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F71;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F70;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F73;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F72;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F71;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F70;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F73;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F72;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F71;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F70;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F73;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F72;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F71;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F70;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F73;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F72;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F71;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F70;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F73;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F72;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F71;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F70;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F73;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F72;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F71;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F70;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F73;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F72;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F71;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F70;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F73;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F72;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F71;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F70;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F73;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F72;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F71;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F70;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F73;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F72;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F71;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F70;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F73;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F72;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F71;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F70;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F73;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F72;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F71;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F70;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F73;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F72;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F71;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F70;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F73;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F72;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F71;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F70;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F73;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F72;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F71;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F70;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F73;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F72;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F71;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F70;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F73;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F72;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F71;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F70;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F73;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F72;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F71;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F70;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F73;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F72;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F71;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F70;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F73;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F72;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F71;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F70;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F73;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F72;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F71;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F70;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F73;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F72;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F71;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F70;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F73;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F72;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F71;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F70;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F73;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F72;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F71;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F70;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F73;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F72;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F71;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F70;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F73;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F72;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F71;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F70;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F73;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F72;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F71;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F70;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F73;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F72;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F71;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F70;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F73;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F72;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F71;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F70;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F73;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F72;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F71;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F70;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F73;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F72;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F71;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F70;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F73;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F72;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F71;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F70;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F73;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F72;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F71;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F70;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F73;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F72;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F71;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F70;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F73;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F72;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F71;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F70;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F73;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F72;LD90.Y
Autosomal recessive non-syndromic intellectual disability;F71;LD90.Y
S-adenosylhomocysteine hydrolase deficiency;E72.1;5C50.B
Familial acute necrotizing encephalopathy;G93.4;
Isolated congenital anosmia;Q07.8;CA0Y
Isolated congenital anosmia;Q07.8;CA0Y
Ichthyosis-prematurity syndrome;Q80.8;LD27.2
Posterior column ataxia-retinitis pigmentosa syndrome;G11.1;
Tritanopia;H53.5;9D44
Terminal osseous dysplasia-pigmentary defects syndrome;Q87.2;LD24.8Y
Vacuolar myopathy with sarcoplasmic reticulum protein aggregates;G71.8;8C7Y
Hypomyelination-hypogonadotropic hypogonadism-hypodontia syndrome;G11.1;8A44.3
Hypomyelination-hypogonadotropic hypogonadism-hypodontia syndrome;G11.1;8A44.3
Hypomyelination-hypogonadotropic hypogonadism-hypodontia syndrome;G11.1;8A44.3
Neurodegeneration due to 3-hydroxyisobutyryl-CoA hydrolase deficiency;E71.1;5C50.E0
Congenital insensitivity to pain-anosmia-neuropathic arthropathy;G60.8;
Congenital insensitivity to pain-anosmia-neuropathic arthropathy;G60.8;
Congenital insensitivity to pain-anosmia-neuropathic arthropathy;G60.8;
Autosomal recessive ataxia, Beauce type;G11.2;
X-linked Alport syndrome;Q87.8;LD2H.Y
Autosomal dominant Alport syndrome;Q87.8;LD2H.Y
Autosomal dominant Alport syndrome;Q87.8;LD2H.Y
Autosomal recessive Alport syndrome;Q87.8;LD2H.Y
Autosomal recessive Alport syndrome;Q87.8;LD2H.Y
Autosomal dominant polycystic kidney disease type 1 with tuberous sclerosis;Q61.2;LD2F.1Y
Autosomal dominant polycystic kidney disease type 1 with tuberous sclerosis;Q61.2;LD2F.1Y
Pseudohypoaldosteronism type 2B;I15.1;BA04.Y
Pseudohypoaldosteronism type 2C;I15.1;BA04.Y
MUC1-related autosomal dominant tubulointerstitial kidney disease;Q61.5;GB82
UMOD-related autosomal dominant tubulointerstitial kidney disease;Q61.5;GB82
Autosomal recessive generalized epidermolysis bullosa simplex;Q81.0;EC30
Autosomal recessive generalized dystrophic epidermolysis bullosa, intermediate form;Q81.2;EC32
Dystrophic epidermolysis bullosa pruriginosa;Q81.2;EC32
Lissencephaly syndrome, Norman-Roberts type;Q04.3;LD20.1
Lissencephaly syndrome, Norman-Roberts type;Q04.3;LD20.1
Lissencephaly syndrome, Norman-Roberts type;Q04.3;LD20.1
X-linked hypophosphatemia;E83.3;5C63.22
Autosomal dominant hypophosphatemic rickets;E83.3;5C63.22
Bartter syndrome type 4;E26.8;GB90.43
Bartter syndrome type 4;E26.8;GB90.43
Bartter syndrome type 4;E26.8;GB90.43
X-linked cone dysfunction syndrome with myopia;H53.8;9B70
X-linked cone dysfunction syndrome with myopia;H53.8;9B70
Parkinson-dementia complex of Guam;G12.2;6D85.Y
Parkinson-dementia complex of Guam;G12.2;6D85.Y
Primary immunodeficiency syndrome due to LAMTOR2 deficiency;;
Deafness with labyrinthine aplasia, microtia, and microdontia;Q16.5;LD2H.Y
Primary erythromelalgia;I73.8;EG00
Primary erythromelalgia;I73.8;EG00
Primary erythromelalgia;I73.8;EG00
Hemolytic anemia due to glutathione reductase deficiency;D55.1;3A10.0Y
Non-spherocytic hemolytic anemia due to hexokinase deficiency;D55.2;3A10.Y
Hemoglobin D disease;D58.2;3A51.6
Primary familial polycythemia;D75.0;3A80.0
Familial pseudohyperkalemia;D58.8;3A10.3
Hereditary folate malabsorption;D52.8;5C63.1
Retinopathy of prematurity;H35.1;9B71.3
Retinopathy of prematurity;H35.1;9B71.3
Retinopathy of prematurity;H35.1;9B71.3
Hereditary motor and sensory neuropathy, Okinawa type;G60.0;8C20.Y
Severe early-onset axonal neuropathy due to MFN2 deficiency;G60.0;
Hereditary motor and sensory neuropathy type 6;G60.0;8C20.1
Hereditary motor and sensory neuropathy type 6;G60.0;8C20.1
Mandibuloacral dysplasia with type A lipodystrophy;Q87.5;LD27.6Z
Mandibuloacral dysplasia with type A lipodystrophy;Q87.5;LD27.6Z
Mandibuloacral dysplasia with type B lipodystrophy;Q87.5;LD27.6Z
Meige disease;Q82.0;BD93.0
Parkes Weber syndrome;Q87.2;LD26.60
Klippel-Trénaunay syndrome;Q87.2;LD26.60
Cockayne syndrome type 1;Q87.8;LD2B
Cockayne syndrome type 1;Q87.8;LD2B
Cockayne syndrome type 1;Q87.8;LD2B
Cockayne syndrome type 2;Q87.8;LD2B
Cockayne syndrome type 2;Q87.8;LD2B
Cockayne syndrome type 2;Q87.8;LD2B
Cockayne syndrome type 3;Q87.8;LD2B
Cockayne syndrome type 3;Q87.8;LD2B
Blau syndrome;D89.8;4A60.Y
Xeroderma pigmentosum variant;Q82.1;LD27.Y
Autosomal dominant cutis laxa;Q82.8;LD28.2
Autosomal dominant cutis laxa;Q82.8;LD28.2
Autosomal dominant cutis laxa;Q82.8;LD28.2
Autosomal recessive cutis laxa type 1;Q82.8;LD28.2
Autosomal recessive cutis laxa type 1;Q82.8;LD28.2
Autosomal recessive cutis laxa type 1;Q82.8;LD28.2
Brittle cornea syndrome;Q79.6;LD28.1Y
Brittle cornea syndrome;Q79.6;LD28.1Y
Hypotrichosis simplex of the scalp;L65.8;EC21.2
Hypotrichosis simplex of the scalp;L65.8;EC21.2
Telangiectasia macularis eruptiva perstans;Q82.2;2A21.1Y
X-linked non-syndromic sensorineural deafness type DFN;;
X-linked non-syndromic sensorineural deafness type DFN;;
X-linked non-syndromic sensorineural deafness type DFN;;
Autosomal dominant non-syndromic sensorineural deafness type DFNA;;
Autosomal dominant non-syndromic sensorineural deafness type DFNA;;
Autosomal dominant non-syndromic sensorineural deafness type DFNA;;
Autosomal dominant non-syndromic sensorineural deafness type DFNA;;
Autosomal dominant non-syndromic sensorineural deafness type DFNA;;
Autosomal dominant non-syndromic sensorineural deafness type DFNA;;
Autosomal dominant non-syndromic sensorineural deafness type DFNA;;
Autosomal dominant non-syndromic sensorineural deafness type DFNA;;
Autosomal dominant non-syndromic sensorineural deafness type DFNA;;
Autosomal dominant non-syndromic sensorineural deafness type DFNA;;
Autosomal dominant non-syndromic sensorineural deafness type DFNA;;
Autosomal dominant non-syndromic sensorineural deafness type DFNA;;
Autosomal dominant non-syndromic sensorineural deafness type DFNA;;
Autosomal dominant non-syndromic sensorineural deafness type DFNA;;
Autosomal dominant non-syndromic sensorineural deafness type DFNA;;
Autosomal dominant non-syndromic sensorineural deafness type DFNA;;
Autosomal dominant non-syndromic sensorineural deafness type DFNA;;
Autosomal dominant non-syndromic sensorineural deafness type DFNA;;
Autosomal dominant non-syndromic sensorineural deafness type DFNA;;
Autosomal dominant non-syndromic sensorineural deafness type DFNA;;
Autosomal dominant non-syndromic sensorineural deafness type DFNA;;
Autosomal dominant non-syndromic sensorineural deafness type DFNA;;
Autosomal dominant non-syndromic sensorineural deafness type DFNA;;
Autosomal dominant non-syndromic sensorineural deafness type DFNA;;
Autosomal dominant non-syndromic sensorineural deafness type DFNA;;
Autosomal dominant non-syndromic sensorineural deafness type DFNA;;
Autosomal dominant non-syndromic sensorineural deafness type DFNA;;
Autosomal dominant non-syndromic sensorineural deafness type DFNA;;
Autosomal dominant non-syndromic sensorineural deafness type DFNA;;
Autosomal dominant non-syndromic sensorineural deafness type DFNA;;
Autosomal dominant non-syndromic sensorineural deafness type DFNA;;
Autosomal dominant non-syndromic sensorineural deafness type DFNA;;
Autosomal dominant non-syndromic sensorineural deafness type DFNA;;
Autosomal dominant non-syndromic sensorineural deafness type DFNA;;
Autosomal dominant non-syndromic sensorineural deafness type DFNA;;
Autosomal dominant non-syndromic sensorineural deafness type DFNA;;
Autosomal dominant non-syndromic sensorineural deafness type DFNA;;
Autosomal dominant non-syndromic sensorineural deafness type DFNA;;
Autosomal dominant non-syndromic sensorineural deafness type DFNA;;
Autosomal dominant non-syndromic sensorineural deafness type DFNA;;
Autosomal dominant non-syndromic sensorineural deafness type DFNA;;
Autosomal dominant non-syndromic sensorineural deafness type DFNA;;
Autosomal dominant non-syndromic sensorineural deafness type DFNA;;
Autosomal dominant non-syndromic sensorineural deafness type DFNA;;
Autosomal dominant non-syndromic sensorineural deafness type DFNA;;
Autosomal recessive non-syndromic sensorineural deafness type DFNB;;
Autosomal recessive non-syndromic sensorineural deafness type DFNB;;
Autosomal recessive non-syndromic sensorineural deafness type DFNB;;
Autosomal recessive non-syndromic sensorineural deafness type DFNB;;
Autosomal recessive non-syndromic sensorineural deafness type DFNB;;
Autosomal recessive non-syndromic sensorineural deafness type DFNB;;
Autosomal recessive non-syndromic sensorineural deafness type DFNB;;
Autosomal recessive non-syndromic sensorineural deafness type DFNB;;
Autosomal recessive non-syndromic sensorineural deafness type DFNB;;
Autosomal recessive non-syndromic sensorineural deafness type DFNB;;
Autosomal recessive non-syndromic sensorineural deafness type DFNB;;
Autosomal recessive non-syndromic sensorineural deafness type DFNB;;
Autosomal recessive non-syndromic sensorineural deafness type DFNB;;
Autosomal recessive non-syndromic sensorineural deafness type DFNB;;
Autosomal recessive non-syndromic sensorineural deafness type DFNB;;
Autosomal recessive non-syndromic sensorineural deafness type DFNB;;
Autosomal recessive non-syndromic sensorineural deafness type DFNB;;
Autosomal recessive non-syndromic sensorineural deafness type DFNB;;
Autosomal recessive non-syndromic sensorineural deafness type DFNB;;
Autosomal recessive non-syndromic sensorineural deafness type DFNB;;
Autosomal recessive non-syndromic sensorineural deafness type DFNB;;
Autosomal recessive non-syndromic sensorineural deafness type DFNB;;
Autosomal recessive non-syndromic sensorineural deafness type DFNB;;
Autosomal recessive non-syndromic sensorineural deafness type DFNB;;
Autosomal recessive non-syndromic sensorineural deafness type DFNB;;
Autosomal recessive non-syndromic sensorineural deafness type DFNB;;
Autosomal recessive non-syndromic sensorineural deafness type DFNB;;
Autosomal recessive non-syndromic sensorineural deafness type DFNB;;
Autosomal recessive non-syndromic sensorineural deafness type DFNB;;
Autosomal recessive non-syndromic sensorineural deafness type DFNB;;
Autosomal recessive non-syndromic sensorineural deafness type DFNB;;
Autosomal recessive non-syndromic sensorineural deafness type DFNB;;
Autosomal recessive non-syndromic sensorineural deafness type DFNB;;
Autosomal recessive non-syndromic sensorineural deafness type DFNB;;
Autosomal recessive non-syndromic sensorineural deafness type DFNB;;
Autosomal recessive non-syndromic sensorineural deafness type DFNB;;
Autosomal recessive non-syndromic sensorineural deafness type DFNB;;
Autosomal recessive non-syndromic sensorineural deafness type DFNB;;
Autosomal recessive non-syndromic sensorineural deafness type DFNB;;
Autosomal recessive non-syndromic sensorineural deafness type DFNB;;
Autosomal recessive non-syndromic sensorineural deafness type DFNB;;
Autosomal recessive non-syndromic sensorineural deafness type DFNB;;
Autosomal recessive non-syndromic sensorineural deafness type DFNB;;
Autosomal recessive non-syndromic sensorineural deafness type DFNB;;
Autosomal recessive non-syndromic sensorineural deafness type DFNB;;
Autosomal recessive non-syndromic sensorineural deafness type DFNB;;
Autosomal recessive non-syndromic sensorineural deafness type DFNB;;
Autosomal recessive non-syndromic sensorineural deafness type DFNB;;
Autosomal recessive non-syndromic sensorineural deafness type DFNB;;
Autosomal recessive non-syndromic sensorineural deafness type DFNB;;
Autosomal recessive non-syndromic sensorineural deafness type DFNB;;
Autosomal recessive non-syndromic sensorineural deafness type DFNB;;
Autosomal recessive non-syndromic sensorineural deafness type DFNB;;
Autosomal recessive non-syndromic sensorineural deafness type DFNB;;
Autosomal recessive non-syndromic sensorineural deafness type DFNB;;
Autosomal recessive non-syndromic sensorineural deafness type DFNB;;
Autosomal recessive non-syndromic sensorineural deafness type DFNB;;
Autosomal recessive non-syndromic sensorineural deafness type DFNB;;
Autosomal recessive non-syndromic sensorineural deafness type DFNB;;
Autosomal recessive non-syndromic sensorineural deafness type DFNB;;
Autosomal recessive non-syndromic sensorineural deafness type DFNB;;
Autosomal recessive non-syndromic sensorineural deafness type DFNB;;
Autosomal recessive non-syndromic sensorineural deafness type DFNB;;
Autosomal recessive non-syndromic sensorineural deafness type DFNB;;
Autosomal recessive non-syndromic sensorineural deafness type DFNB;;
Autosomal recessive non-syndromic sensorineural deafness type DFNB;;
Autosomal recessive non-syndromic sensorineural deafness type DFNB;;
Autosomal recessive non-syndromic sensorineural deafness type DFNB;;
Autosomal recessive non-syndromic sensorineural deafness type DFNB;;
Autosomal recessive non-syndromic sensorineural deafness type DFNB;;
Autosomal recessive non-syndromic sensorineural deafness type DFNB;;
Autosomal recessive non-syndromic sensorineural deafness type DFNB;;
Autosomal recessive non-syndromic sensorineural deafness type DFNB;;
Mitochondrial non-syndromic sensorineural deafness;;
Mitochondrial non-syndromic sensorineural deafness;;
Mitochondrial non-syndromic sensorineural deafness;;
Mitochondrial non-syndromic sensorineural deafness;;
Mitochondrial non-syndromic sensorineural deafness;;
Mitochondrial non-syndromic sensorineural deafness;;
Jervell and Lange-Nielsen syndrome;I45.8;BC65.0
Jervell and Lange-Nielsen syndrome;I45.8;BC65.0
Otopalatodigital syndrome type 1;Q87.0;LD25.1
Otopalatodigital syndrome type 2;Q87.0;LD25.1
Stickler syndrome type 1;Q87.5;LD2F.1Y
Stickler syndrome type 2;Q87.5;LD2F.1Y
Charcot-Marie-Tooth disease type 1E;G60.0;8C20.0
Hypothyroidism due to TSH receptor mutations;E03.1;5A00.01
Isolated thyroid-stimulating hormone deficiency;E03.1;5A00.01
Non-acquired panhypopituitarism;E23.0;5A61.0
Non-acquired panhypopituitarism;E23.0;5A61.0
Congenital adrenal hyperplasia due to 3-beta-hydroxysteroid dehydrogenase deficiency;E25.0;5A71.01
Congenital adrenal hyperplasia due to 17-alpha-hydroxylase deficiency;E25.0;5A71.01
Congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency;E25.0;5A71.01
46,XY disorder of sex development due to isolated 17,20-lyase deficiency;;
46,XY disorder of sex development due to isolated 17,20-lyase deficiency;;
Partial androgen insensitivity syndrome;E34.5;LD2A.4
Cardiomyopathy-hypotonia-lactic acidosis syndrome;G71.3;5C53.30
DK1-CDG;E77.8;5C54.2
Ichthyosis-hypotrichosis syndrome;Q80.8;LD27.2
Body skin hyperlaxity due to vitamin K-dependent coagulation factor deficiency;D68.4;
TSH-secreting pituitary adenoma;D35.2;2F37.Y
Germinoma of the central nervous system;C72.9;2A00.1Y
Familial thoracic aortic aneurysm and aortic dissection;I71.2;LD28.0Y
Familial thoracic aortic aneurysm and aortic dissection;I71.2;LD28.0Y
Familial thoracic aortic aneurysm and aortic dissection;I71.2;LD28.0Y
Familial thoracic aortic aneurysm and aortic dissection;I71.2;LD28.0Y
Familial thoracic aortic aneurysm and aortic dissection;I71.2;LD28.0Y
Familial thoracic aortic aneurysm and aortic dissection;I71.2;LD28.0Y
Familial thoracic aortic aneurysm and aortic dissection;I71.2;LD28.0Y
Familial thoracic aortic aneurysm and aortic dissection;I71.2;LD28.0Y
Familial thoracic aortic aneurysm and aortic dissection;I71.2;LD28.0Y
Familial thoracic aortic aneurysm and aortic dissection;I71.2;LD28.0Y
Familial thoracic aortic aneurysm and aortic dissection;I71.2;LD28.0Y
Familial thoracic aortic aneurysm and aortic dissection;I71.2;LD28.0Y
Familial thoracic aortic aneurysm and aortic dissection;I71.2;LD28.0Y
Familial thoracic aortic aneurysm and aortic dissection;I71.2;LD28.0Y
Familial thoracic aortic aneurysm and aortic dissection;I71.2;LD28.0Y
Familial thoracic aortic aneurysm and aortic dissection;I71.2;LD28.0Y
Familial thoracic aortic aneurysm and aortic dissection;I71.2;LD28.0Y
Familial thoracic aortic aneurysm and aortic dissection;I71.2;LD28.0Y
Congenital ptosis;Q10.0;LA14.04
Congenital ptosis;Q10.0;LA14.04
Pilomatrixoma;D23.3;2F22
Pilomatrixoma;D23.4;2F22
Pilomatrixoma;D23.6;2F22
Ring dermoid of cornea;D31.1;2F36.Y
Rieger anomaly;Q13.8;LA11.2
Rieger anomaly;Q13.8;LA11.2
Isolated congenital megalocornea;Q15.8;LA11.1
Isolated congenital sclerocornea;Q13.3;LA11.1
Persistent hyperplastic primary vitreous;Q14.0;LA13.Y
Persistent hyperplastic primary vitreous;Q14.0;LA13.Y
Persistent hyperplastic primary vitreous;Q14.0;LA13.Y
Snowflake vitreoretinal degeneration;H35.5;9B70
Congenital tufting enteropathy;P78.3;DA90.Y
Congenital tufting enteropathy;P78.3;DA90.Y
Renal agenesis, unilateral;Q60.0;LB30.00
Renal agenesis, unilateral;Q60.0;LB30.00
Renal agenesis, unilateral;Q60.0;LB30.00
Renal agenesis, unilateral;Q60.0;LB30.00
Renal agenesis, unilateral;Q60.0;LB30.00
Renal agenesis, unilateral;Q60.0;LB30.00
Renal agenesis, unilateral;Q60.0;LB30.00
Renal agenesis, unilateral;Q60.0;LB30.00
Posterior urethral valve;Q64.2;LB31.2
HNF1B-related autosomal dominant tubulointerstitial kidney disease;N11.8;5A13.6
Autosomal dominant intermediate Charcot-Marie-Tooth disease type E;G60.0;8C20.2
Hypocalcemic vitamin D-resistant rickets;E83.3;5C63.21
Renal dysplasia, unilateral;Q61.4;LB30.1
Renal dysplasia, bilateral;Q61.4;LB30.1
Fragile X-associated tremor/ataxia syndrome;G11.2;8A03.1Y
Pfeiffer syndrome type 1;Q87.0;LD24.G0
Pfeiffer syndrome type 1;Q87.0;LD24.G0
Pfeiffer syndrome type 2;Q87.0;LD24.G0
Pfeiffer syndrome type 3;Q87.0;LD24.G0
Crouzon syndrome-acanthosis nigricans syndrome;Q75.1;LD24.GY
Short rib-polydactyly syndrome, Beemer-Langer type;Q77.2;LD24.B0
Short rib-polydactyly syndrome, Beemer-Langer type;Q77.2;LD24.B0
Short rib-polydactyly syndrome, Majewski type;Q77.2;LD24.B0
Short rib-polydactyly syndrome, Majewski type;Q77.2;LD24.B0
Short rib-polydactyly syndrome, Majewski type;Q77.2;LD24.B0
Short rib-polydactyly syndrome, Saldino-Noonan type;Q77.2;LD24.B0
Short rib-polydactyly syndrome, Verma-Naumoff type;Q77.2;LD24.B0
Short rib-polydactyly syndrome, Verma-Naumoff type;Q77.2;LD24.B0
Short rib-polydactyly syndrome, Verma-Naumoff type;Q77.2;LD24.B0
Short rib-polydactyly syndrome, Verma-Naumoff type;Q77.2;LD24.B0
Short rib-polydactyly syndrome, Verma-Naumoff type;Q77.2;LD24.B0
Thanatophoric dysplasia type 2;Q77.1;LD24.02
Polyostotic fibrous dysplasia;Q78.1;FB80.0
Monostotic fibrous dysplasia;M85.0;FB80.0
Mild spondyloepiphyseal dysplasia due to COL2A1 mutation with early-onset osteoarthritis;Q77.7;LD24.3
Spondyloepimetaphyseal dysplasia, PAPSS2 type;Q77.7;LD24.3
Spondyloepiphyseal dysplasia, Kimberley type;Q77.7;LD24.3
Spondyloepiphyseal dysplasia tarda;Q77.7;LD24.3
Achondrogenesis type 2;Q77.0;LD24.50
Hypochondrogenesis;Q77.0;LD24.51
Achondrogenesis type 1B;Q77.0;LD24.50
Achondrogenesis type 1A;Q77.0;LD24.50
Autosomal dominant brachyolmia;Q76.3;LD24.5Y
Multiple epiphyseal dysplasia type 4;Q77.3;LD24.61
Multiple epiphyseal dysplasia type 1;Q77.3;LD24.61
Multiple epiphyseal dysplasia type 5;Q77.3;LD24.61
Spondylometaphyseal dysplasia, Kozlowski type;Q77.8;LD24.4
Spondylometaphyseal dysplasia, 'corner fracture' type;Q77.8;LD24.4
Spondylometaphyseal dysplasia, 'corner fracture' type;Q77.8;LD24.4
Spondylometaphyseal dysplasia, Schmidt type;Q77.8;LD24.4
Spondylometaphyseal dysplasia, Sedaghatian type;Q77.8;LD24.5Y
Radial hemimelia;;
Radial hemimelia;;
Tibial hemimelia;;
Autosomal recessive Kenny-Caffey syndrome;Q87.1;LD24.D
Autosomal dominant Kenny-Caffey syndrome;Q87.1;LD24.D
Autosomal dominant omodysplasia;Q78.8;LD24.A
Autosomal recessive omodysplasia;Q78.8;LD24.A
Pelviscapular dysplasia;Q87.5;
Postaxial polydactyly type A;Q69.0;LB78.2
Postaxial polydactyly type A;Q69.0;LB78.2
Postaxial polydactyly type A;Q69.0;LB78.2
Postaxial polydactyly type A;Q69.0;LB78.2
Postaxial polydactyly type A;Q69.0;LB78.2
Postaxial polydactyly type A;Q69.0;LB78.2
Postaxial polydactyly type B;Q69.0;LB78.2
Postaxial polydactyly type B;Q69.0;LB78.2
Polydactyly of a triphalangeal thumb;Q69.1;LD26.2
Polydactyly of a triphalangeal thumb;Q69.1;LD26.2
Polysyndactyly;Q70.4;LB78.1
Polydactyly of a biphalangeal thumb;;
Spondyloepimetaphyseal dysplasia congenita, Strudwick type;Q77.7;LD24.3
Anauxetic dysplasia;Q77.7;LD24.3
Anauxetic dysplasia;Q77.7;LD24.3
X-linked spondyloepimetaphyseal dysplasia;Q77.7;LD24.3
Spondyloepimetaphyseal dysplasia, Shohat type;Q77.7;LD24.3
Spondyloepimetaphyseal dysplasia, Missouri type;Q77.7;LD24.3
SPONASTRIME dysplasia;Q77.7;LD24.3
Spondyloepimetaphyseal dysplasia-short limb-abnormal calcification syndrome;Q77.7;LD24.3
Spondyloepimetaphyseal dysplasia with joint laxity;Q77.8;
Spondyloepimetaphyseal dysplasia with joint laxity;Q77.8;
Spondyloepimetaphyseal dysplasia with multiple dislocations;Q77.8;
Familial hypocalciuric hypercalcemia type 1;E83.5;5A51.2
Brachydactyly type C;Q73.8;LD26.1
Brachydactyly type C;Q73.8;LD26.1
NON RARE IN EUROPE: Brachydactyly type D;;
Brachydactyly type E;Q73.8;LD26.1
Brachydactyly type E;Q73.8;LD26.1
Brachydactyly type A1;Q73.8;LD26.1
Brachydactyly type A1;Q73.8;LD26.1
Brachydactyly type A1;Q73.8;LD26.1
Brachydactyly type A2;Q73.8;LD26.1
Brachydactyly type A2;Q73.8;LD26.1
Brachydactyly type A2;Q73.8;LD26.1
Juvenile sialidosis type 2;E77.1;5C56.21
Congenital sialidosis type 2;E77.1;5C56.21
Syndactyly type 3;Q70.1;LB79.Y
Syndactyly type 4;Q70.4;LB79.Y
Syndactyly type 4;Q70.4;LB79.Y
Syndactyly type 5;Q70.0;LB79.Y
Syndactyly type 5;Q70.2;LB79.Y
Brachydactyly-syndactyly, Zhao type;Q73.8;LD26.2
Hurler syndrome;E76.0;5C56.30
Scheie syndrome;E76.0;5C56.30
Hurler-Scheie syndrome;E76.0;5C56.30
Pediatric systemic lupus erythematosus;M32.0;4A40.0Y
Pediatric systemic lupus erythematosus;M32.1;4A40.0Y
Pediatric systemic lupus erythematosus;M32.8;4A40.0Y
Pediatric systemic lupus erythematosus;M32.9;4A40.0Y
Pediatric systemic lupus erythematosus;M32.0;4A40.0Y
Pediatric systemic lupus erythematosus;M32.1;4A40.0Y
Pediatric systemic lupus erythematosus;M32.8;4A40.0Y
Pediatric systemic lupus erythematosus;M32.9;4A40.0Y
Pediatric systemic lupus erythematosus;M32.0;4A40.0Y
Pediatric systemic lupus erythematosus;M32.1;4A40.0Y
Pediatric systemic lupus erythematosus;M32.8;4A40.0Y
Pediatric systemic lupus erythematosus;M32.9;4A40.0Y
AApoAI amyloidosis;E85.0;5D00.2Y
ALys amyloidosis;E85.0;5D00.2Y
AFib amyloidosis;E85.0;5D00.2Y
Dense deposit disease;N03.6;GB40
Dense deposit disease;N03.6;GB40
Atypical hemolytic uremic syndrome with anti-factor H antibodies;D58.8;3A21.Y
Atypical hemolytic uremic syndrome with anti-factor H antibodies;D58.8;3A21.Y
Atypical hemolytic uremic syndrome with anti-factor H antibodies;D58.8;3A21.Y
Atypical hemolytic uremic syndrome with anti-factor H antibodies;D58.8;3A21.Y
Congenital thrombotic thrombocytopenic purpura;M31.1;3B64.14
Late-onset nephronophthisis;Q61.5;GB83
Late-onset nephronophthisis;Q61.5;GB83
Late-onset nephronophthisis;Q61.5;GB83
Infantile nephronophthisis;Q61.5;GB83
Infantile nephronophthisis;Q61.5;GB83
Infantile nephronophthisis;Q61.5;GB83
Infantile nephronophthisis;Q61.5;GB83
Infantile nephronophthisis;Q61.5;GB83
Infantile nephronophthisis;Q61.5;GB83
Infantile nephronophthisis;Q61.5;GB83
Juvenile nephronophthisis;Q61.5;GB83
Juvenile nephronophthisis;Q61.5;GB83
Juvenile nephronophthisis;Q61.5;GB83
Juvenile nephronophthisis;Q61.5;GB83
Juvenile nephronophthisis;Q61.5;GB83
Juvenile nephronophthisis;Q61.5;GB83
Juvenile nephronophthisis;Q61.5;GB83
Primary hyperoxaluria type 1;E74.8;5C51.20
Primary hyperoxaluria type 2;E74.8;5C51.2Y
Primary hyperoxaluria type 3;E74.8;5C51.2Y
Xanthinuria type I;E79.8;5C55.00
Xanthinuria type II;E79.8;5C55.00
Bartter syndrome type 3;E26.8;GB90.43
Nephrogenic syndrome of inappropriate antidiuresis;E22.2;5A60.20
Autosomal recessive proximal renal tubular acidosis;N25.8;GB90.44
Autosomal dominant distal renal tubular acidosis;N25.8;GB90.44
Distal renal tubular acidosis with anemia;N25.8;GB90.44
Cystinuria type A;E72.0;5C60.2
Cystinuria type B;E72.0;5C60.2
Hemoglobin H disease;D56.0;3A50.02
Hemoglobin H disease;D56.0;3A50.02
Dent disease type 1;N25.8;GB90.42
Dent disease type 2;N25.8;GB90.42
Full schwannomatosis;Q85.0;LD2D.1Y
Full schwannomatosis;Q85.0;LD2D.1Y
Full schwannomatosis;Q85.0;LD2D.1Y
Full schwannomatosis;Q85.0;LD2D.1Y
Lobar holoprosencephaly;Q04.2;LA05.2
Lobar holoprosencephaly;Q04.2;LA05.2
Lobar holoprosencephaly;Q04.2;LA05.2
Lobar holoprosencephaly;Q04.2;LA05.2
Lobar holoprosencephaly;Q04.2;LA05.2
Lobar holoprosencephaly;Q04.2;LA05.2
Lobar holoprosencephaly;Q04.2;LA05.2
Lobar holoprosencephaly;Q04.2;LA05.2
Lobar holoprosencephaly;Q04.2;LA05.2
Lobar holoprosencephaly;Q04.2;LA05.2
Lobar holoprosencephaly;Q04.2;LA05.2
Lobar holoprosencephaly;Q04.2;LA05.2
Lobar holoprosencephaly;Q04.2;LA05.2
Lobar holoprosencephaly;Q04.2;LA05.2
Lobar holoprosencephaly;Q04.2;LA05.2
Lobar holoprosencephaly;Q04.2;LA05.2
Alobar holoprosencephaly;Q04.2;LA05.2
Alobar holoprosencephaly;Q04.2;LA05.2
Alobar holoprosencephaly;Q04.2;LA05.2
Alobar holoprosencephaly;Q04.2;LA05.2
Alobar holoprosencephaly;Q04.2;LA05.2
Alobar holoprosencephaly;Q04.2;LA05.2
Alobar holoprosencephaly;Q04.2;LA05.2
Alobar holoprosencephaly;Q04.2;LA05.2
Alobar holoprosencephaly;Q04.2;LA05.2
Alobar holoprosencephaly;Q04.2;LA05.2
Alobar holoprosencephaly;Q04.2;LA05.2
Alobar holoprosencephaly;Q04.2;LA05.2
Alobar holoprosencephaly;Q04.2;LA05.2
Alobar holoprosencephaly;Q04.2;LA05.2
Alobar holoprosencephaly;Q04.2;LA05.2
Alobar holoprosencephaly;Q04.2;LA05.2
Alobar holoprosencephaly;Q04.2;LA05.2
Midline interhemispheric variant of holoprosencephaly;Q04.2;LA05.2
Midline interhemispheric variant of holoprosencephaly;Q04.2;LA05.2
Midline interhemispheric variant of holoprosencephaly;Q04.2;LA05.2
Midline interhemispheric variant of holoprosencephaly;Q04.2;LA05.2
Midline interhemispheric variant of holoprosencephaly;Q04.2;LA05.2
Midline interhemispheric variant of holoprosencephaly;Q04.2;LA05.2
Midline interhemispheric variant of holoprosencephaly;Q04.2;LA05.2
Midline interhemispheric variant of holoprosencephaly;Q04.2;LA05.2
Midline interhemispheric variant of holoprosencephaly;Q04.2;LA05.2
Midline interhemispheric variant of holoprosencephaly;Q04.2;LA05.2
Midline interhemispheric variant of holoprosencephaly;Q04.2;LA05.2
Midline interhemispheric variant of holoprosencephaly;Q04.2;LA05.2
Midline interhemispheric variant of holoprosencephaly;Q04.2;LA05.2
Midline interhemispheric variant of holoprosencephaly;Q04.2;LA05.2
Midline interhemispheric variant of holoprosencephaly;Q04.2;LA05.2
Bladder exstrophy;Q64.1;LB31.3
Bladder exstrophy;Q64.1;LB31.3
FG syndrome type 1;Q87.8;LD2F.1Y
X-linked intellectual disability, Porteous type;Q87.8;LD90.Y
Hamel cerebro-palato-cardiac syndrome;Q87.8;LD90.Y
X-linked intellectual disability, Golabi-Ito-Hall type;Q87.8;LD90.Y
X-linked intellectual disability, Sutherland-Haan type;Q87.5;LD90.Y
X-linked intellectual disability, Hedera type;G25.8;LD90
12q14 microdeletion syndrome;Q93.5;LD2F.1Y
12q14 microdeletion syndrome;Q93.5;LD2F.1Y
Deafness-infertility syndrome;Q93.5;LD2H.Y
Deafness-infertility syndrome;Q93.5;LD2H.Y
15q24 microdeletion syndrome;Q93.5;LD44.F
Spondyloepiphyseal dysplasia congenita;Q77.7;LD24.3
Partington syndrome;G93.4;LD90.Y
Hereditary renal hypouricemia;N25.8;GB90.4Y
Hereditary renal hypouricemia;N25.8;GB90.4Y
Pseudohypoparathyroidism type 1B;E20.1;5A50.1
Pseudohypoparathyroidism type 1B;E20.1;5A50.1
Cerebellar ataxia, Cayman type;G11.0;
Spinocerebellar ataxia with axonal neuropathy type 1;G60.2;
Recessive mitochondrial ataxia syndrome;G11.8;5C53.21
Spinocerebellar ataxia type 7;G11.8;8A03.16
Anonychia congenita totalis;Q84.3;EC22.0
Hepatoerythropoietic porphyria;E80.2;5C58.1Y
Lissencephaly due to LIS1 mutation;Q04.3;LD20.1
COG8-CDG;E77.8;5C54.2
Autosomal recessive spinocerebellar ataxia-blindness-deafness syndrome;G11.1;8A03.1Y
Autosomal recessive cerebellar ataxia-movement disorder syndrome;G11.1;8A03.1Y
Autosomal recessive cerebellar ataxia-movement disorder syndrome;G11.1;8A03.1Y
Combined pituitary hormone deficiencies, genetic forms;E23.0;
Combined pituitary hormone deficiencies, genetic forms;E23.0;
Combined pituitary hormone deficiencies, genetic forms;E23.0;
Combined pituitary hormone deficiencies, genetic forms;E23.0;
Combined pituitary hormone deficiencies, genetic forms;E23.0;
Combined pituitary hormone deficiencies, genetic forms;E23.0;
Combined pituitary hormone deficiencies, genetic forms;E23.0;
Pituitary stalk interruption syndrome;E23.6;5A61.0
Pituitary stalk interruption syndrome;E23.6;5A61.0
Pituitary stalk interruption syndrome;E23.6;5A61.0
Pituitary stalk interruption syndrome;E23.6;5A61.0
Pituitary stalk interruption syndrome;E23.6;5A61.0
Pituitary stalk interruption syndrome;E23.6;5A61.0
Pituitary stalk interruption syndrome;E23.6;5A61.0
NON RARE IN EUROPE: Non-classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency;;
Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency;E25.0;5A71.01
X-linked adrenal hypoplasia congenita;E27.1;LC80
Non-syndromic posterior hypospadias;Q54.2;LB53.2
Non-syndromic posterior hypospadias;Q54.2;LB53.3
Non-syndromic posterior hypospadias;Q54.2;LB53.4
Non-syndromic posterior hypospadias;Q54.3;LB53.2
Non-syndromic posterior hypospadias;Q54.3;LB53.3
Non-syndromic posterior hypospadias;Q54.3;LB53.4
Non-syndromic posterior hypospadias;Q54.2;LB53.2
Non-syndromic posterior hypospadias;Q54.2;LB53.3
Non-syndromic posterior hypospadias;Q54.2;LB53.4
Non-syndromic posterior hypospadias;Q54.3;LB53.2
Non-syndromic posterior hypospadias;Q54.3;LB53.3
Non-syndromic posterior hypospadias;Q54.3;LB53.4
Thyroid ectopia;E03.1;5A00.01
Thyroid ectopia;E03.1;5A00.01
Athyreosis;E03.1;5A00.01
Athyreosis;E03.1;5A00.01
Athyreosis;E03.1;5A00.01
Athyreosis;E03.1;5A00.01
Athyreosis;E03.1;5A00.01
Athyreosis;E03.1;5A00.01
Familial thyroid dyshormonogenesis;E03.0;5A00.00
Familial thyroid dyshormonogenesis;E03.1;5A00.00
Familial thyroid dyshormonogenesis;E03.0;5A00.00
Familial thyroid dyshormonogenesis;E03.1;5A00.00
Familial thyroid dyshormonogenesis;E03.0;5A00.00
Familial thyroid dyshormonogenesis;E03.1;5A00.00
Familial thyroid dyshormonogenesis;E03.0;5A00.00
Familial thyroid dyshormonogenesis;E03.1;5A00.00
Familial thyroid dyshormonogenesis;E03.0;5A00.00
Familial thyroid dyshormonogenesis;E03.1;5A00.00
Familial thyroid dyshormonogenesis;E03.0;5A00.00
Familial thyroid dyshormonogenesis;E03.1;5A00.00
Thyroid hypoplasia;E03.1;5A00.01
Thyroid hypoplasia;E03.1;5A00.01
Thyroid hypoplasia;E03.1;5A00.01
Kleefstra syndrome due to 9q34 microdeletion;Q87.8;LD2F.1Y
Silver-Russell syndrome due to maternal uniparental disomy of chromosome 7;Q87.1;LD2F.1Y
Temple syndrome due to maternal uniparental disomy of chromosome 14;Q99.8;LD2Y
Temple syndrome due to maternal uniparental disomy of chromosome 14;Q99.8;LD2Y
Paternal uniparental disomy of chromosome 6;Q99.8;LD45.1
Cushing disease;E24.0;5A70.0
Cushing disease;D35.2;5A70.0
Cushing disease;E24.0;5A70.0
Cushing disease;D35.2;5A70.0
Cushing disease;E24.0;5A70.0
Cushing disease;D35.2;5A70.0
Cushing disease;E24.0;5A70.0
Cushing disease;D35.2;5A70.0
Cushing disease;E24.0;5A70.0
Cushing disease;D35.2;5A70.0
Cushing disease;E24.0;5A70.0
Cushing disease;D35.2;5A70.0
Cushing disease;E24.0;5A70.0
Cushing disease;D35.2;5A70.0
Leydig cell hypoplasia due to complete LH resistance;Q56.1;LD2A.3
Leydig cell hypoplasia due to partial LH resistance;Q56.1;LD2A.3
Kagami-Ogata syndrome due to paternal uniparental disomy of chromosome 14;Q99.8;LD2Y
Kagami-Ogata syndrome due to paternal uniparental disomy of chromosome 14;Q99.8;LD2Y
Glycogen storage disease due to phosphoglycerate mutase deficiency;E74.0;5C51.3
Rippling muscle disease;G71.8;8C71.Y
Reducing body myopathy;G71.2;8C72.Y
Zebra body myopathy;G71.2;8C72.0Y
Rigid spine syndrome;G71.2;8C70.6
Rigid spine syndrome;G71.2;8C70.6
Pontocerebellar hypoplasia type 3;Q04.3;LD20.01
Insulinoma;D37.7;2C10.1
Insulinoma;C25.4;2C10.1
Insulinoma;D13.7;2C10.1
Insulinoma;D37.7;2C10.1
Insulinoma;C25.4;2C10.1
Insulinoma;D13.7;2C10.1
Carney-Stratakis syndrome;D44.8;2F7A.0
Carney-Stratakis syndrome;D44.8;2F7A.0
Carney-Stratakis syndrome;D44.8;2F7A.0
Bohring-Opitz syndrome;Q87.8;
Melanoma of soft tissue;C43.6;
Melanoma of soft tissue;C43.7;
Melanoma of soft tissue;C43.6;
Melanoma of soft tissue;C43.7;
Melanoma of soft tissue;C43.6;
Melanoma of soft tissue;C43.7;
ABri amyloidosis;E85.4+;5D00.2Y
ABri amyloidosis;I68.0*;5D00.2Y
ADan amyloidosis;E85.4+;5D00.2Y
ADan amyloidosis;I68.0*;5D00.2Y
Renal hypoplasia, bilateral;Q60.4;LB30.0Y
Renal hypoplasia, bilateral;Q60.4;LB30.0Y
Unilateral multicystic dysplastic kidney;Q61.4;LB30.9
Bilateral multicystic dysplastic kidney;Q61.4;LB30.9
Renal tubular dysgenesis of genetic origin;Q63.8;LB30.3
Renal tubular dysgenesis of genetic origin;Q63.8;LB30.3
Renal tubular dysgenesis of genetic origin;Q63.8;LB30.3
Renal tubular dysgenesis of genetic origin;Q63.8;LB30.3
Right sided atrial isomerism;Q20.6;LA8Y
NON RARE IN EUROPE: Benign familial hematuria;;
NON RARE IN EUROPE: Benign familial hematuria;;
NON RARE IN EUROPE: Benign familial hematuria;;
17q11 microdeletion syndrome;Q85.0;LD44.H0
Hereditary combined deficiency of vitamin K-dependent clotting factors;D68.2;3B14.2
Hereditary combined deficiency of vitamin K-dependent clotting factors;D68.2;3B14.2
Rare isolated myopia;H52.1;
Rare isolated myopia;H52.1;
Rare isolated myopia;H52.1;
Autosomal dominant optic atrophy, classic form;H47.2;9C40.8
Autosomal dominant optic atrophy, classic form;H47.2;9C40.8
Autosomal recessive isolated optic atrophy;H47.2;9C40.8
Autosomal recessive isolated optic atrophy;H47.2;9C40.8
Autosomal recessive isolated optic atrophy;H47.2;9C40.8
Autosomal recessive isolated optic atrophy;H47.2;9C40.8
Prader-Willi syndrome due to maternal uniparental disomy of chromosome 15;Q87.1;LD90.3
Prader-Willi syndrome due to maternal uniparental disomy of chromosome 15;Q87.1;LD90.3
Prader-Willi syndrome due to maternal uniparental disomy of chromosome 15;Q87.1;LD90.3
Prader-Willi syndrome due to maternal uniparental disomy of chromosome 15;Q87.1;LD90.3
Spinocerebellar ataxia type 1;G11.8;8A03.16
Spinocerebellar ataxia type 2;G11.2;8A03.16
Spinocerebellar ataxia type 6;G11.2;8A03.16
Spinocerebellar ataxia type 17;G11.8;8A03.16
Spinocerebellar ataxia type 8;G11.2;8A03.16
Spinocerebellar ataxia type 8;G11.2;8A03.16
Spinocerebellar ataxia type 10;G11.2;8A03.16
Spinocerebellar ataxia type 12;G11.2;8A03.16
Spinocerebellar ataxia type 14;G11.2;8A03.16
Spinocerebellar ataxia type 27;G11.8;8A03.16
Spinocerebellar ataxia type 4;G11.2;8A03.16
Spinocerebellar ataxia type 5;G11.2;8A03.16
Spinocerebellar ataxia type 11;G11.8;8A03.16
Spinocerebellar ataxia type 13;G11.2;8A03.16
Spinocerebellar ataxia type 15/16;G11.2;8A03.16
Spinocerebellar ataxia type 18;G11.8;8A03.16
Spinocerebellar ataxia type 19/22;G11.2;8A03.16
Spinocerebellar ataxia type 21;G11.1;8A03.16
Autosomal dominant nocturnal frontal lobe epilepsy;G40.0;8A61.4Y
Autosomal dominant nocturnal frontal lobe epilepsy;G40.0;8A61.4Y
Autosomal dominant nocturnal frontal lobe epilepsy;G40.0;8A61.4Y
Autosomal dominant nocturnal frontal lobe epilepsy;G40.0;8A61.4Y
Autosomal dominant nocturnal frontal lobe epilepsy;G40.0;8A61.4Y
Autosomal dominant nocturnal frontal lobe epilepsy;G40.0;8A61.4Y
Autosomal dominant nocturnal frontal lobe epilepsy;G40.0;8A61.4Y
Alpha-thalassemia-intellectual disability syndrome linked to chromosome 16;D56.0;3A50.1
Alpha-thalassemia-intellectual disability syndrome linked to chromosome 16;D56.0;3A50.1
Angelman syndrome due to maternal 15q11q13 deletion;Q93.5;LD90.0
Angelman syndrome due to maternal 15q11q13 deletion;Q93.5;LD90.0
Angelman syndrome due to paternal uniparental disomy of chromosome 15;Q93.5;LD90.0
Primary dystonia, DYT4 type;G24.1;8A02.0Y
Primary dystonia, DYT6 type;G24.1;8A02.0Y
Autosomal dominant dopa-responsive dystonia;G24.1;8A02.11
Autosomal dominant dopa-responsive dystonia;G24.1;8A02.11
Autosomal dominant dopa-responsive dystonia;G24.1;8A02.11
Paroxysmal kinesigenic dyskinesia;G24.8;8A02.2
Paroxysmal kinesigenic dyskinesia;G24.8;8A02.2
Paroxysmal non-kinesigenic dyskinesia;G24.8;
Paroxysmal non-kinesigenic dyskinesia;G24.8;
Paroxysmal exertion-induced dyskinesia;G24.8;8A02.2
Paroxysmal exertion-induced dyskinesia;G24.8;8A02.2
Hypohidrotic ectodermal dysplasia with immunodeficiency;D82.8;LD27.02
Hypohidrotic ectodermal dysplasia with immunodeficiency;D82.8;LD27.02
Landau-Kleffner syndrome;F80.3;8A62.2
Familial focal epilepsy with variable foci;G40.0;8A61.4Y
Familial focal epilepsy with variable foci;G40.0;8A61.4Y
Familial focal epilepsy with variable foci;G40.0;8A61.4Y
Chronic myelomonocytic leukemia;C93.1;2A40
Chronic myelomonocytic leukemia;C93.1;2A40
Chronic myelomonocytic leukemia;C93.1;2A40
Chronic myelomonocytic leukemia;C93.1;2A40
Atypical chronic myeloid leukemia;C92.2;2A41
Refractory anemia;;
Unclassified myelodysplastic syndrome;D46.7;2A37
"Acute myeloid leukemia with abnormal bone marrow eosinophils inv(16)(p13q22) or t(16;16)(p13;q22)";C92.7;2A60.0
"Acute myeloid leukemia with abnormal bone marrow eosinophils inv(16)(p13q22) or t(16;16)(p13;q22)";C92.7;2A60.0
"Acute myeloid leukemia with abnormal bone marrow eosinophils inv(16)(p13q22) or t(16;16)(p13;q22)";C92.7;2A60.0
"Acute myeloid leukemia with abnormal bone marrow eosinophils inv(16)(p13q22) or t(16;16)(p13;q22)";C92.7;2A60.0
Acute myeloid leukemia with 11q23 abnormalities;C92.6;XH1E41
Acute myeloid leukemia with 11q23 abnormalities;C92.6;2A60.0
Acute myeloid leukemia with minimal differentiation;C92.0;XH90G0
Acute myeloid leukemia with minimal differentiation;C92.0;2A60.30
Acute myeloblastic leukemia without maturation;C92.0;2A60.31
Acute myeloblastic leukemia without maturation;C92.0;2A60.31
Acute myeloblastic leukemia with maturation;C92.0;2A60.32
Acute myeloblastic leukemia with maturation;C92.0;2A60.32
Acute myeloblastic leukemia with maturation;C92.0;2A60.32
Acute undifferentiated leukemia;C95.0;2A60.30
Primary mediastinal large B-cell lymphoma;C83.3;2A81.0
Primary mediastinal large B-cell lymphoma;C83.3;2A81.0
Intravascular large B-cell lymphoma;C83.3;2A81.1
Intravascular large B-cell lymphoma;C83.3;2A81.1
Lymphomatoid papulosis;C86.6;2B03.1
Lymphomatoid papulosis;C86.6;2B03.1
Classic Hodgkin lymphoma, nodular sclerosis type;C81.1;2B30.10
Systemic mastocytosis with associated hematologic neoplasm;C96.2;XH5195
Systemic mastocytosis with associated hematologic neoplasm;C96.2;2A21.0Y
Systemic mastocytosis with associated hematologic neoplasm;C96.2;XH5195
Systemic mastocytosis with associated hematologic neoplasm;C96.2;2A21.0Y
Systemic mastocytosis with associated hematologic neoplasm;C96.2;XH5195
Systemic mastocytosis with associated hematologic neoplasm;C96.2;2A21.0Y
Systemic mastocytosis with associated hematologic neoplasm;C96.2;XH5195
Systemic mastocytosis with associated hematologic neoplasm;C96.2;2A21.0Y
Aggressive systemic mastocytosis;C96.2;2A21.0Y
Aggressive systemic mastocytosis;C96.2;XH10N1
Aggressive systemic mastocytosis;C96.2;2A21.0Y
Aggressive systemic mastocytosis;C96.2;XH10N1
Aggressive systemic mastocytosis;C96.2;2A21.0Y
Aggressive systemic mastocytosis;C96.2;XH10N1
Aggressive systemic mastocytosis;C96.2;2A21.0Y
Aggressive systemic mastocytosis;C96.2;XH10N1
Aggressive systemic mastocytosis;C96.2;2A21.0Y
Aggressive systemic mastocytosis;C96.2;XH10N1
Autosomal dominant Emery-Dreifuss muscular dystrophy;G71.0;8C70.2
Autosomal dominant Emery-Dreifuss muscular dystrophy;G71.0;8C70.2
Autosomal dominant Emery-Dreifuss muscular dystrophy;G71.0;8C70.2
Autosomal dominant Emery-Dreifuss muscular dystrophy;G71.0;8C70.2
Autosomal recessive Emery-Dreifuss muscular dystrophy;G71.0;8C70.2
Charcot-Marie-Tooth disease type 2B1;G60.0;8C20.1
X-linked Emery-Dreifuss muscular dystrophy;G71.0;8C70.2
X-linked Emery-Dreifuss muscular dystrophy;G71.0;8C70.2
Southeast Asian ovalocytosis;D58.1;3A10.Y
Congenital dyserythropoietic anemia type I;D64.4;3A73
Congenital dyserythropoietic anemia type I;D64.4;3A73
Congenital dyserythropoietic anemia type III;D64.4;3A73
Congenital dyserythropoietic anemia type II;D64.4;3A73
Familial afibrinogenemia;D68.2;3B14.0
Familial afibrinogenemia;D68.2;3B14.0
Familial afibrinogenemia;D68.2;3B14.0
Familial dysfibrinogenemia;D68.2;3B14.0
Familial dysfibrinogenemia;D68.2;3B14.0
Familial dysfibrinogenemia;D68.2;3B14.0
Bleeding diathesis due to glycoprotein VI deficiency;D69.8;3B62.Y
Bilateral perisylvian polymicrogyria;Q04.3;LA05.50
Bilateral perisylvian polymicrogyria;Q04.3;LA05.50
Bilateral perisylvian polymicrogyria;Q04.3;LA05.50
Periventricular nodular heterotopia;Q04.8;LA05.5Y
Periventricular nodular heterotopia;Q04.8;LA05.5Y
Periventricular nodular heterotopia;Q04.8;LA05.5Y
Periventricular nodular heterotopia;Q04.8;LA05.5Y
Periventricular nodular heterotopia;Q04.8;LA05.5Y
Periventricular nodular heterotopia;Q04.8;LA05.5Y
Periventricular nodular heterotopia;Q04.8;LA05.5Y
Becker muscular dystrophy;G71.0;8C70.0
Duchenne muscular dystrophy;G71.0;8C70.1
Duchenne muscular dystrophy;G71.0;8C70.1
Oculopharyngodistal myopathy;G71.0;9C82.1
Oculopharyngodistal myopathy;G71.0;9C82.1
Amish nemaline myopathy;G71.2;8C72.00
Congenital myopathy with excess of thin filaments;G71.2;8C72.0Y
Congenital multicore myopathy with external ophthalmoplegia;G71.2;8C72.0Y
Neutral lipid storage disease with ichthyosis;E75.5;5C52.2
Neutral lipid storage myopathy;E88.9;
Desminopathy;G71.8;
Distal myotilinopathy;G71.8;8C76
Late-onset distal myopathy, Markesbery-Griggs type;G71.8;
Postsynaptic congenital myasthenic syndromes;G70.2;8C61
Postsynaptic congenital myasthenic syndromes;G70.2;8C61
Postsynaptic congenital myasthenic syndromes;G70.2;8C61
Postsynaptic congenital myasthenic syndromes;G70.2;8C61
Postsynaptic congenital myasthenic syndromes;G70.2;8C61
Postsynaptic congenital myasthenic syndromes;G70.2;8C61
Postsynaptic congenital myasthenic syndromes;G70.2;8C61
Postsynaptic congenital myasthenic syndromes;G70.2;8C61
Postsynaptic congenital myasthenic syndromes;G70.2;8C61
Postsynaptic congenital myasthenic syndromes;G70.2;8C61
Postsynaptic congenital myasthenic syndromes;G70.2;8C61
Postsynaptic congenital myasthenic syndromes;G70.2;8C61
Presynaptic congenital myasthenic syndromes;G70.2;8C61
Presynaptic congenital myasthenic syndromes;G70.2;8C61
Presynaptic congenital myasthenic syndromes;G70.2;8C61
Presynaptic congenital myasthenic syndromes;G70.2;8C61
Presynaptic congenital myasthenic syndromes;G70.2;8C61
Presynaptic congenital myasthenic syndromes;G70.2;8C61
Presynaptic congenital myasthenic syndromes;G70.2;8C61
Presynaptic congenital myasthenic syndromes;G70.2;8C61
Presynaptic congenital myasthenic syndromes;G70.2;8C61
Presynaptic congenital myasthenic syndromes;G70.2;8C61
Synaptic congenital myasthenic syndromes;G70.2;8C61
Synaptic congenital myasthenic syndromes;G70.2;8C61
Acute inflammatory demyelinating polyradiculoneuropathy;G61.0;8C01.0
Spinal muscular atrophy with respiratory distress type 1;G12.2;8B61.0
Multiple system atrophy, parkinsonian type;G23.2;8D87.01
Huntington disease-like 2;G10;8A01.11
Colobomatous microphthalmia;Q11.2;LA10.0
Colobomatous microphthalmia;Q11.2;LA10.0
Colobomatous microphthalmia;Q11.2;LA10.0
Colobomatous microphthalmia;Q11.2;LA10.0
Colobomatous microphthalmia;Q11.2;LA10.0
Colobomatous microphthalmia;Q11.2;LA10.0
Colobomatous microphthalmia;Q11.2;LA10.0
Colobomatous microphthalmia;Q11.2;LA10.0
Colobomatous microphthalmia;Q11.2;LA10.0
Colobomatous microphthalmia;Q11.2;LA10.0
Colobomatous microphthalmia;Q11.2;LA10.0
Colobomatous microphthalmia;Q11.2;LA10.0
Colobomatous microphthalmia;Q11.2;LA10.0
Colobomatous microphthalmia;Q11.2;LA10.0
Coloboma of choroid and retina;Q14.8;LA13.1
Coloboma of choroid and retina;Q14.8;LA13.1
Coloboma of choroid and retina;Q14.8;LA13.1
Coloboma of choroid and retina;Q14.8;LA13.1
Coloboma of choroid and retina;Q14.8;LA13.1
Coloboma of eye lens;Q12.2;LA12.0
Coloboma of eye lens;Q12.2;LA12.0
Coloboma of eye lens;Q12.2;LA12.0
Coloboma of eye lens;Q12.2;LA12.0
Coloboma of iris;Q13.0;LA11.4
Coloboma of iris;Q13.0;LA11.4
Coloboma of iris;Q13.0;LA11.4
Coloboma of iris;Q13.0;LA11.4
Coloboma of iris;Q13.0;LA11.4
Coloboma of macula;Q14.8;LA13.2
Coloboma of macula;Q14.8;LA13.2
Coloboma of macula;Q14.8;LA13.2
Coloboma of macula;Q14.8;LA13.2
Coloboma of eyelid;Q10.3;LA14.00
Coloboma of eyelid;Q10.3;LA14.00
Coloboma of eyelid;Q10.3;LA14.00
Coloboma of eyelid;Q10.3;LA14.00
Coloboma of optic disc;Q14.2;LA13.76
Coloboma of optic disc;Q14.2;LA13.76
Coloboma of optic disc;Q14.2;LA13.76
Coloboma of optic disc;Q14.2;LA13.76
Complete cryptophthalmia;Q11.2;LA14.01
Meesmann corneal dystrophy;H18.5;9A70.Y
Meesmann corneal dystrophy;H18.5;9A70.Y
Epithelial basement membrane dystrophy;H18.5;9A70.Y
Gelatinous drop-like corneal dystrophy;H18.5;9A70.Y
Thiel-Behnke corneal dystrophy;H18.5;9A70.Y
Reis-Bücklers corneal dystrophy;H18.5;9A70.Y
Granular corneal dystrophy type I;H18.5;9A70.Y
Granular corneal dystrophy type II;H18.5;9A70.Y
Lattice corneal dystrophy type I;H18.5;9A70.Y
Schnyder corneal dystrophy;H18.5;9A70.Y
Macular corneal dystrophy;H18.5;9A70.Y
Fleck corneal dystrophy;H18.5;9A70.Y
Posterior polymorphous corneal dystrophy;H18.5;LA11.5
Posterior polymorphous corneal dystrophy;H18.5;LA11.5
Posterior polymorphous corneal dystrophy;H18.5;LA11.5
Posterior polymorphous corneal dystrophy;H18.5;LA11.5
Posterior polymorphous corneal dystrophy;H18.5;LA11.5
Fuchs endothelial corneal dystrophy;H18.5;9A70.0
Fuchs endothelial corneal dystrophy;H18.5;9A70.0
Fuchs endothelial corneal dystrophy;H18.5;9A70.0
Fuchs endothelial corneal dystrophy;H18.5;9A70.0
Fuchs endothelial corneal dystrophy;H18.5;9A70.0
Congenital hereditary endothelial dystrophy type I;H18.5;LA11.5
Congenital glaucoma;Q15.0;9C61.40
Congenital glaucoma;Q15.0;9C61.40
Congenital glaucoma;Q15.0;9C61.40
Congenital glaucoma;Q15.0;9C61.40
Juvenile glaucoma;H40.1;9C61.41
Juvenile glaucoma;H40.1;9C61.41
Juvenile glaucoma;H40.1;9C61.41
Axenfeld anomaly;Q15.0;LA11.2
Axenfeld anomaly;Q15.0;LA11.2
Pulverulent cataract;Q12.0;LA12.1
Pulverulent cataract;Q12.0;LA12.1
Pulverulent cataract;Q12.0;LA12.1
Pulverulent cataract;Q12.0;LA12.1
Pulverulent cataract;Q12.0;LA12.1
Pulverulent cataract;Q12.0;LA12.1
Pulverulent cataract;Q12.0;LA12.1
Pulverulent cataract;Q12.0;LA12.1
Pulverulent cataract;Q12.0;LA12.1
Early-onset sutural cataract;Q12.0;LA12.1
Early-onset sutural cataract;Q12.0;LA12.1
Early-onset sutural cataract;Q12.0;LA12.1
Early-onset sutural cataract;Q12.0;LA12.1
Early-onset sutural cataract;Q12.0;LA12.1
Early-onset sutural cataract;Q12.0;LA12.1
Early-onset anterior polar cataract;Q12.0;LA12.1
Early-onset anterior polar cataract;Q12.0;LA12.1
Early-onset anterior polar cataract;Q12.0;LA12.1
Early-onset anterior polar cataract;Q12.0;LA12.1
Cerulean cataract;Q12.0;LA12.1
Cerulean cataract;Q12.0;LA12.1
Cerulean cataract;Q12.0;LA12.1
Cerulean cataract;Q12.0;LA12.1
Coralliform cataract;Q12.0;LA12.1
Early-onset nuclear cataract;Q12.0;LA12.1
Early-onset nuclear cataract;Q12.0;LA12.1
Early-onset nuclear cataract;Q12.0;LA12.1
Early-onset nuclear cataract;Q12.0;LA12.1
Early-onset nuclear cataract;Q12.0;LA12.1
Early-onset nuclear cataract;Q12.0;LA12.1
Early-onset nuclear cataract;Q12.0;LA12.1
Early-onset nuclear cataract;Q12.0;LA12.1
Early-onset nuclear cataract;Q12.0;LA12.1
Early-onset nuclear cataract;Q12.0;LA12.1
Early-onset nuclear cataract;Q12.0;LA12.1
Early-onset nuclear cataract;Q12.0;LA12.1
Early-onset nuclear cataract;Q12.0;LA12.1
Early-onset nuclear cataract;Q12.0;LA12.1
Early-onset nuclear cataract;Q12.0;LA12.1
Early-onset nuclear cataract;Q12.0;LA12.1
Early-onset nuclear cataract;Q12.0;LA12.1
Early-onset nuclear cataract;Q12.0;LA12.1
Early-onset posterior polar cataract;Q12.0;LA12.1
Early-onset posterior polar cataract;Q12.0;LA12.1
Early-onset posterior polar cataract;Q12.0;LA12.1
Early-onset posterior polar cataract;Q12.0;LA12.1
Early-onset posterior polar cataract;Q12.0;LA12.1
Early-onset posterior polar cataract;Q12.0;LA12.1
Early-onset posterior polar cataract;Q12.0;LA12.1
Early-onset posterior polar cataract;Q12.0;LA12.1
Total early-onset cataract;Q12.0;LA12.1
Total early-onset cataract;Q12.0;LA12.1
Total early-onset cataract;Q12.0;LA12.1
Total early-onset cataract;Q12.0;LA12.1
Total early-onset cataract;Q12.0;LA12.1
Total early-onset cataract;Q12.0;LA12.1
Total early-onset cataract;Q12.0;LA12.1
Total early-onset cataract;Q12.0;LA12.1
Total early-onset cataract;Q12.0;LA12.1
Total early-onset cataract;Q12.0;LA12.1
Total early-onset cataract;Q12.0;LA12.1
Total early-onset cataract;Q12.0;LA12.1
Total early-onset cataract;Q12.0;LA12.1
Total early-onset cataract;Q12.0;LA12.1
Total early-onset cataract;Q12.0;LA12.1
Total early-onset cataract;Q12.0;LA12.1
Total early-onset cataract;Q12.0;LA12.1
Adult-onset foveomacular vitelliform dystrophy;H35.5;9B70
Adult-onset foveomacular vitelliform dystrophy;H35.5;9B70
Adult-onset foveomacular vitelliform dystrophy;H35.5;9B70
Adult-onset foveomacular vitelliform dystrophy;H35.5;9B70
Butterfly-shaped pigment dystrophy;H35.5;9B70
Butterfly-shaped pigment dystrophy;H35.5;9B70
Butterfly-shaped pigment dystrophy;H35.5;9B70
Reticular dystrophy of the retinal pigment epithelium;H35.5;9B70
Multifocal pattern dystrophy simulating fundus flavimaculatus;H35.5;9B70
Spastic paraplegia type 7;G11.4;8B44.01
X-linked Charcot-Marie-Tooth disease type 5;G60.0;LD90.Y
Spastic paraplegia type 2;G11.4;LD90.Y
Adult-onset autosomal dominant leukodystrophy;E75.2;8A44.1
Congenitally uncorrected transposition of the great arteries with coarctation;Q20.3;
Complete atrioventricular septal defect with ventricular hypoplasia;Q21.2;
Complete atrioventricular septal defect with ventricular hypoplasia;Q21.2;
Complete atrioventricular septal defect with ventricular hypoplasia;Q21.2;
Complete atrioventricular septal defect with ventricular hypoplasia;Q21.2;
Complete atrioventricular septal defect-tetralogy of Fallot;Q21.2;LA87.45
Complete atrioventricular septal defect-tetralogy of Fallot;Q21.2;LA87.45
Complete atrioventricular septal defect-tetralogy of Fallot;Q21.2;LA87.45
Atrial septal defect, ostium secundum type;Q21.1;LA8E.1
Atrial septal defect, ostium secundum type;Q21.1;LA8E.1
Atrial septal defect, ostium secundum type;Q21.1;LA8E.1
Atrial septal defect, ostium secundum type;Q21.1;LA8E.1
Atrial septal defect, ostium secundum type;Q21.1;LA8E.1
Atrial septal defect, ostium secundum type;Q21.1;LA8E.1
Atrial septal defect, ostium secundum type;Q21.1;LA8E.1
Atrial septal defect, ostium secundum type;Q21.1;LA8E.1
Atrial septal defect, sinus venosus type;Q21.1;LA8E.2
Atrial septal defect, ostium primum type;Q21.2;LA87.40
Lymphedema-posterior choanal atresia syndrome;Q82.0;
Familial medullary thyroid carcinoma;C73;
Familial medullary thyroid carcinoma;C73;
Familial medullary thyroid carcinoma;C73;
Complete androgen insensitivity syndrome;E34.5;LD2A.4
Metaphyseal chondromatosis with D-2-hydroxyglutaric aciduria;Q78.8;LD24.2Y
Primary dystonia, DYT2 type;G24.1;8A02.0Y
Leber plus disease;H47.2;8C73.Y
Leber plus disease;H47.2;8C73.Y
Leber plus disease;H47.2;8C73.Y
Pituitary gigantism;E22.0;5A60.0
Pituitary gigantism;E22.0;5A60.0
Isolated sulfite oxidase deficiency;E72.1;5C50.B
Myotonia fluctuans;G71.1;8C71.2
Myotonia permanens;G71.1;8C71.2
Acetazolamide-responsive myotonia;G71.1;8C71.2
King-Denborough syndrome;G71.2;8C72.Y
Amish lethal microcephaly;Q02;LA05.0
Kostmann syndrome;D70;4B00.00
Alveolar rhabdomyosarcoma;C49.9;2B55.1
Alveolar rhabdomyosarcoma;C49.9;XH7099
Alveolar rhabdomyosarcoma;C49.9;2B55.1
Alveolar rhabdomyosarcoma;C49.9;XH7099
Alveolar rhabdomyosarcoma;C49.9;2B55.1
Alveolar rhabdomyosarcoma;C49.9;XH7099
Alveolar rhabdomyosarcoma;C49.9;2B55.1
Alveolar rhabdomyosarcoma;C49.9;XH7099
Alveolar rhabdomyosarcoma;C49.9;2B55.1
Alveolar rhabdomyosarcoma;C49.9;XH7099
Embryonal rhabdomyosarcoma;C49.9;
Embryonal rhabdomyosarcoma;C49.9;
Embryonal rhabdomyosarcoma;C49.9;
Embryonal rhabdomyosarcoma;C49.9;
Bifid uvula;Q35.7;LA42.2
Bifid uvula;Q35.7;LA42.2
Cleft velum;Q35.3;LA42.1
Cleft velum;Q35.3;LA42.1
Dentin dysplasia type I;K00.5;LA30.7
Dentin dysplasia type I;K00.5;LA30.7
Dentin dysplasia type I;K00.5;LA30.7
Dentin dysplasia type II;K00.5;LA30.7
Subcortical band heterotopia;Q04.3;LD20.1
Subcortical band heterotopia;Q04.3;LD20.1
Subcortical band heterotopia;Q04.3;LD20.1
Oligodontia;K00.0;LA30.2
Oligodontia;K00.0;LA30.2
Oligodontia;K00.0;LA30.2
Oligodontia;K00.0;LA30.2
Oligodontia;K00.0;LA30.2
Oligodontia;K00.0;LA30.2
Oligodontia;K00.0;LA30.2
Oligodontia;K00.0;LA30.2
Oligodontia;K00.0;LA30.2
Oligodontia;K00.0;LA30.2
Oligodontia;K00.0;LA30.2
Oligodontia;K00.0;LA30.2
Hemimegalencephaly;Q04.5;LA05.1
Hemimegalencephaly;Q04.5;LA05.1
Hemimegalencephaly;Q04.5;LA05.1
Haddad syndrome;G47.3;LD2F.1Y
Haddad syndrome;G47.3;LD2F.1Y
Haddad syndrome;G47.3;LD2F.1Y
Oculootodental syndrome;K07.8;
Oculootodental syndrome;K07.8;
PEHO-like syndrome;G93.4;
Familial porencephaly;Q04.6;LA05.60
Familial porencephaly;Q04.6;LA05.60
Neuronal intestinal pseudoobstruction;K59.8;DA90.2
LIG4 syndrome;D81.1;4A01.1Y
LIG4 syndrome;D81.1;4A01.1Y
Turcot syndrome with polyposis;D12.6;2B90.Y
Familial gestational hyperthyroidism;O99.2;5A02.Y
Familial gestational hyperthyroidism;E05.8;5A02.Y
Resistance to thyrotropin-releasing hormone syndrome;E03.1;5A00.01
Leukocyte adhesion deficiency type I;D84.8;4A00.0Y
Leukocyte adhesion deficiency type II;D84.8;5C54.2
Leukocyte adhesion deficiency type III;D84.8;4A00.0Y
Genetic recurrent myoglobinuria;R82.1;5C5Y
Genetic recurrent myoglobinuria;R82.1;5C5Y
Genetic recurrent myoglobinuria;R82.1;5C5Y
Glycogen storage disease due to muscle beta-enolase deficiency;E74.0;5C51.3
Ovarioleukodystrophy;E75.2;8A44.3
Ovarioleukodystrophy;E75.2;8A44.3
Ovarioleukodystrophy;E75.2;8A44.3
Ovarioleukodystrophy;E75.2;8A44.3
Ovarioleukodystrophy;E75.2;8A44.3
Ovarioleukodystrophy;E75.2;8A44.3
Cree leukoencephalopathy;E75.2;8A44.3
Cree leukoencephalopathy;E75.2;8A44.3
Cree leukoencephalopathy;E75.2;8A44.3
Cree leukoencephalopathy;E75.2;8A44.3
Cree leukoencephalopathy;E75.2;8A44.3
Precursor T-cell acute lymphoblastic leukemia;C91.0;2A71
Precursor T-cell acute lymphoblastic leukemia;C91.0;2A71
Precursor T-cell acute lymphoblastic leukemia;C91.0;2A71
Precursor T-cell acute lymphoblastic leukemia;C91.0;2A71
Precursor T-cell acute lymphoblastic leukemia;C91.0;2A71
Precursor T-cell acute lymphoblastic leukemia;C91.0;2A71
Precursor T-cell acute lymphoblastic leukemia;C91.0;2A71
Precursor T-cell acute lymphoblastic leukemia;C91.0;2A71
Precursor T-cell acute lymphoblastic leukemia;C91.0;2A71
Precursor T-cell acute lymphoblastic leukemia;C91.0;2A71
Precursor T-cell acute lymphoblastic leukemia;C91.0;2A71
Precursor T-cell acute lymphoblastic leukemia;C91.0;2A71
Precursor T-cell acute lymphoblastic leukemia;C91.0;2A71
Precursor T-cell acute lymphoblastic leukemia;C91.0;2A71
Precursor T-cell acute lymphoblastic leukemia;C91.0;2A71
Precursor T-cell acute lymphoblastic leukemia;C91.0;2A71
Precursor T-cell acute lymphoblastic leukemia;C91.0;2A71
Precursor T-cell acute lymphoblastic leukemia;C91.0;2A71
Precursor T-cell acute lymphoblastic leukemia;C91.0;2A71
Precursor T-cell acute lymphoblastic leukemia;C91.0;2A71
Precursor T-cell acute lymphoblastic leukemia;C91.0;2A71
Precursor T-cell acute lymphoblastic leukemia;C91.0;2A71
Familial isolated hyperparathyroidism;E21.0;5A51.0
Familial isolated hyperparathyroidism;E21.0;5A51.0
Familial isolated hyperparathyroidism;E21.0;5A51.0
Hyperparathyroidism-jaw tumor syndrome;E21.0;5A51.0
Isolated permanent neonatal diabetes mellitus;P70.2;KB60.2Y
Isolated permanent neonatal diabetes mellitus;P70.2;KB60.2Y
Isolated permanent neonatal diabetes mellitus;P70.2;KB60.2Y
Isolated permanent neonatal diabetes mellitus;P70.2;KB60.2Y
Isolated permanent neonatal diabetes mellitus;P70.2;KB60.2Y
Isolated permanent neonatal diabetes mellitus;P70.2;KB60.2Y
Transient neonatal diabetes mellitus;P70.2;KB60.20
Transient neonatal diabetes mellitus;P70.2;KB60.20
Transient neonatal diabetes mellitus;P70.2;KB60.20
Transient neonatal diabetes mellitus;P70.2;KB60.20
Acute megakaryoblastic leukemia in Down syndrome;;
Mendelian susceptibility to mycobacterial diseases due to complete IFNgammaR1 deficiency;D84.8;4A00.2
Acyl-CoA dehydrogenase 9 deficiency;E71.3;
Gynandroblastoma;D39.1;2C73.Y
Gynandroblastoma;D39.1;2F96
Gynandroblastoma;D39.1;XH0Q64
Gynandroblastoma;D40.1;2C73.Y
Gynandroblastoma;D40.1;2F96
Gynandroblastoma;D40.1;XH0Q64
Maligant granulosa cell tumor of the ovary;;
Maligant granulosa cell tumor of the ovary;;
Malignant Sertoli-Leydig cell tumor of the ovary;C56;2C73.Y
Autosomal dominant Charcot-Marie-Tooth disease type 2B;G60.0;8C20.1
Autosomal dominant Charcot-Marie-Tooth disease type 2C;G60.0;8C20.1
Autosomal dominant Charcot-Marie-Tooth disease type 2D;G60.0;8C20.1
Autosomal dominant Charcot-Marie-Tooth disease type 2E;G60.0;8C20.1
Autosomal dominant Charcot-Marie-Tooth disease type 2F;G60.0;8C20.1
Autosomal dominant Charcot-Marie-Tooth disease type 2I;G60.0;8C20.1
Autosomal dominant Charcot-Marie-Tooth disease type 2J;G60.0;8C20.1
Autosomal dominant Charcot-Marie-Tooth disease type 2K;G60.0;8C20.1
Autosomal dominant Charcot-Marie-Tooth disease type 2L;G60.0;8C20.1
Autosomal dominant Charcot-Marie-Tooth disease type 2A1;G60.0;8C20.1
Autosomal dominant Charcot-Marie-Tooth disease type 2A2;G60.0;8C20.1
Charcot-Marie-Tooth disease type 4A;G60.0;8C20.0
Charcot-Marie-Tooth disease type 4C;G60.0;8C20.0
Charcot-Marie-Tooth disease type 4D;G60.0;8C20.0
Charcot-Marie-Tooth disease type 4E;G60.0;8C20.0
Charcot-Marie-Tooth disease type 4F;G60.0;8C20.0
Charcot-Marie-Tooth disease type 4G;G60.0;8C20.0
Charcot-Marie-Tooth disease type 4H;G60.0;8C20.0
Charcot-Marie-Tooth disease type 4B1;G60.0;8C20.0
Charcot-Marie-Tooth disease type 4B2;G60.0;8C20.0
Benign recurrent intrahepatic cholestasis type 1;K83.1;5C58.04
Benign recurrent intrahepatic cholestasis type 2;K83.1;5C58.04
Atypical teratoid rhabdoid tumor;C49.9;2A00.1Y
Myxoid/round cell liposarcoma;C49.9;
Myxoid/round cell liposarcoma;C49.9;
Dedifferentiated liposarcoma;C49.9;
Dedifferentiated liposarcoma;C49.9;
Dedifferentiated liposarcoma;C49.9;
Well-differentiated liposarcoma;C49.9;
Well-differentiated liposarcoma;C49.9;
Well-differentiated liposarcoma;C49.9;
Squamous cell carcinoma of the esophagus;C15.4;2B70.1
Squamous cell carcinoma of the esophagus;C15.3;2B70.1
Squamous cell carcinoma of the esophagus;C15.1;2B70.1
Squamous cell carcinoma of the esophagus;C15.0;2B70.1
Squamous cell carcinoma of the esophagus;C15.4;2B70.1
Squamous cell carcinoma of the esophagus;C15.3;2B70.1
Squamous cell carcinoma of the esophagus;C15.1;2B70.1
Squamous cell carcinoma of the esophagus;C15.0;2B70.1
Squamous cell carcinoma of the esophagus;C15.4;2B70.1
Squamous cell carcinoma of the esophagus;C15.3;2B70.1
Squamous cell carcinoma of the esophagus;C15.1;2B70.1
Squamous cell carcinoma of the esophagus;C15.0;2B70.1
Squamous cell carcinoma of the esophagus;C15.4;2B70.1
Squamous cell carcinoma of the esophagus;C15.3;2B70.1
Squamous cell carcinoma of the esophagus;C15.1;2B70.1
Squamous cell carcinoma of the esophagus;C15.0;2B70.1
Intermediate DEND syndrome;P70.2;
ABeta amyloidosis, Dutch type;E85.4+;8B22.3
ABeta amyloidosis, Dutch type;I68.0*;8B22.3
ACys amyloidosis;E85.4+;8B22.3
ACys amyloidosis;I68.0*;8B22.3
Refractory anemia with excess blasts type 1;;
Refractory anemia with excess blasts type 2;;
Hypoplastic amelogenesis imperfecta;K00.5;LA30.6
Hypoplastic amelogenesis imperfecta;K00.5;LA30.6
Hypoplastic amelogenesis imperfecta;K00.5;LA30.6
Hypoplastic amelogenesis imperfecta;K00.5;LA30.6
Hypoplastic amelogenesis imperfecta;K00.5;LA30.6
Hypoplastic amelogenesis imperfecta;K00.5;LA30.6
Hypocalcified amelogenesis imperfecta;K00.5;LA30.6
Hypocalcified amelogenesis imperfecta;K00.5;LA30.6
Hypocalcified amelogenesis imperfecta;K00.5;LA30.6
Hypocalcified amelogenesis imperfecta;K00.5;LA30.6
Hypomaturation amelogenesis imperfecta;K00.5;LA30.6
Hypomaturation amelogenesis imperfecta;K00.5;LA30.6
Hypomaturation amelogenesis imperfecta;K00.5;LA30.6
Hypomaturation amelogenesis imperfecta;K00.5;LA30.6
Hypomaturation amelogenesis imperfecta;K00.5;LA30.6
Hypomaturation amelogenesis imperfecta;K00.5;LA30.6
Hypomaturation amelogenesis imperfecta;K00.5;LA30.6
Hypomaturation-hypoplastic amelogenesis imperfecta with taurodontism;K00.5;LA30.6
Autosomal dominant intermediate Charcot-Marie-Tooth disease type B;G60.0;8C20.2
Autosomal dominant intermediate Charcot-Marie-Tooth disease type C;G60.0;8C20.2
Autosomal dominant intermediate Charcot-Marie-Tooth disease type D;G60.0;8C20.2
Hereditary angioedema type 1;D84.1;4A00.14
Hereditary angioedema type 2;D84.1;4A00.14
F12-related hereditary angioedema with normal C1Inh;T78.3;4A00.14
Renin-angiotensin-aldosterone system-blocker-induced angioedema;T78.3;EH61.1
Semantic dementia;G31.0;6D83
Semantic dementia;G31.0;6D83
Semantic dementia;G31.0;6D83
Semantic dementia;G31.0;6D83
Semantic dementia;G31.0;6D83
Semantic dementia;G31.0;6D83
Semantic dementia;G31.0;6D83
Progressive non-fluent aphasia;G31.0;6D83
Progressive non-fluent aphasia;G31.0;6D83
Progressive non-fluent aphasia;G31.0;6D83
Progressive non-fluent aphasia;G31.0;6D83
Progressive non-fluent aphasia;G31.0;6D83
Progressive non-fluent aphasia;G31.0;6D83
Progressive non-fluent aphasia;G31.0;6D83
Progressive non-fluent aphasia;G31.0;6D83
Neuroendocrine tumor of stomach;C16.9;2B72.1
Neuroendocrine tumor of stomach;C16.9;2B72.1
Carcinoid syndrome;E34.0;5B10
Porphyria due to ALA dehydratase deficiency;E80.2;5C58.1Y
FRAXE intellectual disability;Q99.2;LD90.Y
FRAXF syndrome;Q99.2;
Bathing suit ichthyosis;Q80.2;EC20.02
Autosomal dominant spastic paraplegia type 3;G11.4;8B44.00
Autosomal dominant spastic paraplegia type 4;G11.4;8B44.00
Autosomal recessive spastic paraplegia type 5A;G11.4;8B44.01
Autosomal dominant spastic paraplegia type 6;G11.4;8B44.00
Autosomal dominant spastic paraplegia type 8;G11.4;8B44.00
Autosomal dominant spastic paraplegia type 10;G11.4;8B44.00
Autosomal dominant spastic paraplegia type 12;G11.4;8B44.00
Autosomal dominant spastic paraplegia type 12;G11.4;8B44.00
Autosomal dominant spastic paraplegia type 13;G11.4;8B44.00
Autosomal recessive spastic paraplegia type 15;G11.4;8B44.01
Autosomal dominant spastic paraplegia type 17;G11.4;8B44.00
Autosomal recessive spastic paraplegia type 20;G11.4;8B44.01
Autosomal recessive spastic paraplegia type 21;G11.4;8B44.01
Autosomal recessive spastic paraplegia type 23;G11.4;8B44.01
Autosomal recessive spastic paraplegia type 26;G11.4;8B44.01
Autosomal recessive spastic paraplegia type 28;G11.4;8B44.01
Autosomal spastic paraplegia type 30;G11.4;8B44.0Y
Autosomal dominant spastic paraplegia type 31;G11.4;8B44.00
Romano-Ward syndrome;I45.8;BC65.0
Romano-Ward syndrome;I45.8;BC65.0
Romano-Ward syndrome;I45.8;BC65.0
Romano-Ward syndrome;I45.8;BC65.0
Romano-Ward syndrome;I45.8;BC65.0
Romano-Ward syndrome;I45.8;BC65.0
Romano-Ward syndrome;I45.8;BC65.0
Romano-Ward syndrome;I45.8;BC65.0
Romano-Ward syndrome;I45.8;BC65.0
Romano-Ward syndrome;I45.8;BC65.0
Romano-Ward syndrome;I45.8;BC65.0
Romano-Ward syndrome;I45.8;BC65.0
Romano-Ward syndrome;I45.8;BC65.0
Romano-Ward syndrome;I45.8;BC65.0
Romano-Ward syndrome;I45.8;BC65.0
Romano-Ward syndrome;I45.8;BC65.0
Romano-Ward syndrome;I45.8;BC65.0
Romano-Ward syndrome;I45.8;BC65.0
Romano-Ward syndrome;I45.8;BC65.0
Cleft hard palate;Q35.1;LA42.0
Cleft hard palate;Q35.1;LA42.0
Transaldolase deficiency;E74.8;5C51.0
Female restricted epilepsy with intellectual disability;G40.8;8A61.1Y
Familial hypofibrinogenemia;D68.2;3B14.0
Familial hypofibrinogenemia;D68.2;3B14.0
Familial hypofibrinogenemia;D68.2;3B14.0
Autosomal dominant epilepsy with auditory features;G40.0;8A61.3Y
Autosomal dominant epilepsy with auditory features;G40.0;8A61.3Y
Autosomal dominant epilepsy with auditory features;G40.0;8A61.3Y
Familial hypocalciuric hypercalcemia type 2;E83.5;5A51.2
Familial hypocalciuric hypercalcemia type 3;E83.5;5A51.2
Situs inversus totalis;Q89.3;LA82
Situs inversus totalis;Q89.3;LA82
Situs inversus totalis;Q89.3;LA82
Situs inversus totalis;Q89.3;LA82
Situs inversus totalis;Q89.3;LA82
Situs inversus totalis;Q89.3;LA82
Situs inversus totalis;Q89.3;LA82
Situs inversus totalis;Q89.3;LA82
Situs inversus totalis;Q89.3;LA82
Congenital stromal corneal dystrophy;H18.5;9A70.Y
Bilateral frontoparietal polymicrogyria;Q04.3;LA05.50
Bilateral frontoparietal polymicrogyria;Q04.3;LA05.50
X-linked Charcot-Marie-Tooth disease type 1;G60.0;8C20.0
X-linked Charcot-Marie-Tooth disease type 4;G60.0;LD90.Y
Charcot-Marie-Tooth disease type 1A;G60.0;LD41.G1
Charcot-Marie-Tooth disease type 1B;G60.0;8C20.0
Charcot-Marie-Tooth disease type 1C;G60.0;8C20.0
Charcot-Marie-Tooth disease type 1D;G60.0;8C20.0
Charcot-Marie-Tooth disease type 1F;G60.0;8C20.0
X-linked hyper-IgM syndrome;D80.5;4A01.1Y
Hyper-IgM syndrome type 2;D80.5;4A01.05
Hyper-IgM syndrome type 3;D80.5;4A01.1Y
Hyper-IgM syndrome type 5;D80.5;4A01.05
Autosomal recessive Charcot-Marie-Tooth disease with hoarseness;G60.0;8C20.1
Charcot-Marie-Tooth disease type 2B2;G60.0;8C20.1
Charcot-Marie-Tooth disease type 2H;G60.0;8C20.1
Spinocerebellar ataxia type 23;G11.2;8A03.16
Spinocerebellar ataxia type 28;G11.1;8A03.16
Spinocerebellar ataxia type 25;G11.8;8A03.16
Spinocerebellar ataxia type 26;G11.2;8A03.16
Autosomal recessive dopa-responsive dystonia;G24.1;8A02.11
Autosomal recessive dopa-responsive dystonia;G24.1;8A02.11
Familial isolated congenital asplenia;Q89.0;LB22.0
Familial isolated congenital asplenia;Q89.0;LB22.0
"Acute myeloid leukemia with t(8;21)(q22;q22) translocation";C92.0;2A60.0
"Acute myeloid leukemia with t(8;21)(q22;q22) translocation";C92.0;2A60.0
"Acute myeloid leukemia with t(8;21)(q22;q22) translocation";C92.0;2A60.0
"Acute myeloid leukemia with t(8;21)(q22;q22) translocation";C92.0;2A60.0
"Acute myeloid leukemia with t(8;21)(q22;q22) translocation";C92.0;2A60.0
Congenital sodium diarrhea;K90.8;DA90.1
Congenital sodium diarrhea;K90.8;DA90.1
Trehalase deficiency;E74.3;5C61.3
Tropical pancreatitis;K86.1;DC32.5
Tropical pancreatitis;K86.1;DC32.5
Myopathic intestinal pseudoobstruction;K59.8;DA90.2
Legius syndrome;Q85.0;LD27.5
Segmental outgrowth-lipomatosis-arteriovenous malformation-epidermal nevus syndrome;Q87.3;LD2D.Y
Glycogen storage disease due to muscle and heart glycogen synthase deficiency;E74.0;5C51.3
Overgrowth-macrocephaly-facial dysmorphism syndrome;Q87.3;LD2C
Hypomyelinating leukodystrophy-ataxia-hypodontia-hypomyelination syndrome;E75.2;
Capillary malformation-arteriovenous malformation;Q27.3;LA90.3Y
Capillary malformation-arteriovenous malformation;Q27.3;LA90.3Y
Histiocytoid cardiomyopathy;I42.0;BC43.00
Spondyloepiphyseal dysplasia with metatarsal shortening;Q77.7;LD24.3
Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1;E88.8;5C53.23
Neurological conditions associated with aminoacylase 1 deficiency;;
Lethal congenital contracture syndrome type 2;Q68.8;LD26.4Y
Lethal congenital contracture syndrome type 3;Q68.8;LD26.4Y
Lethal congenital contracture syndrome type 3;Q68.8;LD26.4Y
X-linked intellectual disability-cerebellar hypoplasia syndrome;Q04.3;LD90
Frank-Ter Haar syndrome;Q87.8;LD25.1
Auriculocondylar syndrome;Q75.8;LD2F.16
Auriculocondylar syndrome;Q75.8;LD2F.16
Auriculocondylar syndrome;Q75.8;LD2F.16
Male infertility due to large-headed multiflagellar polyploid spermatozoa;N46;MF7Y
Male infertility due to large-headed multiflagellar polyploid spermatozoa;N46;MF7Y
Male infertility due to large-headed multiflagellar polyploid spermatozoa;N46;MF7Y
Male infertility due to large-headed multiflagellar polyploid spermatozoa;N46;MF7Y
Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome;E88.8;5C53.23
Isolated optic nerve hypoplasia/aplasia;;
Hypotonia with lactic acidemia and hyperammonemia;E88.8;5C53.23
X-linked cerebral adrenoleukodystrophy;E71.3;5C57.1
Adrenomyeloneuropathy;E71.3;5C57.1
Encephalopathy due to prosaposin deficiency;E75.2;5C56.0Y
Hypomyelination with atrophy of basal ganglia and cerebellum;E75.2;8A44.3
Hypomyelination with atrophy of basal ganglia and cerebellum;E75.2;8A44.3
Progressive cavitating leukoencephalopathy;E75.2;8A44.3
Autosomal recessive bestrophinopathy;H35.5;9B71.Y
SERKAL syndrome;Q87.8;
Microphthalmia with brain and digit anomalies;Q11.2;
17q11.2 microduplication syndrome;Q92.3;LD41.G0
Autosomal recessive spastic paraplegia type 39;G11.4;8B44.01
Autosomal recessive ataxia due to ubiquinone deficiency;G11.1;LD90.Y
Hemochromatosis type 4;E83.118;
NON RARE IN EUROPE: Hemochromatosis type 1;;
Neuropathy with hearing impairment;G60.8;LD2H.1
Charcot-Marie-Tooth disease type 4J;G60.0;8C20.0
Distal hereditary motor neuropathy type 2;G12.2;8B61.4
Distal hereditary motor neuropathy type 2;G12.2;8B61.4
Distal hereditary motor neuropathy type 2;G12.2;8B61.4
Distal hereditary motor neuropathy type 2;G12.2;8B61.4
Distal hereditary motor neuropathy type 5;G12.2;8B61.4
Distal hereditary motor neuropathy type 5;G12.2;8B61.4
Distal hereditary motor neuropathy type 5;G12.2;8B61.4
Distal hereditary motor neuropathy, Jerash type;G12.2;8B61.4
X-linked distal spinal muscular atrophy type 3;G12.2;
Mutilating hereditary sensory neuropathy with spastic paraplegia;G60.8;
X-linked hereditary sensory and autonomic neuropathy with deafness;G60.8;8C21.Y
Distal hereditary motor neuropathy type 7;G12.2;8B61.4
Distal hereditary motor neuropathy type 7;G12.2;8B61.4
Primary intraosseous venous malformation;D18.0;
Autosomal dominant slowed nerve conduction velocity;G60.0;
Hyperlipidemia due to hepatic triacylglycerol lipase deficiency;E78.4;
Brachydactyly type B2;Q73.8;LD26.1
Stapes ankylosis with broad thumbs and toes;Q87.8;LD2F.1Y
Titin-related limb-girdle muscular dystrophy R10;G71.0;
Benign familial neonatal-infantile seizures;G40.4;
Benign familial neonatal-infantile seizures;G40.4;
Short stature due to primary acid-labile subunit deficiency;E34.3;5A61.0
CLOVES syndrome;Q87.3;LD2C
Syndactyly-telecanthus-anogenital and renal malformations syndrome;Q87.8;LD2F.1Y
Autosomal dominant macrothrombocytopenia;D69.4;
Autosomal dominant macrothrombocytopenia;D69.4;
Autosomal dominant macrothrombocytopenia;D69.4;
Autosomal dominant macrothrombocytopenia;D69.4;
Autosomal dominant macrothrombocytopenia;D69.4;
Autosomal dominant macrothrombocytopenia;D69.4;
Autosomal dominant macrothrombocytopenia;D69.4;
Autosomal dominant macrothrombocytopenia;D69.4;
Autosomal dominant macrothrombocytopenia;D69.4;
Bilateral microtia-deafness-cleft palate syndrome;Q87.0;LD2H.Y
Palmoplantar keratoderma, Nagashima type;Q82.8;EC20.30
Saldino-Mainzer syndrome;Q87.5;LD24.8Y
Saldino-Mainzer syndrome;Q87.5;LD24.8Y
RHYNS syndrome;Q87.8;LD2F.1Y
External auditory canal aplasia/hypoplasia;Q16.1;LA22.2
Tessier number 4 facial cleft;Q18.8;LA51
Tessier number 7 facial cleft;Q18.4;LA51
Tessier number 7 facial cleft;Q18.4;LA51
Cleft lip and alveolus;Q36.0;LA41
Cleft lip and alveolus;Q36.1;LA41
Cleft lip and alveolus;Q36.9;LA41
Cleft lip and alveolus;Q36.0;LA41
Cleft lip and alveolus;Q36.1;LA41
Cleft lip and alveolus;Q36.9;LA41
Cleft lip and alveolus;Q36.0;LA41
Cleft lip and alveolus;Q36.1;LA41
Cleft lip and alveolus;Q36.9;LA41
Cleft lip and alveolus;Q36.0;LA41
Cleft lip and alveolus;Q36.1;LA41
Cleft lip and alveolus;Q36.9;LA41
Submucosal cleft palate;Q35.9;LA4Y
Submucosal cleft palate;Q35.9;LA4Y
Spondyloepimetaphyseal dysplasia, matrilin-3 type;Q77.7;LD24.3
Hereditary hypophosphatemic rickets with hypercalciuria;E83.3;5C63.22
Hereditary hypophosphatemic rickets with hypercalciuria;E83.3;5C63.22
Congenital or early infantile CACH syndrome;E75.2;8A44.3
Congenital or early infantile CACH syndrome;E75.2;8A44.3
Congenital or early infantile CACH syndrome;E75.2;8A44.3
Congenital or early infantile CACH syndrome;E75.2;8A44.3
Congenital or early infantile CACH syndrome;E75.2;8A44.3
Late infantile CACH syndrome;E75.2;8A44.3
Late infantile CACH syndrome;E75.2;8A44.3
Late infantile CACH syndrome;E75.2;8A44.3
Late infantile CACH syndrome;E75.2;8A44.3
Late infantile CACH syndrome;E75.2;8A44.3
Juvenile or adult CACH syndrome;E75.2;8A44.3
Juvenile or adult CACH syndrome;E75.2;8A44.3
Juvenile or adult CACH syndrome;E75.2;8A44.3
Juvenile or adult CACH syndrome;E75.2;8A44.3
Juvenile or adult CACH syndrome;E75.2;8A44.3
Situs ambiguus;Q89.3;
Situs ambiguus;Q89.3;
Situs ambiguus;Q89.3;
Situs ambiguus;Q89.3;
Situs ambiguus;Q89.3;
Situs ambiguus;Q89.3;
Situs ambiguus;Q89.3;
Situs ambiguus;Q89.3;
Situs ambiguus;Q89.3;
Epithelioid hemangioendothelioma;D48.1;XH9GF8
Epithelioid hemangioendothelioma;D48.1;2B5Y
Epithelioid hemangioendothelioma;D48.1;XH9GF8
Epithelioid hemangioendothelioma;D48.1;2B5Y
Epithelioid hemangioendothelioma;D48.1;XH9GF8
Epithelioid hemangioendothelioma;D48.1;2B5Y
Epithelioid hemangioendothelioma;D48.1;XH9GF8
Epithelioid hemangioendothelioma;D48.1;2B5Y
Hereditary mixed polyposis syndrome;D12.6;2E92.40
Hereditary mixed polyposis syndrome;D12.6;2E92.40
Serrated polyposis syndrome;D12.6;2E92.40
Mesoaxial synostotic syndactyly with phalangeal reduction;Q70.0;LB79.Y
Mesoaxial synostotic syndactyly with phalangeal reduction;Q70.2;LB79.Y
Cold-induced sweating syndrome;G90.8;8C21.Y
Cold-induced sweating syndrome;G90.8;8C21.Y
Cold-induced sweating syndrome;G90.8;8C21.Y
Neuroferritinopathy;G23.0;8A01.1Y
Huntington disease-like 1;G10;8A01.11
Combined immunodeficiency with granulomatosis;D81.1;
Combined immunodeficiency with granulomatosis;D81.1;
Combined immunodeficiency with granulomatosis;D81.1;
ANE syndrome;E23.0;
Oculoauricular syndrome, Schorderet type;Q87.8;
SLC39A13-related spondylodysplastic Ehlers-Danlos syndrome;Q79.6;LD28.1Y
Congenital muscular dystrophy due to LMNA mutation;G71.2;
Sea-blue histiocytosis;D76.3;EK92
Ectodermal dysplasia-skin fragility syndrome;Q81.0;EC30
Localized dystrophic epidermolysis bullosa, acral form;Q81.2;EC32
Localized dystrophic epidermolysis bullosa, nails only;Q81.2;EC32
Epidermolysis bullosa simplex with circinate migratory erythema;Q81.0;EC30
Epidermolysis bullosa simplex with pyloric atresia;Q81.0;EC30
Epidermolysis bullosa simplex with pyloric atresia;Q81.0;EC30
Lethal acantholytic erosive disorder;Q81.0;EC30
Lethal acantholytic erosive disorder;Q81.0;EC30
Typical urticaria pigmentosa;Q82.2;2A21.10
Plaque-form urticaria pigmentosa;Q82.2;2A21.10
Nodular urticaria pigmentosa;Q82.2;2A21.10
Smoldering systemic mastocytosis;C96.2;2A21.0Y
Isolated bone marrow mastocytosis;D47.0;2A21.0Y
Hb Bart's hydrops fetalis;D56.0;3A50.03
Hb Bart's hydrops fetalis;D56.0;3A50.03
Maffucci syndrome;Q78.4;LD2F.1Y
Maffucci syndrome;Q78.4;LD2F.1Y
CNTNAP2-related developmental and epileptic encephalopathy;Q04.8;
Leukoencephalopathy-dystonia-motor neuropathy syndrome;E75.2;
Hypotonia-cystinuria syndrome;E72.0;5C60.Y
Hypotonia-cystinuria syndrome;E72.0;5C60.Y
2p21 microdeletion syndrome;Q93.5;LD44.21
2p21 microdeletion syndrome;Q93.5;LD44.21
2p21 microdeletion syndrome;Q93.5;LD44.21
2p21 microdeletion syndrome;Q93.5;LD44.21
Action myoclonus-renal failure syndrome;G40.4;GB4Z
Alveolar soft tissue sarcoma;C49.9;
Alveolar soft tissue sarcoma;C49.9;
Benign familial mesial temporal lobe epilepsy;G40.0;8A61.4Y
Rolandic epilepsy-speech dyspraxia syndrome;G40.8;8A61.2Y
Rolandic epilepsy-speech dyspraxia syndrome;G40.8;8A61.2Y
Rolandic epilepsy-paroxysmal exercise-induced dystonia-writer's cramp syndrome;G40.4;8A61.2Y
Peripheral demyelinating neuropathy-central dysmyelinating leukodystrophy-Waardenburg syndrome-Hirschsprung disease;E75.2;
Pustulosis palmaris et plantaris;L40.3;EA90.42
Pustulosis palmaris et plantaris;L40.3;EA90.42
Acrodermatitis continua of Hallopeau;L40.2;EA90.41
Acrodermatitis continua of Hallopeau;L40.2;EA90.41
X-linked intellectual disability, Najm type;Q04.3;LD90.Y
X-linked intellectual disability, Nascimento type;Q87.8;LD90
X-linked dominant chondrodysplasia, Chassaing-Lacombe type;Q87.8;
X-linked intellectual disability, Van Esch type;Q87.8;LD90
Hyperekplexia-epilepsy syndrome;G25.8;
Familial advanced sleep-phase syndrome;G47.2;7A6Z
Familial advanced sleep-phase syndrome;G47.2;7A6Z
Familial advanced sleep-phase syndrome;G47.2;7A6Z
Familial mesial temporal lobe epilepsy with febrile seizures;G40.0;8A61.4Y
Exercise-induced hyperinsulinism;E16.1;5A45
Multiple epiphyseal dysplasia due to collagen 9 anomaly;Q77.3;LD24.61
Multiple epiphyseal dysplasia due to collagen 9 anomaly;Q77.3;LD24.61
Multiple epiphyseal dysplasia due to collagen 9 anomaly;Q77.3;LD24.61
Multiple epiphyseal dysplasia, Beighton type;;
Multiple epiphyseal dysplasia, Al-Gazali type;Q78.8;
Brachydactyly-short stature-retinitis pigmentosa syndrome;Q87.8;
Pontocerebellar hypoplasia type 4;Q04.3;LD20.01
Pontocerebellar hypoplasia type 6;Q04.3;LD20.01
Von Willebrand disease type 1;D68.0;3B12
Von Willebrand disease type 2A;D68.0;3B12
Von Willebrand disease type 2B;D68.0;3B12
Von Willebrand disease type 2M;D68.0;3B12
Von Willebrand disease type 2N;D68.0;3B12
Von Willebrand disease type 3;D68.0;3B12
Autosomal dominant otospondylomegaepiphyseal dysplasia;Q87.0;LD2F.1Y
Autosomal dominant otospondylomegaepiphyseal dysplasia;Q87.0;LD2F.1Y
FASTKD2-related infantile mitochondrial encephalomyopathy;G71.3;5C53.2Y
Intellectual disability, Birk-Barel type;Q87.8;
Isolated osteopoikilosis;Q78.8;LD24.11
Dentinogenesis imperfecta type 2;K00.5;LA30.8
Dentinogenesis imperfecta type 3;K00.5;LA30.8
Odontochondrodysplasia;Q78.8;
Familial sick sinus syndrome;I49.5;BC65.Y
Familial sick sinus syndrome;I49.5;BC65.Y
Familial sick sinus syndrome;I49.5;BC65.Y
Porokeratotic eccrine ostial and dermal duct nevus;Q82.5;LC02
Hot water reflex epilepsy;G40.5;8A61.40
Spondyloepimetaphyseal dysplasia, Geneviève type;Q77.7;LD24.3
46,XY disorder of sex development-adrenal insufficiency due to CYP11A1 deficiency;E25.0;
46,XY gonadal dysgenesis-motor and sensory neuropathy syndrome;Q56.1;LD2A.1
Fatal mitochondrial disease due to combined oxidative phosphorylation defect type 3;E88.8;5C53.23
H syndrome;D76.3;LD27.Y
Native American myopathy;G71.2;8C72.Y
Hereditary cryohydrocytosis with reduced stomatin;D58.8;3A10.Y
Hereditary North American Indian childhood cirrhosis;K74.6;DB93.20
Hyperandrogenism due to cortisone reductase deficiency;E25.8;5A71.Y
Hyperandrogenism due to cortisone reductase deficiency;E25.8;5A71.Y
Sudden infant death-dysgenesis of the testes syndrome;G90.8;MH11.Z
Brain demyelination due to methionine adenosyltransferase deficiency;;
Congenital enteropathy due to enteropeptidase deficiency;K90.8;DA90.Y
Seborrhea-like dermatitis with psoriasiform elements;L21.8;
Congenital deficiency in alpha-fetoprotein;R77.2;
Hereditary persistence of alpha-fetoprotein;R77.2;
Familial scaphocephaly syndrome, McGillivray type;Q87.0;LD24.GY
Autosomal thrombocytopenia with normal platelets;D69.4;
Autosomal thrombocytopenia with normal platelets;D69.4;
Autosomal thrombocytopenia with normal platelets;D69.4;
Autosomal thrombocytopenia with normal platelets;D69.4;
Heart-hand syndrome, Slovenian type;Q87.2;LD2F.1Y
Primary peritoneal carcinoma;C48.2;
Chronic eosinophilic leukemia;D47.5;2A20.3
Chronic eosinophilic leukemia;D47.5;2A20.3
Myeloid/lymphoid neoplasm associated with PDGFRA rearrangement;D47.1;2A50
Myeloid/lymphoid neoplasm associated with PDGFRB rearrangement;D47.1;2A51
Myeloid/lymphoid neoplasm associated with FGFR1 rearrangement;D47.1;2A52
Cernunnos-XLF deficiency;D81.1;4A01.1Y
Combined immunodeficiency due to CD3gamma deficiency;D81.2;4A01.1Y
Susceptibility to respiratory infections associated with CD8alpha chain mutation;D84.8;4A01.1Y
Severe combined immunodeficiency due to FOXN1 deficiency;D82.8;4A01.1Y
Immunodeficiency due to CD25 deficiency;D89.8;4A01.21
Recurrent infection due to specific granule deficiency;;
Recurrent infection due to specific granule deficiency;;
Immunodeficiency due to a classical component pathway complement deficiency;D84.1;4A00.10
Immunodeficiency due to a classical component pathway complement deficiency;D84.1;4A00.10
Immunodeficiency due to a classical component pathway complement deficiency;D84.1;4A00.10
Immunodeficiency due to a classical component pathway complement deficiency;D84.1;4A00.10
Immunodeficiency due to a classical component pathway complement deficiency;D84.1;4A00.10
Immunodeficiency due to a classical component pathway complement deficiency;D84.1;4A00.10
Immunodeficiency due to a classical component pathway complement deficiency;D84.1;4A00.10
Immunodeficiency due to a classical component pathway complement deficiency;D84.1;4A00.10
Immunodeficiency due to a late component of complement deficiency;D84.1;4A00.11
Immunodeficiency due to a late component of complement deficiency;D84.1;4A00.11
Immunodeficiency due to a late component of complement deficiency;D84.1;4A00.11
Immunodeficiency due to a late component of complement deficiency;D84.1;4A00.11
Immunodeficiency due to a late component of complement deficiency;D84.1;4A00.11
Immunodeficiency due to a late component of complement deficiency;D84.1;4A00.11
Immunodeficiency due to a late component of complement deficiency;D84.1;4A00.11
T-B+ severe combined immunodeficiency due to IL-7Ralpha deficiency;D81.2;4A01.10
T-B+ severe combined immunodeficiency due to CD45 deficiency;D81.2;4A01.10
T-B+ severe combined immunodeficiency due to CD3delta/CD3epsilon/CD3zeta;D81.2;4A01.10
T-B+ severe combined immunodeficiency due to CD3delta/CD3epsilon/CD3zeta;D81.2;4A01.10
T-B+ severe combined immunodeficiency due to CD3delta/CD3epsilon/CD3zeta;D81.2;4A01.10
Autosomal recessive centronuclear myopathy;G71.2;8C72.01
Autosomal recessive centronuclear myopathy;G71.2;8C72.01
Autosomal recessive centronuclear myopathy;G71.2;8C72.01
Autosomal recessive centronuclear myopathy;G71.2;8C72.01
Autosomal dominant centronuclear myopathy;G71.2;8C72.01
Autosomal dominant centronuclear myopathy;G71.2;8C72.01
Autosomal dominant centronuclear myopathy;G71.2;8C72.01
Autosomal dominant centronuclear myopathy;G71.2;8C72.01
Autosomal dominant centronuclear myopathy;G71.2;8C72.01
Primary CD59 deficiency;D84.1;4A00.1Y
Recurrent Neisseria infections due to factor D deficiency;D84.1;4A00.1Y
Idiopathic central precocious puberty;;
Idiopathic central precocious puberty;;
Idiopathic central precocious puberty;;
Severe hemophilia B;D67;3B11.0
Moderate hemophilia B;D67;3B11.0
Mild hemophilia B;D67;3B11.0
Severe hemophilia A;D66;3B10.0
Moderate hemophilia A;D66;3B10.0
Mild hemophilia A;D66;3B10.0
Severe congenital nemaline myopathy;G71.2;8C72.00
Severe congenital nemaline myopathy;G71.2;8C72.00
Severe congenital nemaline myopathy;G71.2;8C72.00
Severe congenital nemaline myopathy;G71.2;8C72.00
Severe congenital nemaline myopathy;G71.2;8C72.00
Intermediate nemaline myopathy;G71.2;8C72.00
Intermediate nemaline myopathy;G71.2;8C72.00
Intermediate nemaline myopathy;G71.2;8C72.00
Intermediate nemaline myopathy;G71.2;8C72.00
Typical nemaline myopathy;G71.2;8C72.00
Typical nemaline myopathy;G71.2;8C72.00
Typical nemaline myopathy;G71.2;8C72.00
Typical nemaline myopathy;G71.2;8C72.00
Typical nemaline myopathy;G71.2;8C72.00
Typical nemaline myopathy;G71.2;8C72.00
Childhood-onset nemaline myopathy;G71.2;8C72.00
Childhood-onset nemaline myopathy;G71.2;8C72.00
Childhood-onset nemaline myopathy;G71.2;8C72.00
Childhood-onset nemaline myopathy;G71.2;8C72.00
Childhood-onset nemaline myopathy;G71.2;8C72.00
Childhood-onset nemaline myopathy;G71.2;8C72.00
Childhood-onset nemaline myopathy;G71.2;8C72.00
Muscle filaminopathy;G71.8;8C76
Autosomal dominant spastic paraplegia type 37;G11.4;8B44.00
Autosomal recessive spastic paraplegia type 35;G11.4;8B44.01
Lissencephaly due to TUBA1A mutation;Q04.3;LD20.1
Metabolic myopathy due to lactate transporter defect;G72.8;
Parkinsonian-pyramidal syndrome;G20;8A00.1Y
Parkinsonian-pyramidal syndrome;G20;8A00.1Y
Diffuse panbronchiolitis;J44.8;CA26.1
Diffuse panbronchiolitis;J44.8;CA26.1
Microcephaly-polymicrogyria-corpus callosum agenesis syndrome;Q04.3;
Microcephaly-polymicrogyria-corpus callosum agenesis syndrome;Q04.3;
Short stature-delayed bone age due to thyroid hormone metabolism deficiency;E03.1;
Male infertility due to globozoospermia;N46;
Male infertility due to globozoospermia;N46;
Male infertility due to globozoospermia;N46;
Male infertility due to globozoospermia;N46;
White sponge nevus;Q38.6;DA02.0
White sponge nevus;Q38.6;DA02.0
6q16 microdeletion syndrome;Q93.5;LD29
Polyneuropathy-hearing loss-ataxia-retinitis pigmentosa-cataract syndrome;G60.1;LD2H.Y
MEDNIK syndrome;E83.0;LD2H.Y
MEDNIK syndrome;E83.0;LD2H.Y
Autosomal dominant spastic paraplegia type 42;G11.4;8B44.00
Spondyloepimetaphyseal dysplasia, aggrecan type;Q77.7;LD24.3
Renal pseudohypoaldosteronism type 1;N25.8;GB90.41
Generalized pseudohypoaldosteronism type 1;N25.8;GB90.41
Generalized pseudohypoaldosteronism type 1;N25.8;GB90.41
Generalized pseudohypoaldosteronism type 1;N25.8;GB90.41
Cap myopathy;G71.2;8C72.0Y
Cap myopathy;G71.2;8C72.0Y
Cap myopathy;G71.2;8C72.0Y
Prader-Willi syndrome due to paternal deletion of 15q11q13 type 1;Q87.1;LD90.3
Prader-Willi syndrome due to paternal deletion of 15q11q13 type 1;Q87.1;LD90.3
Prader-Willi syndrome due to paternal deletion of 15q11q13 type 1;Q87.1;LD90.3
Prader-Willi syndrome due to paternal deletion of 15q11q13 type 1;Q87.1;LD90.3
Prader-Willi syndrome due to paternal deletion of 15q11q13 type 2;Q87.1;LD90.3
Prader-Willi syndrome due to paternal deletion of 15q11q13 type 2;Q87.1;LD90.3
Prader-Willi syndrome due to paternal deletion of 15q11q13 type 2;Q87.1;LD90.3
Prader-Willi syndrome due to paternal deletion of 15q11q13 type 2;Q87.1;LD90.3
Prader-Willi syndrome due to translocation;Q87.1;LD90.3
Prader-Willi syndrome due to imprinting mutation;Q87.1;LD90.3
Prader-Willi syndrome due to imprinting mutation;Q87.1;LD90.3
Prader-Willi syndrome due to imprinting mutation;Q87.1;LD90.3
Bleeding disorder in hemophilia A carriers;D66;3B10.0
Bleeding disorder in hemophilia B carriers;D67;3B11.0
Moderate multiminicore disease with hand involvement;G71.2;8C72.0Y
Reticulate acropigmentation of Kitamura;L81.8;
Åland Islands eye disease;H35.5;9B7Y
UV-sensitive syndrome;L56.8;
UV-sensitive syndrome;L56.8;
UV-sensitive syndrome;L56.8;
Inflammatory myofibroblastic tumor;D48.7;2F30.Y
Inflammatory myofibroblastic tumor;D48.7;2E92.1
Inflammatory myofibroblastic tumor;D48.7;2F30.Y
Inflammatory myofibroblastic tumor;D48.7;2E92.1
Inflammatory myofibroblastic tumor;D48.7;2F30.Y
Inflammatory myofibroblastic tumor;D48.7;2E92.1
Inflammatory myofibroblastic tumor;D48.7;2F30.Y
Inflammatory myofibroblastic tumor;D48.7;2E92.1
Inflammatory myofibroblastic tumor;D48.7;2F30.Y
Inflammatory myofibroblastic tumor;D48.7;2E92.1
Inflammatory myofibroblastic tumor;D48.7;2F30.Y
Inflammatory myofibroblastic tumor;D48.7;2E92.1
Aromatase excess syndrome;E30.1;5A92
Smith-McCort dysplasia;Q77.7;LD24.3
Smith-McCort dysplasia;Q77.7;LD24.3
Syndromic microphthalmia type 5;Q11.2;LD21.0
Osteosclerosis-developmental delay-craniosynostosis syndrome;Q75.8;LD2F.1Y
Osteopetrosis-hypogammaglobulinemia syndrome;Q78.2;4A01.0Y
Hemorrhagic disease due to alpha-1-antitrypsin Pittsburgh mutation;D68.8;5C5A
Distal myopathy with anterior tibial onset;G71.0;8C75
X-linked myopathy with postural muscle atrophy;G71.0;8C70.Y
Hereditary myopathy with early respiratory failure;G71.0;8C70.Y
Autosomal dominant non-syndromic intellectual disability;F71;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F72;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F73;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F70;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F71;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F72;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F73;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F70;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F71;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F72;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F73;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F70;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F71;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F72;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F73;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F70;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F71;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F72;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F73;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F70;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F71;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F72;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F73;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F70;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F71;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F72;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F73;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F70;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F71;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F72;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F73;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F70;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F71;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F72;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F73;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F70;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F71;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F72;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F73;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F70;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F71;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F72;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F73;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F70;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F71;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F72;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F73;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F70;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F71;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F72;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F73;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F70;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F71;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F72;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F73;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F70;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F71;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F72;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F73;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F70;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F71;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F72;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F73;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F70;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F71;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F72;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F73;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F70;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F71;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F72;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F73;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F70;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F71;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F72;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F73;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F70;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F71;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F72;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F73;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F70;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F71;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F72;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F73;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F70;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F71;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F72;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F73;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F70;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F71;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F72;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F73;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F70;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F71;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F72;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F73;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F70;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F71;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F72;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F73;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F70;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F71;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F72;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F73;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F70;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F71;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F72;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F73;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F70;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F71;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F72;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F73;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F70;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F71;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F72;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F73;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F70;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F71;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F72;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F73;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F70;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F71;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F72;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F73;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F70;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F71;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F72;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F73;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F70;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F71;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F72;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F73;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F70;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F71;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F72;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F73;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F70;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F71;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F72;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F73;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F70;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F71;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F72;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F73;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F70;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F71;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F72;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F73;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F70;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F71;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F72;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F73;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F70;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F71;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F72;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F73;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F70;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F71;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F72;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F73;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F70;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F71;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F72;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F73;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F70;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F71;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F72;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F73;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F70;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F71;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F72;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F73;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F70;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F71;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F72;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F73;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F70;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F71;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F72;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F73;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F70;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F71;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F72;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F73;LD90.Y
Autosomal dominant non-syndromic intellectual disability;F70;LD90.Y
Brain calcification, Rajab type;G93.8;LD20.4
Perry syndrome;G23.8;8A00.1Y
Obesity due to leptin receptor gene deficiency;E66.8;5B81.Y
Isolated congenital breast hypoplasia/aplasia;Q83.0;LB60
MYH9-related disease;D69.4;3B64.01
Recurrent infections associated with rare immunoglobulin isotypes deficiency;D80.8;4A01.04
Recurrent infections associated with rare immunoglobulin isotypes deficiency;D80.8;4A01.04
Hermansky-Pudlak syndrome due to AP-3 deficiency;E70.3;EC23.20
Neutrophil immunodeficiency syndrome;D72.9;
Bacterial susceptibility due to TLR signaling pathway deficiency;D84.8;
Cushing syndrome due to macronodular adrenal hyperplasia;;
Cushing syndrome due to macronodular adrenal hyperplasia;;
Primary pigmented nodular adrenocortical disease;;
Primary pigmented nodular adrenocortical disease;;
Primary pigmented nodular adrenocortical disease;;
Primary pigmented nodular adrenocortical disease;;
Familial isolated hypoparathyroidism due to impaired PTH secretion;E20.8;5A50.0Y
Familial isolated hypoparathyroidism due to impaired PTH secretion;E20.8;5A50.0Y
Pulmonary capillary hemangiomatosis;D18.0;BB01.0
Corticosteroid-binding globulin deficiency;E27.8;
Hereditary hypercarotenemia and vitamin A deficiency;E50.8;5C63.Y
Congenital isolated ACTH deficiency;E23.6;5A74.Y
Isolated cleft lip;Q36.0;LA40
Isolated cleft lip;Q36.1;LA40
Isolated cleft lip;Q36.9;LA40
Isolated cleft lip;Q36.0;LA40
Isolated cleft lip;Q36.1;LA40
Isolated cleft lip;Q36.9;LA40
Isolated cleft lip;Q36.0;LA40
Isolated cleft lip;Q36.1;LA40
Isolated cleft lip;Q36.9;LA40
Isolated cleft lip;Q36.0;LA40
Isolated cleft lip;Q36.1;LA40
Isolated cleft lip;Q36.9;LA40
Cleft lip/palate;Q37.0;LA42
Cleft lip/palate;Q37.0;LA40
Cleft lip/palate;Q37.4;LA42
Cleft lip/palate;Q37.4;LA40
Cleft lip/palate;Q37.5;LA42
Cleft lip/palate;Q37.5;LA40
Cleft lip/palate;Q37.8;LA42
Cleft lip/palate;Q37.8;LA40
Cleft lip/palate;Q37.9;LA42
Cleft lip/palate;Q37.9;LA40
Cleft lip/palate;Q37.1;LA42
Cleft lip/palate;Q37.1;LA40
Cleft lip/palate;Q37.2;LA42
Cleft lip/palate;Q37.2;LA40
Cleft lip/palate;Q37.3;LA42
Cleft lip/palate;Q37.3;LA40
Cleft lip/palate;Q37.0;LA42
Cleft lip/palate;Q37.0;LA40
Cleft lip/palate;Q37.4;LA42
Cleft lip/palate;Q37.4;LA40
Cleft lip/palate;Q37.5;LA42
Cleft lip/palate;Q37.5;LA40
Cleft lip/palate;Q37.8;LA42
Cleft lip/palate;Q37.8;LA40
Cleft lip/palate;Q37.9;LA42
Cleft lip/palate;Q37.9;LA40
Cleft lip/palate;Q37.1;LA42
Cleft lip/palate;Q37.1;LA40
Cleft lip/palate;Q37.2;LA42
Cleft lip/palate;Q37.2;LA40
Cleft lip/palate;Q37.3;LA42
Cleft lip/palate;Q37.3;LA40
Cleft lip/palate;Q37.0;LA42
Cleft lip/palate;Q37.0;LA40
Cleft lip/palate;Q37.4;LA42
Cleft lip/palate;Q37.4;LA40
Cleft lip/palate;Q37.5;LA42
Cleft lip/palate;Q37.5;LA40
Cleft lip/palate;Q37.8;LA42
Cleft lip/palate;Q37.8;LA40
Cleft lip/palate;Q37.9;LA42
Cleft lip/palate;Q37.9;LA40
Cleft lip/palate;Q37.1;LA42
Cleft lip/palate;Q37.1;LA40
Cleft lip/palate;Q37.2;LA42
Cleft lip/palate;Q37.2;LA40
Cleft lip/palate;Q37.3;LA42
Cleft lip/palate;Q37.3;LA40
Cleft lip/palate;Q37.0;LA42
Cleft lip/palate;Q37.0;LA40
Cleft lip/palate;Q37.4;LA42
Cleft lip/palate;Q37.4;LA40
Cleft lip/palate;Q37.5;LA42
Cleft lip/palate;Q37.5;LA40
Cleft lip/palate;Q37.8;LA42
Cleft lip/palate;Q37.8;LA40
Cleft lip/palate;Q37.9;LA42
Cleft lip/palate;Q37.9;LA40
Cleft lip/palate;Q37.1;LA42
Cleft lip/palate;Q37.1;LA40
Cleft lip/palate;Q37.2;LA42
Cleft lip/palate;Q37.2;LA40
Cleft lip/palate;Q37.3;LA42
Cleft lip/palate;Q37.3;LA40
Cleft lip/palate;Q37.0;LA42
Cleft lip/palate;Q37.0;LA40
Cleft lip/palate;Q37.4;LA42
Cleft lip/palate;Q37.4;LA40
Cleft lip/palate;Q37.5;LA42
Cleft lip/palate;Q37.5;LA40
Cleft lip/palate;Q37.8;LA42
Cleft lip/palate;Q37.8;LA40
Cleft lip/palate;Q37.9;LA42
Cleft lip/palate;Q37.9;LA40
Cleft lip/palate;Q37.1;LA42
Cleft lip/palate;Q37.1;LA40
Cleft lip/palate;Q37.2;LA42
Cleft lip/palate;Q37.2;LA40
Cleft lip/palate;Q37.3;LA42
Cleft lip/palate;Q37.3;LA40
Cleft lip/palate;Q37.0;LA42
Cleft lip/palate;Q37.0;LA40
Cleft lip/palate;Q37.4;LA42
Cleft lip/palate;Q37.4;LA40
Cleft lip/palate;Q37.5;LA42
Cleft lip/palate;Q37.5;LA40
Cleft lip/palate;Q37.8;LA42
Cleft lip/palate;Q37.8;LA40
Cleft lip/palate;Q37.9;LA42
Cleft lip/palate;Q37.9;LA40
Cleft lip/palate;Q37.1;LA42
Cleft lip/palate;Q37.1;LA40
Cleft lip/palate;Q37.2;LA42
Cleft lip/palate;Q37.2;LA40
Cleft lip/palate;Q37.3;LA42
Cleft lip/palate;Q37.3;LA40
Cleft lip/palate;Q37.0;LA42
Cleft lip/palate;Q37.0;LA40
Cleft lip/palate;Q37.4;LA42
Cleft lip/palate;Q37.4;LA40
Cleft lip/palate;Q37.5;LA42
Cleft lip/palate;Q37.5;LA40
Cleft lip/palate;Q37.8;LA42
Cleft lip/palate;Q37.8;LA40
Cleft lip/palate;Q37.9;LA42
Cleft lip/palate;Q37.9;LA40
Cleft lip/palate;Q37.1;LA42
Cleft lip/palate;Q37.1;LA40
Cleft lip/palate;Q37.2;LA42
Cleft lip/palate;Q37.2;LA40
Cleft lip/palate;Q37.3;LA42
Cleft lip/palate;Q37.3;LA40
Cleft lip/palate;Q37.0;LA42
Cleft lip/palate;Q37.0;LA40
Cleft lip/palate;Q37.4;LA42
Cleft lip/palate;Q37.4;LA40
Cleft lip/palate;Q37.5;LA42
Cleft lip/palate;Q37.5;LA40
Cleft lip/palate;Q37.8;LA42
Cleft lip/palate;Q37.8;LA40
Cleft lip/palate;Q37.9;LA42
Cleft lip/palate;Q37.9;LA40
Cleft lip/palate;Q37.1;LA42
Cleft lip/palate;Q37.1;LA40
Cleft lip/palate;Q37.2;LA42
Cleft lip/palate;Q37.2;LA40
Cleft lip/palate;Q37.3;LA42
Cleft lip/palate;Q37.3;LA40
Cleft lip/palate;Q37.0;LA42
Cleft lip/palate;Q37.0;LA40
Cleft lip/palate;Q37.4;LA42
Cleft lip/palate;Q37.4;LA40
Cleft lip/palate;Q37.5;LA42
Cleft lip/palate;Q37.5;LA40
Cleft lip/palate;Q37.8;LA42
Cleft lip/palate;Q37.8;LA40
Cleft lip/palate;Q37.9;LA42
Cleft lip/palate;Q37.9;LA40
Cleft lip/palate;Q37.1;LA42
Cleft lip/palate;Q37.1;LA40
Cleft lip/palate;Q37.2;LA42
Cleft lip/palate;Q37.2;LA40
Cleft lip/palate;Q37.3;LA42
Cleft lip/palate;Q37.3;LA40
Cleft lip/palate;Q37.0;LA42
Cleft lip/palate;Q37.0;LA40
Cleft lip/palate;Q37.4;LA42
Cleft lip/palate;Q37.4;LA40
Cleft lip/palate;Q37.5;LA42
Cleft lip/palate;Q37.5;LA40
Cleft lip/palate;Q37.8;LA42
Cleft lip/palate;Q37.8;LA40
Cleft lip/palate;Q37.9;LA42
Cleft lip/palate;Q37.9;LA40
Cleft lip/palate;Q37.1;LA42
Cleft lip/palate;Q37.1;LA40
Cleft lip/palate;Q37.2;LA42
Cleft lip/palate;Q37.2;LA40
Cleft lip/palate;Q37.3;LA42
Cleft lip/palate;Q37.3;LA40
15q13.3 microdeletion syndrome;Q93.5;LD44.F
Isolated autosomal dominant hypomagnesemia, Glaudemans type;E83.4;5C64.41
Congenital myopathy, Paradas type;G71.2;8C70.6
Endocrine-cerebro-osteodysplasia syndrome;Q87.8;LD2F.1Y
Pancreatic insufficiency-anemia-hyperostosis syndrome;E88.8;5C53.2Y
Muscular dystrophy, Selcen type;G71.8;8C76
EAST syndrome;G40.4;LD2H.Y
Thiamine-responsive encephalopathy;E51.2;
Adult-onset dystonia-parkinsonism;G24.1;8A00.1Y
Cerebral autosomal recessive arteriopathy-subcortical infarcts-leukoencephalopathy;I67.8;8B22.C1
Immunodeficiency with factor I anomaly;D84.1;4A00.1Y
Immunodeficiency with factor H anomaly;D84.1;4A00.1Y
Infantile Krabbe disease;E75.2;8A44.4
Infantile Krabbe disease;E75.2;8A44.4
Late-infantile/juvenile Krabbe disease;E75.2;8A44.4
Adult Krabbe disease;E75.2;8A44.4
Symptomatic form of muscular dystrophy of Duchenne and Becker in female carriers;G71.0;8C70.0
Symptomatic form of muscular dystrophy of Duchenne and Becker in female carriers;G71.0;8C70.1
Anoctamin-5-related limb-girdle muscular dystrophy R12;G71.0;
Fukutin-related limb-girdle muscular dystrophy R13;G71.0;
POMT2-related limb-girdle muscular dystrophy R14;G71.0;
POMGNT1-related limb-girdle muscular dystrophy R15;G71.0;
Autosomal recessive lower motor neuron disease with childhood onset;G12.2;8B61.4
Adult polyglucosan body disease;E74.0;5C51.3
Isolated asymptomatic elevation of creatine phosphokinase;R74.8;
Bilateral parasagittal parieto-occipital polymicrogyria;Q04.3;LA05.50
Bilateral generalized polymicrogyria;Q04.3;LA05.50
Spinocerebellar ataxia type 29;G11.0;8A03.16
Autosomal dominant adult-onset proximal spinal muscular atrophy;G12.1;8B61.Y
DYNC1H1-related autosomal dominant childhood-onset proximal spinal muscular atrophy;G12.1;
Severe neonatal-onset encephalopathy with microcephaly;Q02;LD20.2
Autosomal dominant rhegmatogenous retinal detachment;H33.0;9B73.0
NON RARE IN EUROPE: Congenital isolated thyroxine-binding globulin deficiency;;
Hypercholesterolemia due to cholesterol 7alpha-hydroxylase deficiency;E78.0;
Brain-lung-thyroid syndrome;E03.1;CB04.5
Isolated childhood apraxia of speech;F80.0;
Extraskeletal myxoid chondrosarcoma;C49.9;2B50.Y
Extraskeletal myxoid chondrosarcoma;C49.9;2B50.Y
Extraskeletal myxoid chondrosarcoma;C49.9;2B50.Y
Extraskeletal myxoid chondrosarcoma;C49.9;2B50.Y
Extraskeletal myxoid chondrosarcoma;C49.9;2B50.Y
Cone dystrophy with supernormal rod response;H35.5;9B7Y
Autosomal recessive spastic paraplegia type 18;;
Episodic ataxia type 6;G11.8;8A03.14
IRIDA syndrome;D50.8;3A00.Y
Intermediate osteopetrosis;Q78.2;LD24.10
Intermediate osteopetrosis;Q78.2;LD24.10
Intermediate osteopetrosis;Q78.2;LD24.10
Sterile multifocal osteomyelitis with periostitis and pustulosis;D84.8;4A00.Y
Congenital alveolar capillary dysplasia;Q33.6;CB04.0
Urocanic aciduria;E70.8;5C50.21
Inherited congenital spastic tetraplegia;G82.4;MB50.1
Inherited congenital spastic tetraplegia;G82.4;MB50.1
Inherited congenital spastic tetraplegia;G82.4;MB50.1
Lethal polymalformative syndrome, Boissel type;Q87.8;LD2F.1Y
Adult hepatocellular carcinoma;C22.0;
Adult hepatocellular carcinoma;C22.0;
Adult hepatocellular carcinoma;C22.0;
Adult hepatocellular carcinoma;C22.0;
Adult hepatocellular carcinoma;C22.0;
Adult hepatocellular carcinoma;C22.0;
Adult hepatocellular carcinoma;C22.0;
Adult hepatocellular carcinoma;C22.0;
Adult hepatocellular carcinoma;C22.0;
Congenital lethal myopathy, Compton-North type;G71.2;
Macrocephaly-intellectual disability-autism syndrome;Q87.8;
Macrocephaly-intellectual disability-autism syndrome;Q87.8;
Dystonia 16;G24.1;8A02.12
Episodic ataxia type 5;G11.8;8A03.14
Adenocarcinoma of ovary;C56;
Hereditary site-specific ovarian cancer syndrome;;
Hereditary site-specific ovarian cancer syndrome;;
Endometrial stromal sarcoma;C54.1;2B5C
Endometrial stromal sarcoma;C54.1;XH1S94
Endometrial stromal sarcoma;C54.1;XH1TK5
Endometrial stromal sarcoma;C54.1;XH2CV3
Endometrial stromal sarcoma;C54.1;2B5C
Endometrial stromal sarcoma;C54.1;XH1S94
Endometrial stromal sarcoma;C54.1;XH1TK5
Endometrial stromal sarcoma;C54.1;XH2CV3
Endometrial stromal sarcoma;C54.1;2B5C
Endometrial stromal sarcoma;C54.1;XH1S94
Endometrial stromal sarcoma;C54.1;XH1TK5
Endometrial stromal sarcoma;C54.1;XH2CV3
Endometrial stromal sarcoma;C54.1;2B5C
Endometrial stromal sarcoma;C54.1;XH1S94
Endometrial stromal sarcoma;C54.1;XH1TK5
Endometrial stromal sarcoma;C54.1;XH2CV3
Endometrial stromal sarcoma;C54.1;2B5C
Endometrial stromal sarcoma;C54.1;XH1S94
Endometrial stromal sarcoma;C54.1;XH1TK5
Endometrial stromal sarcoma;C54.1;XH2CV3
Isolated congenitally uncorrected transposition of the great arteries;Q20.3;
Isolated congenitally uncorrected transposition of the great arteries;Q20.3;
Isolated congenitally uncorrected transposition of the great arteries;Q20.3;
Isolated congenitally uncorrected transposition of the great arteries;Q20.3;
Congenitally uncorrected transposition of the great arteries with cardiac malformation;Q20.3;
Osteogenesis imperfecta type 1;Q78.0;LD24.K0
Osteogenesis imperfecta type 1;Q78.0;LD24.K0
Osteogenesis imperfecta type 1;Q78.0;LD24.K0
Osteogenesis imperfecta type 1;Q78.0;LD24.K0
Osteogenesis imperfecta type 1;Q78.0;LD24.K0
Osteogenesis imperfecta type 2;Q78.0;LD24.K0
Osteogenesis imperfecta type 2;Q78.0;LD24.K0
Osteogenesis imperfecta type 2;Q78.0;LD24.K0
Osteogenesis imperfecta type 2;Q78.0;LD24.K0
Osteogenesis imperfecta type 2;Q78.0;LD24.K0
Osteogenesis imperfecta type 2;Q78.0;LD24.K0
Osteogenesis imperfecta type 3;Q78.0;LD24.K0
Osteogenesis imperfecta type 3;Q78.0;LD24.K0
Osteogenesis imperfecta type 3;Q78.0;LD24.K0
Osteogenesis imperfecta type 3;Q78.0;LD24.K0
Osteogenesis imperfecta type 3;Q78.0;LD24.K0
Osteogenesis imperfecta type 3;Q78.0;LD24.K0
Osteogenesis imperfecta type 3;Q78.0;LD24.K0
Osteogenesis imperfecta type 3;Q78.0;LD24.K0
Osteogenesis imperfecta type 3;Q78.0;LD24.K0
Osteogenesis imperfecta type 3;Q78.0;LD24.K0
Osteogenesis imperfecta type 3;Q78.0;LD24.K0
Osteogenesis imperfecta type 3;Q78.0;LD24.K0
Osteogenesis imperfecta type 4;Q78.0;LD24.K0
Osteogenesis imperfecta type 4;Q78.0;LD24.K0
Osteogenesis imperfecta type 4;Q78.0;LD24.K0
Osteogenesis imperfecta type 4;Q78.0;LD24.K0
Osteogenesis imperfecta type 4;Q78.0;LD24.K0
Osteogenesis imperfecta type 4;Q78.0;LD24.K0
Osteogenesis imperfecta type 4;Q78.0;LD24.K0
Osteogenesis imperfecta type 4;Q78.0;LD24.K0
Osteogenesis imperfecta type 4;Q78.0;LD24.K0
Osteogenesis imperfecta type 4;Q78.0;LD24.K0
Osteogenesis imperfecta type 5;Q78.0;LD24.K0
Classic pantothenate kinase-associated neurodegeneration;G23.0;5C64.10
Atypical pantothenate kinase-associated neurodegeneration;G23.0;5C64.10
Niemann-Pick disease type C, severe perinatal form;E75.2;5C56.0Y
Niemann-Pick disease type C, severe perinatal form;E75.2;5C56.0Y
Niemann-Pick disease type C, severe early infantile neurologic onset;E75.2;5C56.0Y
Niemann-Pick disease type C, severe early infantile neurologic onset;E75.2;5C56.0Y
Niemann-Pick disease type C, late infantile neurologic onset;E75.2;5C56.0Y
Niemann-Pick disease type C, late infantile neurologic onset;E75.2;5C56.0Y
Niemann-Pick disease type C, juvenile neurologic onset;E75.2;5C56.0Y
Niemann-Pick disease type C, juvenile neurologic onset;E75.2;5C56.0Y
Niemann-Pick disease type C, adult neurologic onset;E75.2;5C56.0Y
Niemann-Pick disease type C, adult neurologic onset;E75.2;5C56.0Y
Spinocerebellar ataxia type 31;G11.8;8A03.16
NON RARE IN EUROPE: Obesity due to MC3R deficiency;;
Autosomal recessive intermediate Charcot-Marie-Tooth disease type A;G60.0;8C20.2
Isolated congenital digital clubbing;;
Mucopolysaccharidosis type 2, severe form;E76.1;5C56.31
Mucopolysaccharidosis type 2, attenuated form;E76.1;5C56.31
BNAR syndrome;Q87.8;LD2F.1Y
REN-related autosomal dominant tubulointerstitial kidney disease;Q61.5;
RIN2 syndrome;Q82.8;LD28.2
Acute infantile liver failure due to synthesis defect of mtDNA-encoded proteins;E88.8;5C53.23
Microduplication Xp11.22p11.23 syndrome;Q99.8;LD51
Neurodegenerative syndrome due to cerebral folate transport deficiency;G31.8;5C63.1
17p13.3 microduplication syndrome;Q92.3;LD41.G1
17p13.3 microduplication syndrome;Q92.3;LD41.G1
Combined immunodeficiency due to DOCK8 deficiency;D81.1;4A01.1Y
Progressive polyneuropathy with bilateral striatal necrosis;E88.8;
Hereditary hypotrichosis with recurrent skin vesicles;Q84.2;
Hereditary thrombophilia due to congenital histidine-rich (poly-L) glycoprotein deficiency;D68.5;3B61.0Y
Neonatal acute respiratory distress due to SP-B deficiency;P28.0;CB04.2
Chronic respiratory distress with surfactant metabolism deficiency;J84.8;
Sensorineural deafness with dilated cardiomyopathy;I42.0;
Xeroderma pigmentosum-Cockayne syndrome complex;Q87.1;LD2B
Xeroderma pigmentosum-Cockayne syndrome complex;Q87.1;LD2B
Xeroderma pigmentosum-Cockayne syndrome complex;Q87.1;LD2B
Xeroderma pigmentosum-Cockayne syndrome complex;Q87.1;LD2B
Semilobar holoprosencephaly;Q04.2;LA05.2
Semilobar holoprosencephaly;Q04.2;LA05.2
Semilobar holoprosencephaly;Q04.2;LA05.2
Semilobar holoprosencephaly;Q04.2;LA05.2
Semilobar holoprosencephaly;Q04.2;LA05.2
Semilobar holoprosencephaly;Q04.2;LA05.2
Semilobar holoprosencephaly;Q04.2;LA05.2
Semilobar holoprosencephaly;Q04.2;LA05.2
Semilobar holoprosencephaly;Q04.2;LA05.2
Semilobar holoprosencephaly;Q04.2;LA05.2
Semilobar holoprosencephaly;Q04.2;LA05.2
Semilobar holoprosencephaly;Q04.2;LA05.2
Semilobar holoprosencephaly;Q04.2;LA05.2
Semilobar holoprosencephaly;Q04.2;LA05.2
Semilobar holoprosencephaly;Q04.2;LA05.2
Semilobar holoprosencephaly;Q04.2;LA05.2
Semilobar holoprosencephaly;Q04.2;LA05.2
Semilobar holoprosencephaly;Q04.2;LA05.2
Diffuse cutaneous systemic sclerosis;M34.0;4A42.1
Diffuse cutaneous systemic sclerosis;M34.0;4A42.1
Diffuse cutaneous systemic sclerosis;M34.0;4A42.1
Diffuse cutaneous systemic sclerosis;M34.0;4A42.1
Diffuse cutaneous systemic sclerosis;M34.0;4A42.1
Limited cutaneous systemic sclerosis;M34.1;
Limited cutaneous systemic sclerosis;M34.1;
Limited cutaneous systemic sclerosis;M34.1;
Limited cutaneous systemic sclerosis;M34.1;
Limited cutaneous systemic sclerosis;M34.1;
Limited cutaneous systemic sclerosis;M34.1;
Limited systemic sclerosis;M34.0;4A42.2
Quebec platelet disorder;D69.1;3B62.00
Bleeding diathesis due to thromboxane synthesis deficiency;D69.8;3B62.1
Laron syndrome with immunodeficiency;D82.8;5A61.0
Laron syndrome with immunodeficiency;E34.3;5A61.0
Joubert syndrome with ocular defect;H35.5;LD20.0Y
Joubert syndrome with ocular defect;Q04.3;LD20.0Y
Joubert syndrome with ocular defect;H35.5;LD20.0Y
Joubert syndrome with ocular defect;Q04.3;LD20.0Y
Joubert syndrome with ocular defect;H35.5;LD20.0Y
Joubert syndrome with ocular defect;Q04.3;LD20.0Y
Joubert syndrome with ocular defect;H35.5;LD20.0Y
Joubert syndrome with ocular defect;Q04.3;LD20.0Y
Joubert syndrome with ocular defect;H35.5;LD20.0Y
Joubert syndrome with ocular defect;Q04.3;LD20.0Y
Joubert syndrome with renal defect;Q04.3;LD20.0Y
Joubert syndrome with renal defect;Q61.5;LD20.0Y
Joubert syndrome with renal defect;Q04.3;LD20.0Y
Joubert syndrome with renal defect;Q61.5;LD20.0Y
Joubert syndrome with renal defect;Q04.3;LD20.0Y
Joubert syndrome with renal defect;Q61.5;LD20.0Y
Rothmund-Thomson syndrome type 1;Q82.8;LD2B
Rothmund-Thomson syndrome type 2;Q82.8;LD2B
Hereditary fibrosing poikiloderma-tendon contractures-myopathy-pulmonary fibrosis syndrome;Q82.8;
Poikiloderma with neutropenia;D82.8;EC10
Familial cerebral cavernous malformation;Q28.3;LA90.0Y
Familial cerebral cavernous malformation;Q28.3;LA90.0Y
Familial cerebral cavernous malformation;Q28.3;LA90.0Y
Fowler vasculopathy;Q04.8;
Combined immunodeficiency with faciooculoskeletal anomalies;D81.9;
Combined immunodeficiency with faciooculoskeletal anomalies;D81.9;
Cutis laxa with severe pulmonary, gastrointestinal and urinary anomalies;Q82.8;LD28.2
Hemochromatosis type 3;E83.118;
Familial infantile bilateral striatal necrosis;G23.2;LD90.Y
Familial infantile bilateral striatal necrosis;G23.2;LD90.Y
Familial infantile bilateral striatal necrosis;G23.2;LD90.Y
Hypothyroidism due to deficient transcription factors involved in pituitary development or function;E03.1;5A00.01
Hypothyroidism due to deficient transcription factors involved in pituitary development or function;E03.1;5A00.01
Hypothyroidism due to deficient transcription factors involved in pituitary development or function;E03.1;5A00.01
Hypothyroidism due to deficient transcription factors involved in pituitary development or function;E03.1;5A00.01
Hypothyroidism due to deficient transcription factors involved in pituitary development or function;E03.1;5A00.01
Genetic transient congenital hypothyroidism;P72.2;
Multiple system atrophy, cerebellar type;G23.3;8D87.00
Hereditary breast cancer;C50.1;2C6Y
Hereditary breast cancer;C50.2;2C6Y
Hereditary breast cancer;C50.3;2C6Y
Hereditary breast cancer;C50.4;2C6Y
Hereditary breast cancer;C50.5;2C6Y
Hereditary breast cancer;C50.6;2C6Y
Hereditary breast cancer;C50.8;2C6Y
Hereditary breast cancer;C50.0;2C6Y
Hereditary breast cancer;C50.1;2C6Y
Hereditary breast cancer;C50.2;2C6Y
Hereditary breast cancer;C50.3;2C6Y
Hereditary breast cancer;C50.4;2C6Y
Hereditary breast cancer;C50.5;2C6Y
Hereditary breast cancer;C50.6;2C6Y
Hereditary breast cancer;C50.8;2C6Y
Hereditary breast cancer;C50.0;2C6Y
Hereditary breast cancer;C50.1;2C6Y
Hereditary breast cancer;C50.2;2C6Y
Hereditary breast cancer;C50.3;2C6Y
Hereditary breast cancer;C50.4;2C6Y
Hereditary breast cancer;C50.5;2C6Y
Hereditary breast cancer;C50.6;2C6Y
Hereditary breast cancer;C50.8;2C6Y
Hereditary breast cancer;C50.0;2C6Y
Hereditary breast cancer;C50.1;2C6Y
Hereditary breast cancer;C50.2;2C6Y
Hereditary breast cancer;C50.3;2C6Y
Hereditary breast cancer;C50.4;2C6Y
Hereditary breast cancer;C50.5;2C6Y
Hereditary breast cancer;C50.6;2C6Y
Hereditary breast cancer;C50.8;2C6Y
Hereditary breast cancer;C50.0;2C6Y
Hereditary breast cancer;C50.1;2C6Y
Hereditary breast cancer;C50.2;2C6Y
Hereditary breast cancer;C50.3;2C6Y
Hereditary breast cancer;C50.4;2C6Y
Hereditary breast cancer;C50.5;2C6Y
Hereditary breast cancer;C50.6;2C6Y
Hereditary breast cancer;C50.8;2C6Y
Hereditary breast cancer;C50.0;2C6Y
Hereditary breast cancer;C50.1;2C6Y
Hereditary breast cancer;C50.2;2C6Y
Hereditary breast cancer;C50.3;2C6Y
Hereditary breast cancer;C50.4;2C6Y
Hereditary breast cancer;C50.5;2C6Y
Hereditary breast cancer;C50.6;2C6Y
Hereditary breast cancer;C50.8;2C6Y
Hereditary breast cancer;C50.0;2C6Y
Hereditary breast cancer;C50.1;2C6Y
Hereditary breast cancer;C50.2;2C6Y
Hereditary breast cancer;C50.3;2C6Y
Hereditary breast cancer;C50.4;2C6Y
Hereditary breast cancer;C50.5;2C6Y
Hereditary breast cancer;C50.6;2C6Y
Hereditary breast cancer;C50.8;2C6Y
Hereditary breast cancer;C50.0;2C6Y
Hereditary breast cancer;C50.1;2C6Y
Hereditary breast cancer;C50.2;2C6Y
Hereditary breast cancer;C50.3;2C6Y
Hereditary breast cancer;C50.4;2C6Y
Hereditary breast cancer;C50.5;2C6Y
Hereditary breast cancer;C50.6;2C6Y
Hereditary breast cancer;C50.8;2C6Y
Hereditary breast cancer;C50.0;2C6Y
Hereditary breast cancer;C50.1;2C6Y
Hereditary breast cancer;C50.2;2C6Y
Hereditary breast cancer;C50.3;2C6Y
Hereditary breast cancer;C50.4;2C6Y
Hereditary breast cancer;C50.5;2C6Y
Hereditary breast cancer;C50.6;2C6Y
Hereditary breast cancer;C50.8;2C6Y
Hereditary breast cancer;C50.0;2C6Y
Fundus albipunctatus;H35.5;9B70
Fundus albipunctatus;H35.5;9B70
Fundus albipunctatus;H35.5;9B70
Autosomal recessive optic atrophy, OPA7 type;H47.2;
Idiopathic CD4 lymphocytopenia;D72.8;4A00.2
Severe combined immunodeficiency due to CORO1A deficiency;D81.2;4A01.10
Progressive sensorineural hearing loss-hypertrophic cardiomyopathy syndrome;H90.3;
Idiopathic ventricular fibrillation, non Brugada type;I49.0;
Idiopathic ventricular fibrillation, non Brugada type;I49.0;
Autosomal dominant striatal neurodegeneration;G31.8;
Autosomal dominant Charcot-Marie-Tooth disease type 2N;G60.0;8C20.1
Autosomal dominant Charcot-Marie-Tooth disease type 2M;G60.0;8C20.1
Carnitine palmitoyl transferase II deficiency, myopathic form;E71.3;5C52.00
Carnitine palmitoyl transferase II deficiency, severe infantile form;E71.3;5C52.00
Carnitine palmitoyl transferase II deficiency, neonatal form;E71.3;5C52.00
CLN1 disease;;
CLN10 disease;;
CLN4A disease;;
CLN4B disease;;
CLN3 disease;;
CLN2 disease;;
CLN8 disease;;
CLN5 disease;;
CLN6 disease;;
CLN7 disease;;
Charcot-Marie-Tooth disease type 2B5;G60.0;8C20.1
5q14.3 microdeletion syndrome;Q93.5;LD44.50
Spondylo-megaepiphyseal-metaphyseal dysplasia;Q77.7;
Frontonasal dysplasia-alopecia-genital anomalies syndrome;Q87.0;
2q23.1 microdeletion syndrome;Q93.5;LD44.20
Polyvalvular heart disease syndrome;;
5q35 microduplication syndrome;Q92.3;LD41.40
Monocytopenia with susceptibility to infections;D72.8;
Syndromic multisystem autoimmune disease due to Itch deficiency;D89.8;4A43.Y
Classical-like Ehlers-Danlos syndrome type 1;Q79.6;LD28.1Y
Cardiac-valvular Ehlers-Danlos syndrome;Q79.6;LD28.1Y
Ehlers-Danlos/osteogenesis imperfecta syndrome;Q79.6;LD28.1Y
Ehlers-Danlos/osteogenesis imperfecta syndrome;Q79.6;LD28.1Y
Familial generalized lentiginosis;L81.4;EC23.0
Familial rhabdoid tumor;;
Familial rhabdoid tumor;;
Beckwith-Wiedemann syndrome due to imprinting defect of 11p15;Q87.3;LD2C
Beckwith-Wiedemann syndrome due to CDKN1C mutation;Q87.3;LD2C
Silver-Russell syndrome due to an imprinting defect of 11p15;Q87.1;LD2F.1Y
Silver-Russell syndrome due to 11p15 microduplication;Q87.1;LD2F.1Y
Combined immunodeficiency due to partial RAG1 deficiency;D81.8;4A01.1Y
Familial cerebral saccular aneurysm;I67.1;8B22.6
Familial cerebral saccular aneurysm;I67.1;8B22.6
Familial cerebral saccular aneurysm;I67.1;8B22.6
Familial cerebral saccular aneurysm;I67.1;8B22.6
Familial cerebral saccular aneurysm;I67.1;8B22.6
Usher syndrome type 1;H35.5;LD2H.4
Usher syndrome type 1;H35.5;LD2H.4
Usher syndrome type 1;H35.5;LD2H.4
Usher syndrome type 1;H35.5;LD2H.4
Usher syndrome type 1;H35.5;LD2H.4
Usher syndrome type 1;H35.5;LD2H.4
Usher syndrome type 1;H35.5;LD2H.4
Usher syndrome type 2;H35.5;LD2H.4
Usher syndrome type 2;H35.5;LD2H.4
Usher syndrome type 2;H35.5;LD2H.4
Usher syndrome type 2;H35.5;LD2H.4
Usher syndrome type 2;H35.5;LD2H.4
Usher syndrome type 3;H35.5;LD2H.4
Usher syndrome type 3;H35.5;LD2H.4
Usher syndrome type 3;H35.5;LD2H.4
Usher syndrome type 3;H35.5;LD2H.4
Beta-thalassemia major;D56.1;3A50.2
Beta-thalassemia intermedia;D56.1;3A50.2
Dominant beta-thalassemia;D56.1;3A50.2
Delta-beta-thalassemia;D56.2;3A50.3
Delta-beta-thalassemia;D56.2;3A50.3
Delta-beta-thalassemia;D56.2;3A50.3
Hemoglobin C-beta-thalassemia syndrome;D58.2;3A50.Y
Hemoglobin E-beta-thalassemia syndrome;D58.2;3A50.2
Beta-thalassemia-X-linked thrombocytopenia syndrome;D69.4;3A50.2
Alpha-thalassemia-myelodysplastic syndrome;D46.7;3A50.0Y
Alpha-thalassemia-myelodysplastic syndrome;D56.0;3A50.0Y
Hermansky-Pudlak syndrome due to BLOC-3 deficiency;E70.3;EC23.20
Hermansky-Pudlak syndrome due to BLOC-3 deficiency;E70.3;EC23.20
Hermansky-Pudlak syndrome due to BLOC-2 deficiency;E70.3;EC23.20
Hermansky-Pudlak syndrome due to BLOC-2 deficiency;E70.3;EC23.20
Hermansky-Pudlak syndrome due to BLOC-2 deficiency;E70.3;EC23.20
Hermansky-Pudlak syndrome due to BLOC-1 deficiency;E70.3;EC23.20
Hermansky-Pudlak syndrome due to BLOC-1 deficiency;E70.3;EC23.20
Hermansky-Pudlak syndrome due to BLOC-1 deficiency;E70.3;EC23.20
Hermansky-Pudlak syndrome due to BLOC-1 deficiency;E70.3;EC23.20
Autosomal dominant generalized dystrophic epidermolysis bullosa;Q81.2;
Isolated growth hormone deficiency type IA;E23.0;5A61.3
Isolated growth hormone deficiency type IA;E23.0;5A61.3
Isolated growth hormone deficiency type IB;E23.0;5A61.3
Isolated growth hormone deficiency type IB;E23.0;5A61.3
Isolated growth hormone deficiency type II;E23.0;5A61.3
Isolated growth hormone deficiency type II;E23.0;5A61.3
Non-acquired combined pituitary hormone deficiency-sensorineural hearing loss-spine abnormalities syndrome;E23.0;
AApoAII amyloidosis;E85.0;5D00.2Y
Severe X-linked mitochondrial encephalomyopathy;E88.8;5C53.23
15q11q13 microduplication syndrome;Q92.3;LD41.E
Infantile dystonia-parkinsonism;G24.8;8A02.12
SLC35A1-CDG;E77.8;5C54.2
Familial hypercholanemia;E88.8;
Familial hypercholanemia;E88.8;
Familial hypercholanemia;E88.8;
Familial hypercholanemia;E88.8;
Combined immunodeficiency due to CD27 deficiency;D47.9;
Atypical hypotonia-cystinuria syndrome;E72.0;GB90.40
Atypical hypotonia-cystinuria syndrome;E72.0;GB90.40
Atypical hypotonia-cystinuria syndrome;E72.0;GB90.40
Chuvash erythrocytosis;D75.1;3A80.0
Immune dysregulation-inflammatory bowel disease-arthritis-recurrent infections syndrome;K52.8;
Immune dysregulation-inflammatory bowel disease-arthritis-recurrent infections syndrome;K52.8;
Immune dysregulation-inflammatory bowel disease-arthritis-recurrent infections syndrome;K52.8;
Familial clubfoot due to 17q23.1q23.2 microduplication;Q66.8;LD41.G0
Beckwith-Wiedemann syndrome due to NSD1 mutation;Q87.3;LD2C
NON RARE IN EUROPE: Alzheimer disease;;
NON RARE IN EUROPE: Alzheimer disease;;
NON RARE IN EUROPE: Alzheimer disease;;
NON RARE IN EUROPE: Alzheimer disease;;
Isolated thyrotropin-releasing hormone deficiency;E03.1;5A00.01
Familial congenital mirror movements;G25.8;8A0Y
Familial congenital mirror movements;G25.8;8A0Y
Familial congenital mirror movements;G25.8;8A0Y
Familial congenital mirror movements;G25.8;8A0Y
Glaucoma secondary to spherophakia/ectopia lentis and megalocornea;Q15.8;
1q44 microdeletion syndrome;Q93.5;LD44.10
Classic progressive supranuclear palsy syndrome;G23.1;8A00.10
Progressive supranuclear palsy-parkinsonism syndrome;;
Progressive supranuclear palsy-pure akinesia with gait freezing syndrome;G23.1;8A00.10
Progressive supranuclear palsy-corticobasal syndrome;G23.1;8A00.10
Progressive supranuclear palsy-progressive non-fluent aphasia syndrome;G23.1;8A00.10
Nijmegen breakage syndrome-like disorder;Q87.8;4A01.31
Nijmegen breakage syndrome-like disorder;Q87.8;4A01.31
Dimethylglycine dehydrogenase deficiency;E72.5;
Acute fatty liver of pregnancy;O26.6;JA65.0
NON RARE IN EUROPE: Diabetes mellitus type 1;E10;
NON RARE IN EUROPE: Diabetes mellitus type 1;E10;
NON RARE IN EUROPE: Diabetes mellitus type 1;E10;
NON RARE IN EUROPE: Essential hypertension;I10;
NON RARE IN EUROPE: Essential hypertension;I10;
NON RARE IN EUROPE: Essential hypertension;I10;
NON RARE IN EUROPE: Essential hypertension;I10;
HELLP syndrome;O14.2;JA24.2
HELLP syndrome;O14.2;JA24.2
HELLP syndrome;O14.2;JA24.2
De novo thrombotic microangiopathy after kidney transplantation;M31.1;
De novo thrombotic microangiopathy after kidney transplantation;M31.1;
Biliary atresia with splenic malformation syndrome;Q44.2;
Dominant hypophosphatemia with nephrolithiasis or osteoporosis;N25.8;
Dominant hypophosphatemia with nephrolithiasis or osteoporosis;N25.8;
RFT1-CDG;E77.8;5C54.0
Progressive cerebello-cerebral atrophy;G31.8;
Progressive cerebello-cerebral atrophy;G31.8;
Hyperphosphatasia-intellectual disability syndrome;Q87.8;
Hyperphosphatasia-intellectual disability syndrome;Q87.8;
Hyperphosphatasia-intellectual disability syndrome;Q87.8;
Hyperphosphatasia-intellectual disability syndrome;Q87.8;
Hyperphosphatasia-intellectual disability syndrome;Q87.8;
Hyperphosphatasia-intellectual disability syndrome;Q87.8;
Hyperphosphatasia-intellectual disability syndrome;Q87.8;
Generalized pustular psoriasis;L40.1;EA90.40
Generalized pustular psoriasis;L40.1;EA90.40
Autosomal recessive secondary polycythemia not associated with VHL gene;D75.1;
Autosomal dominant secondary polycythemia;D75.1;
Autosomal dominant secondary polycythemia;D75.1;
Autosomal dominant secondary polycythemia;D75.1;
Autosomal dominant secondary polycythemia;D75.1;
Autosomal dominant secondary polycythemia;D75.1;
Autosomal dominant secondary polycythemia;D75.1;
Primary ciliary dyskinesia-retinitis pigmentosa syndrome;Q34.8;LA75.Y
Acute neonatal citrullinemia type I;E72.2;5C50.A3
Adult-onset citrullinemia type I;;
Citrullinemia type II;E72.2;5C50.A3
Neonatal intrahepatic cholestasis due to citrin deficiency;E72.2;5C50.A3
Juvenile primary lateral sclerosis;G12.2;
Juvenile primary lateral sclerosis;G12.2;
Perinatal lethal hypophosphatasia;E83.3;5C64.3
Prenatal benign hypophosphatasia;E83.3;5C64.3
Infantile hypophosphatasia;E83.3;5C64.3
Childhood-onset hypophosphatasia;E83.3;5C64.3
Adult hypophosphatasia;E83.3;5C64.3
Odontohypophosphatasia;E83.3;
Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations;I77.8;9B78.0
Multiple endocrine neoplasia type 2A;D44.8;2F7A.0
Multiple endocrine neoplasia type 2B;D44.8;2F7A.0
Müllerian aplasia and hyperandrogenism;Q51.8;
FTH1-related iron overload;E83.1;
Juvenile cataract-microcornea-renal glucosuria syndrome;E88.8;
MUTYH-related attenuated familial adenomatous polyposis;D12.6;2B90.Y
APC-related attenuated familial adenomatous polyposis;D12.6;2B90.Y
Autosomal recessive ataxia due to PEX10 deficiency;G11.8;
Ectodermal dysplasia-syndactyly syndrome;Q82.4;
Occult macular dystrophy;H35.5;9B75.Y
NLRP12-associated hereditary periodic fever syndrome;E85.0;4A60.Y
Juvenile Huntington disease;G10;
Isolated delta-storage pool disease;D69.1;3B62.3
Familial hypodysfibrinogenemia;D68.2;3B14.0
Familial hypodysfibrinogenemia;D68.2;3B14.0
Familial hypodysfibrinogenemia;D68.2;3B14.0
Isolated aniridia;Q13.1;LA11.3
Isolated aniridia;Q13.1;LA11.3
Isolated aniridia;Q13.1;LA11.3
Polymicrogyria with optic nerve hypoplasia;Q04.3;
AICA-ribosiduria;E79.8;5C55.0Y
Autosomal recessive Stickler syndrome;Q87.5;LD2F.1Y
Autosomal recessive Stickler syndrome;Q87.5;LD2F.1Y
Autosomal recessive Stickler syndrome;Q87.5;LD2F.1Y
Autosomal recessive Stickler syndrome;Q87.5;LD2F.1Y
Autosomal recessive Stickler syndrome;Q87.5;LD2F.1Y
2q32q33 microdeletion syndrome;Q93.5;LD44.20
SATB2-associated syndrome due to a chromosomal rearrangement;Q93.5;
6q25 microdeletion syndrome;;
7q31 microdeletion syndrome;Q93.5;LD44.70
8p11.2 deletion syndrome;Q93.5;LD44.81
8p23.1 microdeletion syndrome;Q93.5;LD44.81
Familial osteochondritis dissecans;M93.2;FB82.1
Familial hyperaldosteronism type III;E26.0;5A72.0
Microphthalmia-retinitis pigmentosa-foveoschisis-optic disc drusen syndrome;Q15.8;
Autosomal dominant spastic ataxia type 1;G11.4;8A03.1Y
Benign concentric annular macular dystrophy;H35.5;9B75.Y
Parietal foramina with clavicular hypoplasia;Q74.0;
Pigmented paravenous retinochoroidal atrophy;H35.5;9B7Y
Ataxia-telangiectasia-like disorder;G11.3;4A01.31
Sickle cell-beta-thalassemia disease syndrome;D57.2;3A51.3
Sickle cell-beta-thalassemia disease syndrome;D57.2;3A51.4
Sickle cell-hemoglobin C disease syndrome;D57.2;3A51.4
Sickle cell-hemoglobin C disease syndrome;D57.2;3A51.3
Sickle cell-hemoglobin D disease syndrome;D57.2;3A51.3
Sickle cell-hemoglobin E disease syndrome;D57.2;3A51.3
Hereditary persistence of fetal hemoglobin-sickle cell disease syndrome;D57.2;3A51.3
Hereditary persistence of fetal hemoglobin-sickle cell disease syndrome;D57.2;3A51.3
Hereditary persistence of fetal hemoglobin-sickle cell disease syndrome;D57.2;3A51.3
Hereditary persistence of fetal hemoglobin-sickle cell disease syndrome;D57.2;3A51.3
Hereditary persistence of fetal hemoglobin-sickle cell disease syndrome;D57.2;3A51.3
CK syndrome;Q87.0;
Localized junctional epidermolysis bullosa;Q81.8;EC31
Localized junctional epidermolysis bullosa;Q81.8;EC31
46,XY partial gonadal dysgenesis;Q56.1;LD2A.1
46,XY partial gonadal dysgenesis;Q56.1;LD2A.1
46,XY partial gonadal dysgenesis;Q56.1;LD2A.1
46,XY partial gonadal dysgenesis;Q56.1;LD2A.1
46,XY partial gonadal dysgenesis;Q56.1;LD2A.1
46,XY partial gonadal dysgenesis;Q56.1;LD2A.1
46,XY partial gonadal dysgenesis;Q56.1;LD2A.1
46,XY partial gonadal dysgenesis;Q56.1;LD2A.1
46,XY partial gonadal dysgenesis;Q56.1;LD2A.1
46,XY partial gonadal dysgenesis;Q56.1;LD2A.1
46,XY partial gonadal dysgenesis;Q56.1;LD2A.1
46,XY partial gonadal dysgenesis;Q56.1;LD2A.1
Hyperzincemia and hypercalprotectinemia;E83.2;
Gliosarcoma;C71.9;2A00.00
Gliosarcoma;C71.9;XH9RC8
Gliosarcoma;C71.9;2A00.00
Gliosarcoma;C71.9;XH9RC8
Gliosarcoma;C71.9;2A00.00
Gliosarcoma;C71.9;XH9RC8
Gliosarcoma;C71.9;2A00.00
Gliosarcoma;C71.9;XH9RC8
Gliosarcoma;C71.9;2A00.00
Gliosarcoma;C71.9;XH9RC8
Gliosarcoma;C71.9;2A00.00
Gliosarcoma;C71.9;XH9RC8
Gliosarcoma;C71.9;2A00.00
Gliosarcoma;C71.9;XH9RC8
Gliosarcoma;C71.9;2A00.00
Gliosarcoma;C71.9;XH9RC8
Gliosarcoma;C71.9;2A00.00
Gliosarcoma;C71.9;XH9RC8
Gliosarcoma;C71.9;2A00.00
Gliosarcoma;C71.9;XH9RC8
Gliosarcoma;C71.9;2A00.00
Gliosarcoma;C71.9;XH9RC8
Gliosarcoma;C71.9;2A00.00
Gliosarcoma;C71.9;XH9RC8
Giant cell glioblastoma;C71.9;2A00.00
Giant cell glioblastoma;C71.9;XH8UC5
Giant cell glioblastoma;C71.9;2A00.00
Giant cell glioblastoma;C71.9;XH8UC5
Giant cell glioblastoma;C71.9;2A00.00
Giant cell glioblastoma;C71.9;XH8UC5
Giant cell glioblastoma;C71.9;2A00.00
Giant cell glioblastoma;C71.9;XH8UC5
Giant cell glioblastoma;C71.9;2A00.00
Giant cell glioblastoma;C71.9;XH8UC5
Giant cell glioblastoma;C71.9;2A00.00
Giant cell glioblastoma;C71.9;XH8UC5
Giant cell glioblastoma;C71.9;2A00.00
Giant cell glioblastoma;C71.9;XH8UC5
Giant cell glioblastoma;C71.9;2A00.00
Giant cell glioblastoma;C71.9;XH8UC5
Giant cell glioblastoma;C71.9;2A00.00
Giant cell glioblastoma;C71.9;XH8UC5
Giant cell glioblastoma;C71.9;2A00.00
Giant cell glioblastoma;C71.9;XH8UC5
Giant cell glioblastoma;C71.9;2A00.00
Giant cell glioblastoma;C71.9;XH8UC5
Giant cell glioblastoma;C71.9;2A00.00
Giant cell glioblastoma;C71.9;XH8UC5
Anaplastic astrocytoma;C71.9;XH39Z7
Anaplastic astrocytoma;C71.9;XH96C7
Anaplastic astrocytoma;C71.9;XH7HQ6
Anaplastic astrocytoma;C71.9;2A00.0Y
Protoplasmic astrocytoma;C71.9;2A00.0Y
Protoplasmic astrocytoma;C71.9;XH6UV4
Fibrillary astrocytoma;C71.9;XH6C35
Fibrillary astrocytoma;C71.9;2A00.0Y
Gemistocytic astrocytoma;C71.9;XH5Y81
Gemistocytic astrocytoma;C71.9;2A00.0Y
Pilomyxoid astrocytoma;C71.9;XH29Q5
Pilomyxoid astrocytoma;C71.9;2A00.0Y
Pilomyxoid astrocytoma;C71.9;XH29Q5
Pilomyxoid astrocytoma;C71.9;2A00.0Y
Pilomyxoid astrocytoma;C71.9;XH29Q5
Pilomyxoid astrocytoma;C71.9;2A00.0Y
Pilomyxoid astrocytoma;C71.9;XH29Q5
Pilomyxoid astrocytoma;C71.9;2A00.0Y
Pilomyxoid astrocytoma;C71.9;XH29Q5
Pilomyxoid astrocytoma;C71.9;2A00.0Y
Pilomyxoid astrocytoma;C71.9;XH29Q5
Pilomyxoid astrocytoma;C71.9;2A00.0Y
Pilomyxoid astrocytoma;C71.9;XH29Q5
Pilomyxoid astrocytoma;C71.9;2A00.0Y
Oligodendroglioma;C71.9;2A00.0Y
Oligodendroglioma;C71.9;XH7W59
Oligodendroglioma;C71.9;XH7K31
Oligodendroglioma;C71.9;2A00.0Y
Oligodendroglioma;C71.9;XH7W59
Oligodendroglioma;C71.9;XH7K31
Anaplastic oligodendroglioma;C71.9;2A00.0Y
Anaplastic oligodendroglioma;C71.9;XH8844
Anaplastic oligodendroglioma;C71.9;XH9QF3
Anaplastic oligodendroglioma;C71.9;2A00.0Y
Anaplastic oligodendroglioma;C71.9;XH8844
Anaplastic oligodendroglioma;C71.9;XH9QF3
Ependymoma;D43.2;
Ependymoma;D43.2;
Oligoastrocytoma;C71.9;2A00.0Y
Anaplastic oligoastrocytoma;C71.9;2A00.0Y
Anaplastic oligoastrocytoma;C71.9;XH6F49
Angiocentric glioma;C71.9;2A00.0Y
Angiocentric glioma;C71.9;2A00.0Y
Medulloblastoma with extensive nodularity;C71.6;XH6JN6
Medulloblastoma with extensive nodularity;C71.6;2A00.10
Desmoplastic/nodular medulloblastoma;C71.6;XH7PN5
Desmoplastic/nodular medulloblastoma;C71.6;2A00.10
Choroid plexus carcinoma;C71.7;XH3M77
Choroid plexus carcinoma;C71.7;2A00.22
Malignant peripheral nerve sheath tumor with perineurial differentiation;C47.9;2C41
Malignant peripheral nerve sheath tumor with perineurial differentiation;C47.9;2C41
Constitutional mismatch repair deficiency syndrome;D80.8;
Constitutional mismatch repair deficiency syndrome;D80.8;
Constitutional mismatch repair deficiency syndrome;D80.8;
Constitutional mismatch repair deficiency syndrome;D80.8;
Melanoma and neural system tumor syndrome;D43;
Malignant triton tumor;C47.9;XH2VV8
Malignant triton tumor;C47.9;XH2VV8
Autosomal recessive intermediate Charcot-Marie-Tooth disease type B;G60.0;8C20.2
Autosomal recessive spastic ataxia-optic atrophy-dysarthria syndrome;E88.8;
Plectin-related limb-girdle muscular dystrophy R17;G71.0;
Temple syndrome due to paternal 14q32.2 microdeletion;Q93.5;LD44.E
Temple syndrome due to paternal 14q32.2 microdeletion;Q93.5;LD44.E
Kagami-Ogata syndrome due to maternal 14q32.2 microdeletion;Q93.5;LD44.E
Kagami-Ogata syndrome due to maternal 14q32.2 microdeletion;Q93.5;LD44.E
Temple syndrome due to paternal 14q32.2 hypomethylation;Q87.8;LD2Y
Temple syndrome due to paternal 14q32.2 hypomethylation;Q87.8;LD2Y
Kagami-Ogata syndrome due to maternal 14q32.2 hypermethylation;Q99.8;LD2Y
Kagami-Ogata syndrome due to maternal 14q32.2 hypermethylation;Q99.8;LD2Y
Complete hydatidiform mole;O01.0;JA02.0
Complete hydatidiform mole;O01.0;JA02.0
Complete hydatidiform mole;O01.0;JA02.0
Complete hydatidiform mole;O01.0;JA02.0
Partial hydatidiform mole;O01.1;JA02.1
Partial hydatidiform mole;O01.1;JA02.1
Genetic hyperferritinemia without iron overload;R77.8;
Mitochondrial myopathy with reversible cytochrome C oxidase deficiency;G71.3;8C73.Y
Mitochondrial DNA depletion syndrome, myopathic form;G71.3;5C53.20
Spinocerebellar ataxia with epilepsy;E88.8;5C53.21
Autosomal recessive progressive external ophthalmoplegia;H49.4;9C82.0
Autosomal recessive progressive external ophthalmoplegia;H49.4;9C82.0
Autosomal dominant progressive external ophthalmoplegia;H49.4;9C82.0
Autosomal dominant progressive external ophthalmoplegia;H49.4;9C82.0
Autosomal dominant progressive external ophthalmoplegia;H49.4;9C82.0
Autosomal dominant progressive external ophthalmoplegia;H49.4;9C82.0
Autosomal dominant progressive external ophthalmoplegia;H49.4;9C82.0
Deafness-encephaloneuropathy-obesity-valvulopathy syndrome;E88.8;5C53.22
Renal tubulopathy-encephalopathy-liver failure syndrome;E88.8;5C53.2Y
Isolated cytochrome C oxidase deficiency;E88.8;5C53.2Y
Isolated cytochrome C oxidase deficiency;E88.8;5C53.2Y
Isolated cytochrome C oxidase deficiency;E88.8;5C53.2Y
Isolated cytochrome C oxidase deficiency;E88.8;5C53.2Y
Isolated cytochrome C oxidase deficiency;E88.8;5C53.2Y
Isolated cytochrome C oxidase deficiency;E88.8;5C53.2Y
Isolated cytochrome C oxidase deficiency;E88.8;5C53.2Y
Isolated cytochrome C oxidase deficiency;E88.8;5C53.2Y
Isolated cytochrome C oxidase deficiency;E88.8;5C53.2Y
Isolated cytochrome C oxidase deficiency;E88.8;5C53.2Y
Isolated cytochrome C oxidase deficiency;E88.8;5C53.2Y
Isolated cytochrome C oxidase deficiency;E88.8;5C53.2Y
Isolated cytochrome C oxidase deficiency;E88.8;5C53.2Y
Isolated ATP synthase deficiency;E88.8;5C53.25
Isolated ATP synthase deficiency;E88.8;5C53.25
Isolated ATP synthase deficiency;E88.8;5C53.25
Isolated ATP synthase deficiency;E88.8;5C53.25
Isolated ATP synthase deficiency;E88.8;5C53.25
Isolated ATP synthase deficiency;E88.8;5C53.25
Isolated ATP synthase deficiency;E88.8;5C53.25
Isolated ATP synthase deficiency;E88.8;5C53.25
Combined oxidative phosphorylation defect type 2;E88.8;5C53.23
Combined oxidative phosphorylation defect type 4;E88.8;5C53.23
Combined oxidative phosphorylation defect type 7;E88.8;5C53.23
Adult-onset autosomal recessive sideroblastic anemia;D64.0;3A72.00
Pyruvate dehydrogenase E1-beta deficiency;E74.4;5C53.02
Pyruvate dehydrogenase E3-binding protein deficiency;E74.4;5C53.02
Mitochondrial DNA-associated Leigh syndrome;E88.8;8C73.Y
Mitochondrial DNA-associated Leigh syndrome;E88.8;8C73.Y
Mitochondrial DNA-associated Leigh syndrome;E88.8;8C73.Y
Mitochondrial DNA-associated Leigh syndrome;E88.8;8C73.Y
Mitochondrial DNA-associated Leigh syndrome;E88.8;8C73.Y
Mitochondrial DNA-associated Leigh syndrome;E88.8;8C73.Y
Mitochondrial DNA-associated Leigh syndrome;E88.8;8C73.Y
Navajo neurohepatopathy;E88.8;5C53.20
Mitochondrial DNA depletion syndrome, encephalomyopathic form with renal tubulopathy;G31.8;5C53.20
Leigh syndrome with leukodystrophy;;
Leigh syndrome with leukodystrophy;;
Leigh syndrome with leukodystrophy;;
Leigh syndrome with leukodystrophy;;
Leigh syndrome with leukodystrophy;;
Leigh syndrome with leukodystrophy;;
Leigh syndrome with leukodystrophy;;
Leigh syndrome with leukodystrophy;;
Leigh syndrome with leukodystrophy;;
Leigh syndrome with leukodystrophy;;
Leigh syndrome with leukodystrophy;;
Leigh syndrome with leukodystrophy;;
Leigh syndrome with leukodystrophy;;
Leigh syndrome with leukodystrophy;;
Leigh syndrome with leukodystrophy;;
Leigh syndrome with leukodystrophy;;
Leigh syndrome with leukodystrophy;;
Leigh syndrome with leukodystrophy;;
Leigh syndrome with leukodystrophy;;
Leigh syndrome with leukodystrophy;;
Leigh syndrome with leukodystrophy;;
Leigh syndrome with leukodystrophy;;
Leigh syndrome with leukodystrophy;;
Leigh syndrome with leukodystrophy;;
Leigh syndrome with leukodystrophy;;
Leigh syndrome with leukodystrophy;;
Leigh syndrome with leukodystrophy;;
Leigh syndrome with leukodystrophy;;
Leigh syndrome with nephrotic syndrome;;
Leigh syndrome with nephrotic syndrome;;
Autosomal recessive sideroblastic anemia;D64.0;3A72.00
Autosomal recessive sideroblastic anemia;D64.0;3A72.00
FOXG1 syndrome due to 14q12 microdeletion;Q93.5;LD44.E
15q11.2 microdeletion syndrome;Q93.5;LD44.F
15q11.2 microdeletion syndrome;Q93.5;LD44.F
15q11.2 microdeletion syndrome;Q93.5;LD44.F
15q14 microdeletion syndrome;;
Proximal 16p11.2 microdeletion syndrome;Q93.5;LD44.G1
Distal 16p11.2 microdeletion syndrome;Q93.5;LD44.G1
14q11.2 microduplication syndrome;Q92.3;LD41.D
16q24.3 microdeletion syndrome;Q93.5;LD44.G0
Distal 17p13.3 microdeletion syndrome;Q93.5;LD44.H1
17q12 microdeletion syndrome;Q93.5;LD44.H0
17q12 microdeletion syndrome;Q93.5;LD44.H0
17q23.1q23.2 microdeletion syndrome;Q93.5;LD44.H0
20p12.3 microdeletion syndrome;Q93.5;LD44.L1
21q22.11q22.12 microdeletion syndrome;Q93.5;LD44.M
Distal 22q11.2 microdeletion syndrome;Q93.5;LD44.NY
Distal 22q11.2 microdeletion syndrome;Q93.5;LD44.NY
Distal 22q11.2 microdeletion syndrome;Q93.5;LD44.NY
Xq27.3q28 duplication syndrome;Q99.8;LD51
Mowat-Wilson syndrome due to monosomy 2q22;Q43.1;LD2F.1Y
Mowat-Wilson syndrome due to a ZEB2 point mutation;Q43.1;LD2F.1Y
Familial adenomatous polyposis due to 5q22.2 microdeletion;D12.6;2B90.Y
Alagille syndrome due to 20p12 microdeletion;Q44.7;LB20.0Y
Alagille syndrome due to a JAG1 point mutation;Q44.7;LB20.0Y
Alagille syndrome due to a NOTCH2 point mutation;Q44.7;LB20.0Y
Okihiro syndrome due to 20q13 microdeletion;Q87.8;LD44.L0
Okihiro syndrome due to a point mutation;Q87.8;LD2F.1Y
Kleefstra syndrome due to a point mutation;Q87.8;LD2F.1Y
Kleefstra syndrome due to a point mutation;Q87.8;LD2F.1Y
Glycogen storage disease with severe cardiomyopathy due to glycogenin deficiency;E74.0;5C51.3
MRCS syndrome;H35.5;9E1Y
Infantile spasms-psychomotor retardation-progressive brain atrophy-basal ganglia disease syndrome;E88.8;
Hyperinsulinism due to HNF4A deficiency;;
Hyperinsulinism due to INSR deficiency;E16.1;
CHST3-related skeletal dysplasia;Q74.8;LD24.3
Spondyloepiphyseal dysplasia, Maroteaux type;;
COG5-CDG;E77.8;5C54.2
DPM3-CDG;E77.8;5C54.0
COG4-CDG;E77.8;5C54.2
COG1-CDG;E77.8;5C54.2
Progressive myoclonic epilepsy type 3;G40.3;8A61.41
Acute necrotizing encephalopathy of childhood;G31.8;
Acute necrotizing encephalopathy of childhood;G31.8;
Acral peeling skin syndrome;Q80.8;EC20.1
Acral peeling skin syndrome;Q80.8;EC20.1
Peeling skin syndrome type A;Q80.8;EC20.1
Peeling skin syndrome type A;Q80.8;EC20.1
Peeling skin syndrome type B;Q80.8;EC20.1
Familial multiple meningioma;D32.9;2A01.00
Familial multiple meningioma;D32.9;2A01.00
Familial multiple meningioma;D32.9;2A01.00
Familial multiple meningioma;D32.9;2A01.00
Familial multiple meningioma;D32.9;2A01.00
Glycogen storage disease due to liver phosphorylase kinase deficiency;E74.0;5C51.3
Glycogen storage disease due to liver phosphorylase kinase deficiency;E74.0;5C51.3
Hereditary pulmonary alveolar proteinosis;J84.0;CB04.31
Hereditary pulmonary alveolar proteinosis;J84.0;CB04.31
RAS-associated autoimmune leukoproliferative disease;D72.8;
RAS-associated autoimmune leukoproliferative disease;D72.8;
Spheroid body myopathy;G71.8;8C72.0Y
Classic maple syrup urine disease;E71.0;5C50.D0
Classic maple syrup urine disease;E71.0;5C50.D0
Classic maple syrup urine disease;E71.0;5C50.D0
Intermediate maple syrup urine disease;E71.0;5C50.D0
Intermediate maple syrup urine disease;E71.0;5C50.D0
Intermediate maple syrup urine disease;E71.0;5C50.D0
Intermediate maple syrup urine disease;E71.0;5C50.D0
Intermittent maple syrup urine disease;E71.0;5C50.D0
Intermittent maple syrup urine disease;E71.0;5C50.D0
Intermittent maple syrup urine disease;E71.0;5C50.D0
Thiamine-responsive maple syrup urine disease;E71.0;5C50.D0
Thiamine-responsive maple syrup urine disease;E71.0;5C50.D0
Thiamine-responsive maple syrup urine disease;E71.0;5C50.D0
DYRK1A-related intellectual disability syndrome due to 21q22.13q22.2 microdeletion;Q93.5;LD44.M
Total spina bifida aperta;;
Total spina bifida aperta;;
Total spina bifida aperta;;
Total spina bifida aperta;;
Total spina bifida aperta;;
Total spina bifida aperta;;
Thoracolumbosacral spina bifida aperta;;
Thoracolumbosacral spina bifida aperta;;
Thoracolumbosacral spina bifida aperta;;
Thoracolumbosacral spina bifida aperta;;
Thoracolumbosacral spina bifida aperta;;
Thoracolumbosacral spina bifida aperta;;
Lumbosacral spina bifida aperta;;
Lumbosacral spina bifida aperta;;
Lumbosacral spina bifida aperta;;
Lumbosacral spina bifida aperta;;
Lumbosacral spina bifida aperta;;
Lumbosacral spina bifida aperta;;
Cervical spina bifida aperta;;
Cervical spina bifida aperta;;
Cervical spina bifida aperta;;
Cervical spina bifida aperta;;
Cervical spina bifida aperta;;
Cervical spina bifida aperta;;
Cervicothoracic spina bifida aperta;;
Cervicothoracic spina bifida aperta;;
Cervicothoracic spina bifida aperta;;
Cervicothoracic spina bifida aperta;;
Cervicothoracic spina bifida aperta;;
Cervicothoracic spina bifida aperta;;
Upper thoracic spina bifida aperta;;
Upper thoracic spina bifida aperta;;
Upper thoracic spina bifida aperta;;
Upper thoracic spina bifida aperta;;
Upper thoracic spina bifida aperta;;
Upper thoracic spina bifida aperta;;
Total spina bifida cystica;;
Total spina bifida cystica;;
Total spina bifida cystica;;
Total spina bifida cystica;;
Total spina bifida cystica;;
Total spina bifida cystica;;
Thoracolumbosacral spina bifida cystica;;
Thoracolumbosacral spina bifida cystica;;
Thoracolumbosacral spina bifida cystica;;
Thoracolumbosacral spina bifida cystica;;
Thoracolumbosacral spina bifida cystica;;
Thoracolumbosacral spina bifida cystica;;
Lumbosacral spina bifida cystica;;
Lumbosacral spina bifida cystica;;
Lumbosacral spina bifida cystica;;
Lumbosacral spina bifida cystica;;
Lumbosacral spina bifida cystica;;
Lumbosacral spina bifida cystica;;
Cervical spina bifida cystica;;
Cervical spina bifida cystica;;
Cervical spina bifida cystica;;
Cervical spina bifida cystica;;
Cervical spina bifida cystica;;
Cervical spina bifida cystica;;
Cervicothoracic spina bifida cystica;;
Cervicothoracic spina bifida cystica;;
Cervicothoracic spina bifida cystica;;
Cervicothoracic spina bifida cystica;;
Cervicothoracic spina bifida cystica;;
Cervicothoracic spina bifida cystica;;
Upper thoracic spina bifida cystica;;
Upper thoracic spina bifida cystica;;
Upper thoracic spina bifida cystica;;
Upper thoracic spina bifida cystica;;
Upper thoracic spina bifida cystica;;
Upper thoracic spina bifida cystica;;
Occipital encephalocele;Q01.2;LA01
Arnold-Chiari malformation type I;Q07.0;LA07.4
Isolated megalencephaly;Q04.5;LA05.1
Isolated focal cortical dysplasia type Ia;Q04.8;LA05.51
Isolated focal cortical dysplasia type IIa;Q04.8;LA05.51
Isolated focal cortical dysplasia type IIa;Q04.8;LA05.51
Isolated focal cortical dysplasia type IIb;Q04.8;LA05.51
Isolated focal cortical dysplasia type IIb;Q04.8;LA05.51
Isolated focal cortical dysplasia type IIb;Q04.8;LA05.51
Isolated Dandy-Walker malformation with hydrocephalus;Q03.1;LA06.0
Isolated Dandy-Walker malformation with hydrocephalus;Q03.1;LA06.0
Isolated Dandy-Walker malformation without hydrocephalus;Q03.1;LA06.0
Isolated Dandy-Walker malformation without hydrocephalus;Q03.1;LA06.0
Isolated Dandy-Walker malformation without hydrocephalus;Q03.1;LA06.0
Congenital communicating hydrocephalus;Q03.8;
Congenital communicating hydrocephalus;Q03.8;
Congenital non-communicating hydrocephalus;Q03.1;8D64.1
Congenital non-communicating hydrocephalus;Q03.8;8D64.1
Autoimmune lymphoproliferative syndrome with recurrent viral infections;;
Preeclampsia;O14.2;JA24.0
Preeclampsia;O14.2;JA24.1
Preeclampsia;O14.2;JA24
Preeclampsia;O14.9;JA24.0
Preeclampsia;O14.9;JA24.1
Preeclampsia;O14.9;JA24
Preeclampsia;O14.0;JA24.0
Preeclampsia;O14.0;JA24.1
Preeclampsia;O14.0;JA24
Preeclampsia;O14.1;JA24.0
Preeclampsia;O14.1;JA24.1
Preeclampsia;O14.1;JA24
Preeclampsia;O14.2;JA24.0
Preeclampsia;O14.2;JA24.1
Preeclampsia;O14.2;JA24
Preeclampsia;O14.9;JA24.0
Preeclampsia;O14.9;JA24.1
Preeclampsia;O14.9;JA24
Preeclampsia;O14.0;JA24.0
Preeclampsia;O14.0;JA24.1
Preeclampsia;O14.0;JA24
Preeclampsia;O14.1;JA24.0
Preeclampsia;O14.1;JA24.1
Preeclampsia;O14.1;JA24
Preeclampsia;O14.2;JA24.0
Preeclampsia;O14.2;JA24.1
Preeclampsia;O14.2;JA24
Preeclampsia;O14.9;JA24.0
Preeclampsia;O14.9;JA24.1
Preeclampsia;O14.9;JA24
Preeclampsia;O14.0;JA24.0
Preeclampsia;O14.0;JA24.1
Preeclampsia;O14.0;JA24
Preeclampsia;O14.1;JA24.0
Preeclampsia;O14.1;JA24.1
Preeclampsia;O14.1;JA24
Heritable pulmonary arterial hypertension;I27.0;BB01.0
Heritable pulmonary arterial hypertension;I27.0;BB01.0
Heritable pulmonary arterial hypertension;I27.0;BB01.0
Heritable pulmonary arterial hypertension;I27.0;BB01.0
Heritable pulmonary arterial hypertension;I27.0;BB01.0
Heritable pulmonary arterial hypertension;I27.0;BB01.0
Heritable pulmonary arterial hypertension;I27.0;BB01.0
Heritable pulmonary arterial hypertension;I27.0;BB01.0
Drug- or toxin-induced pulmonary arterial hypertension;;
Pulmonary arterial hypertension associated with connective tissue disease;;
Behavioral variant of frontotemporal dementia;G31.0;6D83
Behavioral variant of frontotemporal dementia;G31.0;6D83
Behavioral variant of frontotemporal dementia;G31.0;6D83
Behavioral variant of frontotemporal dementia;G31.0;6D83
Behavioral variant of frontotemporal dementia;G31.0;6D83
Behavioral variant of frontotemporal dementia;G31.0;6D83
Behavioral variant of frontotemporal dementia;G31.0;6D83
Behavioral variant of frontotemporal dementia;G31.0;6D83
Behavioral variant of frontotemporal dementia;G31.0;6D83
Frontotemporal dementia with motor neuron disease;G31.0;6D83
Frontotemporal dementia with motor neuron disease;G31.0;6D83
Frontotemporal dementia with motor neuron disease;G31.0;6D83
Frontotemporal dementia with motor neuron disease;G31.0;6D83
Frontotemporal dementia with motor neuron disease;G31.0;6D83
Frontotemporal dementia with motor neuron disease;G31.0;6D83
Frontotemporal dementia with motor neuron disease;G31.0;6D83
Bile acid CoA ligase deficiency and defective amidation;K76.8;
Multiple endocrine neoplasia type 4;D44.8;2F7A.0
Spinocerebellar ataxia type 35;G11.8;8A03.16
Spinocerebellar ataxia type 36;G11.8;8A03.16
Mucopolysaccharidosis type 6, rapidly progressing;E76.2;5C56.33
Mucopolysaccharidosis type 6, slowly progressing;E76.2;5C56.33
Non-syndromic male infertility due to sperm motility disorder;N46;
Non-syndromic male infertility due to sperm motility disorder;N46;
Non-syndromic male infertility due to sperm motility disorder;N46;
Non-syndromic male infertility due to sperm motility disorder;N46;
Non-syndromic male infertility due to sperm motility disorder;N46;
Non-syndromic male infertility due to sperm motility disorder;N46;
Non-syndromic male infertility due to sperm motility disorder;N46;
Non-syndromic male infertility due to sperm motility disorder;N46;
Non-syndromic male infertility due to sperm motility disorder;N46;
Non-syndromic male infertility due to sperm motility disorder;N46;
Non-syndromic male infertility due to sperm motility disorder;N46;
Non-syndromic male infertility due to sperm motility disorder;N46;
Non-syndromic male infertility due to sperm motility disorder;N46;
Non-syndromic male infertility due to sperm motility disorder;N46;
Non-syndromic male infertility due to sperm motility disorder;N46;
Non-syndromic male infertility due to sperm motility disorder;N46;
Non-syndromic male infertility due to sperm motility disorder;N46;
Non-syndromic male infertility due to sperm motility disorder;N46;
Non-syndromic male infertility due to sperm motility disorder;N46;
Non-syndromic male infertility due to sperm motility disorder;N46;
Non-syndromic male infertility due to sperm motility disorder;N46;
Machado-Joseph disease type 1;G11.8;8A03.16
Machado-Joseph disease type 2;G11.8;8A03.16
Machado-Joseph disease type 3;G11.8;8A03.16
NON RARE IN EUROPE: Familial dysalbuminemic hyperthyroxinemia;;
Hemihyperplasia-multiple lipomatosis syndrome;Q87.3;
Familial multinodular goiter;E04.2;
Familial multinodular goiter;E04.2;
Hyperbiliverdinemia;K76.8;
Ogden syndrome;E34.8;
Lower motor neuron syndrome with late-adult onset;G12.1;8B60.Y
Hyperinsulinism due to UCP2 deficiency;E16.1;
Autosomal dominant hyperinsulinism due to SUR1 deficiency;E16.1;
Autosomal dominant hyperinsulinism due to Kir6.2 deficiency;E16.1;
Diazoxide-resistant focal hyperinsulinism due to SUR1 deficiency;E16.1;
Diazoxide-resistant focal hyperinsulinism due to Kir6.2 deficiency;E16.1;
Sporadic pheochromocytoma/secreting paraganglioma;D35.0;
Sporadic pheochromocytoma/secreting paraganglioma;C74.1;
Sporadic pheochromocytoma/secreting paraganglioma;D35.0;
Sporadic pheochromocytoma/secreting paraganglioma;C74.1;
Sporadic pheochromocytoma/secreting paraganglioma;D35.0;
Sporadic pheochromocytoma/secreting paraganglioma;C74.1;
Sporadic pheochromocytoma/secreting paraganglioma;D35.0;
Sporadic pheochromocytoma/secreting paraganglioma;C74.1;
Sporadic pheochromocytoma/secreting paraganglioma;D35.0;
Sporadic pheochromocytoma/secreting paraganglioma;C74.1;
Sporadic pheochromocytoma/secreting paraganglioma;D35.0;
Sporadic pheochromocytoma/secreting paraganglioma;C74.1;
Symptomatic form of Coffin-Lowry syndrome in female carriers;Q87.0;
Mitochondrial DNA depletion syndrome, hepatocerebral form due to DGUOK deficiency;E88.8;
Hereditary neutrophilia;D72.8;
ALG11-CDG;E77.8;5C54.0
NON RARE IN EUROPE: Paget disease of bone;;
NON RARE IN EUROPE: Paget disease of bone;;
NON RARE IN EUROPE: Paget disease of bone;;
Complement component 3 deficiency;D84.1;4A00.1Y
Severe combined immunodeficiency due to LCK deficiency;D81.1;4A01.10
Methylmalonic aciduria due to transcobalamin receptor defect;E71.1;
Septopreoptic holoprosencephaly;Q04.2;LA05.2
Septopreoptic holoprosencephaly;Q04.2;LA05.2
Septopreoptic holoprosencephaly;Q04.2;LA05.2
Septopreoptic holoprosencephaly;Q04.2;LA05.2
Septopreoptic holoprosencephaly;Q04.2;LA05.2
Septopreoptic holoprosencephaly;Q04.2;LA05.2
Septopreoptic holoprosencephaly;Q04.2;LA05.2
Septopreoptic holoprosencephaly;Q04.2;LA05.2
Septopreoptic holoprosencephaly;Q04.2;LA05.2
Septopreoptic holoprosencephaly;Q04.2;LA05.2
Septopreoptic holoprosencephaly;Q04.2;LA05.2
Septopreoptic holoprosencephaly;Q04.2;LA05.2
Septopreoptic holoprosencephaly;Q04.2;LA05.2
Septopreoptic holoprosencephaly;Q04.2;LA05.2
Septopreoptic holoprosencephaly;Q04.2;LA05.2
Microform holoprosencephaly;Q04.2;LA05.2
Microform holoprosencephaly;Q04.2;LA05.2
Microform holoprosencephaly;Q04.2;LA05.2
Microform holoprosencephaly;Q04.2;LA05.2
Microform holoprosencephaly;Q04.2;LA05.2
Microform holoprosencephaly;Q04.2;LA05.2
Microform holoprosencephaly;Q04.2;LA05.2
Microform holoprosencephaly;Q04.2;LA05.2
Microform holoprosencephaly;Q04.2;LA05.2
Microform holoprosencephaly;Q04.2;LA05.2
Microform holoprosencephaly;Q04.2;LA05.2
Microform holoprosencephaly;Q04.2;LA05.2
Microform holoprosencephaly;Q04.2;LA05.2
Microform holoprosencephaly;Q04.2;LA05.2
Microform holoprosencephaly;Q04.2;LA05.2
Microform holoprosencephaly;Q04.2;LA05.2
Pelizaeus-Merzbacher disease, connatal form;E75.2;8A44.0
Pelizaeus-Merzbacher disease, classic form;E75.2;8A44.0
Pelizaeus-Merzbacher disease, transitional form;E75.2;8A44.0
Pelizaeus-Merzbacher disease in female carriers;E75.2;8A44.0
Null syndrome;E75.2;8A44.0
Pelizaeus-Merzbacher-like disease due to GJC2 mutation;E75.2;LD90.2
Pelizaeus-Merzbacher-like disease due to HSPD1 mutation;E75.2;LD90.2
Pelizaeus-Merzbacher-like disease due to AIMP1 mutation;E75.2;LD90.2
Distal monosomy 12p;;
Alpha-dystroglycan-related limb-girdle muscular dystrophy R16;G71.0;
PLIN1-related familial partial lipodystrophy;E88.1;
Autosomal semi-dominant severe lipodystrophic laminopathy;E88.1;
Recessive intellectual disability-motor dysfunction-multiple joint contractures syndrome;Q68.8;
Familial Alzheimer-like prion disease;A81.8;8E02.3
Familial steroid-resistant nephrotic syndrome with sensorineural deafness;N04.8;
Fatal infantile hypertonic myofibrillar myopathy;G71.2;8C76
Warsaw breakage syndrome;Q87.8;LD2F.1Y
Nestor-Guillermo progeria syndrome;E34.8;
Chondrodysplasia with joint dislocations, gPAPP type;M85.0;
Hereditary sensorimotor neuropathy with hyperelastic skin;G60.0;8C20.0
Hemoglobinopathy Toms River;D58.2;
Progressive myoclonic epilepsy type 6;G40.3;8A61.41
Familial progressive hyper- and hypopigmentation;L81.8;EC23.Y
Multiple congenital anomalies-hypotonia-seizures syndrome;Q87.8;
Occipital pachygyria and polymicrogyria;Q04.3;
Acrodysostosis with multiple hormone resistance;;
Acrodysostosis with multiple hormone resistance;;
Autosomal recessive nail dysplasia;Q84.6;
Megaconial congenital muscular dystrophy;G71.2;8C70.6
Moyamoya angiopathy-short stature-facial dysmorphism-hypergonadotropic hypogonadism syndrome;Q87.8;LD2F.Y
Severe intellectual disability and progressive spastic paraplegia;G11.4;
Severe intellectual disability and progressive spastic paraplegia;G11.4;
Severe intellectual disability and progressive spastic paraplegia;G11.4;
Severe intellectual disability and progressive spastic paraplegia;G11.4;
Bullous diffuse cutaneous mastocytosis;Q82.2;2A21.1Y
Pseudoxanthomatous diffuse cutaneous mastocytosis;Q82.2;2A21.1Y
Syndromic recessive X-linked ichthyosis;Q80.1;
Self-improving collodion baby;Q80.2;EC20.02
Self-improving collodion baby;Q80.2;EC20.02
Self-improving collodion baby;Q80.2;EC20.02
Acral self-healing collodion baby;Q80.2;EC20.02
Annular epidermolytic ichthyosis;Q80.3;EC20.03
Annular epidermolytic ichthyosis;Q80.3;EC20.03
Congenital reticular ichthyosiform erythroderma;Q80.8;EC20.0Y
Congenital reticular ichthyosiform erythroderma;Q80.8;EC20.0Y
Keratosis linearis-ichthyosis congenita-sclerosing keratoderma syndrome;Q82.8;EC20.0Y
Inherited Creutzfeldt-Jakob disease;A81.0;8E02.0
NON RARE IN EUROPE: Rheumatoid arthritis;;
Larsen-like syndrome, B3GAT3 type;Q74.8;
Craniosynostosis-dental anomalies;Q87.0;
Facial dysmorphism-developmental delay-behavioral abnormalities syndrome due to 10p11.21p12.31 microdeletion;Q87.8;LD44.A1
Autosomal dominant Charcot-Marie-Tooth disease type 2O;G60.0;8C20.1
Familial retinal arterial macroaneurysm;H35.0;9B7Y
Autosomal recessive cerebellar ataxia-psychomotor delay syndrome;G11.1;
Autosomal recessive cerebellar ataxia-epilepsy-intellectual disability syndrome due to WWOX deficiency;G11.1;
Adult-onset autosomal recessive cerebellar ataxia;G11.2;
Childhood-onset autosomal recessive slowly progressive spinocerebellar ataxia;G11.1;
Pontocerebellar hypoplasia type 7;Q04.3;
Pontocerebellar hypoplasia type 7;Q04.3;
DICER1 tumor-predisposition syndrome;C34.8;
Glycerol kinase deficiency, juvenile form;E74.8;5C51.1
Glycerol kinase deficiency, adult form;E74.8;5C51.1
Phosphoserine aminotransferase deficiency, infantile/juvenile form;E72.8;
Glycogen storage disease due to lactate dehydrogenase M-subunit deficiency;E74.0;5C51.3
Glycogen storage disease due to lactate dehydrogenase H-subunit deficiency;E74.0;5C51.3
Marfan syndrome type 1;Q87.4;LD28.01
Marfan syndrome type 2;Q87.4;LD28.01
Neonatal Marfan syndrome;Q87.4;LD28.0Y
Aneurysm-osteoarthritis syndrome;Q87.8;LD28.0Y
Hypocalcemic vitamin D-dependent rickets;E55.0;5C63.20
Hypocalcemic vitamin D-dependent rickets;E55.0;5C63.20
Autosomal recessive hypophosphatemic rickets;E83.3;5C63.22
Autosomal recessive hypophosphatemic rickets;E83.3;5C63.22
Early-onset epileptic encephalopathy and intellectual disability due to GRIN2A mutation;E72.1;8A61.2Y
Hypermethioninemia encephalopathy due to adenosine kinase deficiency;E72.1;5C50.B
Developmental delay due to methylmalonate semialdehyde dehydrogenase deficiency;E71.1;5C50.E0
Familial vesicoureteral reflux;N13.7;GB56.5
Familial vesicoureteral reflux;N13.7;GB56.5
Familial vesicoureteral reflux;N13.7;GB56.5
Early-onset myopathy with fatal cardiomyopathy;G71.8;
Myosclerosis;G71.8;8C72.1
Isolated congenital adermatoglyphia;Q82.8;
Congenital cataract microcornea with corneal opacity;Q12.0;
Congenital cataract microcornea with corneal opacity;Q12.0;
Combined malonic and methylmalonic acidemia;E71.1;
12q15q21.1 microdeletion syndrome;Q93.5;
BAP1-related tumor predisposition syndrome;D23.9;
Inherited isolated adrenal insufficiency due to partial CYP11A1 deficiency;E27.1;
Mitochondrial membrane protein-associated neurodegeneration;G23.0;5C64.10
Exfoliative ichthyosis;Q80.8;EC20.02
Exfoliative ichthyosis;Q80.8;EC20.02
Hereditary arterial and articular multiple calcification syndrome;I77.8;
Glutathione synthetase deficiency with 5-oxoprolinuria;D55.1;3A10.0Y
Glutathione synthetase deficiency without 5-oxoprolinuria;D55.1;3A10.0Y
Neonatal glycine encephalopathy;E72.5;5C50.70
Neonatal glycine encephalopathy;E72.5;5C50.70
Neonatal glycine encephalopathy;E72.5;5C50.70
Infantile glycine encephalopathy;E72.5;5C50.70
Infantile glycine encephalopathy;E72.5;5C50.70
Infantile glycine encephalopathy;E72.5;5C50.70
Infantile glycine encephalopathy;E72.5;5C50.70
Atypical glycine encephalopathy;E72.5;5C50.70
Atypical glycine encephalopathy;E72.5;5C50.70
Atypical glycine encephalopathy;E72.5;5C50.70
Atypical glycine encephalopathy;E72.5;5C50.70
Hypermethioninemia due to glycine N-methyltransferase deficiency;E72.1;5C50.B
Vitamin B12-unresponsive methylmalonic acidemia type mut0;E71.1;5C50.E0
Familial clubfoot due to 5q31 microdeletion;Q66.8;LB98.Y
Familial clubfoot due to PITX1 point mutation;Q66.8;LB98.Y
Skin fragility-woolly hair-palmoplantar keratoderma syndrome;Q82.8;
Infantile-onset ascending hereditary spastic paralysis;G12.2;
Malignant migrating focal seizures of infancy;G40.0;8A61.12
Malignant migrating focal seizures of infancy;G40.0;8A61.12
Malignant migrating focal seizures of infancy;G40.0;8A61.12
Malignant migrating focal seizures of infancy;G40.0;8A61.12
Malignant migrating focal seizures of infancy;G40.0;8A61.12
Malignant migrating focal seizures of infancy;G40.0;8A61.12
Malignant migrating focal seizures of infancy;G40.0;8A61.12
Malignant migrating focal seizures of infancy;G40.0;8A61.12
Malignant migrating focal seizures of infancy;G40.0;8A61.12
Pleomorphic rhabdomyosarcoma;C49.9;
Pleomorphic rhabdomyosarcoma;C49.9;
Tetrahydrobiopterin-responsive hyperphenylalaninemia/phenylketonuria;E70.1;
Epithelial recurrent erosion dystrophy;H18.5;9A70.Y
Congenital hereditary endothelial dystrophy type II;H18.5;9A70.0
PYCR1-related De Barsy syndrome;Q87.8;
Blepharophimosis-intellectual disability syndrome, MKB type;Q87.8;
MITF-related melanoma and renal cell carcinoma predisposition syndrome;C43.9;
Congenital dyserythropoietic anemia type IV;D64.4;
3MC syndrome;Q87.8;LD2F.1Y
3MC syndrome;Q87.8;LD2F.1Y
3MC syndrome;Q87.8;LD2F.1Y
Hypoplastic pancreas-intestinal atresia-hypoplastic gallbladder syndrome;Q45.8;
Familial isolated arrhythmogenic ventricular dysplasia, left dominant form;;
Familial isolated arrhythmogenic ventricular dysplasia, left dominant form;;
Familial isolated arrhythmogenic ventricular dysplasia, left dominant form;;
Familial isolated arrhythmogenic ventricular dysplasia, left dominant form;;
Familial isolated arrhythmogenic ventricular dysplasia, left dominant form;;
Familial isolated arrhythmogenic ventricular dysplasia, left dominant form;;
Familial isolated arrhythmogenic ventricular dysplasia, left dominant form;;
Familial isolated arrhythmogenic ventricular dysplasia, left dominant form;;
Familial isolated arrhythmogenic ventricular dysplasia, left dominant form;;
Familial isolated arrhythmogenic ventricular dysplasia, left dominant form;;
Familial isolated arrhythmogenic ventricular dysplasia, left dominant form;;
Familial isolated arrhythmogenic ventricular dysplasia, left dominant form;;
Familial isolated arrhythmogenic ventricular dysplasia, biventricular form;;
Familial isolated arrhythmogenic ventricular dysplasia, biventricular form;;
Familial isolated arrhythmogenic ventricular dysplasia, biventricular form;;
Familial isolated arrhythmogenic ventricular dysplasia, biventricular form;;
Familial isolated arrhythmogenic ventricular dysplasia, biventricular form;;
Familial isolated arrhythmogenic ventricular dysplasia, biventricular form;;
Familial isolated arrhythmogenic ventricular dysplasia, biventricular form;;
Familial isolated arrhythmogenic ventricular dysplasia, biventricular form;;
Familial isolated arrhythmogenic ventricular dysplasia, biventricular form;;
Familial isolated arrhythmogenic ventricular dysplasia, biventricular form;;
Familial isolated arrhythmogenic ventricular dysplasia, biventricular form;;
Familial isolated arrhythmogenic ventricular dysplasia, biventricular form;;
Familial isolated arrhythmogenic ventricular dysplasia, right dominant form;;
Familial isolated arrhythmogenic ventricular dysplasia, right dominant form;;
Familial isolated arrhythmogenic ventricular dysplasia, right dominant form;;
Familial isolated arrhythmogenic ventricular dysplasia, right dominant form;;
Familial isolated arrhythmogenic ventricular dysplasia, right dominant form;;
Familial isolated arrhythmogenic ventricular dysplasia, right dominant form;;
Familial isolated arrhythmogenic ventricular dysplasia, right dominant form;;
Familial isolated arrhythmogenic ventricular dysplasia, right dominant form;;
Familial isolated arrhythmogenic ventricular dysplasia, right dominant form;;
Familial isolated arrhythmogenic ventricular dysplasia, right dominant form;;
Familial isolated arrhythmogenic ventricular dysplasia, right dominant form;;
Familial isolated arrhythmogenic ventricular dysplasia, right dominant form;;
Familial isolated arrhythmogenic ventricular dysplasia, right dominant form;;
Lethal occipital encephalocele-skeletal dysplasia syndrome;Q87.5;
1p21.3 microdeletion syndrome;Q93.5;LD44.11
Childhood encephalopathy due to thiamine pyrophosphokinase deficiency;G96.8;
Hypoinsulinemic hypoglycemia and body hemihypertrophy;Q87.3;
Deficiency in anterior pituitary function-variable immunodeficiency syndrome;E23.0;
Microcephaly-capillary malformation syndrome;Q87.8;LD2F.1Y
Neonatal inflammatory skin and bowel disease;D84.8;
Neonatal inflammatory skin and bowel disease;D84.8;
Renal-hepatic-pancreatic dysplasia;Q45.8;
Renal-hepatic-pancreatic dysplasia;Q45.8;
Zygodactyly type 3;Q70.0;LB79.Y
Zygodactyly type 3;Q70.1;LB79.Y
Zygodactyly type 3;Q70.2;LB79.Y
Zygodactyly type 3;Q70.3;LB79.Y
Synpolydactyly type 1;Q70.2;LB79.Y
Synpolydactyly type 1;Q70.0;LB79.Y
Synpolydactyly type 2;Q70.0;LB79.Y
Synpolydactyly type 2;Q70.2;LB79.Y
Congenital vertical talus, unilateral;Q66.8;LB98.4
Congenital vertical talus, bilateral;Q66.8;LB98.4
Macrodactyly of fingers, unilateral;Q74.0;LB97.0
Macrodactyly of toes, unilateral;Q74.2;LB97.1
Kyphoscoliotic Ehlers-Danlos syndrome due to FKBP22 deficiency;Q79.6;LD28.1Y
Connective tissue disorder due to lysyl hydroxylase-3 deficiency;M35.8;
Transient infantile hypertriglyceridemia and hepatosteatosis;K76.0;
Severe congenital hypochromic anemia with ringed sideroblasts;D64.0;3A72.00
Congenital cataract-hearing loss-severe developmental delay syndrome;E88.8;
Charcot-Marie-Tooth disease type 2P;G60.0;
Persistent polyclonal B-cell lymphocytosis;D72.8;
Nephrotic syndrome-epidermolysis bullosa-sensorineural deafness syndrome;N08.2;
Autosomal systemic lupus erythematosus;M32.8;
Autosomal systemic lupus erythematosus;M32.8;
Autosomal systemic lupus erythematosus;M32.8;
Autosomal systemic lupus erythematosus;M32.8;
Autosomal systemic lupus erythematosus;M32.8;
Autosomal systemic lupus erythematosus;M32.8;
PLCG2-associated antibody deficiency and immune dysregulation;L50.2;
Progeroid and marfanoid aspect-lipodystrophy syndrome;E88.1;
Multiple congenital anomalies-hypotonia-seizures syndrome type 2;Q87.8;
Pseudohypoaldosteronism type 2D;I15.1;BA04.Y
Pseudohypoaldosteronism type 2E;I15.1;BA04.Y
DDOST-CDG;E77.8;
Autosomal recessive infantile hypercalcemia;E83.5;
Autosomal recessive infantile hypercalcemia;E83.5;
Cortical dysgenesis with pontocerebellar hypoplasia due to TUBB3 mutation;Q04.3;
Polymicrogyria due to TUBB2B mutation;Q04.3;
Oligodontia-cancer predisposition syndrome;C19;LD27.0Y
Juvenile amyotrophic lateral sclerosis;G12.2;
Juvenile amyotrophic lateral sclerosis;G12.2;
Juvenile amyotrophic lateral sclerosis;G12.2;
Juvenile amyotrophic lateral sclerosis;G12.2;
Juvenile amyotrophic lateral sclerosis;G12.2;
Familial dilated cardiomyopathy with conduction defect due to LMNA mutation;I42.0;
Primary cutaneous anaplastic large cell lymphoma;C86.6;2B03.0
Primary cutaneous anaplastic large cell lymphoma;C86.6;2B03.0
Hairy cell leukemia variant;C91.4;2A82.3
ALK-positive anaplastic large cell lymphoma;C84.6;XH9484
ALK-positive anaplastic large cell lymphoma;C84.6;2A90.A
Interstitial lung disease-nephrotic syndrome-epidermolysis bullosa syndrome;J84.8;
Autosomal recessive spastic paraplegia type 48;G11.4;
Congenital hereditary facial paralysis-variable hearing loss syndrome;Q87.0;
Frontonasal dysplasia-severe microphthalmia-severe facial clefting syndrome;Q87.0;
Porencephaly-microcephaly-bilateral congenital cataract syndrome;Q07.8;
FADD-related immunodeficiency;D89.8;4A01.21
Primary microcephaly-epilepsy-permanent neonatal diabetes syndrome;Q02;
Primary microcephaly-epilepsy-permanent neonatal diabetes syndrome;Q02;
Sodium channelopathy-related small fiber neuropathy;;
Sodium channelopathy-related small fiber neuropathy;;
Sodium channelopathy-related small fiber neuropathy;;
X-linked complicated spastic paraplegia type 1;;
Familial normophosphatemic tumoral calcinosis;M11.2;5C64.5
Familial hyperphosphatemic tumoral calcinosis/Hyperphosphatemic hyperostosis syndrome;M11.2;
Familial hyperphosphatemic tumoral calcinosis/Hyperphosphatemic hyperostosis syndrome;M11.2;
Familial hyperphosphatemic tumoral calcinosis/Hyperphosphatemic hyperostosis syndrome;M11.2;
Kufor-Rakeb syndrome;G23.0;
Primary dystonia, DYT21 type;G24.1;
Methylcobalamin deficiency type cblDv1;E72.1;5C50.B
Sulfite oxidase deficiency due to molybdenum cofactor deficiency type A;E72.1;5C50.B
Sulfite oxidase deficiency due to molybdenum cofactor deficiency type B;E72.1;5C50.B
Sulfite oxidase deficiency due to molybdenum cofactor deficiency type C;E72.1;5C50.B
Autism-epilepsy syndrome due to branched chain ketoacid dehydrogenase kinase deficiency;E71.1;
Methylmalonic acidemia due to methylmalonyl-CoA epimerase deficiency;E71.1;5C50.E0
Vitamin B12-responsive methylmalonic acidemia, type cblDv2;E71.1;5C50.E0
Erythrocyte galactose epimerase deficiency;E74.2;5C51.4Y
Generalized galactose epimerase deficiency;E74.2;5C51.4Y
Glycogen storage disease due to acid maltase deficiency, infantile onset;E74.0;5C51.3
Glycogen storage disease due to glycogen branching enzyme deficiency, progressive hepatic form;E74.0;5C51.3
Glycogen storage disease due to glycogen branching enzyme deficiency, non progressive hepatic form;E74.0;5C51.3
Glycogen storage disease due to glycogen branching enzyme deficiency, fatal perinatal neuromuscular form;E74.0;5C51.3
Glycogen storage disease due to glycogen branching enzyme deficiency, congenital neuromuscular form;E74.0;5C51.3
Glycogen storage disease due to glycogen branching enzyme deficiency, childhood combined hepatic and myopathic form;E74.0;5C51.3
Glycogen storage disease due to glycogen branching enzyme deficiency, childhood neuromuscular form;E74.0;5C51.3
Glycogen storage disease due to glycogen branching enzyme deficiency, adult neuromuscular form;E74.0;5C51.3
Familial lipoprotein lipase deficiency;E78.3;5C80.1
Familial apolipoprotein C-II deficiency;E78.3;5C80.1
Sandhoff disease, infantile form;E75.0;5C56.00
Sandhoff disease, juvenile form;E75.0;5C56.00
Sandhoff disease, adult form;E75.0;5C56.00
Tay-Sachs disease, B variant, infantile form;;
Tay-Sachs disease, B variant, juvenile form;;
Tay-Sachs disease, B variant, adult form;;
Tay-Sachs disease, B1 variant;;
GM2 gangliosidosis, AB variant;E75.0;5C56.00
Atypical Gaucher disease due to saposin C deficiency;E75.2;5C56.0Y
Metachromatic leukodystrophy, late infantile form;E75.2;5C56.02
Metachromatic leukodystrophy, late infantile form;E75.2;5C56.02
Metachromatic leukodystrophy, juvenile form;E75.2;5C56.02
Metachromatic leukodystrophy, juvenile form;E75.2;5C56.02
Metachromatic leukodystrophy, adult form;E75.2;5C56.02
Metachromatic leukodystrophy, adult form;E75.2;5C56.02
Alpha-mannosidosis, infantile form;E77.1;5C56.21
Alpha-mannosidosis, adult form;E77.1;5C56.21
Mucopolysaccharidosis type 4A;E76.2;5C56.32
Mucopolysaccharidosis type 4B;E76.2;5C56.32
Free sialic acid storage disease, infantile form;E77.8;5C56.4
Intermediate severe Salla disease;E77.8;5C56.4
Salla disease;E77.8;
Rhizomelic chondrodysplasia punctata type 1;Q77.3;LD24.04
Rhizomelic chondrodysplasia punctata type 2;Q77.3;LD24.04
Rhizomelic chondrodysplasia punctata type 3;Q77.3;LD24.04
Cirrhosis-dystonia-polycythemia-hypermanganesemia syndrome;E88.8;
Early-onset spastic ataxia-myoclonic epilepsy-neuropathy syndrome;G11.4;
Jawad syndrome;Q87.8;
Retinal dystrophy-optic nerve edema-splenomegaly-anhidrosis-migraine headache syndrome;H35.8;
Hereditary diffuse leukoencephalopathy with axonal spheroids and pigmented glia;;
Hereditary diffuse leukoencephalopathy with axonal spheroids and pigmented glia;;
Coats plus syndrome;H35.0;
Coats plus syndrome;H35.0;
Familial cutaneous telangiectasia and oropharyngeal cancer predisposition syndrome;C10.9;
Infantile cerebellar-retinal degeneration;E88.8;
FGFR2-related bent bone dysplasia;M85.8;
12p12.1 microdeletion syndrome;Q93.5;
Developmental and speech delay due to SOX5 deficiency;Q87.8;
Gastric adenocarcinoma and proximal polyposis of the stomach;C16.9;
High bone mass osteogenesis imperfecta;Q78.0;
High bone mass osteogenesis imperfecta;Q78.0;
High bone mass osteogenesis imperfecta;Q78.0;
Leukoencephalopathy-thalamus and brainstem anomalies-high lactate syndrome;E88.8;
Chronic infantile diarrhea due to guanylate cyclase 2C overactivity;P78.3;
Intestinal obstruction in the newborn due to guanylate cyclase 2C deficiency;P76.0;
Hereditary sensory and autonomic neuropathy type 6;G60.8;
Short stature-onychodysplasia-facial dysmorphism-hypotrichosis syndrome;Q87.1;
Autosomal dominant aplasia and myelodysplasia;D61.0;
Autosomal dominant cerebellar ataxia-deafness-narcolepsy syndrome;G11.2;
Young adult-onset distal hereditary motor neuropathy;G12.2;
Young adult-onset distal hereditary motor neuropathy;G12.2;
Facial dysmorphism-ocular anomalies-osteopenia-intellectual disability-dental anomalies syndrome;Q87.5;
Chudley-McCullough syndrome;Q04.8;
Autosomal recessive spastic ataxia with leukoencephalopathy;E88.8;
CLN11 disease;;
ATP13A2-related juvenile neuronal ceroid lipofuscinosis;;
Mitochondrial hypertrophic cardiomyopathy with lactic acidosis due to MTO1 deficiency;E88.8;
Non-progressive cerebellar ataxia with intellectual disability;G11.0;
Non-progressive cerebellar ataxia with intellectual disability;G11.0;
Variant ABeta2M amyloidosis;E85.1;5D00.3
Severe neonatal hypotonia-seizures-encephalopathy syndrome due to 5q31.3 microdeletion;Q93.5;
Segmental progressive overgrowth syndrome with fibroadipose hyperplasia;Q87.3;
TMEM165-CDG;E77.8;
Cerebrofacioarticular syndrome;Q87.8;
Cerebrofacioarticular syndrome;Q87.8;
Combined immunodeficiency due to STK4 deficiency;D81.8;
Lethal arteriopathy syndrome due to fibulin-4 deficiency;Q28.8;
Atypical dentin dysplasia due to SMOC2 deficiency;K00.5;
Familial isolated pituitary adenoma;D35.2;
Familial isolated pituitary adenoma;D35.2;
Silent pituitary adenoma;D35.2;
Silent pituitary adenoma;D35.2;
Null pituitary adenoma;D35.2;
Null pituitary adenoma;D35.2;
SHOX-related short stature;Q87.1;
Short stature due to partial GHR deficiency;E34.3;
Short stature due to GHSR deficiency;E34.3;
Severe Canavan disease;E75.2;5C50.E1
Mild Canavan disease;E75.2;5C50.E1
Primary hypereosinophilic syndrome;D47.5;
Primary hypereosinophilic syndrome;D47.5;
Primary hypereosinophilic syndrome;D47.5;
Primary hypereosinophilic syndrome;D47.5;
Primary hypereosinophilic syndrome;D47.5;
X-linked non progressive cerebellar ataxia;G11.0;
Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, salt wasting form;E25.0;5A71.01
Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, simple virilizing form;E25.0;5A71.01
Severe combined immunodeficiency due to DNA-PKcs deficiency;D81.1;4A01.10
Combined immunodeficiency due to ORAI1 deficiency;D81.8;4A01.1Y
Combined immunodeficiency due to STIM1 deficiency;D81.8;4A01.1Y
Pancytopenia due to IKZF1 mutations;D81.8;4A01.1Y
X-linked immunodeficiency with magnesium defect, Epstein-Barr virus infection and neoplasia;;
Congenital myopathy with internal nuclei and atypical cores;G71.2;
Wiedemann-Steiner syndrome;Q87.1;
Familial cortical myoclonus;G25.3;
Diencephalic-mesencephalic junction dysplasia;Q04.8;
Autosomal recessive spastic paraplegia type 53;G11.4;
Papillary renal cell carcinoma;C64;2C90.Y
Papillary renal cell carcinoma;C64;2C90.Y
Chromophobe renal cell carcinoma;C64;
MiT family translocation renal cell carcinoma;C64;
MiT family translocation renal cell carcinoma;C64;
MiT family translocation renal cell carcinoma;C64;
MiT family translocation renal cell carcinoma;C64;
MiT family translocation renal cell carcinoma;C64;
MiT family translocation renal cell carcinoma;C64;
MiT family translocation renal cell carcinoma;C64;
Autosomal recessive myogenic arthrogryposis multiplex congenita;Q74.3;
Carney complex-trismus-pseudocamptodactyly syndrome;Q68.8;
Inherited cancer-predisposing syndrome due to biallelic BRCA2 mutations;D61.0;
Inherited acute myeloid leukemia;C92.0;
Inherited acute myeloid leukemia;C92.0;
Inherited acute myeloid leukemia;C92.0;
Inherited acute myeloid leukemia;C92.0;
Acute myeloid leukemia with CEBPA somatic mutations;C92.0;
Familial papillary or follicular thyroid carcinoma;C73;
Familial papillary or follicular thyroid carcinoma;C73;
Familial papillary or follicular thyroid carcinoma;C73;
Combined oxidative phosphorylation defect type 8;E88.8;5C53.23
Combined oxidative phosphorylation defect type 9;E88.8;5C53.23
Combined oxidative phosphorylation defect type 13;E88.8;5C53.23
Combined oxidative phosphorylation defect type 14;E88.8;5C53.23
Combined oxidative phosphorylation defect type 15;E88.8;5C53.23
Mendelian susceptibility to mycobacterial diseases due to complete IFNgammaR2 deficiency;D84.8;4A00.2
Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency;D84.8;4A00.2
Mendelian susceptibility to mycobacterial diseases due to complete IL12B deficiency;D84.8;4A00.2
Mendelian susceptibility to mycobacterial diseases due to complete ISG15 deficiency;D84.8;4A00.2
Autosomal recessive mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR1 deficiency;D84.8;4A00.2
Autosomal recessive mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR2 deficiency;D84.8;4A00.2
Autosomal dominant mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR1 deficiency;D84.8;4A00.2
Autosomal dominant mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR2 deficiency;D84.8;4A00.2
Mendelian susceptibility to mycobacterial diseases due to partial STAT1 deficiency;D84.8;4A00.2
Mendelian susceptibility to mycobacterial diseases due to partial IRF8 deficiency;D84.8;4A00.2
X-linked mendelian susceptibility to mycobacterial diseases due to IKBKG deficiency;D84.8;4A00.2
X-linked mendelian susceptibility to mycobacterial diseases due to CYBB deficiency;D84.8;4A00.2
Amyloidosis cutis dyschromia;E85.4+;
Amyloidosis cutis dyschromia;L99.0*;
Retinal macular dystrophy type 2;H35.5;
PGM1-CDG;E77.8;5C54.0
Constitutional megaloblastic anemia with severe neurologic disease;D52.8;3A02.Y
Alazami syndrome;Q87.1;
Microcephalic primordial dwarfism, Dauber type;Q87.1;
Encephalopathy-hypertrophic cardiomyopathy-renal tubular disease syndrome;E88.8;
NON RARE IN EUROPE: Lactase non-persistence in adulthood;;
NON RARE IN EUROPE: Lactase non-persistence in adulthood;;
NON RARE IN EUROPE: Partial color blindness, protan type;;
NON RARE IN EUROPE: Partial color blindness, deutan type;;
NON RARE IN EUROPE: Parkinson disease;G20;
MT-ATP6-related mitochondrial spastic paraplegia;G11.4;8B44.0Y
Autosomal recessive spastic paraplegia type 43;G11.4;8B44.01
Autosomal recessive spastic paraplegia type 55;G11.4;8B44.01
Autosomal recessive spastic paraplegia type 54;G11.4;8B44.01
Hereditary sensory and autonomic neuropathy due to TECPR2 mutation;G11.4;8C21.Y
Autosomal recessive spastic paraplegia type 46;G11.4;8B44.01
Autosomal recessive spastic paraplegia type 45;G11.4;8B44.01
Autosomal recessive spastic paraplegia type 44;G11.4;8B44.01
Spastic paraplegia-optic atrophy-neuropathy syndrome;G11.4;8B44.01
Spastic paraplegia-optic atrophy-neuropathy syndrome;G11.4;8B44.01
Autosomal recessive spastic paraplegia type 56;G11.4;8B44.01
Autosomal recessive congenital cerebellar ataxia due to MGLUR1 deficiency;G11.1;5C50.Y
Early-onset Lafora body disease;G40.3;8A61.41
T-cell immunodeficiency with epidermodysplasia verruciformis;D84.8;
Multiple paragangliomas associated with polycythemia;D75.1;
Sinoatrial node dysfunction and deafness;H91.8;
X-linked intellectual disability-cardiomegaly-congestive heart failure syndrome;Q87.8;LD90
ALG13-CDG;E77.8;5C54.0
Autosomal recessive axonal neuropathy with neuromyotonia;G60.0;
Autoinflammation-PLCG2-associated antibody deficiency-immune dysregulation;D89.8;
Combined oxidative phosphorylation defect type 11;E88.8;
Hypopigmentation-punctate palmoplantar keratoderma syndrome;Q82.8;
Pontocerebellar hypoplasia type 8;Q04.3;
Hyperinsulinism due to HNF1A deficiency;E16.1;
Benign Samaritan congenital myopathy;G71.2;
Autosomal dominant intermediate Charcot-Marie-Tooth disease with neuropathic pain;G60.0;8C20.2
Familial dyskinesia and facial myokymia;G51.4;
X-linked cleft palate and ankyloglossia;Q38.6;
Classic multiminicore myopathy;G71.2;8C72.0Y
Classic multiminicore myopathy;G71.2;8C72.0Y
Classic multiminicore myopathy;G71.2;8C72.0Y
Autosomal dominant Charcot-Marie-Tooth disease type 2 due to KIF5A mutation;G60.0;
ABetaL34V amyloidosis;E85.4+;8B22.3
ABetaL34V amyloidosis;I68.0*;8B22.3
ABeta amyloidosis, Iowa type;E85.4+;8B22.3
ABeta amyloidosis, Iowa type;I68.0*;8B22.3
ABeta amyloidosis, Italian type;I68.0*;8B22.3
ABeta amyloidosis, Italian type;E85.4+;8B22.3
ABetaA21G amyloidosis;E85.4+;8B22.3
ABetaA21G amyloidosis;I68.0*;8B22.3
ABeta amyloidosis, Arctic type;E85.4+;8B22.3
ABeta amyloidosis, Arctic type;I68.0*;8B22.3
SRD5A3-CDG;E77.8;5C54.0
Proteasome-associated autoinflammatory syndrome;D89.8;
Leydig cell hypoplasia due to LHB deficiency;Q56.1;LD2A.3
Classic congenital lipoid adrenal hyperplasia due to STAR deficency;E25.0;5A71.01
Non-classic congenital lipoid adrenal hyperplasia due to STAR deficency;E25.0;5A71.01
Autoinflammatory syndrome with pyogenic bacterial infection and amylopectinosis;D89.8;
Autoinflammatory syndrome with pyogenic bacterial infection and amylopectinosis;D89.8;
Congenital muscular dystrophy with intellectual disability and severe epilepsy;E77.8;
Tall stature-long halluces-multiple extra-epiphyses syndrome;Q87.3;LD2C
Developmental delay with autism spectrum disorder and gait instability;F84.8;
Autosomal dominant neovascular inflammatory vitreoretinopathy;H35.2;
Cerebral sinovenous thrombosis;I67.6;8B22
Cerebral sinovenous thrombosis;I67.6;8B22
Cerebral sinovenous thrombosis;I67.6;8B22
Intellectual disability-craniofacial dysmorphism-cryptorchidism syndrome;;
Microcephalic primordial dwarfism due to ZNF335 deficiency;Q87.1;
X-linked central congenital hypothyroidism with late-onset testicular enlargement;E03.1;
Congenital chronic diarrhea with protein-losing enteropathy;K52.8;
Congenital chronic diarrhea with protein-losing enteropathy;K52.8;
Severe early-onset obesity-insulin resistance syndrome due to SH2B1 deficiency;E66.8;5B81.Y
Autosomal dominant Charcot-Marie-Tooth disease type 2Q;G60.0;
Beta-propeller protein-associated neurodegeneration;G23.0;
Fatty acid hydroxylase-associated neurodegeneration;G23.0;
Adult-onset multiple mitochondrial DNA deletion syndrome due to DGUOK deficiency;G71.3;
Thrombocythemia with distal limb defects;Q87.2;
Adult-onset chronic progressive external ophthalmoplegia with mitochondrial myopathy;G71.3;
Adult-onset chronic progressive external ophthalmoplegia with mitochondrial myopathy;G71.3;
Distal arthrogryposis type 5D;Q68.8;
Autosomal dominant focal dystonia, DYT25 type;G24.1;
Acute megakaryoblastic leukemia without Down syndrome;;
Acute megakaryoblastic leukemia without Down syndrome;;
Spastic paraplegia-Paget disease of bone syndrome;G11.4;
Adult-onset distal myopathy due to VCP mutation;G71.0;
Lipoprotein glomerulopathy;N07.8;MF82
5p13 microduplication syndrome;Q92.3;
Immunoglobulin-mediated membranoproliferative glomerulonephritis;N03.5;
Immunoglobulin-mediated membranoproliferative glomerulonephritis;N03.5;
C3 glomerulonephritis;N03.5;MF8Y
C3 glomerulonephritis;N03.5;MF8Y
C3 glomerulonephritis;N03.5;MF8Y
C3 glomerulonephritis;N03.5;MF8Y
Intermittent hydrarthrosis;M12.4;FA27.4
Intermittent hydrarthrosis;M12.4;FA27.4
Generalized juvenile polyposis/juvenile polyposis coli;D12.6;2B90.Y
Generalized juvenile polyposis/juvenile polyposis coli;D12.6;2B90.Y
Generalized juvenile polyposis/juvenile polyposis coli;D12.6;2B90.Y
Hemoglobin Lepore-beta-thalassemia syndrome;D56.8;
Hemoglobin Lepore-beta-thalassemia syndrome;D56.8;
Hemoglobin M disease;D74.0;3A92
Hemoglobin M disease;D74.0;3A92
Hemoglobin M disease;D74.0;3A92
DNM1L-related encephalopathy due to mitochondrial and peroxisomal fission defect;E88.8;LD2E
DNM1L-related encephalopathy due to mitochondrial and peroxisomal fission defect;E88.8;5C5Y
Congenital cataract-progressive muscular hypotonia-hearing loss-developmental delay syndrome;G71.3;
Autosomal recessive severe congenital neutropenia due to G6PC3 deficiency;D70.0;
Immunodeficiency due to MASP-2 deficiency;D84.1;4A00.1Y
Immunodeficiency due to ficolin3 deficiency;D84.1;4A00.1Y
Severe combined immunodeficiency due to complete RAG1/2 deficiency;D81.1;
Severe combined immunodeficiency due to complete RAG1/2 deficiency;D81.1;
Susceptibility to infection due to TYK2 deficiency;D82.4;
MEGDEL syndrome;E71.1;
Congenital ichthyosis-intellectual disability-spastic quadriplegia syndrome;Q80.8;
Spectrin-associated autosomal recessive cerebellar ataxia;G11.1;
Progressive external ophthalmoplegia-myopathy-emaciation syndrome;G71.3;
DNA2-related mitochondrial DNA deletion syndrome;G71.3;
ISPD-related limb-girdle muscular dystrophy R20;G71.0;
Autism spectrum disorder due to AUTS2 deficiency;F84.1;
Intellectual disability-obesity-brain malformations-facial dysmorphism syndrome;Q04.8;
Infantile hypertrophic cardiomyopathy due to MRPL44 deficiency;E88.8;
Bainbridge-Ropers syndrome;Q87.0;
Familial infantile myoclonic epilepsy;G40.3;
Familial infantile myoclonic epilepsy;G40.3;
Focal epilepsy-intellectual disability-cerebro-cerebellar malformation;Q04.8;
Progressive myoclonic epilepsy with dystonia;G40.3;
Autosomal recessive cerebellar ataxia with late-onset spasticity;G11.8;
Brain dopamine-serotonin vesicular transport disease;G25.8;
Early-onset progressive neurodegeneration-blindness-ataxia-spasticity syndrome;G31.8;
Corneal intraepithelial dyskeratosis-palmoplantar hyperkeratosis-laryngeal dyskeratosis syndrome;Q82.8;
Neurodevelopmental disorder-craniofacial dysmorphism-cardiac defect-skeletal anomalies syndrome due to 9q21.3 microdeletion;Q93.5;
Autosomal dominant intermediate Charcot-Marie-Tooth disease type F;G60.0;8C20.2
X-linked Charcot-Marie-Tooth disease type 6;G60.0;
Cobblestone lissencephaly without muscular or ocular involvement;Q04.3;
CLN13 disease;;
Facial dysmorphism-immunodeficiency-livedo-short stature syndrome;Q87.1;
Progressive retinal dystrophy due to retinol transport defect;H35.5;
Attenuated Chédiak-Higashi syndrome;E70.3;
Minimal pigment oculocutaneous albinism type 1;E70.3;EC23.20
Temperature-sensitive oculocutaneous albinism type 1;E70.3;EC23.20
Oculocutaneous albinism type 7;E70.3;EC23.20
Epileptic encephalopathy with global cerebral demyelination;E88.8;5C53.30
Familial primary localized cutaneous amyloidosis;E85.4+;
Familial primary localized cutaneous amyloidosis;L99.0*;
Familial primary localized cutaneous amyloidosis;E85.4+;
Familial primary localized cutaneous amyloidosis;L99.0*;
NON RARE IN EUROPE: Primary adult open-angle glaucoma;H40.1;
NON RARE IN EUROPE: Primary adult open-angle glaucoma;H40.1;
NON RARE IN EUROPE: Primary adult open-angle glaucoma;H40.1;
NON RARE IN EUROPE: Primary adult open-angle glaucoma;H40.1;
NON RARE IN EUROPE: Primary adult open-angle glaucoma;H40.1;
Rubinstein-Taybi syndrome due to CREBBP mutations;Q87.2;
Rubinstein-Taybi syndrome due to 16p13.3 microdeletion;Q87.2;LD44.G1
Rubinstein-Taybi syndrome due to EP300 haploinsufficiency;Q87.2;
Pyruvate carboxylase deficiency, infantile type;E74.4;5C53.03
Pyruvate carboxylase deficiency, severe neonatal type;E74.4;5C53.03
Pyruvate carboxylase deficiency, benign type;E74.4;5C53.03
Congenital myasthenic syndromes with glycosylation defect;G70.2;8C61
Congenital myasthenic syndromes with glycosylation defect;G70.2;8C61
Congenital myasthenic syndromes with glycosylation defect;G70.2;8C61
Congenital myasthenic syndromes with glycosylation defect;G70.2;8C61
Congenital myasthenic syndromes with glycosylation defect;G70.2;8C61
SLC35A2-CDG;E77.8;5C54.2
D,L-2-hydroxyglutaric aciduria;E72.8;5C50.E1
ANK3-related intellectual disability-sleep disturbance syndrome;G93.8;
Hemolytic uremic syndrome with DGKE deficiency;D58.8;
Hereditary retinoblastoma;C69.2;2D02.2
Hereditary retinoblastoma;C69.2;2D02.2
Non-hereditary retinoblastoma;C69.2;2D02.2
Non-hereditary retinoblastoma;C69.2;2D02.2
Amyotrophic lateral sclerosis type 4;G12.2;8B60.0
Autosomal recessive cutis laxa type 2B;Q82.8;LD28.2
Autosomal recessive cutis laxa type 2, classic type;Q82.8;
Autosomal recessive cutis laxa type 2, classic type;Q82.8;
Autosomal recessive cutis laxa type 2, classic type;Q82.8;
Severe combined immunodeficiency due to CARD11 deficiency;D81.9;
Combined immunodeficiency due to IL21R deficiency;D81.8;
High myopia-sensorineural deafness syndrome;H90.5;
Severe neurodegenerative syndrome with lipodystrophy;G31.8;
Fetal akinesia-cerebral and retinal hemorrhage syndrome;G71.2;
Hypomyelination with brain stem and spinal cord involvement and leg spasticity;E75.2;
Temtamy preaxial brachydactyly syndrome;Q87.2;
Multiple mitochondrial dysfunctions syndrome type 3;E88.8;
Autosomal recessive congenital cerebellar ataxia due to GRID2 deficiency;G11.1;
THOC6-related developmental delay-microcephaly-facial dysmorphism syndrome;Q87.0;
BICD2-related autosomal dominant childhood-onset proximal spinal muscular atrophy;G12.1;
Non-seminomatous germ cell tumor of testis;C62.1;
Non-seminomatous germ cell tumor of testis;C62.1;
Hypohidrosis-enamel hypoplasia-palmoplantar keratoderma-intellectual disability syndrome;Q82.8;
Intellectual disability-strabismus syndrome;H50.8;
Mitochondrial DNA depletion syndrome, hepatocerebrorenal form;E88.8;5C53.20
Leukoencephalopathy with mild cerebellar ataxia and white matter edema;E75.2;
Acute encephalopathy with biphasic seizures and late reduced diffusion;G40.4;
CTCF-related neurodevelopmental disorder;Q87.8;
LMNA-related cardiocutaneous progeria syndrome;E34.8;
GMPPB-related limb-girdle muscular dystrophy R19;G71.2;
Mandibular hypoplasia-deafness-progeroid features-lipodystrophy syndrome;E34.8;
X-linked parkinsonism-spasticity syndrome;G20;
Acroosteolysis-keloid-like lesions-premature aging syndrome;E34.8;
Childhood-onset autosomal recessive myopathy with external ophthalmoplegia;G71.2;
Severe intellectual disability-poor language-strabismus-grimacing face-long fingers syndrome;Q87.8;
Hyperuricemia-pulmonary hypertension-renal failure-alkalosis syndrome;E88.8;
Neurofibromatosis type 1 due to NF1 mutation or intragenic deletion;Q85.0;
Spinocerebellar ataxia type 37;G11.8;8A03.16
Alexander disease type I;G93.8;8A44.2
Alexander disease type II;G93.8;
X-linked dyserythropoietic anemia with abnormal platelets and neutropenia;D64.4;
17q21.31 microdeletion syndrome;Q93.5;LD44.H0
Koolen-De Vries syndrome due to a point mutation;Q87.8;LD24.GY
Autosomal recessive cerebral atrophy;G31.8;
Noonan syndrome-like disorder with juvenile myelomonocytic leukemia;C93.3;
Charcot-Marie-Tooth disease type 4B3;G60.0;
Familial benign flecked retina;H35.5;
Ichthyosis-short stature-brachydactyly-microspherophakia syndrome;Q87.8;
Ichthyosis-short stature-brachydactyly-microspherophakia syndrome;Q87.8;
Non-immune hydrops fetalis;P83.2;KC41.1
Non-immune hydrops fetalis;P83.2;KC41.1
X-linked intellectual disability due to GRIA3 mutations;F72;LD90
ALK-positive large B-cell lymphoma;C83.3;XH1EB9
ALK-positive large B-cell lymphoma;C83.3;2A81.8
Severe early-childhood-onset retinal dystrophy;H35.5;
Severe early-childhood-onset retinal dystrophy;H35.5;
Severe early-childhood-onset retinal dystrophy;H35.5;
Severe early-childhood-onset retinal dystrophy;H35.5;
Infantile epileptic-dyskinetic encephalopathy;G40.4;
Intellectual disability-seizures-hypophosphatasia-ophthalmic-skeletal anomalies syndrome;Q87.8;
TRAPPC11-related limb-girdle muscular dystrophy R18;G71.0;
Intellectual disability-hyperkinetic movement-truncal ataxia syndrome;G25.5;
Congenital neutropenia-myelofibrosis-nephromegaly syndrome;D70;
Congenital neutropenia-myelofibrosis-nephromegaly syndrome;D70;
Congenital sideroblastic anemia-B-cell immunodeficiency-periodic fever-developmental delay syndrome;D64.0;
Autosomal recessive intermediate Charcot-Marie-Tooth disease type C;G60.0;
Obesity due to SIM1 deficiency;E66.8;5B81.Y
2p21 microdeletion syndrome without cystinuria;Q93.5;
2p21 microdeletion syndrome without cystinuria;Q93.5;
Developmental delay-facial dysmorphism syndrome due to MED13L deficiency;Q87.8;
Mitochondrial DNA depletion syndrome, encephalomyopathic form with variable craniofacial anomalies;E88.8;
Combined oxidative phosphorylation defect type 17;E88.8;
Pontocerebellar hypoplasia type 9;Q04.3;
Primary hyperaldosteronism-seizures-neurological abnormalities syndrome;E26.0;
Severe motor and intellectual disabilities-sensorineural deafness-dystonia syndrome;Q87.8;
CADDS;Q87.8;
CADDS;Q87.8;
Methylmalonic acidemia with homocystinuria, type cblJ;E71.1;5C50.E0
Methylmalonic acidemia with homocystinuria, type cblX;E71.1;5C50.E0
Microcornea-myopic chorioretinal atrophy-telecanthus syndrome;Q15.8;
Severe dermatitis-multiple allergies-metabolic wasting syndrome;Q82.8;
Severe dermatitis-multiple allergies-metabolic wasting syndrome;Q82.8;
Diffuse palmoplantar keratoderma with painful fissures;Q82.8;
Focal palmoplantar keratoderma with joint keratoses;Q82.8;
Ataxia-intellectual disability-oculomotor apraxia-cerebellar cysts syndrome;G11.1;
"Acute myeloid leukemia with t(8;16)(p11;p13) translocation";C92.0;
"Acute myeloid leukemia with t(8;16)(p11;p13) translocation";C92.0;
Acute infantile liver failure-multisystemic involvement syndrome;K72.0;
Oculocutaneous albinism type 6;E70.3;EC23.20
Ataxia-telangiectasia variant;G11.3;
Extraskeletal Ewing sarcoma;C49.9;2B52.Y
Extraskeletal Ewing sarcoma;C49.9;2B52.Y
Extraskeletal Ewing sarcoma;C49.9;2B52.Y
Extraskeletal Ewing sarcoma;C49.9;2B52.Y
Peripheral primitive neuroectodermal tumor;C71.9;
Small cell carcinoma of the ovary;C56;
STT3A-CDG;E77.8;5C54.0
STT3B-CDG;E77.8;5C54.0
SSR4-CDG;E77.8;5C54.0
XYLT1-CDG;E77.8;5C54.1
GM3 synthase deficiency;E77.8;5C54.Y
Autism spectrum disorder-epilepsy-arthrogryposis syndrome;Q87.8;5C54.0
Congenital muscular dystrophy with cerebellar involvement;G71.2;8C70.6
Congenital muscular dystrophy with cerebellar involvement;G71.2;8C70.6
Congenital muscular dystrophy with cerebellar involvement;G71.2;8C70.6
Congenital muscular dystrophy with cerebellar involvement;G71.2;8C70.6
Congenital muscular dystrophy with cerebellar involvement;G71.2;8C70.6
Congenital muscular dystrophy with cerebellar involvement;G71.2;8C70.6
Congenital muscular dystrophy with intellectual disability;G71.2;
Congenital muscular dystrophy with intellectual disability;G71.2;
Congenital muscular dystrophy with intellectual disability;G71.2;
Congenital muscular dystrophy with intellectual disability;G71.2;
Congenital muscular dystrophy with intellectual disability;G71.2;
Congenital muscular dystrophy without intellectual disability;G71.2;
Congenital muscular dystrophy without intellectual disability;G71.2;
Congenital muscular dystrophy without intellectual disability;G71.2;
Congenital muscular dystrophy without intellectual disability;G71.2;
Muscle-eye-brain disease with bilateral multicystic leucodystrophy;G71.0;
Hypotonia-speech impairment-severe cognitive delay syndrome;Q87.8;
Hypotonia-speech impairment-severe cognitive delay syndrome;Q87.8;
Multicentric osteolysis-nodulosis-arthropathy spectrum;M89.5;
Multicentric osteolysis-nodulosis-arthropathy spectrum;M89.5;
Severe intellectual disability-short stature-behavioral abnormalities-facial dysmorphism syndrome;Q87.8;
Susceptibility to viral and mycobacterial infections due to STAT1 deficiency;D84.8;
Infantile-onset mesial temporal lobe epilepsy with severe cognitive regression;G40.2;
East Texas bleeding disorder;D68.2;3B14.Z
X-linked osteoporosis with fractures;M80.5;
Fatal post-viral neurodegenerative disorder;G04.8;
Growth and developmental delay-hypotonia-vision impairment-lactic acidosis syndrome;E88.8;
SURF1-related Charcot-Marie-Tooth disease type 4;G60.0;
Growth retardation-mild developmental delay-chronic hepatitis syndrome;K73.8;
Intellectual disability-severe speech delay-mild dysmorphism syndrome;F79;
Congenital microcephaly-severe encephalopathy-progressive cerebral atrophy syndrome;E72.8;
Familial episodic pain syndrome with predominantly upper body involvement;M79.6;MG31.Y
Familial episodic pain syndrome with predominantly lower limb involvement;M79.6;MG31.Y
Hereditary sensory and autonomic neuropathy type 7;G60.8;
Primary microcephaly-mild intellectual disability-young-onset diabetes syndrome;Q87.8;
Primary microcephaly-mild intellectual disability-young-onset diabetes syndrome;Q87.8;
Atypical juvenile parkinsonism;G20;
Atypical juvenile parkinsonism;G20;
Atypical juvenile parkinsonism;G20;
HSD10 disease, infantile type;E72.8;5C52.01
HSD10 disease, neonatal type;E72.8;5C52.01
Frontorhiny;Q75.8;
Autoimmune enteropathy and endocrinopathy-susceptibility to chronic infections syndrome;;
Autoimmune enteropathy and endocrinopathy-susceptibility to chronic infections syndrome;;
Adult-onset myasthenia gravis;G70.0;8C60
Adult-onset myasthenia gravis;G70.0;8C60
Adult-onset myasthenia gravis;G70.0;8C60
Feingold syndrome type 1;Q87.8;LD2F.1Y
Feingold syndrome type 2;Q87.8;LD2F.1Y
Homozygous familial hypercholesterolemia;E78.0;5C80.00
Homozygous familial hypercholesterolemia;E78.0;5C80.00
Homozygous familial hypercholesterolemia;E78.0;5C80.00
Homozygous familial hypercholesterolemia;E78.0;5C80.00
Homozygous familial hypercholesterolemia;E78.0;5C80.00
Homozygous familial hypercholesterolemia;E78.0;5C80.00
Short stature-optic atrophy-Pelger-Huët anomaly syndrome;Q87.1;
Multiple acyl-CoA dehydrogenase deficiency, severe neonatal type;E71.3;5C52.01
Multiple acyl-CoA dehydrogenase deficiency, severe neonatal type;E71.3;5C52.01
Multiple acyl-CoA dehydrogenase deficiency, severe neonatal type;E71.3;5C52.01
Multiple acyl-CoA dehydrogenase deficiency, severe neonatal type;E71.3;5C52.01
Multiple acyl-CoA dehydrogenase deficiency, mild type;E71.3;5C52.01
Multiple acyl-CoA dehydrogenase deficiency, mild type;E71.3;5C52.01
Multiple acyl-CoA dehydrogenase deficiency, mild type;E71.3;5C52.01
Multiple acyl-CoA dehydrogenase deficiency, mild type;E71.3;5C52.01
Multiple acyl-CoA dehydrogenase deficiency, mild type;E71.3;5C52.01
Silver-Russell syndrome due to a point mutation;Q87.1;LD2F.1Y
Silver-Russell syndrome due to a point mutation;Q87.1;LD2F.1Y
Silver-Russell syndrome due to a point mutation;Q87.1;LD2F.1Y
Silver-Russell syndrome due to a point mutation;Q87.1;LD2F.1Y
Severe neonatal lactic acidosis due to NFS1-ISD11 complex deficiency;E88.8;
Severe neonatal lactic acidosis due to NFS1-ISD11 complex deficiency;E88.8;
Activated PI3K-delta syndrome;D81.8;
Activated PI3K-delta syndrome;D81.8;
Activated PI3K-delta syndrome;D81.8;
PrP systemic amyloidosis;G60.8;
Macrocephaly-developmental delay syndrome;Q75.3;
Obesity due to CEP19 deficiency;E66.8;5B81.Y
Foveal hypoplasia-optic nerve decussation defect-anterior segment dysgenesis syndrome;Q15.8;
Short stature-auditory canal atresia-mandibular hypoplasia-skeletal anomalies syndrome;Q87.1;
Familial hyperprolactinemia;E22.1;
Hereditary isolated aplastic anemia;D61.0;3A70.0
Hereditary isolated aplastic anemia;D61.0;3A70.0
Hereditary isolated aplastic anemia;D61.0;3A70.0
Intellectual disability-coarse face-macrocephaly-cerebellar hypotrophy syndrome;Q87.8;
Joubert syndrome with Jeune asphyxiating thoracic dystrophy;Q04.3;
Joubert syndrome with Jeune asphyxiating thoracic dystrophy;Q04.3;
COASY protein-associated neurodegeneration;G23.0;
Autosomal dominant Charcot-Marie-Tooth disease type 2U;G60.0;
Peripheral neuropathy-myopathy-hoarseness-hearing loss syndrome;G60.0;
Periodic paralysis with later-onset distal motor neuropathy;G72.3;
Periodic paralysis with later-onset distal motor neuropathy;G72.3;
Periodic paralysis with transient compartment-like syndrome;G72.3;
Retinal dystrophy with inner retinal dysfunction and ganglion cell anomalies;H35.5;
Severe combined immunodeficiency due to IKK2 deficiency;D81.2;
Ferro-cerebro-cutaneous syndrome;G23.0;
Sacral agenesis-abnormal ossification of the vertebral bodies-persistent notochordal canal syndrome;Q87.5;
Severe intellectual disability-progressive postnatal microcephaly-midline stereotypic hand movements syndrome;Q87.8;
Polyglucosan body myopathy type 1;E74.0;
MAN1B1-CDG;E77.8;
Autosomal spastic paraplegia type 58;G11.4;
Microcephaly-thin corpus callosum-intellectual disability syndrome;Q87.8;
TCR-alpha-beta-positive T-cell deficiency;D81.8;
Combined immunodeficiency due to MALT1 deficiency;D81.8;
Charcot-Marie-Tooth disease type 2R;G60.0;
MAGEL2-related Prader-Willi-like syndrome;Q87.1;
SIM1-related Prader-Willi-like syndrome;Q87.1;
Hereditary cryohydrocytosis with normal stomatin;D58.8;
Focal facial dermal dysplasia type IV;Q82.8;LD27.0Y
Alpha-B crystallin-related late-onset myopathy;G71.0;
KLHL9-related early-onset distal myopathy;G71.0;
Distal anoctaminopathy;G71.0;
Distal nebulin myopathy;G71.0;
Male infertility with azoospermia or oligozoospermia due to single gene mutation;N46;
Male infertility with azoospermia or oligozoospermia due to single gene mutation;N46;
Male infertility with azoospermia or oligozoospermia due to single gene mutation;N46;
Male infertility with azoospermia or oligozoospermia due to single gene mutation;N46;
Male infertility with azoospermia or oligozoospermia due to single gene mutation;N46;
Male infertility with azoospermia or oligozoospermia due to single gene mutation;N46;
Male infertility with azoospermia or oligozoospermia due to single gene mutation;N46;
Male infertility with azoospermia or oligozoospermia due to single gene mutation;N46;
Male infertility with azoospermia or oligozoospermia due to single gene mutation;N46;
Male infertility with azoospermia or oligozoospermia due to single gene mutation;N46;
Male infertility with azoospermia or oligozoospermia due to single gene mutation;N46;
Male infertility with azoospermia or oligozoospermia due to single gene mutation;N46;
Male infertility with azoospermia or oligozoospermia due to single gene mutation;N46;
Male infertility with azoospermia or oligozoospermia due to single gene mutation;N46;
Male infertility with azoospermia or oligozoospermia due to single gene mutation;N46;
Male infertility with azoospermia or oligozoospermia due to single gene mutation;N46;
Male infertility with azoospermia or oligozoospermia due to single gene mutation;N46;
Male infertility with azoospermia or oligozoospermia due to single gene mutation;N46;
Male infertility with teratozoospermia due to single gene mutation;N46;
Pancytopenia-developmental delay syndrome;D61.0;
Proximal myopathy with extrapyramidal signs;G71.3;
Optic atrophy-intellectual disability syndrome;H47.2;
Autosomal recessive spastic paraplegia type 61;G11.4;8B44.01
Autosomal recessive spastic paraplegia type 62;G11.4;8B44.01
Autosomal recessive spastic paraplegia type 59;G11.4;8B44.01
Autosomal recessive spastic paraplegia type 60;G11.4;8B44.01
Autosomal recessive spastic paraplegia type 63;G11.4;8B44.01
Autosomal recessive spastic paraplegia type 64;G11.4;8B44.01
Autosomal recessive spastic paraplegia type 66;G11.4;8B44.01
Autosomal recessive spastic paraplegia type 67;G11.4;8B44.01
Autosomal recessive spastic paraplegia type 69;G11.4;8B44.01
Autosomal recessive spastic paraplegia type 70;G11.4;8B44.01
Autosomal recessive spastic paraplegia type 71;G11.4;8B44.01
Autosomal spastic paraplegia type 72;G11.4;8B44.00
Autosomal spastic paraplegia type 72;G11.4;8B44.01
Lipoic acid synthetase deficiency;E88.8;
Lipoyl transferase 1 deficiency;E88.8;
Childhood-onset spasticity with hyperglycinemia;E88.8;
Multiple mitochondrial dysfunctions syndrome type 1;E88.8;5C53.21
Multiple mitochondrial dysfunctions syndrome type 2;E88.8;5C53.21
Huntington disease-like syndrome due to C9ORF72 expansions;G10;
AXIN2-related attenuated familial adenomatous polyposis;D12.6;2B90.Y
Fibrolamellar hepatocellular carcinoma;C22.0;XH9Q35
Fibrolamellar hepatocellular carcinoma;C22.0;2C12.02
Fibrolamellar hepatocellular carcinoma;C22.0;XH9Q35
Fibrolamellar hepatocellular carcinoma;C22.0;2C12.02
Moyamoya disease with early-onset achalasia;I67.5;
Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency;E74.8;
Partial corpus callosum agenesis-cerebellar vermis hypoplasia with posterior fossa cysts syndrome;Q04.3;
Autosomal dominant Charcot-Marie-Tooth disease type 2 with giant axons;G60.0;
MEND syndrome;Q87.8;
Autosomal recessive spondylometaphyseal dysplasia, Mégarbané type;Q77.8;
1p31p32 microdeletion syndrome;Q93.5;
Karyomegalic interstitial nephritis;N11.8;
Autosomal dominant focal non-epidermolytic palmoplantar keratoderma with plantar blistering;Q82.8;
"Acute myeloid leukemia with t(6;9)(p23;q34)";C92.0;
"Acute myeloid leukemia with t(6;9)(p23;q34)";C92.0;
"Acute myeloid leukemia with t(9;11)(p22;q23)";C92.0;
"Acute myeloid leukemia with t(9;11)(p22;q23)";C92.0;
"Acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2)";C92.0;
"Acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2)";C92.0;
"Megakaryoblastic acute myeloid leukemia with t(1;22)(p13;q13)";C94.2;
"Megakaryoblastic acute myeloid leukemia with t(1;22)(p13;q13)";C94.2;
Acute myeloid leukemia with NPM1 somatic mutations;C92.0;
Autosomal recessive distal renal tubular acidosis;N25.8;
Autosomal recessive distal renal tubular acidosis;N25.8;
Autosomal recessive distal renal tubular acidosis;N25.8;
Autosomal recessive distal renal tubular acidosis;N25.8;
Familial bicuspid aortic valve;Q23.1;
Familial bicuspid aortic valve;Q23.1;
Familial bicuspid aortic valve;Q23.1;
Familial bicuspid aortic valve;Q23.1;
Progressive myoclonic epilepsy type 5;G40.3;
Progressive myoclonic epilepsy type 5;G40.3;
Infantile cerebral and cerebellar atrophy with postnatal progressive microcephaly;Q04.3;
Diffuse cerebral and cerebellar atrophy-intractable seizures-progressive microcephaly syndrome;G98;
Intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency;Q87.0;
Tatton-Brown-Rahman syndrome;Q87.3;LD2C
ADNP syndrome;Q87.0;
FBLN1-related developmental delay-central nervous system anomaly-syndactyly syndrome;Q87.8;
Alacrimia-choreoathetosis-liver dysfunction syndrome;E77.8;
Multisystemic smooth muscle dysfunction syndrome;I73.8;
Female infertility due to zona pellucida defect;N97.8;
Female infertility due to zona pellucida defect;N97.8;
Female infertility due to zona pellucida defect;N97.8;
Severe intellectual disability-progressive spastic diplegia syndrome;G80.1;
Global developmental delay-lung cysts-overgrowth-Wilms tumor syndrome;Q87.3;LD2C
Autosomal recessive cerebellar ataxia-epilepsy-intellectual disability syndrome due to TUD deficiency;G11.1;
Autosomal recessive cerebellar ataxia-epilepsy-intellectual disability syndrome due to RUBCN deficiency;G11.1;
Chondromyxoid fibroma;D16.9;
Clear cell papillary renal cell carcinoma;C64;
Clear cell papillary renal cell carcinoma;C64;
Clear cell papillary renal cell carcinoma;C64;
Clear cell papillary renal cell carcinoma;C64;
Spinal muscular atrophy with respiratory distress type 2;G12.2;
DITRA;L40.1;
Vasculitis due to ADA2 deficiency;D89.89;
Familial atypical multiple mole melanoma syndrome;C43.9;
Pontocerebellar hypoplasia type 10;Q04.3;
Angelman syndrome due to a point mutation;Q93.5;LD90.0
Angelman syndrome due to imprinting defect in 15q11-q13;Q93.5;LD90.0
Angelman syndrome due to imprinting defect in 15q11-q13;Q93.5;LD90.0
Angelman syndrome due to imprinting defect in 15q11-q13;Q93.5;LD90.0
NON RARE IN EUROPE: Melanoma;;
NON RARE IN EUROPE: Melanoma;;
Mild phosphoribosylpyrophosphate synthetase superactivity;E79.8;5C55.0Y
Severe phosphoribosylpyrophosphate synthetase superactivity;E79.8;5C55.0Y
Wolfram-like syndrome;E34.8;
Hereditary late-onset Parkinson disease;G20;
Hereditary late-onset Parkinson disease;G20;
Hereditary late-onset Parkinson disease;G20;
Hereditary late-onset Parkinson disease;G20;
Hereditary late-onset Parkinson disease;G20;
Hereditary late-onset Parkinson disease;G20;
Hereditary late-onset Parkinson disease;G20;
Infantile nephropathic cystinosis;E72.0+;5C60.1
Infantile nephropathic cystinosis;N16.3*;5C60.1
Juvenile nephropathic cystinosis;E72.0+;5C60.1
Juvenile nephropathic cystinosis;N16.3*;5C60.1
Ocular cystinosis;E72.0;
Maternal riboflavin deficiency;P00.4;
Familial isolated trichomegaly;Q84.2;LD27.0Y
NON RARE IN EUROPE: Metabolic syndrome;;
NON RARE IN EUROPE: Metabolic syndrome;;
NON RARE IN EUROPE: Metabolic syndrome;;
Early-onset epileptic encephalopathy-cortical blindness-intellectual disability-facial dysmorphism syndrome;G40.4;
Facial dysmorphism-lens dislocation-anterior segment abnormalities-spontaneous filtering blebs syndrome;Q87.0;
Autosomal recessive cerebellar ataxia due to STUB1 deficiency;G11.1;
PRKAR1B-related neurodegenerative dementia with intermediate filaments;G31.8;
AHDC1-related intellectual disability-obstructive sleep apnea-mild dysmorphism syndrome;Q87.8;
Epidermolysis bullosa simplex due to BP230 deficiency;Q81.0;EC30
Epidermolysis bullosa simplex due to exophilin 5 deficiency;Q81.0;
Primary failure of tooth eruption;K00.8;
Malan overgrowth syndrome;Q87.3;LD2C
Glycogen storage disease due to acid maltase deficiency, late-onset;E74.0;5C51.3
Cranio-cervical dystonia with laryngeal and upper-limb involvement;G24.8;
Adult-onset cervical dystonia, DYT23 type;G24.8;
Temple-Baraitser syndrome;Q87.2;
Bleeding disorder due to CalDAG-GEFI deficiency;D69.1;
Severe combined immunodeficiency due to CTPS1 deficiency;D81.2;
Postaxial polydactyly-anterior pituitary anomalies-facial dysmorphism syndrome;Q87.8;
Transient myeloproliferative syndrome;D47.7;2A60.40
Woolly hair-palmoplantar keratoderma syndrome;Q82.8;
Autosomal recessive severe congenital neutropenia due to CXCR2 deficiency;D70;
Autosomal recessive severe congenital neutropenia due to CSF3R deficiency;D70;
Combined oxidative phosphorylation defect type 20;E88.8;5C53.23
Combined oxidative phosphorylation defect type 21;E88.8;5C53.23
RIDDLE syndrome;D82.8;
Hereditary clear cell renal cell carcinoma;C64;
Hereditary clear cell renal cell carcinoma;C64;
Hereditary clear cell renal cell carcinoma;C64;
Hereditary clear cell renal cell carcinoma;C64;
Hereditary clear cell renal cell carcinoma;C64;
Hereditary clear cell renal cell carcinoma;C64;
Hereditary clear cell renal cell carcinoma;C64;
Spinocerebellar ataxia type 40;G11.8;8A03.16
Spinocerebellar ataxia type 38;G11.8;8A03.16
Microcephaly-short stature-intellectual disability-facial dysmorphism syndrome;Q87.1;
Autosomal recessive severe congenital neutropenia due to JAGN1 deficiency;;
Nail and teeth abnormalities-marginal palmoplantar keratoderma-oral hyperpigmentation syndrome;Q82.8;
Mucolipidosis type III alpha/beta;E77.0;5C56.20
Mucolipidosis type III gamma;E77.0;5C56.20
X-linked intellectual disability-limb spasticity-retinal dystrophy-diabetes insipidus syndrome;;
Microcephaly-complex motor and sensory axonal neuropathy syndrome;G60.0;
Progressive myoclonic epilepsy type 8;G40.3;
Colobomatous microphthalmia-rhizomelic dysplasia syndrome;Q87.5;
Congenital myopathy with myasthenic-like onset;G71.2;
TOR1AIP1-related limb-girdle muscular dystrophy;G71.0;
STING-associated vasculopathy with onset in infancy;M35.8;
Combined immunodeficiency due to OX40 deficiency;D81.8;
Primary immunodeficiency with post-measles-mumps-rubella vaccine viral infection;D84.8;
Primary immunodeficiency with post-measles-mumps-rubella vaccine viral infection;D84.8;
Scapuloperoneal spinal muscular atrophy;G12.1;8B61.4
X-linked scapuloperoneal muscular dystrophy;G71.0;8C70.5
Autosomal recessive spastic paraplegia type 57;G11.4;8B44.01
Progressive encephalopathy with leukodystrophy due to DECR deficiency;G31.8;
Orofaciodigital syndrome type 14;Q87.0;LD25.00
Autosomal dominant Charcot-Marie-Tooth disease type 2Y;G60.0;8C20.1
Progressive myoclonic epilepsy type 7;G40.3;8A61.41
Keppen-Lubinsky syndrome;E88.1;
CIDEC-related familial partial lipodystrophy;E88.1;5A44
LIPE-related familial partial lipodystrophy;E88.1;5A44
Short stature-advanced bone age-early-onset osteoarthritis syndrome;M89.8;
Autosomal dominant Charcot-Marie-Tooth disease type 2 due to TFG mutation;G60.0;
Lethal neonatal spasticity-epileptic encephalopathy syndrome;G40.4;
Colobomatous optic disc-macular atrophy-chorioretinopathy syndrome;Q14.8;
COG2-CDG;E77.8;5C54.2
X-linked microcephaly-growth retardation-prognathism-cryptorchidism syndrome;Q87.8;
Progeroid features-hepatocellular carcinoma predisposition syndrome;C22.0;
Chronic atrial and intestinal dysrhythmia syndrome;K59.8;
Autosomal recessive intermediate Charcot-Marie-Tooth disease type D;G60.0;
Intrauterine growth restriction-short stature-early adult-onset diabetes syndrome;Q87.1;
Intellectual disability-expressive aphasia-facial dysmorphism syndrome;Q87.0;
Autoimmune lymphoproliferative syndrome due to CTLA4 haploinsuffiency;D84.8;
Periodic fever-infantile enterocolitis-autoinflammatory syndrome;E85.0;
Thrombomodulin-related bleeding disorder;D68.3;
Cataract-growth hormone deficiency-sensory neuropathy-sensorineural hearing loss-skeletal dysplasia syndrome;E88.8;
Microcephalic primordial dwarfism-insulin resistance syndrome;Q87.1;
Microcephalic primordial dwarfism-insulin resistance syndrome;Q87.1;
Familial atrial tachyarrhythmia-infra-Hisian cardiac conduction disease;I45.8;
Retinitis pigmentosa-juvenile cataract-short stature-intellectual disability syndrome;Q87.8;
Combined immunodeficiency-enteropathy spectrum;Q82.8;
Combined immunodeficiency-enteropathy spectrum;Q82.8;
Non-progressive predominantly posterior cavitating leukoencephalopathy with peripheral neuropathy;G93.4;
Pseudoxanthoma elasticum-like skin manifestations with retinitis pigmentosa;Q82.8;
Autosomal recessive primary immunodeficiency with defective spontaneous natural killer cell cytotoxicity;D84.8;
MYH7-related late-onset scapuloperoneal muscular dystrophy;;
Ketoacidosis due to monocarboxylate transporter-1 deficiency;E88.8;
RARS-related autosomal recessive hypomyelinating leukodystrophy;E75.2;
Steel syndrome;Q87.5;
PCNA-related progressive neurodegenerative photosensitivity syndrome;G11.3;
STAT3-related early-onset multisystem autoimmune disease;M35.8;
Fatty acyl-CoA reductase 1 deficiency;E71.3;
Severe autosomal recessive macrothrombocytopenia;D69.4;
Severe autosomal recessive macrothrombocytopenia;D69.4;
PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome due to a point mutation;G40.4;
GCGR-related hyperglucagonemia;E16.3;
Early-onset myopathy-areflexia-respiratory distress-dysphagia syndrome;G71.2;
KCNQ2-related epileptic encephalopathy;G40.4;
PDE4D haploinsufficiency syndrome;Q87.8;
Fatal congenital hypertrophic cardiomyopathy due to glycogen storage disease;E74.0;
Lethal fetal cerebrorenogenitourinary agenesis/hypoplasia syndrome;Q87.8;
Autosomal dominant myopia-midfacial retrusion-sensorineural hearing loss-rhizomelic dysplasia syndrome;Q87.5;
Interstitial lung disease due to SP-C deficiency;J84.8;
Interstitial lung disease due to ABCA3 deficiency;J84.8;
Severe early-onset pulmonary alveolar proteinosis due to MARS deficiency;J84.0;
Familial colorectal cancer Type X;C18.0;
Familial colorectal cancer Type X;C18.1;
Familial colorectal cancer Type X;C18.2;
Familial colorectal cancer Type X;C18.3;
Familial colorectal cancer Type X;C18.4;
Familial colorectal cancer Type X;C18.5;
Familial colorectal cancer Type X;C18.6;
Familial colorectal cancer Type X;C18.7;
Familial colorectal cancer Type X;C18.0;
Familial colorectal cancer Type X;C18.1;
Familial colorectal cancer Type X;C18.2;
Familial colorectal cancer Type X;C18.3;
Familial colorectal cancer Type X;C18.4;
Familial colorectal cancer Type X;C18.5;
Familial colorectal cancer Type X;C18.6;
Familial colorectal cancer Type X;C18.7;
Familial colorectal cancer Type X;C18.0;
Familial colorectal cancer Type X;C18.1;
Familial colorectal cancer Type X;C18.2;
Familial colorectal cancer Type X;C18.3;
Familial colorectal cancer Type X;C18.4;
Familial colorectal cancer Type X;C18.5;
Familial colorectal cancer Type X;C18.6;
Familial colorectal cancer Type X;C18.7;
Ribose-5-P isomerase deficiency;G93.8;
Isolated sedoheptulokinase deficiency;E88.8;
L-ferritin deficiency;E88.0;
Early-onset posterior subcapsular cataract;H26.0;
Early-onset posterior subcapsular cataract;H26.0;
Early-onset posterior subcapsular cataract;H26.0;
Early-onset posterior subcapsular cataract;H26.0;
Early-onset posterior subcapsular cataract;H26.0;
Early-onset lamellar cataract;H26.8;
Early-onset lamellar cataract;H26.8;
Early-onset lamellar cataract;H26.8;
Early-onset lamellar cataract;H26.8;
Early-onset lamellar cataract;H26.8;
Early-onset lamellar cataract;H26.8;
Early-onset lamellar cataract;H26.8;
Early-onset lamellar cataract;H26.8;
Early-onset lamellar cataract;H26.8;
Early-onset lamellar cataract;H26.8;
Early-onset lamellar cataract;H26.8;
Non-specific early-onset epileptic encephalopathy;G40.4;
Non-specific early-onset epileptic encephalopathy;G40.4;
Non-specific early-onset epileptic encephalopathy;G40.4;
Non-specific early-onset epileptic encephalopathy;G40.4;
Non-specific early-onset epileptic encephalopathy;G40.4;
Non-specific early-onset epileptic encephalopathy;G40.4;
Non-specific early-onset epileptic encephalopathy;G40.4;
Non-specific early-onset epileptic encephalopathy;G40.4;
Non-specific early-onset epileptic encephalopathy;G40.4;
Non-specific early-onset epileptic encephalopathy;G40.4;
Non-specific early-onset epileptic encephalopathy;G40.4;
Non-specific early-onset epileptic encephalopathy;G40.4;
Non-specific early-onset epileptic encephalopathy;G40.4;
Non-specific early-onset epileptic encephalopathy;G40.4;
Non-specific early-onset epileptic encephalopathy;G40.4;
Non-specific early-onset epileptic encephalopathy;G40.4;
Non-specific early-onset epileptic encephalopathy;G40.4;
Non-specific early-onset epileptic encephalopathy;G40.4;
Non-specific early-onset epileptic encephalopathy;G40.4;
Non-specific early-onset epileptic encephalopathy;G40.4;
Non-specific early-onset epileptic encephalopathy;G40.4;
Non-specific early-onset epileptic encephalopathy;G40.4;
Non-specific early-onset epileptic encephalopathy;G40.4;
Non-specific early-onset epileptic encephalopathy;G40.4;
Non-specific early-onset epileptic encephalopathy;G40.4;
Non-specific early-onset epileptic encephalopathy;G40.4;
Non-specific early-onset epileptic encephalopathy;G40.4;
Non-specific early-onset epileptic encephalopathy;G40.4;
Non-specific early-onset epileptic encephalopathy;G40.4;
Non-specific early-onset epileptic encephalopathy;G40.4;
Non-specific early-onset epileptic encephalopathy;G40.4;
Non-specific early-onset epileptic encephalopathy;G40.4;
Non-specific early-onset epileptic encephalopathy;G40.4;
Non-specific early-onset epileptic encephalopathy;G40.4;
Non-specific early-onset epileptic encephalopathy;G40.4;
Non-specific early-onset epileptic encephalopathy;G40.4;
Non-specific early-onset epileptic encephalopathy;G40.4;
Non-specific early-onset epileptic encephalopathy;G40.4;
Non-specific early-onset epileptic encephalopathy;G40.4;
Non-specific early-onset epileptic encephalopathy;G40.4;
Non-specific early-onset epileptic encephalopathy;G40.4;
Non-specific early-onset epileptic encephalopathy;G40.4;
Non-specific early-onset epileptic encephalopathy;G40.4;
Non-specific early-onset epileptic encephalopathy;G40.4;
Non-specific early-onset epileptic encephalopathy;G40.4;
Non-specific early-onset epileptic encephalopathy;G40.4;
Non-specific early-onset epileptic encephalopathy;G40.4;
Non-specific early-onset epileptic encephalopathy;G40.4;
Sporadic porphyria cutanea tarda;E80.1;5C58.10
Familial porphyria cutanea tarda;E80.1;5C58.10
Familial porphyria cutanea tarda;E80.1;5C58.10
Charcot-Marie-Tooth disease type 2S;G60.0;
46,XY disorder of sex development due to testicular 17,20-desmolase deficiency;E25.0;
46,XY disorder of sex development due to testicular 17,20-desmolase deficiency;E25.0;
NDE1-related microhydranencephaly;Q04.8;
NUT midline carcinoma;C80.9;
NUT midline carcinoma;C80.9;
X-linked erythropoietic protoporphyria;E80.0;
Postural orthostatic tachycardia syndrome due to NET deficiency;I95.1;
PGM3-CDG;E77.8;
DNAJB2-related Charcot-Marie-Tooth disease type 2;G60.0;
Ventriculomegaly-cystic kidney disease;Q04.8;
Mandibulofacial dysostosis with alopecia;Q75.4;
Combined oxidative phosphorylation defect type 23;E88.8;
46,XX ovarian dysgenesis-short stature syndrome;Q96.8;
Lethal fetal brain malformation-duodenal atresia-bilateral renal hypoplasia syndrome;Q87.8;
Cerebellar-facial-dental syndrome;Q87.0;
Cognitive impairment-coarse facies-heart defects-obesity-pulmonary involvement-short stature-skeletal dysplasia syndrome;Q87.8;
Autoimmune interstitial lung disease-arthritis syndrome;J84.8;
Autosomal dominant spastic paraplegia type 73;G11.4;8B44.00
Peeling skin-leukonychia-acral punctate keratoses-cheilitis-knuckle pads syndrome;Q82.8;
Combined oxidative phosphorylation defect type 24;E88.8;5C53.23
Autoimmune hemolytic anemia-autoimmune thrombocytopenia-primary immunodeficiency syndrome;;
Combined immunodeficiency due to LRBA deficiency;D81.8;4A01.21
3-methylglutaconic aciduria type 7;;
Juvenile-onset diabetes mellitus-central and peripheral neurodegeneration syndrome;G31.8;
Limb-girdle muscular dystrophy due to POMK deficiency;G71.0;8C70.41
NIK deficiency;D81.8;4A01.1Y
DOCK2 deficiency;D81.9;
Susceptibility to localized juvenile periodontitis;D71;
Autosomal dominant spastic paraplegia type 9A;G11.4;8B44.00
Autosomal dominant spastic paraplegia type 9A;G11.4;8B44.00
Autosomal dominant spastic paraplegia type 9B;G11.4;8B44.00
Autosomal recessive spastic paraplegia type 9B;G11.4;8B44.00
Mitochondrial pyruvate carrier deficiency;E74.4;5C53.0Y
Lipoyl transferase 2 deficiency;E88.8;
Polymerase proofreading-related adenomatous polyposis;D12.6;
Polymerase proofreading-related adenomatous polyposis;D12.6;
Hypomyelination-cerebellar atrophy-hypoplasia of the corpus callosum syndrome;E75.2;
Tremor-ataxia-central hypomyelination syndrome;E75.2;
Combined oxidative phosphorylation defect type 25;E88.8;5C53.23
Pigmentation defects-palmoplantar keratoderma-skin carcinoma syndrome;D04.8;
Autosomal dominant Charcot-Marie-Tooth disease type 2V;G60.0;
Klippel-Feil anomaly-myopathy-facial dysmorphism syndrome;Q76.1;
Progressive scapulohumeroperoneal distal myopathy;G71.0;
19p13.3 microduplication syndrome;Q92.3;
Spastic tetraplegia-thin corpus callosum-progressive postnatal microcephaly syndrome;Q02;
CAD-CDG;E77.8;5C54.2
Autosomal recessive brachyolmia;Q76.3;LD24.5Y
Progressive autosomal recessive ataxia-deafness syndrome;G11.1;
Isolated focal non-epidermolytic palmoplantar keratoderma;L98.8;
Isolated focal non-epidermolytic palmoplantar keratoderma;L98.8;
Regressive spondylometaphyseal dysplasia;Q77.8;
NON RARE IN EUROPE: Primary bile acid malabsorption;;
Symptomatic form of fragile X syndrome in female carriers;Q99.2;
Familial congenital nasolacrimal duct obstruction;Q10.5;LA14.14
Neurodevelopmental disorder-craniofacial dysmorphism-cardiac defect-skeletal anomalies syndrome due to a point mutation;Q87.8;
Congenital insensitivity to pain with severe intellectual disability;G60.8;
Autosomal recessive cerebellar ataxia due to CWF19L1 deficiency;G11.1;
Polyendocrine-polyneuropathy syndrome;E34.8;
Kuru;A81.8;8E01.1
Pleomorphic salivary gland adenoma;D11.0;
Pleomorphic salivary gland adenoma;D11.0;
NTHL1-related attenuated familial adenomatous polyposis;D12.6;
Infantile multisystem neurologic-endocrine-pancreatic disease;Q87.8;
Hereditary sensory neuropathy-deafness-dementia syndrome;G60.8;
X-linked myotubular myopathy-abnormal genitalia syndrome;Q99.8;
X-linked myotubular myopathy-abnormal genitalia syndrome;Q99.8;
Hereditary neuroendocrine tumor of small intestine;C17.9;
Polyglucosan body myopathy type 2;E74.0;
Autosomal dominant mitochondrial myopathy with exercise intolerance;G71.3;
Predisposition to invasive fungal disease due to CARD9 deficiency;D84.8;
Neonatal encephalomyopathy-cardiomyopathy-respiratory distress syndrome;E88.8;
Autosomal dominant intellectual disability-craniofacial anomalies-cardiac defects syndrome;Q87.8;
Progressive essential tremor-speech impairment-facial dysmorphism-intellectual disability-abnormal behavior syndrome;F78.1;
Syndromic sensorineural deafness due to combined oxidative phosphorylation defect;E88.8;
X-linked intellectual disability-short stature-overweight syndrome;Q87.8;LD90
Clear cell sarcoma of kidney;C64;
Clear cell sarcoma of kidney;C64;
Clear cell sarcoma of kidney;C64;
Clear cell sarcoma of kidney;C64;
Clear cell sarcoma of kidney;C64;
Clear cell sarcoma of kidney;C64;
X-linked intellectual disability-hypotonia-movement disorder syndrome;F78.8;LD90
Progressive myoclonic epilepsy type 9;G40.3;
Intellectual disability-macrocephaly-hypotonia-behavioral abnormalities syndrome;Q87.8;
Microcephaly-corpus callosum hypoplasia-intellectual disability-facial dysmorphism syndrome;Q87.0;
Microcephaly-intellectual disability-sensorineural hearing loss-epilepsy-abnormal muscle tone syndrome;Q02;
Megalencephaly-severe kyphoscoliosis-overgrowth syndrome;Q87.3;LD2C
ITPA-related lethal infantile neurological disorder with cataract and cardiac involvement;G40.4;
Complex lethal osteochondrodysplasia;Q78.8;
Progressive spondyloepimetaphyseal dysplasia-short stature-short fourth metatarsals-intellectual disability syndrome;Q87.8;
Multiple mitochondrial dysfunctions syndrome type 4;E88.8;
Macrocephaly-intellectual disability-neurodevelopmental disorder-small thorax syndrome;Q87.0;
NON RARE IN EUROPE: Specific language impairment;;
Spinocerebellar ataxia type 41;G11.2;
Spinocerebellar ataxia type 42;G11.8;
Ataxia-oculomotor apraxia type 4;G60.2;
Spondyloepiphyseal dysplasia, Stanescu type;Q77.7;
Autosomal recessive spastic paraplegia type 75;G11.4;
Craniofacial dysplasia-short stature-ectodermal anomalies-intellectual disability syndrome;Q87.8;
X-linked intellectual disability-cerebellar hypoplasia-spondylo-epiphyseal dysplasia syndrome;Q87.0;LD90
Spastic paraplegia-severe developmental delay-epilepsy syndrome;Q87.8;
Short stature-brachydactyly-obesity-global developmental delay syndrome;Q87.8;
NON RARE IN EUROPE: Infantile capillary hemangioma;;
NON RARE IN EUROPE: Infantile capillary hemangioma;;
NON RARE IN EUROPE: Infantile capillary hemangioma;;
Intellectual disability syndrome due to a DYRK1A point mutation;Q87.8;LD90.Y
BENTA disease;D81.8;
NEK9-related lethal skeletal dysplasia;Q77.2;
Neonatal alloimmune neutropenia;P61.5;KA8E
Primary dystonia, DYT27 type;G24.1;
COG6-CGD;E77.8;
Fever-associated acute infantile liver failure syndrome;K72.0;
Fever-associated acute infantile liver failure syndrome;K72.0;
Basel-Vanagaite-Smirin-Yosef syndrome;Q87.8;
Familial gastric type 1 neuroendocrine tumor;C16.9;
Familial cavitary optic disc anomaly;Q14.2;
Symptomatic form of hemochromatosis type 1;;
Symptomatic form of hemochromatosis type 1;;
Fetal encasement syndrome;Q87.8;
Class I glucose-6-phosphate dehydrogenase deficiency;D55.0;
Exercise-induced malignant hyperthermia;T88.3;NF06.0
Severe intellectual disability-corpus callosum agenesis-facial dysmorphism-cerebellar ataxia syndrome;Q87.0;
TMEM199-CDG;E77.8;
Martinique crinkled retinal pigment epitheliopathy;H35.5;
Autosomal recessive spastic paraplegia type 77;G11.4;
Familial patent arterial duct;Q25.8;
Familial patent arterial duct;Q25.8;
Autosomal dominant Charcot-Marie-Tooth disease type 2Z;G60.0;
Autosomal recessive Charcot-Marie-Tooth disease type 2X;G60.0;
Neonatal severe cardiopulmonary failure due to mitochondrial methylation defect;E88.8;
Macrocephaly-intellectual disability-left ventricular non compaction syndrome;Q87.8;
Acute infantile liver failure-cerebellar ataxia-peripheral sensory motor neuropathy syndrome;G11.0;
LIMS2-related limb-girdle muscular dystrophy;;
Autosomal dominant thrombocytopenia with platelet secretion defect;D69.4;
Childhood-onset progressive contractures-limb-girdle weakness-muscle dystrophy syndrome;G71.0;
Seizures-scoliosis-macrocephaly syndrome;E77.8;
VPS11-related autosomal recessive hypomyelinating leukodystrophy;G93.8;
Facial dysmorphism-developmental delay-behavioral abnormalities syndrome due to WAC point mutation;Q87.8;
SMARCA4-deficient sarcoma of thorax;C49.3;
Tubulinopathy-associated dysgyria;Q04.8;
Tubulinopathy-associated dysgyria;Q04.8;
Tubulinopathy-associated dysgyria;Q04.8;
Severe hypotonia-psychomotor developmental delay-strabismus-cardiac septal defect syndrome;G71.2;
Intellectual disability-epilepsy-extrapyramidal syndrome;G93.8;
Microcephalic cortical malformations-short stature due to RTTN deficiency;Q02;
Cryptogenic multifocal ulcerous stenosing enteritis;K63.8;DA94.02
Chronic enteropathy associated with SLCO2A1 gene;K63.8;
Autosomal recessive spastic paraplegia type 74;G11.4;
Isolated generalized anhidrosis with normal sweat glands;L98.8;
Colobomatous macrophthalmia-microcornea syndrome;Q15.8;
White-Sutton syndrome;Q87.0;
CCDC115-CDG;E77.8;
SLC39A8-CDG;E77.8;
Rhizomelic chondrodysplasia punctata type 5;Q77.3;LD24.04
Severe primary trimethylaminuria;E88.8;
BVES-related limb-girdle muscular dystrophy;G71.0;
Autosomal dominant distal axonal motor neuropathy-myofibrillar myopathy syndrome;G60.8;
Erythrokeratodermia-cardiomyopathy syndrome;I42.0;
Hereditary pediatric Behçet-like disease;;
Hereditary pediatric Behçet-like disease;;
Hereditary pediatric Behçet-like disease;;
Combined immunodeficiency due to TFRC deficiency;D81.8;
Autosomal dominant preaxial polydactyly-upperback hypertrichosis syndrome;Q87.2;
Micrognathia-recurrent infections-behavioral abnormalities-mild intellectual disability syndrome;Q87.8;
PMP2-related Charcot-Marie-Tooth disease type 1;G60.0;
Congenital generalized hypercontractile muscle stiffness syndrome;G71.2;
IL21-related infantile inflammatory bowel disease;D84.8;
Postnatal microcephaly-infantile hypotonia-spastic diplegia-dysarthria-intellectual disability syndrome;G11.4;
Combined oxidative phosphorylation defect type 26;E88.8;
Pediatric multiple sclerosis;G35;
Pediatric multiple sclerosis;G35;
Nodular fasciitis;M79.8;FB51.2
Nodular fasciitis;M79.8;FB51.2
Pontine autosomal dominant microangiopathy with leukoencephalopathy;I67.8;
Combined oxidative phosphorylation defect type 27;E88.8;
Cytosolic phospholipase-A2 alpha deficiency associated bleeding disorder;D69.1;
Progressive microcephaly-seizures-cortical blindness-developmental delay syndrome;Q02;
PMP22-RAI1 contiguous gene duplication syndrome;Q92.3;
Kosaki overgrowth syndrome;Q87.3;LD2C
Autosomal recessive mendelian susceptibility to mycobacterial diseases due to complete RORgamma receptor deficiency;D84.8;
Palatal anomalies-widely spaced teeth-facial dysmorphism-developmental delay syndrome;Q87.8;
Combined oxidative phosphorylation defect type 29;E88.8;
Combined oxidative phosphorylation defect type 30;E88.8;
Lethal left ventricular non-compaction-seizures-hypotonia-cataract-developmental delay syndrome;E88.8;
Hereditary sensory and autonomic neuropathy type 8;G60.8;
Progressive familial intrahepatic cholestasis type 5;K76.8;5C58.03
Progressive familial intrahepatic cholestasis type 4;K76.8;
MYO5B-related progressive familial intrahepatic cholestasis;K76.8;5C58.03
Lethal hydranencephaly-diaphragmatic hernia syndrome;Q87.8;
MSH3-related attenuated familial adenomatous polyposis;D12.6;2B90.Y
High grade B-cell lymphoma with MYC and/ or BCL2 and/or BCL6 rearrangement;C85.7;
High grade B-cell lymphoma with MYC and/ or BCL2 and/or BCL6 rearrangement;C85.7;
High grade B-cell lymphoma with MYC and/ or BCL2 and/or BCL6 rearrangement;C85.7;
Isolated neonatal sclerosing cholangitis;K83.0;
POGLUT1-related limb-girdle muscular dystrophy R21;G71.0;
Hereditary thrombocytopenia with early-onset myelofibrosis;D69.4;
Recurrent metabolic encephalomyopathic crises-rhabdomyolysis-cardiac arrhythmia-intellectual disability syndrome;G31.8;
X-linked female restricted facial dysmorphism-short stature-choanal atresia-intellectual disability;Q87.8;
Global developmental delay-visual anomalies-progressive cerebellar atrophy-truncal hypotonia syndrome;Q87.8;
X-linked intellectual disability-global development delay-facial dysmorphism-sacral caudal remnant syndrome;Q87.0;LD90
PYCR2-related microcephaly-progressive leukoencephalopathy;Q87.8;
Familial Chilblain lupus;L93.2;
Familial Chilblain lupus;L93.2;
Familial Chilblain lupus;L93.2;
USP18 deficiency;Q04.8;
Familial schizencephaly;Q04.6;LA05.61
HTRA1-related autosomal dominant cerebral small vessel disease;I67.8;
Adenylosuccinate synthetase-like 1-related distal myopathy;G71.0;
X-linked keloid scarring-reduced joint mobility-increased optic cup-to-disc ratio syndrome;Q87.5;
Acquired schizencephaly;Q04.6;LA05.61
Acquired schizencephaly;Q04.6;LA05.61
Acquired schizencephaly;Q04.6;LA05.61
CLCN4-related X-linked intellectual disability syndrome;F78.1;LD90
EMILIN-1-related connective tissue disease;G60.8;
MFF-related encephalopathy due to mitochondrial and peroxisomal fission defect;E88.8;5C5Y
Prenatal-onset spinal muscular atrophy with congenital bone fractures;G12.8;
Prenatal-onset spinal muscular atrophy with congenital bone fractures;G12.8;
Congenital muscular dystrophy-respiratory failure-skin abnormalities-joint hyperlaxity syndrome;G71.0;
Macrothrombocytopenia-lymphedema-developmental delay-facial dysmorphism-camptodactyly syndrome;D69.49;
Autosomal dominant Charcot-Marie-Tooth disease type 2 due to DGAT2 mutation;G60.0;
Pierpont syndrome;Q87.8;
Microcephaly-congenital cataract-psoriasiform dermatitis syndrome;E88.8;
Female infertility due to oocyte meiotic arrest;N97.8;
Female infertility due to oocyte meiotic arrest;N97.8;
Female infertility due to oocyte meiotic arrest;N97.8;
Female infertility due to oocyte meiotic arrest;N97.8;
Split-foot malformation-mesoaxial polydactyly syndrome;Q74.8;
Osteofibrous dysplasia;M85.0;
Autosomal dominant Charcot-Marie-Tooth disease type 2W;G60.0;
SIX2-related frontonasal dysplasia;Q75.8;
Autosomal recessive spastic paraplegia type 76;G11.4;
Global developmental delay-neuro-ophthalmological abnormalities-seizures-intellectual disability syndrome;F84.8;
Transketolase deficiency;E88.8;5C51.0
Severe growth deficiency-strabismus-extensive dermal melanocytosis-intellectual disability syndrome;Q87.8;
TBCK-related intellectual disability syndrome;Q87.0;
Early-onset epilepsy-intellectual disability-brain anomalies syndrome;E77.8;
TELO2-related intellectual disability-neurodevelopmental disorder;Q87.8;
DDX41-related hematologic malignancy predisposition syndrome;C96.7;
Distal myopathy, Tateyama type;G71.0;
Vibratory urticaria;L50.4;EB01.Y
RERE-related neurodevelopmental syndrome;Q87.8;
MIRAGE syndrome;D46.7;
Retinitis pigmentosa-hearing loss-premature aging-short stature-facial dysmorphism syndrome;Q87.8;
DIAPH1-related sensorineural hearing loss-thrombocytopenia syndrome;H90.3;
Infantile-onset generalized dyskinesia with orofacial involvement;G24.8;
Childhood-onset benign chorea with striatal involvement;G25.5;
Squamous cell carcinoma of the hypopharynx;C12;2B6D.0
Squamous cell carcinoma of the hypopharynx;C13.8;2B6D.0
Squamous cell carcinoma of the hypopharynx;C13.0;2B6D.0
Squamous cell carcinoma of the hypopharynx;C13.2;2B6D.0
Squamous cell carcinoma of the hypopharynx;C12;2B6D.0
Squamous cell carcinoma of the hypopharynx;C13.8;2B6D.0
Squamous cell carcinoma of the hypopharynx;C13.0;2B6D.0
Squamous cell carcinoma of the hypopharynx;C13.2;2B6D.0
Squamous cell carcinoma of the hypopharynx;C12;2B6D.0
Squamous cell carcinoma of the hypopharynx;C13.8;2B6D.0
Squamous cell carcinoma of the hypopharynx;C13.0;2B6D.0
Squamous cell carcinoma of the hypopharynx;C13.2;2B6D.0
Squamous cell carcinoma of the larynx;C32.8;
Squamous cell carcinoma of the larynx;C32.8;
Squamous cell carcinoma of the larynx;C32.8;
Charcot-Marie-Tooth disease type 2T;G60.0;
9q33.3q34.11 microdeletion syndrome;Q93.5;
9q33.3q34.11 microdeletion syndrome;Q93.5;
C11ORF73-related autosomal recessive hypomyelinating leukodystrophy;G93.8;
Early-onset progressive diffuse brain atrophy-microcephaly-muscle weakness-optic atrophy syndrome;G93.4;
Kyphosis-lateral tongue atrophy-myofibrillar myopathy syndrome;G71.2;
Kyphoscoliosis-lateral tongue atrophy-hereditary spastic paraplegia syndrome;G11.4;
EVEN-plus syndrome;Q87.8;
Early-onset progressive encephalopathy-spastic ataxia-distal spinal muscular atrophy syndrome;G31.8;
Ocular anomalies-axonal neuropathy-developmental delay syndrome;E88.8;
MME-related autosomal dominant Charcot Marie Tooth disease type 2;G60.0;
Spinocerebellar ataxia type 43;G11.2;8A03.16
Childhood-onset basal ganglia degeneration syndrome;G31.8;
Menstrual cycle-dependent periodic fever;N94.8;
Aquagenic palmoplantar keratoderma;L85.1;EK5Y
LRP5-related primary osteoporosis;M85.8;
Mirror-image polydactyly;Q74.8;
Short rib-polydactyly syndrome type 5;Q77.2;
MYBPC1-related autosomal recessive non-lethal arthrogryposis multiplex congenita syndrome;Q74.3;
16p13.2 microdeletion syndrome;;
Infantile-onset periodic fever-panniculitis-dermatosis syndrome;D89.8;
Tall stature-intellectual disability-renal anomalies syndrome;Q87.3;LD2C
Multinucleated neurons-anhydramnios-renal dysplasia-cerebellar hypoplasia-hydranencephaly syndrome;Q87.8;
Early-onset progressive encephalopathy-hearing loss-pons hypoplasia-brain atrophy syndrome;Q07.8;
Brain malformations-musculoskeletal abnormalities-facial dysmorphism-intellectual disability syndrome;Q87.8;
Microcephaly-corpus callosum and cerebellar vermis hypoplasia-facial dysmorphism-intellectual disability syndrom;Q87.0;
SIN3A-related intellectual disability syndrome due to a point mutation;F79;
SIN3A-related intellectual disability syndrome due to a point mutation;F79;
Childhood-onset motor and cognitive regression syndrome with extrapyramidal movement disorder;G31.8;
X-linked external auditory canal atresia-dilated internal auditory canal-facial dysmorphism syndrome;H91.8;
Squamous cell carcinoma of the nasal cavity and paranasal sinuses;D02.3;
Squamous cell carcinoma of the nasal cavity and paranasal sinuses;D02.3;
Squamous cell carcinoma of the nasal cavity and paranasal sinuses;D02.3;
Squamous cell carcinoma of the oropharynx;C10.8;2B6A.0
Squamous cell carcinoma of the oropharynx;C10.8;2B6A.0
Squamous cell carcinoma of the oropharynx;C10.8;2B6A.0
Squamous cell carcinoma of salivary glands;C06.9;
Squamous cell carcinoma of salivary glands;C07;
Squamous cell carcinoma of salivary glands;C08.8;
Squamous cell carcinoma of salivary glands;C06.9;
Squamous cell carcinoma of salivary glands;C07;
Squamous cell carcinoma of salivary glands;C08.8;
Squamous cell carcinoma of salivary glands;C06.9;
Squamous cell carcinoma of salivary glands;C07;
Squamous cell carcinoma of salivary glands;C08.8;
Squamous cell carcinoma of salivary glands;C06.9;
Squamous cell carcinoma of salivary glands;C07;
Squamous cell carcinoma of salivary glands;C08.8;
Polyhydramnios-megalencephaly-symptomatic epilepsy syndrome;G40.4;
Severe neurodevelopmental disorder with feeding difficulties-stereotypic hand movement-bilateral cataract;F84.8;
Osteosclerotic metaphyseal dysplasia;Q78.5;
Squamous cell carcinoma of the oral cavity;C06.9;
Squamous cell carcinoma of the oral cavity;C06.9;
Squamous cell carcinoma of the oral cavity;C06.9;
Squamous cell carcinoma of the lip;C00.1;2B60.1
Squamous cell carcinoma of the lip;C00.1;2B60.1
Squamous cell carcinoma of the lip;C00.1;2B60.1
Mitochondrial myopathy-cerebellar ataxia-pigmentary retinopathy syndrome;G71.3;
Metopic ridging-ptosis-facial dysmorphism syndrome;;
STAG1-related intellectual disability-facial dysmorphism-gastroesophageal reflux syndrome;Q87.0;
Alkaline ceramidase 3 deficiency;E75.2;
Cerebellar ataxia with neuropathy and bilateral vestibular areflexia syndrome;G11.2;
Severe combined immunodeficiency due to LAT deficiency;D81.2;4A01.10
Combined immunodeficiency due to Moesin deficiency;D81.8;4A01.1Y
3-methylglutaconic aciduria type 8;E71.1;5C50.E0
3-methylglutaconic aciduria type 9;E71.1;5C50.E0
Combined immunodeficiency due to GINS1 deficiency;D81.8;4A01.1Y
Early-onset seizures-distal limb anomalies-facial dysmorphism-global developmental delay syndrome;Q87.8;
Psychomotor regression-oculomotor apraxia-movement disorder-nephropathy syndrome;E83.2;
Mucopolysaccharidosis-like syndrome with congenital heart defects and hematopoietic disorders;Q87.8;
CDKL5-deficiency disorder;G40.4;
Stromme syndrome;Q13.8;
Familial steroid-resistant nephrotic syndrome with adrenal insufficiency;E88.8;
Autosomal recessive complex spastic paraplegia due to Kennedy pathway dysfunction;G11.4;
Gabriele-de Vries syndrome;Q87.8;
MEPAN syndrome;E88.8;
Cleft lip and palate-craniofacial dysmorphism-congenital heart defect-hearing loss syndrome;Q87.8;
8q24.3 microdeletion syndrome;Q93.5;
Intellectual disability-cardiac anomalies-short stature-joint laxity syndrome;Q87.8;
Oral-facial-digital syndrome with short stature and brachymesophalangy;Q87.0;
Intrauterine growth restriction-congenital multiple café-au-lait macules-increased sister chromatid exchange syndrome;Q87.1;
Intrauterine growth restriction-congenital multiple café-au-lait macules-increased sister chromatid exchange syndrome;Q87.1;
Hyperphenylalaninemia due to DNAJC12 deficiency;E70.1;
Intermediate epidermolysis bullosa simplex with cardiomyopathy;Q81.0;
Skeletal dysplasia-T-cell immunodeficiency-developmental delay syndrome;Q87.8;
Congenital progressive bone marrow failure-B-cell immunodeficiency-skeletal dysplasia syndrome;Q87.8;
Chronic lymphoproliferative disorder of natural killer cells;C91.7;2A90.2
Autosomal recessive epidermolytic ichthyosis;Q80.8;EC20.03
Autosomal recessive spastic paraplegia type 78;G11.4;
Intellectual disability-seizures-abnormal gait-facial dysmorphism syndrome;Q87.0;
Autosomal recessive anterior segment dysgenesis;Q13.8;
Xq25 microduplication syndrome;Q98.8;
Proximal myopathy with focal depletion of mitochondria;G72.8;
Spastic paraplegia-intellectual disability-nystagmus-obesity syndrome;G11.4;
NON RARE IN EUROPE: Non rare obesity;;
Dystonia-parkinsonism-hypermanganesemia syndrome;E83.8;
Autosomal recessive axonal Charcot-Marie-Tooth disease due to copper metabolism defect;G60.0;
Autosomal dominant Charcot-Marie-Tooth disease type 2DD;G60.0;
PLAA-associated neurodevelopmental disorder;Q87.8;
Congenital cataract-severe neonatal hepatopathy-global developmental delay syndrome;K83.1;
Congenital vertebral-cardiac-renal anomalies syndrome;Q87.8;
Congenital vertebral-cardiac-renal anomalies syndrome;Q87.8;
Congenital vertebral-cardiac-renal anomalies syndrome;Q87.8;
Microcephaly-facial dysmorphism-ocular anomalies-multiple congenital anomalies syndrome;Q87.8;
LAMA5-related multisystemic syndrome;M79.8;
Infantile hypotonia-oculomotor anomalies-hyperkinetic movements-developmental delay syndrome;F84.8;
Severe myopia-generalized joint laxity-short stature syndrome;Q87.5;
Diaphragmatic hernia-short bowel-asplenia syndrome;Q87.8;
NKX6-2-related autosomal recessive hypomyelinating leukodystrophy;E75.2;
Non-specific syndromic intellectual disability;F84.8;
Non-specific syndromic intellectual disability;F84.8;
Non-specific syndromic intellectual disability;F84.8;
Non-specific syndromic intellectual disability;F84.8;
Non-specific syndromic intellectual disability;F84.8;
Non-specific syndromic intellectual disability;F84.8;
Non-specific syndromic intellectual disability;F84.8;
Non-specific syndromic intellectual disability;F84.8;
Non-specific syndromic intellectual disability;F84.8;
Non-specific syndromic intellectual disability;F84.8;
Non-specific syndromic intellectual disability;F84.8;
Non-specific syndromic intellectual disability;F84.8;
Non-specific syndromic intellectual disability;F84.8;
Non-specific syndromic intellectual disability;F84.8;
Non-specific syndromic intellectual disability;F84.8;
Non-specific syndromic intellectual disability;F84.8;
Non-specific syndromic intellectual disability;F84.8;
Non-specific syndromic intellectual disability;F84.8;
Non-specific syndromic intellectual disability;F84.8;
Non-specific syndromic intellectual disability;F84.8;
Non-specific syndromic intellectual disability;F84.8;
Non-specific syndromic intellectual disability;F84.8;
Non-specific syndromic intellectual disability;F84.8;
Non-specific syndromic intellectual disability;F84.8;
Non-specific syndromic intellectual disability;F84.8;
Non-specific syndromic intellectual disability;F84.8;
Non-specific syndromic intellectual disability;F84.8;
Non-specific syndromic intellectual disability;F84.8;
Non-specific syndromic intellectual disability;F84.8;
Non-specific syndromic intellectual disability;F84.8;
Non-specific syndromic intellectual disability;F84.8;
Non-specific syndromic intellectual disability;F84.8;
Non-specific syndromic intellectual disability;F84.8;
Non-specific syndromic intellectual disability;F84.8;
Non-specific syndromic intellectual disability;F84.8;
Non-specific syndromic intellectual disability;F84.8;
Non-specific syndromic intellectual disability;F84.8;
Non-specific syndromic intellectual disability;F84.8;
Non-specific syndromic intellectual disability;F84.8;
Non-specific syndromic intellectual disability;F84.8;
Non-specific syndromic intellectual disability;F84.8;
Non-specific syndromic intellectual disability;F84.8;
Non-specific syndromic intellectual disability;F84.8;
Non-specific syndromic intellectual disability;F84.8;
Non-specific syndromic intellectual disability;F84.8;
Non-specific syndromic intellectual disability;F84.8;
Non-specific syndromic intellectual disability;F84.8;
Non-specific syndromic intellectual disability;F84.8;
Non-specific syndromic intellectual disability;F84.8;
Non-specific syndromic intellectual disability;F84.8;
Non-specific syndromic intellectual disability;F84.8;
Non-specific syndromic intellectual disability;F84.8;
Non-specific syndromic intellectual disability;F84.8;
Non-specific syndromic intellectual disability;F84.8;
Non-specific syndromic intellectual disability;F84.8;
Non-specific syndromic intellectual disability;F84.8;
Non-specific syndromic intellectual disability;F84.8;
Non-specific syndromic intellectual disability;F84.8;
Non-specific syndromic intellectual disability;F84.8;
Non-specific syndromic intellectual disability;F84.8;
Non-specific syndromic intellectual disability;F84.8;
Non-specific syndromic intellectual disability;F84.8;
Non-specific syndromic intellectual disability;F84.8;
Non-specific syndromic intellectual disability;F84.8;
Non-specific syndromic intellectual disability;F84.8;
Non-specific syndromic intellectual disability;F84.8;
Non-specific syndromic intellectual disability;F84.8;
Non-specific syndromic intellectual disability;F84.8;
Non-specific syndromic intellectual disability;F84.8;
Non-specific syndromic intellectual disability;F84.8;
Non-specific syndromic intellectual disability;F84.8;
Non-specific syndromic intellectual disability;F84.8;
Non-specific syndromic intellectual disability;F84.8;
Non-specific syndromic intellectual disability;F84.8;
Non-specific syndromic intellectual disability;F84.8;
Non-specific syndromic intellectual disability;F84.8;
Non-specific syndromic intellectual disability;F84.8;
Non-specific syndromic intellectual disability;F84.8;
Non-specific syndromic intellectual disability;F84.8;
Non-specific syndromic intellectual disability;F84.8;
Non-specific syndromic intellectual disability;F84.8;
Non-specific syndromic intellectual disability;F84.8;
Non-specific syndromic intellectual disability;F84.8;
Non-specific syndromic intellectual disability;F84.8;
Non-specific syndromic intellectual disability;F84.8;
Hydrops-lactic acidosis-sideroblastic anemia-multisystemic failure syndrome;E88.8;
Hypohidrosis-electrolyte imbalance-lacrimal gland dysfunction-ichthyosis-xerostomia syndrome;N25.8;
Duane retraction syndrome with congenital deafness;H50.8;
Neurodevelopmental delay-seizures-ophthalmic anomalies-osteopenia-cerebellar atrophy syndrome;Q87.8;
NON RARE IN EUROPE: Exfoliation syndrome;;
Letrozole toxicity;T88.7;
17q24.2 microdeletion syndrome;Q93.5;
17q24.2 microdeletion syndrome;Q93.5;
Intellectual disability-autism-speech apraxia-craniofacial dysmorphism syndrome;Q87.0;
Male infertility due to acephalic spermatozoa;N46;
Male infertility due to acephalic spermatozoa;N46;
Immune dysregulation-inflammatory bowel disease-arthritis-recurrent infections-lymphopenia syndrome;D89.8;
Inflammatory bowel disease-recurrent sinopulmonary infections syndrome;D89.8;
Progressive dementia with neuroserpin inclusion bodies;G31.8;
RELA fusion-positive ependymoma;D43.0;
RELA fusion-positive ependymoma;D43.0;
KRT1-related diffuse nonepidermolytic keratoderma;Q82.8;
Familial apolipoprotein A5 deficiency;E78.3;
Familial lipase maturation factor 1 deficiency;E78.3;
Familial GPIHBP1 deficiency;E78.3;
B3GALT6-related spondylodysplastic Ehlers-Danlos syndrome;Q79.6;LD28.1Y
Myopathic Ehlers-Danlos syndrome;Q79.6;LD28.1Y
Classical-like Ehlers-Danlos syndrome type 2;Q79.6;
PLG-related hereditary angioedema with normal C1Inh;T78.3;4A00.14
Palmoplantar keratoderma-hereditary motor and sensory neuropathy syndrome;G60.0;
Palmoplantar keratoderma-hereditary motor and sensory neuropathy syndrome;G60.0;
X-linked lymphoproliferative disease due to SH2D1A deficiency;D82.8;
X-linked lymphoproliferative disease due to XIAP deficiency;D82.3;4A01.22
Combined immunodeficiency due to CD70 deficiency;D82.3;
Combined immunodeficiency due to ITK deficiency;D82.3;
Growth delay-intellectual disability-hepatopathy syndrome;K76.8;
Combined immunodeficiency due to CARMIL2 deficiency;D82.3;
GNB5-related intellectual disability-cardiac arrhythmia syndrome;I49.8;
Auditory neuropathy-optic atrophy syndrome;E88.8;
Isolated hyperchlorhidrosis;L98.8;
Optic atrophy-ataxia-peripheral neuropathy-global developmental delay syndrome;E88.8;
SYNGAP1-related developmental and epileptic encephalopathy;G40.4;LD90.Y
PRUNE1-related neurological syndrome;Q07.8;
Atypical hemolytic uremic syndrome with complement gene abnormality;D58.8;
Atypical hemolytic uremic syndrome with complement gene abnormality;D58.8;
Atypical hemolytic uremic syndrome with complement gene abnormality;D58.8;
Atypical hemolytic uremic syndrome with complement gene abnormality;D58.8;
Atypical hemolytic uremic syndrome with complement gene abnormality;D58.8;
Atypical hemolytic uremic syndrome with complement gene abnormality;D58.8;
Global developmental delay-alopecia-macrocephaly-facial dysmorphism-structural brain anomalies syndrome;E72.4;
RNF13-related severe early-onset epileptic encephalopathy;G40.4;
Congenital myopathy with reduced type 2 muscle fibers;G71.2;
Atypical Fanconi syndrome-neonatal hyperinsulinism syndrome;E34.8;
NAD(P)HX dehydratase deficiency;E88.8;
NAD(P)HX epimerase deficiency;E88.8;
FLNA-related X-linked myxomatous valvular dysplasia;Q23.8;
Early-onset familial hypoaldosteronism;E27.4;5A73
Pancreatic agenesis-holoprosencephaly syndrome;Q87.8;
Early-onset calcifying leukoencephalopathy-skeletal dysplasia;G93.4;
Oculoskeletodental syndrome;Q87.8;
Spastic ataxia-dysarthria due to glutaminase deficiency;E88.8;
Neonatal epileptic encephalopathy due to glutaminase deficiency;E88.8;
Heme oxygenase-1 deficiency;E88.8;
Congenital limbs-face contractures-hypotonia-developmental delay syndrome;Q87.8;
Autosomal recessive extra-oral halitosis;E88.8;
Anterior maxillary protrusion-strabismus-intellectual disability syndrome;F72.8;
TMEM94-associated congenital heart defect-facial dysmorphism-developmental delay syndrome;Q87.8;
Isolated anencephaly;Q00.0;LA00.0
Isolated anencephaly;Q00.0;LA00.0
Isolated exencephaly;Q00.0;LA00.0Y
Isolated exencephaly;Q00.0;LA00.0Y
Syndromic congenital sodium diarrhea;K59.8;
Syndromic congenital sodium diarrhea;K90.8;
Primary hypomagnesemia-refractory seizures-intellectual disability syndrome;E83.4;
Primary triglyceride deposit cardiomyovasculopathy;E75.5;
Combined oxidative phosphorylation defect type 39;E88.8;5C53.23
Infantile inflammatory bowel disease with neurological involvement;D89.8;
Craniosynostosis-microretrognathia-severe intellectual disability syndrome;Q87.8;
Calpain-3-related limb-girdle muscular dystrophy D4;G71.0;
CEBPE-associated autoinflammation-immunodeficiency-neutrophil dysfunction syndrome;D89.8;
Complement hyperactivation-angiopathic thrombosis-protein-losing enteropathy syndrome;D84.1;
Congenital autosomal recessive small-platelet thrombocytopenia;D69.4;
Resistance to thyroid hormone due to a mutation in thyroid hormone receptor alpha;E07.8;
Resistance to thyroid hormone due to a mutation in thyroid hormone receptor beta;E07.8;
Acute mast cell leukemia;C94.3;2A21.00
Chronic mast cell leukemia;C94.3;2A21.00
B-cell immunodeficiency-limb anomaly-urogenital malformation syndrome;Q87.8;
Microcystic stromal tumor;D27;
Multiple mitochondrial dysfunctions syndrome type 5;E88.8;5C53.21
Multiple mitochondrial dysfunctions syndrome type 6;E88.8;5C53.21
Congenital primary lymphedema of Gordon;Q82.0;BD93.0
Bartter syndrome type 5;E26.8;GB90.43
Galactose mutarotase deficiency;E88.8;5C51.4Y
QRSL1-related combined oxidative phosphorylation defect;E88.8;5C53.23
Posterior-predominant lissencephaly-broad flat pons and medulla-midline crossing defects syndrome;Q04.8;
Posterior-predominant lissencephaly-broad flat pons and medulla-midline crossing defects syndrome;Q04.8;
Blepharophimosis-ptosis-epicanthus inversus syndrome plus;Q10.3;LD44.30
Blepharophimosis-ptosis-epicanthus inversus syndrome type 1;Q10.3;LD21.Y
Blepharophimosis-ptosis-epicanthus inversus syndrome type 2;Q10.3;LD21.Y
Brachydactyly type B1;Q73.8;LD26.1
Infantile-onset pulmonary alveolar proteinosis-hypogammaglobulinemia;J84.0;
RFVT2-related riboflavin transporter deficiency;G12.1;LD2H.Y
RFVT3-related riboflavin transporter deficiency;G12.1;LD2H.Y
Microcephaly-micromelia syndrome;Q87.1;
Microcephaly-short stature-limb abnormalities syndrome;Q87.1;
WARS2-related combined oxidative phosphorylation defect;E88.8;5C53.2Y
Predisposition to severe viral infection due to IRF7 deficiency;D84.8;
Autosomal recessive mendelian susceptibility to mycobacterial diseases due to partial JAK1 deficiency;D84.8;4A00.2
Cathepsin A-related arteriopathy-strokes-leukoencephalopathy;I67.8;
Complete atrioventricular septal defect without ventricular hypoplasia;Q21.2;
Partial atrioventricular septal defect with ventricular hypoplasia;Q21.2;
Partial atrioventricular septal defect without ventricular hypoplasia;Q21.2;
SATB2-associated syndrome due to a pathogenic variant;Q87.8;
NLRC4-related familial cold autoinflammatory syndrome;D89.8;4A60.1
Lethal brain and heart developmental defects;Q87.8;
QRICH1-related intellectual disability-chondrodysplasia syndrome;Q87.8;
Cramp-fasciculation syndrome;G90.8;
Neu-laxova syndrome due to phosphoserine aminotransferase deficiency;;
Neu-laxova syndrome due to 3-phosphoglycerate dehydrogenase deficiency;;
B-lymphoblastic leukemia/lymphoma with recurrent genetic abnormality;C91.0;
B-lymphoblastic leukemia/lymphoma with recurrent genetic abnormality;C91.0;
B-lymphoblastic leukemia/lymphoma with recurrent genetic abnormality;C91.0;
B-lymphoblastic leukemia/lymphoma with recurrent genetic abnormality;C91.0;
B-lymphoblastic leukemia/lymphoma with recurrent genetic abnormality;C91.0;
B-lymphoblastic leukemia/lymphoma with recurrent genetic abnormality;C91.0;
B-lymphoblastic leukemia/lymphoma with recurrent genetic abnormality;C91.0;
"B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2)";C91.0;2A70.1
"B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2)";C91.0;2A70.1
"B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2)";C91.0;2A70.1
"B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2)";C91.0;2A70.1
"B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2)";C91.0;2A70.1
"B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2)";C91.0;2A70.1
"B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2)";C91.0;2A70.1
"B-lymphoblastic leukemia/lymphoma with t(v;11q23.3)";C91.0;XH8GG0
"B-lymphoblastic leukemia/lymphoma with t(v;11q23.3)";C91.0;2A70.Y
"B-lymphoblastic leukemia/lymphoma with t(12;21)(p13.2;q22.1)";C91.0;XH4KA2
"B-lymphoblastic leukemia/lymphoma with t(12;21)(p13.2;q22.1)";C91.0;2A70.Y
B-lymphoblastic leukemia/lymphoma with hyperdiploidy;C91.0;2A70.Y
B-lymphoblastic leukemia/lymphoma with hyperdiploidy;C91.0;2A70.Y
"B-lymphoblastic leukemia/lymphoma with t(5;14)(q31.1;q32.3)";C91.0;XH4ZL2
"B-lymphoblastic leukemia/lymphoma with t(5;14)(q31.1;q32.3)";C91.0;2A70.Y
"B-lymphoblastic leukemia/lymphoma with t(1;19)(q23;p13.3)";C91.0;XH3GU8
"B-lymphoblastic leukemia/lymphoma with t(1;19)(q23;p13.3)";C91.0;2A70.Y
"B-lymphoblastic leukemia/lymphoma with t(1;19)(q23;p13.3)";C91.0;XH3GU8
"B-lymphoblastic leukemia/lymphoma with t(1;19)(q23;p13.3)";C91.0;2A70.Y
Spondylometaphyseal dysplasia-corneal dystrophy syndrome;Q87.8;
Short stature-skeletal dysplasia-retinal degeneration-intellectual disability-sensorineural hearing loss syndrome;Q87.8;
PUM1-associated developmental disability-ataxia-seizure syndrome;G11.8;
Spinocerebellar ataxia type 46;G11.8;8A03.16
Spinocerebellar ataxia type 45;G11.8;8A03.16
"Mixed phenotype acute leukemia with t(9;22)(q34.1;q11.2)";C92.7;XH97B7
"Mixed phenotype acute leukemia with t(9;22)(q34.1;q11.2)";C92.7;2A61
"Mixed phenotype acute leukemia with t(9;22)(q34.1;q11.2)";C92.7;XH97B7
"Mixed phenotype acute leukemia with t(9;22)(q34.1;q11.2)";C92.7;2A61
GRIN2B-related developmental delay, intellectual disability and autism spectrum disorder;G93.4;
"Mixed phenotype acute leukemia with t(v;11q23.3)";C92.6;2A61
"Mixed phenotype acute leukemia with t(v;11q23.3)";C92.6;2A61
Linear hypopigmentation and craniofacial asymmetry with acral, ocular and brain anomalies;Q82.4;
Dystonia 28;G24.8;
Congenital-onset Steinert myotonic dystrophy;G71.1;8C71.0
Childhood-onset Steinert myotonic dystrophy;G71.1;8C71.0
Juvenile-onset Steinert myotonic dystrophy;G71.1;8C71.0
Adult-onset Steinert myotonic dystrophy;G71.1;8C71.0
Late-onset Steinert myotonic dystrophy;G71.1;8C71.0
Choanal atresia-athelia-hypothyroidism-delayed puberty-short stature syndrome;Q87.8;
PHIP-related behavioral problems-intellectual disability-obesity-dysmorphic features syndrome;Q87.8;
GNAO1-related developmental delay-seizures-movement disorder spectrum;G93.4;
TRAF7-associated heart defect-digital anomalies-facial dysmorphism-motor and speech delay syndrome;Q87.8;
Menke-Hennekam syndrome;Q87.8;
Timothy syndrome type 1;I49.8;BC65.0
Timothy syndrome type 2;I49.8;BC65.0
Atypical Timothy syndrome;I49.8;BC65.0
Antley-Bixler syndrome without genital anomaly or disorder of steroidogenesis;Q87.8;LD24.GY
VEXAS syndrome;M35.8;
IRF2BPL-related regressive neurodevelopmental disorder-dystonia-seizures syndrome;G93.8;
Oculocutaneous albinism type 8;E70.3;EC23.20
MTHFS-related developmental delay-microcephaly-short stature-epilepsy syndrome;E88.8;
Euthyroid dysprealbuminemic hyperthyroxinemia;E07.8;
Facial dysmorphism-hypertrichosis-epilepsy-intellectual disability/developmental delay-gingival overgrowth syndrome;Q87.8;
CHD3-related developmental delay-speech delay-intellectual disability-abnormalities of vision-facial dysmorphism syndrome;Q87.0;
STXBP1-related encephalopathy;G93.8;
Hypomyelination of early myelinating structures;G37.8;
Hereditary angioedema with normal C1Inh not related to F12 or PLG variant;T78.3;4A00.14
Hereditary angioedema with normal C1Inh not related to F12 or PLG variant;T78.3;4A00.14
Hereditary angioedema with normal C1Inh not related to F12 or PLG variant;T78.3;4A00.14
Hereditary angioedema with normal C1Inh not related to F12 or PLG variant;T78.3;4A00.14
NRXN1-related severe neurodevelopmental disorder-motor stereotypies-chronic constipation-sleep-wake cycle disturbance;G96.8;
CCNK-related neurodevelopmental disorder-severe intellectual disability-facial dysmorphism syndrome;G93.8;
KLHL7-related Bohring-Opitz-like/Cold-induced sweating-like overlap syndrome;;
KLHL7-related Bohring-Opitz-like syndrome;Q87.8;
KLHL7-related cold-induced sweating-like syndrome;;
KIAA1109-related early lethal congenital brain malformations-arthrogryposis syndrome;Q68.8;
CLCN6-related childhood-onset progressive neurodegeneration-peripheral neuropathy syndrome;G93.8;
CLCN6-related childhood-onset progressive neurodegeneration-peripheral neuropathy syndrome;G31.8;
Oculogastrointestinal-neurodevelopmental syndrome;Q87.8;
F12-associated cold autoinflammatory syndrome;L50.2;
Hereditary persistence of fetal hemoglobin-intellectual disability syndrome;Q87.8;
Neonatal-onset severe multisystemic autoinflammatory disease with increased IL18;;
SAMD9L-associated autoinflammatory syndrome;D89.8;
Immune deficiency due to impaired neutrophil phagocytosis and migration;;
Early-onset autoimmunity-autoinflammation-immunodeficiency syndrome;;
Familial hyperinflammatory lymphoproliferative immunodeficiency;D89.8;
CADINS disease;D81.8;
Developmental delay-immunodeficiency-leukoencephalopathy-hypohomocysteinemia syndrome;E72.1;
Non-syndromic non-specific multisutural craniosynostosis;Q75.0;LB70.0Y
Bartter syndrome type 2;E26.8;GB90.43
Primary hypomagnesemia-generalized seizures-intellectual disability-obesity syndrome;E83.4;
EGF-related primary hypomagnesemia with intellectual disability;E83.4;
Fibrosis-neurodegeneration-cerebral angiomatosis syndrome;G31.8;
X-linked severe syndromic thoracic aortic aneurysm and dissection;I71.1;
SBDS-related severe neonatal spondylometaphyseal dysplasia;Q77.7;LD24.4
Autosomal dominant spastic paraplegia type 80;G11.4;8B44.00
Autosomal recessive spastic paraplegia type 82;G11.4;8B44.01
Autosomal recessive spastic paraplegia type 83;G11.4;8B44.01
Autosomal recessive spastic paraplegia type 84;G11.4;8B44.01
Autosomal recessive spastic paraplegia type 85;G11.4;8B44.01
Autosomal recessive spastic paraplegia type 86;G11.4;8B44.01
Autosomal recessive spastic paraplegia type 87;G11.4;8B44.01
Spinocerebellar ataxia type 44;G11.4;8A03.16
Spinocerebellar ataxia type 48;G11.4;8A03.16
Spinocerebellar ataxia type 49;G11.4;8A03.16
Mitchell Syndrome;G60.8;
KDM3B-related intellectual disability-facial dysmorphism-short stature syndrome;Q87.8;
SLC12A2-related autosomal recessive neonatal-developmental delay-intellectual disability-feeding difficulty-sensorineural deafness syndrome;Q87.8;LD90.Y
SLC12A2-related autosomal dominant infantile-developmental delay-intellectual disability-sensorineural deafness syndrome;Q87.8;LD90.Y
